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Summary  
Algae-derived (algicolous) fungi has been regarded as an important source for discovery of novel 
bioactive natural products. As one of the most-widespread brown algae that occur in the shallow coastal 
regions of Baltic Sea, Fucus vesiculosus provides habitat for many invertebrates and vertebrates. 
However, the fungal community associated with F. vesiculosus has not been investigated for their 
chemical constituents or bioactivity potential. This Ph.D. project aimed to pursue a culture-based 
approach to isolate fungi from F. vesiculosus for discovery of new anticancer lead compounds. In order 
to induce the chemical space of fungi associated with Fucus vesiculosus, an OSMAC approach that 
included variations in media composition and culture regimes (liquid/solid) was applied. The crude 
extracts of ten fungal isolates showed anticancer bioactivities against at least one cancer cell line under 
one culture condition. MS/MS-based molecular networking (MN) combined with bioactivity mapping 
was applied to those crude extracts, allowing the identification and prioritization of two endophytic 
fungal strain, Pyrenochaetopsis sp. FVE-001 and FVE-087 with anticancer activity. Both strains were 
selected for large-scale fermentation followed by massive metabolomics analysis and chemical work-
up. 
For Pyrenochaetopsis sp. FVE-001, a modified Kupchan partition method was applied to crude 
extract to separate the crude extract into three subextracts. Bioactivity was tracked to the chloroform 
subextract, which was fractionated on a C18 solid-phase extraction (SPE) cartridge. The anticancer 
activity was mapped onto molecular networks (the so-called bioactivity-based MN), and with the aid of 
additional bioinformatics application, the anticancer activity of the compounds in the network was 
predicted. The compound isolation was carried out in a targeted manner from the bioactive fractions to 
yield three new decalinoylspirotetramic acid derivatives, pyrenosetins A-C, and a known decalin 
derivative, phomasetin. As expected, pyrenosetins A and B showed strong inhibitory potential against 
malignant melanoma cell A-375 with IC50 values of 2.8 and 6.3 μM, respectively.  
The bioactivity-guided isolation of the second Pyrenochaetopsis sp. FVE-087 strain yielded one 
new decalinoyltetramic acid derivative, pyrenosetin D, and two known compounds wakodecalines A 
and B. Pyrenosetin D possesses an unusual pentacyclic ring system, which is rare in nature. Bioassay 
results showed that pyrenosetins D exhibited moderate anticancer bioactivity against A-375 with IC50 
value of 77.5 μM, while wakodecalines A and B were inactive. 
The current study represents a successful application of OSMAC in inducing new compounds with 
anticancer activity in algicolous fungi. Further combination of MN and additional information layers 
such as bioactivity data has successfully led to rapid purification of new compounds pyrenosetins A-D 
from two Fucus vesiculosus-derived Pyrenochaetopsis sp. strains. This is the first study focusing on 
secondary metabolites of algal-derived Pyrenochaetopsis sp. 
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Zusammenfassung 
Algen-assoziierte (algicole) Pilze sind als wichtige Quelle für die Entdeckung neuartiger bioaktiver 
Naturstoffe bekannt.  Als eine der in den flachen Küstenregionen der Ostsee am weitesten verbreiteten 
Braunalgenarten bietet Fucus vesiculosus Lebensraum für viele Wirbellose und Wirbeltiere. Die mit F. 
vesiculosus assoziierte Pilzgemeinschaft wurde jedoch bisher nicht hinsichtlich ihres Potentials zur 
Produktion bioaktiver Sekundärmetabolite untersucht. Dieses Promotionsprojekt verfolgte einen 
kulturbasierten Ansatz zur Isolierung von Pilzen aus F. vesiculosus zur Entdeckung neuer Wirkstoffe 
gegen Krebs. Um eine Vergrößerung des Sekundärmetabolitspektrums der mit F. vesiculosus 
assoziierten Pilze zu erreichen, wurde ein OSMAC-Ansatz angewendet, der Variationen in 
Medienzusammensetzung und Kulturregime (flüssig/fest) umfasste. Im Ergebnis zeigten die 
Rohextrakte von 10 Pilzstämmen eine Induktion der Bioaktivät gegen mindestens eine Krebszelllinie 
bei einer bestimmten Kulturbedingung. MS/MS-basierte molekulare Netzwerke (MN) der Rohextrakte 
in Kombination mit einer Kartierung der krebszell-inhibierenden Bioaktivität resultierten in der 
Identifikation und Priorisierung zweier endophytischer Pilzstämme, Pyrenochaetopsis sp. FVE-001 und 
FVE-087. Beide Stämme wurden für die Fermentation in großem Maßstab ausgewählt, gefolgt von 
einer massiven Metabolomics-Analyse und ihrer chemischen Aufarbeitung. 
Für Pyrenochaetopsis sp. FVE-001 wurde eine modifizierte Kupchan-Partitionierung angewendet, 
um den Rohextrakt in drei Unterextrakte zu trennen. Die krebszell-inhibierende Bioaktivität wurde im 
Chloroform-Subextrakt detektiert, welcher auf einer C18-Festphasenextraktionspatrone fraktioniert 
wurde. Mit Hilfe bioaktivitätsbasierter molekularer Netzwerke konnte die Antikrebszell-Aktivität der 
Verbindungen im Netzwerk vorhergesagt werden. Darauf basierend erfolgte die Isolierung von 
Sekundärmetaboliten gezielt aus den bioaktiven Fraktionen und ergab drei neue 
Decalinoylspirotetraminsäurederivate, Pyrenosetine A-C, und ein bekanntes Decalinderivat, 
Phomasetin. Wie erwartet zeigten die Pyrenosetine A und B eine starke Inhibition gegen maligne 
Melanomzellen A-375 mit IC50 -Werten von 2,8 bzw. 6,3 μM. 
Die bioaktivitäts-geleitete Isolierung des zweiten Pyrenochaetopsis sp. -Stamms FVE-087 ergab 
ein neues Decalinoyltetraminsäurederivat, Pyrenosetin D sowie zwei bekannte Substanzen, 
Wakodecaline A und B. Die neue Verbindung Pyrenosetin D besitzt ein ungewöhnliches, in der Natur 
selten vorkommendes pentacyclisches Ringsystem. Ergebnisse der in vitro Bioassays zeigten, dass 
Pyrenosetin D eine moderate Bioaktivität gegen die Melanom-Zellinie A-375 mit einem IC50 -Wert von 
77,5 μM aufwies, wohingegen die Wakodecaline A und B inaktiv waren. 
Die aktuelle Arbeit stellt eine erfolgreiche Anwendung von OSMAC für die Induktion neuer 
Moleküle mit Antikrebs-Aktivität in algicolen Pilzen dar. Des Weiteren hat die cheminformatische 
Kombination von MN mit zusätzlichen Informationsebenen aus Bioaktivitätsdaten erfolgreich zu einer 
schnellen und gezielten Isolierung der neuen Verbindungen Pyrenosetine A-D aus zwei mit Fucus 
vesiculosus assoziierten Pyrenochaetopsis sp. Stämmen beigetragen. Dies ist die erste Studie, die sich 
mit Sekundärmetaboliten von Pyrenochaetopsis sp. beschäftigt. 
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GENERAL INTRODUCTION 
1. Marine fungi 
Marine fungi represent a large ecological group of eukaryotic microorganisms. They are widely 
distributed in a variety of marine environments, ranging from deep-sea to coastal habitats and including 
water, sediments, ice covers, shallow sea rocks or associations with other organisms (Ogaki et al., 2019; 
Rédou et al., 2015; Zain ul Arifeen et al., 2019). According to their lifestyle, marine fungi can be divided 
into two groups, namely obligate and facultative (Kohlmeyer and Kohlmeyer, 1979). Based on the 
currently accepted definition, obligate marine fungi are those living exclusively in the marine 
environment (e.g. Ascochyta salicorniae) (Osterhage et al., 2000), while facultative marine fungi are 
those adapted to both marine and terrestrial or freshwater environments (e.g. Aspergillus candidus) 
(Rateb and Ebel, 2011; Vala, 2010). Recent molecular studies have revealed that marine habitats contain 
a vast array of obligate and facultative marine fungi, and these coexisting fungi represent one of the 
most underutilized biological resources for discovery of new species as well as of novel natural products 
(Jones et al., 2015; Overy et al., 2014; Reich and Labes, 2017). A high abundance of marine fungal 
species is reported in marine holobionts such as corals and sponges (Amend et al., 2012; Li and Wang, 
2009). Research on marine fungi can be traced back to 1915, with the identification of new fungi from 
the brown alga Pelvetia sp. (Sutherland, 1915). Until 2015, 1,112 marine fungal species belonging to 
472 genera were reported from different marine habitats, with a slow but steady increase to 1,257 in 
2019 (Jones et al., 2019; Jones et al., 2015). With regard to the large and yet underexplored marine 
habitat diversity including numerous holobionts, Jones et al. considered the current number of identified 
marine fungal species an underestimation and estimates > 10,000 marine fungal species in the marine 
environment (Jones, 2011; Jones et al., 2015). Compared to other habitats, the marine environment 
features harsh conditions, and marine fungi are exposed to a number of stressors. High or very low 
salinity, low oxygen content, nutrient limitation but also eutrophication, potential desiccation due to 
water level differences (tides), high hydrostatic pressure, changes in UV radiation intensity, grazing, 
microbial competition with bacteria are only some potential stressors of marine fungi (Jones, 2000; 
Núñez-Pons et al., 2018). Adaptation to these various stressors resulted in the evolution of sometimes 
unique gene clusters in marine fungi (Kumar et al., 2018; Orsi et al., 2015). This also affects their 
enzyme systems, leading to a remarkable chemical difference between marine and terrestrial fungi. 
Screening of carbohydrate-active enzymes and sugar transporters in the genome of the marine fungus 
Calcarisporium sp. revealed that the enzymes were specialized for algae and animal degradation, 
suggesting the adaption of its lifestyle to marine environment (Kumar et al., 2018). Another result of 
this adaptation to challenges is the production of novel bioactive compounds (Ji and Wang, 2016; 
Petersen et al., 2020). As an example, the marine fungus Pestalotia sp. produced the chlorinated 
benzophenone pestalone showing antibiotic activity in response to marine bacterial challenge (Figure 
1a) (Cueto et al., 2001). Since marine fungi remain largely unexplored for their potential as sources of 
bioactive natural products, there is a great need for seeking bioactive natural products from marine 
fungal resources. 
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Figure 1. Structures of representative bioactive compounds associated with marine fungi. a). Pestalone (isolated 
from Pestalotia sp. co-cultured with marine bacteria) with antibiotic activity against methicillin-resistant 
Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. b). Cephalosporin C (origin: 
Acremonium chrysogenum) c). Cephalosporin C-derived drug cephaloridine which is in clinical application as an 
antibiotic (against Streptococcus, Staphylococcus and Pneumococcus infections). 
 
Marine fungi have long been neglected as a research subject, but nowadays they receive increasing 
attention for their ecological roles, their evolutionary complexity as well as for natural product 
prospecting (Gutiérrez et al., 2011; Imhoff, 2016; Richards et al., 2012). The total number of reports 
related to marine fungi increased from 10 papers in 1997 to around 500 publications in 2014 (Figure 2) 
(Overy et al., 2014). This rise in interest of the scientific community was mainly due to the finding that 
marine fungi produce specific, structurally diverse metabolites, often with novel, pharmaceutically 
relevant bioactivities (Imhoff, 2016; König et al., 2006). Those marine fungal natural products (MFNPs) 
have been regarded as promising resources for developing new drugs (Gomes et al., 2015; Silber et al., 
2016). For example, the second generation β-lactam type natural antibiotic cephalosporin C (Figure 1b) 
was purified from the Mediterranean-seawater derived fungus Acremonium chrysogenum. It served as 
a lead compound for the development of the clinically used antibiotic cephaloridine (Figure 1c) (Bugni 
and Ireland, 2004; Murdoch et al., 1964). 
Figure 2. Development of scientific publications on marine fungi. The number of articles from 1996 until 2014 
that include either the term ‘marine-derived fungi’ or ‘sponge-derived fungi’ in title, abstract, or keywords. Picture 
was adapted from Overy et al., 2014. 
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2. Macroalgae-derived fungi 
2.1. Fungal abundance in macroalgae 
Macroalgae, or seaweeds, refer to a group of plant-like multicellular photosynthetic eukaryotes 
that include several types of organisms such as Rhodophyta (red), Phaeophyta (brown) and Chlorophyta 
(green) algae (Figure 3) (Madhusudan et al., 2011). They are widely distributed mostly in shallow 
marine areas, ranging from tropical sea beaches to Antarctica. Seaweeds play an important role in the 
aquatic ecosystem by providing food and habitat for marine macrobiota (e.g. invertebrates and fishes) 
(Fulton et al., 2019; Wikström and Kautsky, 2007). Recently, the close relationship between host and 
the microbiota intimately associated with these hosts physically but also functionally has been 
conceptualized as ‘holobiont’ (Egan et al., 2013; Margulis, 1990; O'Malley, 2017). Similar to most 
marine holobionts, seaweeds harbor a diverse number and assemblage of microorganisms, such as 
bacteria, fungi, and viruses (Egan et al., 2013). Fungi have been reported as common residents on the 
surfaces (epiphytes) or in the inner tissues as endophytes of different marine macroalgae (Abdel-Gawad 
et al., 2014; Flewelling et al., 2013b). In total, more than 150 fungal species were reported from diverse 
algal species, as reviewed by Ji and Wang (2016). Bioprospecting of endophytes from North Atlantic 
marine macroalgae resulted in the isolation of a total number of 632 fungal strains belonging to 79 
different species. (Flewelling et al., 2013b). Additionally, a study investigating the microbial diversity 
of algal surfaces from the Red Sea showed high taxonomic diversity of the fungal epiphytes including 
a wide range of fungal orders such as Capnodiales, Pleosporales and Hypocreales (Abdel-Gawad et al., 
2014). These reports impressively underline, that fungi are frequently found in different algal species, 
implying that they are important “associates” in marine algal holobionts. 
 Figure 3. Representative species for the three groups of seaweeds (red, brown and green algae). a). Red alga 
Gracilaria sp. b). Green alga Ulvophyceae sp. c). Brown alga Fucus sp. 
 
Interestingly, some fungi are obligate symbionts that are exclusively detected in the algal hosts. 
One example is a new Acremonium species termed A. fuci, which was isolated exclusively from Fucus 
serratus (Zuccaro et al., 2004b). Notably, A. fuci only showed conidia germination in the presence of 
its host alga tissue or aqueous tissue homogenate (Zuccaro et al., 2004b). This dependency of A. fuci 
spore germination on the host provides strong evidence for a symbiotic interaction between the alga 
and the fungus. Vice versa, the observed fungal diversity associated with macroalgae suggests that many 
fungal associates are critical for algal life in several aspects, such as nutrient cycling, development and 
chemical defense (Du et al., 2019; Garbary and MacDonald, 1995; Vallet et al., 2018). This is nicely 
exemplified by the role of a fungus for morphological development of the brown seaweed Ascophyllum 
nodosum (Garbary and MacDonald, 1995). After inoculated with ascospores of the endophyte 
Mycosphaerella ascophylli , the alga showed better growth condition, with longer thalli, greater 
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sporeling length and shorter rhizoids compared to non-infected control (Garbary and MacDonald, 
1995). Although the current ecological role of marine algicolous fungi (MAF) in associations with 
seaweeds is still incompletely understood, these complex interactions including nutrient transfer and 
hormonal regulation suggest a mutual adaptation process between algal host and fungi. The versatility 
of fungal-algal interaction also includes a positive or protective role of fungi in their host’s life, 
especially in chemical defense.  Reportedly, fungi produce bioactive metabolites to protect macroalgae 
from pathogen infestation (Vallet et al., 2018). As an example, algal-derived fungi were found to be 
able to produce antifouling metabolites (Flewelling et al., 2015; Overy et al., 2014). Moreover, a recent 
study yielded several isolates from four brown algal species producing antibiotic metabolites active 
against protistan pathogens of the model brown alga Ectocarpus siliculosus (Vallet et al., 2018). Among 
all 99 fungi isolated in the study, one Phaeosphaeria sp. AN596H derived from Ascophyllum nodosum 
produced a new pyrone pyrenocine S (Figure 4), showing activity against the algal-pathogenic 
oomycete Eurychasma dicksonii CCAP 418/3 at 0.1 μg/mL. Additionally, the known pyrone type 
pyrenocines A and B displayed a strong antibiotic effect against all tested algal pathogens - Eurychasma 
dicksonii CCAP 418/3, Anisolpidium ectocarpii (CCAP 4001/1) and Maullinia ectocarpii (CCAP 
1538/1) at 0.1 μg/mL (Vallet et al., 2018) (Figure 4). These results demonstrate that MAF have a high 
potential to produce bioactive small molecules protecting their host, and these small molecules have 
great potential in drug development.  
 
 
Figure 4. Structures of the chemical defense metabolite pyrenocines isolated from brown alga-derived 
Phaeosphaeria sp. AN596H. 
 
2.2. Macroalgae-derived fungi as source of anticancer lead compounds discovery  
Cancer is one of the major fatal diseases of the 21st century that has caused 18 million cases and 
about 10 million deaths in 2018 (Bray et al., 2018). According to global demographic predictions, there 
will be an increase in the incidence of cancer with an estimated 20 million new annual cases by 2025 
(Zugazagoitia et al., 2016). Fortunately, continuous investments in anticancer research have notably 
varied treatment paradigms in past decades, e.g. surgery, chemotherapy, radiotherapy and 
immunotherapy (Arruebo et al., 2011). Among those available methods, chemotherapy is still one of 
the most effective approaches for the treatment of different types of cancers. Despite the significant 
advances in anticancer drug development, strong side effects have been regarded as the biggest 
drawback of current chemotherapy agents, motivating the continuous search for effective cures with 
fewer side effects (Huang et al., 2017). Terrestrial fungal natural products have contributed a number 
of novel molecules for the development of life-saving drugs (e.g. protein-bound polysaccharide K) 
(Jiménez-Medina et al., 2008), while MFNPs and especially those produced by MAF have remained 
largely underexplored until the 1990s.  
In 1993, the alkaloids communesins A and B (Figure 5a, b) were isolated from Penicillium sp. 
derived from the marine green alga Enteromorpha intestinalis. They showed strong anticancer 
bioactivity against the murine leukemia cancer cell line P388 with ED50 values of 3.5 and 4.5 μg/mL, 
respectively (Numata et al., 1993). The remarkable biological properties of these molecules have 
stimulated considerable interest in prospecting bioactive communesin derivatives from marine fungi 
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(Dalsgaard et al., 2005; Jadulco et al., 2004). Motivated by the isolation of the communesins, studies 
on discovering anticancer compounds from algicolous fungi experienced a boost. Between 1994 and 
2004, investigations on the brown alga Sargassum torile-associated fungus Leptosphaeria sp. yielded 
another representative natural product family - the epipolythiodiketopiperazine (ETP) type leptosins - 
which so far includes 23 members (Takahashi et al., 1994a; Takahashi et al., 1994b; Yamada et al., 
2004; Yamada et al., 2002). Leptosins are characterized by the incorporation of an intramolecular 
polysulfide bridge that forms different kinds of dimeric ETPs (Boyer et al., 2013). All leptosins showed 
strong in vitro toxicity against P388 with ED50 values ranging from 1.75 ng/mL to 1.40 μg/mL 
(Takahashi et al., 1994a; Takahashi et al., 1994b; Yamada et al., 2004; Yamada et al., 2002). Subsequent 
mechanistic studies on leptosins revealed inhibition of cancer cell growth through different ways: 
Yamada et al. found that leptosin M specifically inhibits the activity of the protein kinases PTK, 
CaMKIII and the human topoisomerase II to kill cancer cell lines, but did not exhibit any activity against 
topoisomerase I (Yamada et al., 2002; Yanagihara et al., 2005) (Figure 5c). A later study of leptosins C 
and F showed that they exhibit specific inhibition activity against both topoisomerase I and II leading 
to apoptosis induction in cancer cells (Yanagihara et al., 2005) (Figure 5d, e).  
In 1997, the naturally occurring secondary metabolite (SM) diketopiperazine halimide (also named 
phenylahistin, Figure 5f), was isolated from the fungus Aspergillus sp. associated to the marine green 
alga Halimeda copiosa collected off the Philippine (Fenical et al., 2000; Kanoh et al., 1997). It exhibited 
a strong in vitro growth inhibition profiles against the human lung carcinoma cancer cell line A549 and 
murine leukemia cancer cell line P388 (Fenical et al., 2000; Fukumoto et al., 2002; Kanoh et al., 1997; 
Kanoh et al., 1999a). In-depth analysis of its mechanism of action showed that halimide disturbs the 
microtubule network through interaction with the colchicine-binding site on tubulin, which is similar to 
vinca alkaloids and paclitaxel. Subsequent research on halimide focused on structural modifications, 
i.e. removing the chirality and optimizing its anticancer bioactivity. The structure modification effort 
led to the development of plinabulin (Kanoh et al., 1999b) (Figure 5g). Plinabulin is a synthetic tert-
butyl analogue of halimide. It blocks the polymerization of tubulin in cancer cells, which results in the 
disruption of the tumor blood supply to kill cancer cells (Cimino et al., 2019). Plinabulin is subject to 
clinical studies for the treatment of non-small cell lung cancer and recently has been processed to the 
world-wide clinical trial phase III (Blayney et al., 2019). Until now, plinabulin is the only anticancer 
agent derived from a MAF-sourced secondary metabolite in clinical trials.  
In recent years, MAF-derived natural products represent one of the most relevant sources 
contributing to marine-derived new drug leads (Gomes et al., 2015; Montaser and Luesch, 2011). 
Beyond showing in vitro anticancer activity in their natural, unmodified form, they also enlarge drug 
space through providing the basis for semi-synthetic analogs of lead compounds, as well as the natural 
product-inspired structural mimics (Kanoh et al., 1999b). Recent technical advances in dereplication, 
purification and biological activity evaluation, have inspired an ongoing research interest in searching 
anticancer lead compounds from MAF (Hubert et al., 2017; Teixeira et al., 2019). 
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Figure 5. Structures of representative MAF-derived natural products. a-b). Communesins A and B isolated from 
Penicillium sp. c). Leptosin M isolated from Leptosphaeria sp, showing the inhibitive activity of the protein 
kinases PTK, CaMKIII and the human topoisomerase II. d-e). Leptosin C and F, reported from Leptosphaeria sp., 
within inhibitive activity of human topoisomerase I and II. f). Halimide isolated from Aspergillus sp., and g). 
Halimide-derived analogue plinabulin. 
 
Continued isolation efforts have yielded a plethora of purified natural products with excellent 
anticancer bioactivities from fungal taxa collected from different algal hosts including green, red and 
brown algae (Elsebai et al., 2011; Greve et al., 2008; Sun et al., 2012; Zhang et al., 2016). Until late 
2019, approximately 180 MAF-derived metabolites have been purified and reportedly showed activity 
against multiple cancer cell lines (Appendix Table 1). They belong to diverse chemical families such as 
polyketides, steroids, alkaloids, cyclodipeptides and macrodiolides (Lang et al., 2006; Unsöld and Li, 
2006; Usami et al., 2002; Wang, 2012; Zhu et al., 2009) (Appendix Table 1). However, most of the 
published studies on anticancer metabolites from MAF have focused on only a few genera, mainly 
Penicillium, Aspergillus, Fusarium, and Leptosphaeria (Choi et al., 2019; Smetanina et al., 2016; 
Takahashi et al., 1994a; Usami et al., 2002). The high diversity of seaweed-associated fungi (Abdel-
Gawad et al., 2014; Zuccaro et al., 2004b) and the presence of yet understudied fungal genera besides 
the above-mentioned well-studied ones render MAF a promising resource for anticancer lead discovery. 
2.3. Chemical prospecting of Fucus-derived fungi  
The canopy-forming Fucus sp. is the most-widespread brown seaweed inhabiting the shallow 
coastal regions of northern Europe, including the Baltic Sea (Ardehed et al., 2016; Malm and Kautsky, 
2003). As one of the key species in many coastal marine environments, Fucus sp. often forms the basis 
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of species-rich ecosystems, including a rich mycobiome (Wikström and Kautsky, 2007; Zuccaro et al., 
2008; Zuccaro et al., 2004a). Recently, a chemical imaging technique (Desorption Electrospray 
Ionization-Imaging Mass Spectrometry - DESI-IMS) revealed the presence of a rich surface 
metabolome in the bladderwrack Fucus vesiculosus including several fungal metabolites such as 
peptaibol emerimicins, alkaloid pestalamides and bis-indolyl benzenoid ochrindoles (Parrot et al., 2019). 
These results provide further evidence for the important role of fungi in their host´s chemical defense. 
Discovery of bioactive natural products from Fucus-derived fungi started with the purification of 
polyketides 5-hydroxyramulosin and 7-methoxycoumarin (Figure 6a, b). They were produced by 
Phoma sp. derived from Fucus spiralis, and showed anticancer, antifungal and anti-HIV activities 
(Osterhage et al., 2002; Santiago et al., 2012). Since then, several other studies have found bioactive 
metabolites produced by Fucus-derived fungi. For example, a new isobenzofuranone derivative 4,5,6-
trihydroxy-7-methylphthalide (Figure 6c) was produced by the fungus Epicoccum sp. isolated from 
Fucus vesiculosus collected on the North Sea coast (Abdel-Lateff et al., 2003). The obtained compound 
was found to have considerable antioxidant activity, showing 95% radical scavenging effects at 25 
μg/mL in the 2,2-Diphenyl-1-picrylhydrazyl (DPPH) assay and inhibited the peroxidation of linolenic 
acid in the thiobarbituric acid reactive substances (TBARS) assay (62% inhibition at 37 μg/mL) (Abdel-
Lateff et al., 2003). Additionally, Flewelling and colleagues retrieved Aspergillus fumigatus, 
Coniothyrium sp. and Penicillium sp. isolates from Fucus sp. collected from the North Atlantic Ocean 
(Flewelling et al., 2013a). Following initial antibacterial screening results, Penicillium sp. isolated from 
Fucus spiralis was selected for further chemical investigation. Bioassay-guided isolation of the selected 
Penicillium sp. yielded several metabolites such as the polyketides cladosporin, epiepoformin, 
phyllostine, and patulin showing antimicrobial activity (Flewelling et al., 2013c) (Figure 6d-g). Patulin 
has been reported as a mycotoxin exhibiting toxicity to several cancer cell lines (Abastabar et al., 2017). 
Although these examples suggest a high capacity of Fucus sp.-associated fungi for production of 
bioactive natural products, focus of these studies were antibiotic metabolites and hence, their potential 
for production of anticancer leads remains largely unexplored. 
 
 
Figure 6. Structures of bioactive natural products reported from Fucus-derived fungal isolates. a-b). Compounds 
isolated from Phoma sp. originating from F. spiralis. c). New compound purified from Epicoccum sp. isolated 
from F. vesiculosus. d-g). Antibiotic compounds isolated from Penicillium sp. derived from F. spiralis. 
 
3.  The fungal genus Pyrenochaetopsis sp. 
The genus Pyrenochaetopsis sp. taxonomically belongs to the fungal family Cucurbitariaceae (de 
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Gruyter et al., 2010; Valenzuela-Lopez et al., 2018) in the order Pleosporales, which is affiliated to the 
division Ascomycota. Recent studies showed that Pyrenochaetopsis sp. are widely distributed in diverse 
ecological niches, such as soil, plant-associated and airborne (de Gruyter et al., 2010; de Gruyter et al., 
2013). Pyrenochaetopsis sp. has been previously isolated from the marine green alga Flabellia petiolata 
collected in the Mediterranean Sea (Gnavi et al., 2017), suggesting that the marine environment also 
harbors fungi of this genus. Previously, often species of the genera Pyrenochaetopsis and Phoma were 
mixed, since morphological characters did not allow a clear distinction (de Gruyter et al., 2010). Recent 
systematic analysis of the genus Phoma and the closely related genera Pharaphoma, Pyrenochaeta, 
Herpotrichia, Pyrenochaetopsis showed a genetic difference of Pyrenochaetopsis sp. from Phoma sp. 
(de Gruyter et al., 2010) (Figure 7). Recently, several species previously regarded as Phoma sp. have 
been transferred to the genus Pyrenochaetopsis based on a combination of genetic and morphological 
characteristics (Chen et al., 2015; de Gruyter et al., 2010). 
 
Figure 7. Phylogenetic species relationships in genus Paraphoma, Herpotrichia, Pyrenochaeta, Pyrenochaetopsis 
gen. nov. and Phoma. Consensus tree was adapted from de Gruyter et al. 2010. (A). Fungal family 
Cucurbitariaceae. (B). Fungal family Phaeosphaeriaceae. (C). Fungal family Didymellaceae. 
Until now, the genus Pyrenochaetopsis sp. has not been studied extensively, especially regarding 
secondary metabolite production of species belonging to this genus. To our knowledge, to date only 
decalin derivatives such as phomasetin and wakodecalines have been isolated from the genus 
Pyrenochaetopsis sp. (Nogawa et al., 2017) (Figure 8). The wakodecalines showed moderate 
antimalarial activity against Plasmodium falciparum 3D7, but were inactive against tested cancer cell 
lines (Nogawa et al., 2017). Similarly, phomasetin has shown multiple bioactivities including 
antimalarial, toxic and anti-HIV bioactivity (Nogawa et al., 2017; Singh et al., 1998). Interestingly, 
phomasetin and wakodecalines contain the same trans-decalin skeleton, which was proposed to be 
biosynthesized by enzyme-catalyzed [4+2] cycloaddition (Kato et al., 2018). The identification of 
biosynthetic gene clusters of Pyrenochaetopsis sp. revealed that the gene phm7 was involved in the 
reaction and stereocontrol of  [4+2] cycloaddition forming trans-decalin phomasetin, resulting in 
opposite chiral center configurations of phomasetin and equisetin (Kato et al., 2018). Moreover, the 
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BGC screening of Pyrenochaetopsis sp. suggested that it had the potential to produce a high number of 
metabolites containing the ‘trans-decalin’ unit (Kato et al., 2018). Hence, Pyrenochaetopsis sp. is 
supposed to be a promising strain for natural product discovery.  
 
 
 
Figure 8. Structures of wakodecalines and phomasetin produced by Pyrenochaetopsis sp. 
4. Activation of silent biosynthetic gene clusters (BGCs) 
4.1. Approaches to activate silent BGCs for inducing chemical space 
SMs are usually produced by enzymes that are encoded by co-localized genes organized in so-
called BGCs (Keller et al., 2005). However, the vast majority of fungal BGCs for SMs are either inactive 
or only active at a low expression level under standard laboratory culture conditions (Reen et al., 2015) 
and are hence termed ‘silent’ or ‘cryptic’ BGCs. Their silence is mainly caused by a lack of 
environmental cues or stressors in standard lab culture conditions (Romano et al., 2018; Rutledge and 
Challis, 2015). Thus, application of various approaches to activate these silent BGCs has become highly 
relevant in marine fungal research. 
Until now, research on MFNPs has only touched the “tip of the iceberg” (Romano et al., 2018). In 
order to achieve high chemical diversity of marine fungal metabolites, researchers have been 
continuously trying to evoke or enhance the expression of silent BGCs in marine fungi (Brakhage et al., 
2008; Reen et al., 2015). Since the tremendous potential for SM production in many fungi has been 
observed by several genome-based studies (Rokas et al., 2020; Rokas et al., 2018), the development of 
techniques for both cultivation-dependent and -independent approaches to induce the production of 
marine fungal metabolites has become a rapidly developing field. There have been multiple approaches 
established to activate “silent” BGCs for marine fungal SM production. They can be divided into two 
major approaches: 1). Pleiotropic and 2). Pathway-specific methods (Rutledge and Challis, 2015) (Table 
1). Pleiotropic approaches are generally technically simple and are therefore suitable for scaling up to 
high-throughput systems (Baral et al., 2018). The term “pleiotropic approach” refers to methods 
changing a single cultivation parameter but leading to more than one observable change in the regulation 
of secondary metabolite pathways. Pleiotropic approaches include different methods such as variation 
of growth conditions, engineering of the transcription and translation machinery, manipulating global 
regulators and epigenetic perturbation (Table 1). Those approaches have been successfully applied to 
marine fungi for evoking or changing the expression of marine fungal silent BGCs (Chai et al., 2012; 
Wang et al., 2014a; Wu et al., 2020). Pleiotropic approaches may activate more than one biosynthetic 
pathway and result in the production of new compounds belonging to different chemical families. As 
an example, Wu and co-workers applied two different epigenetic modifiers for triggering the production 
GENERAL INTRODUCTION   
12 
 
of bioactive metabolites from a marine-derived Aspergillus versicolor (Wu et al., 2020). The fungus 
displayed different levels of chemical diversity when treated with the histone deacetylase inhibitor 
suberoylanilide hydroxamic acid (SAHA) and the DNA methyltransferase inhibitor 5-azacitidine (5-
Aza). Furthermore, combination of 100 μM SAHA and 100 μM 5-Aza led to an additive effect on the 
epigenetic regulation of the fungal SM production, which finally yielded two new nucleoside 
derivatives, kipukasins K and L (Figure 9a, b), as well as the new bisabolane sesquiterpene 
aspergillusene E (Figure 9c) (Wu et al., 2020).  
 
 
 
Figure 9. Structures of new secondary metabolites obtained from marine-derived Aspergillus versicolor after 
treatment with a pleiotropic approach (epigenetic modifiers). 
In contrast to the pleiotropic approaches, pathway-specific strategies try to control the biosynthesis 
of certain types of compounds by targeting specific genes, but also regulatory elements such as 
activators, repressors or promoters. These strategies include multiple methods such as manipulating 
pathway-specific regulation, reporter-guided mutant selection, refactoring, heterologous expression and 
CRISPR/Cas9-based genome editing (Table 1). In general, pathway-specific strategies are designed 
based on a comprehensive understanding of the genes underlying SM production. Hence, compounds 
obtained after application of pathway-specific strategies highly matched to predicted structures 
(Bergmann et al., 2007; Chiang et al., 2009). However, due to the tight regulation of BGCs in pathway-
specific strategies, those strategies often result in reduced chemical diversity compared to pleiotropic 
approaches (Rutledge and Challis, 2015).  
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Table 1. Different approaches used to activate silent BGCs (table was adapted from Rutledge and Challis et al., 
2015) 
Approach Principle of the method 
Pleiotropic methods 
Variation of growth conditions Subjection of a microorganism to a change in the environment 
in which it is growing (for example, by adding competing 
species, chemical elicitors or other additives) to induce 
changes in BGC expression 
Engineering the transcription and translation 
machinery 
Induction of mutations in RNA polymerase and ribosomal 
proteins to cause upregulation of BGC expression 
Manipulating global regulators Alteration of expression levels of pleiotropic transcriptional 
regulators to modulate BGC expression 
Epigenetic perturbation Use of mutagenesis or small-molecule inhibitors to disrupt 
chromatin structure and thus trigger global changes in gene 
expression 
Pathway-specific methods 
Manipulating pathway-specific regulators Identification of genes encoding putative pathway-specific 
transcription factors within a BGC of interest, followed by 
overexpression (for an activator) or deletion (for a repressor) 
of these genes as appropriate 
Reporter-guided mutant selection Genome-scale random mutagenesis to introduce genetic 
diversity, while coupling a target BGC to a promoter-reporter 
system that visualizes mutants in which target BGC 
transcription is activated 
Refactoring Replacement of the natural promoters within a BGC with 
constitutive or readily inducible promoters 
Heterologous expression Expression of an entire BGC in a heterologous host 
CRISPR/Cas9-based genome editing CRISPR/Cas9 mediated recognition and cleavage of 
specifically targeted DNA motifs to insert, delete, modify or 
replace BGCs  
 
4.2. One-Strain-Many-Compounds (OSMAC) 
The above described pleiotropic approaches include the variation of cultivation conditions to 
trigger the production of SMs in fungi (Hemphill et al., 2017; Meng et al., 2017; Özkaya et al., 2018). 
This approach of changing culture conditions for inducing microbial chemical production has been 
summarized as One-Strain-Many-Compounds (OSMAC) approach. It was conceptualized by Bode and 
co-workers, who found small changes in microbial culture conditions leading to variations in their SM 
production (Bode et al., 2002). The basic theory underlying this approach is that one single strain has 
the genomic potential to produce diverse metabolites, but the actual production is restricted under 
standard culture conditions. This means, that the few metabolites produced in a certain culture condition 
reflect only a subset of the entire potential residing in the genome. By altering culture parameters such 
as temperature, aeration, salinity, and the shape of culture flasks in cultivation of the fungus Aspergillus 
ochraceus, Bode et al. succeeded in isolation of additional 15 metabolites (Bode et al., 2002). This 
pioneering study highlighted the importance of exploring a single fungal strain by applying different 
culture conditions for production of new metabolites (Bode et al., 2002). In the past decades, numerous 
studies have further provided evidence for the sensitivity of fungi towards changes in culture conditions 
(Abdelwahab et al., 2018; Hewage et al., 2014; Wang et al., 2018). A plethora of abiotic cultivation 
parameters, including nutrient changes in carbon or nitrogen sources, salts, trace elements but also 
physical parameters (e.g. pH, shaking condition, temperature) could be optimized for inducing SM 
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production of fungi (Romano et al., 2018) (Figure 10). Furthermore, the application of biotic challenges 
such as co-cultivation of microbes, e.g. bacteria & fungi have extended the OSMAC principle and have 
been successfully applied to fungi for the production of new types of SMs (Wang et al., 2014b; 
Zhuravleva et al., 2016) (Figure 10). In view of the difficulty simulate the real multispecies habitats of 
marine fungi, applying OSMAC approach to those fungi has been regarded as an essential method to 
induce their SM production (Gulder et al., 2012; Leutou et al., 2013). 
 
 
Figure 10. Overview of the “One-Strain-Many-Compounds” (OSMAC) approach to activate silent BGCs for the 
production of new metabolites. Modifiable parameters include (A). Nutrients; (B). Physical parameters; (C). 
Biological stressors induced by co-cultivation of more than one strain; (D). Chemical elicitors. (Picture modified 
based on Romano et al., 2018 and Reen et al., 2015) 
4.3. Application of OSMAC strategy to marine fungi 
Beyond its application in bacteria and terrestrial fungi, the OSMAC approach has also been widely 
applied to marine fungi for new SM production (Meng et al., 2017; Özkaya et al., 2018; Wang et al., 
2014a). There are many parameters to be taken into account when designing OSMAC-based cultivation 
experiments. The effects of the supplied carbon source on microbial metabolism have been subject to 
continuous studies by both industry and research groups (Ruiz et al., 2010; Sánchez et al., 2010). One 
characteristic of microbial secondary metabolism is that it is usually tightly coupled with the growth 
phase, often commencing upon the stationary or resting phase (Calvo et al., 2002). As reviewed by 
Sánchez and co-workers, the type of carbon source has important effects especially on secondary 
metabolism regulation such as polyketide biosynthesis (Sánchez et al., 2010). There are two major types 
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of carbons - rapidly available carbon (e.g. glucose) and rather slowly used carbon (e.g. starch) used in 
the cultivation of marine fungi. Rapidly used carbon sources are often monosaccharides very well suited 
for fast microorganism growth, while slowly used carbon are polysaccharides that are considered as 
‘second-best’ carbon resources for microorganisms (Sánchez et al., 2010). Since glucose was reported 
to inhibit several enzymes involved in the SM production (Gutiérrez et al., 1999), it is important to take 
different carbon resources into account when culturing any microorganism including fungi in the lab. 
The choice of the appropriate carbon source in the medium needs to be balanced between enabling good 
cell growth and favoring SM production. As a successful example, Lin et al. induced production of the 
new pentacyclic cytochalasan spicochalasin A as well as five novel cytochalasan aspochalasins and two 
known aspochalasins in the marine fungus Spicaria elegans by changing the carbon source in the culture 
medium from glucose to 2% starch (Lin et al., 2009). Spicochalasin A (Figure 11a) showed moderate 
cytotoxicity against the human leukemic cancer cell line HL-60 with an IC50 value of 19.9 μM, 
suggesting its potential as an anticancer agent (Lin et al., 2009). Additional research showed that the 
application of different carbon sources to the cultivation of marine fungi changed both typology and 
titration of the produced metabolites (Camila Dos Santos Dias et al., 2017).  
Another important nutrient, the nitrogen source, also plays an important role in marine fungal 
growth and SM production. In particular, organic, amino acid-containing nitrogen sources play an 
important role in all peptide- but also amine- or amide- containing natural products as they provide 
major structural elements for the resulting SMs (Romano et al., 2018). After changing the nitrogen 
source from inorganic NaNO3 to a combination of arginine, asparagine and glutamic acid, the marine 
fungus Asteromyces cruciatus produced new pentapeptide lajollamide A showing weak antibacterial 
activity against Gram-positive bacteria at a concentration of 100 μM (Gulder et al., 2012) (Figure 11b). 
The production of lajollamide A in Asteromyces cruciatus was implied to be strongly affected by 
nitrogen resource, since changing other cultural parameters (e.g. shaking condition, temperature) could 
not induce this productive shift (Gulder et al., 2012). Analog to carbon, also the choice of nitrogen 
source in marine fungal cultivation needs to be well-balanced to enable cell growth on the one hand and 
on the other hand induce production of secondary metabolites. As reported by Miao et al., nitrogen 
limitation (absence or minute concentrations of nitrogen) had negative effects on cell growth but 
positive effects on antibiotics production in the marine-derived fungus Arthrinium c. f. saccharicola 
(Miao et al., 2006). Thus, low nitrogen concentrations seem to be one precondition for unlocking 
bioactive SM production of marine fungi. The carbon-nitrogen ratio should be considered when 
choosing cultivation media for inducing marine fungal SM production. In a study targeting the 
optimization of biosurfactant production from a sponge-derived Aspergillus sp., five different carbon-
nitrogen ratios ranging from 5:1 to 1:5 were chosen. The results showed that the strain produced the 
highest amount of biosurfactant at a C:N ratio of 3:2 whereas the ratio at 1:5 yielded no biosurfactant 
production (Kiran et al., 2009). The above-mentioned studies revealed the importance of nitrogen on 
SM production of marine fungi.  
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Figure 11. Structures of new compounds produced by marine fungi for adaption of OSMAC approach. a). New 
metabolite spicochalasin A produced by marine fungus Spicaria elegans after changing carbon resource in growth 
medium. b). New pentapeptide Lajollamide A purified from Asteromyces cruciatus after modification of nitrogen 
source in culture medium. c-e). Terremides A, B and terrelactone A purified from marine sediment-derived fungus 
Aspergillus terreus treated with high salt stress. f-g). New compounds Adametacorenols A and B purified from 
solid-phase culture extracts derived from marine fungus Penicillium adametzioides AS-53. 
Marine fungi inhabit an environment with an average salinity of 3-3.5% (Li and Liu, 2019). In 
order to adapt to this comparably high salinity environment, marine fungi have developed several 
specific mechanisms such as generating osmotic potential and modifying enzyme systems (Clipson and 
Jennings, 1992; Kumar et al., 2018; Rédou et al., 2015). Production of SMs is one important strategie 
for salt adaptation (Wang et al., 2011a; Wang et al., 2011b). Hence, salt concentration needs to be 
considered when designing or selecting media for cultivation of marine fungi. For instance, Wang and 
colleagues applied three different salt concentrations - 0%, 3% and 10% in order to discover new 
bioactive compounds from the marine sediment-derived fungus Aspergillus terreus. Interestingly, the 
fungus produced three new alkaloids terremides A, B and polyketide terrelactone A (Figure 11c-e) only 
when cultured in the medium with the highest salt concentration (Wang et al., 2011b). Moreover, the 
new compound terremide A showed antibacterial activity against Pseudomonas aeruginosa with 
minimum inhibitory concentration (MIC) value of 63.9 μM and terremide B exhibited antibacterial 
  GENERAL INTRODUCTION 
17 
 
activity against Enterobacter aerogenes at a MIC value of 33.5 μM. This study nicely demonstrates that 
salt stress is one of the dominant factors in activating silent BGCs for new SM production in marine 
fungi. Although salinity has been taken into account into biodiscovery studies on marine fungi, the 
effects of different salt types (e.g. NaCl alone or mixed inorganic salts) are still not well investigated. 
While the above-mentioned studies have all attempted to optimize the culture media, a change of 
physical parameters also has drastic effects on the growth and chemical production of marine 
microorganisms. As recent studies on bacteria showed, changing the culture regime from liquid medium 
in flasks to agar-based medium on plates affected antibiotic production of a marine-derived 
Streptomyces strain, which produced antibiotically active metabolites only on agar (English et al., 2017). 
Similarly, a shift of culture regime from liquid to solid in the marine-derived fungus Penicillium 
adametzioides AS-53 resulted in the production of two new acorane sesquiterpenes adametacorenols A 
and B (Figure 11f, g), which were not produced in liquid culture (Liu et al., 2015). Furthermore, the 
secondary metabolite production of fungi is sensitive to several other physical culture features such as 
pH, temperature, aeration, shaking speed (Romano et al., 2018).  
Notwithstanding the numerous studies which have aimed to elicit the effects and results of 
activation of “silent” BGCs using the OSMAC principle, much remains yet to be investigated, 
particularly with regard to marine fungi. The OSMAC approach is still crucial to gain a better 
understanding of the induction of SM production in marine fungi.  
5. Molecular networking-based metabolomics 
5.1. Advantages of molecular networking 
Loss of initial bioactivity or re-isolation of known compounds are common but sometimes costly 
pitfalls in microbial natural products discovery. Besides activation of silent BGCs for producing new 
SMs, dereplication and targeted isolation are indispensable steps in modern natural product discovery. 
Recently, an open-access platform named Global Natural Product Social molecular networking (GNPS) 
was established which represents a data-driven online platform for stockpile, analysis and dissemination 
of tandem mass (MS/MS) data. It enables community sharing of raw spectra, annotation of known 
compounds in complex mixtures, and collaborative curation of reference spectral data and experimental 
data (Wang et al., 2016). The principle and workflow of molecular networking (MN)-based chemical 
analysis and isolation have been summarized by Wang et al. in 2016 (Figure 12). Implementation of 
MN has revolutionized natural product discovery in the field of dereplication, targeted isolation and 
structure elucidation (Fox Ramos et al., 2019; Olivon et al., 2017c; Yang et al., 2013). Compared to 
traditional dereplication workflows, MN exhibits several advantages: 1). High accuracy of annotating 
known compounds; 2). Enabling a high-throughput dereplication of natural products by querying newly 
acquired MS/MS data against all reference spectra collected in GNPS spectral libraries; and 3). 
Visualizing not only known compounds but also structurally related analogues (Wang et al., 2016). 
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Figure 12. General workflow of GNPS-based chemical analysis and isolation (data was adapted from Wang et al. 
2016). Identical tandem mass spectra of extracts are processed by analytical software (e.g. MZmine2). After 
uploading processed data to the GNPS website and searching against GNPS libraries for dereplication of known 
compounds, the map of related molecules is visualized as a MN online in GNPS or by using the publicly available 
software Cytoscape. The subsequent targeted isolation of potential new compounds is guided by MN. 
Another remarkable advantage of GNPS lies in its continuous expansion of functions, thereby 
enabling researchers to select the appropriate tool for MS/MS data analysis among a variety of 
cheminformatic/database tools. Recently, GNPS has launched several newly developed analytical tools, 
such as in-silico tools, feature-based molecular networking, ReDU-MS2, GC-MS EI data analysis and 
MS2LDA-Motif database available on its website (https://gnps.ucsd.edu/ProteoSAFe/static/gnps-
splash.jsp). These tools substantially enlarged the application field of MN. Moreover, GNPS is a ‘living 
library’, providing the newest annotated natural products using the automated comparison between 
included spectra and newly added datasets generated by its users (Fox Ramos et al., 2019; Olivon et al., 
2017b; Wang et al., 2016; Xu et al., 2019). With the continued growth of GNPS spectral libraries, the 
number of matched known compounds in MN is expected to further increase over time, which further 
ameliorates the efficiency of natural products annotation. 
5.2. Molecular networking as a dereplication tool 
Mass spectrometry is a widely applied technology for analysis of crude extracts in natural product 
discovery studies. Resulting data are usually subject to manual comparison with public and 
commercially available natural product databases such as Dictionary of Natural Products (DNP), 
MarinLit and Reaxys to avoid re-isolation of known compounds (dereplication) (Nielsen et al., 2011). 
MN has been confirmed to be a useful complement to the current MS-based dereplication (Yang et al., 
2013). In several cases, the GNPS workflow provided a fast dereplication process for analyzing 
complex crude extracts (Kang et al., 2018; Maciá-Vicente et al., 2018; Mohimani and Pevzner, 2016). 
The main superiority of using MN in dereplication is that it does not only identify known molecules 
from complex crude extracts, but it also captures related analogues, which challenged other 
dereplication strategies (Yang et al., 2013). Hence, MN can be easily integrated into existing natural 
product discovery workflows to provide comprehensive guidance in the prospecting of new bioactive 
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substances. 
Although GNPS has curated more than 70000 spectra corresponding to known compounds, this is 
still a small number compared to the current number of known natural products. Hence, some alternative 
and complementary methods have been developed to surpass the limitations imposed by GNPS libraries. 
As an example, Allard and colleagues have implemented an extensive in-silico database (ISDB) from 
more than 170,000 natural products included in the Universal Natural Products Database (UNPD) 
(Allard et al., 2016). A total number of 170,602 compounds collected in UNPD have been fragmented 
in silico using the machine learning-based tool CMF-ID. This in-silico dereplication pipeline has been 
applied to dereplicate samples from various natural resources. For instance, application of UNPD-ISDB 
associated with MN resulted in the successful dereplication of marine-derived fungal co-cultivation 
extracts (Oppong-Danquah et al., 2018). A total number of 1370 nodes, grouped into 66 different 
chemical clusters, were observed in MN. The UNPD-ISDB aided the dereplication process that 
successfully annotated several known compounds, such as peptide emerimicins and sesterterpene 
ophiobolins from co-cultivation-derived crude extracts. 
5.3. Bioactivity-based molecular networking for rapid discovery of bioactive natural products 
The application of MN can be further enriched by associating MN with different data types such 
as biological activity, cultivation parameters (e.g. culture media) and genome information (Crüsemann 
et al., 2017; Mohimani and Pevzner, 2016; Nguyen et al., 2013; Purves et al., 2016). One important 
application is the combination of bioactivity data with MN to accelerate the biodiscovery process of 
putative bioactive natural products. The classical discovery process of bioactive natural compounds 
mainly relied on a bioactivity-based workflow, which can be generally described as an “extraction-
bioassay-isolation-bioassay-elucidation-bioassay” cycle (Fox Ramos et al., 2019). This traditional 
bioactivity-guided isolation has yielded several natural products which have resulted in FDA approved 
medicines for the treatment of numerous diseases (Noble, 1990; Oberlies and Kroll, 2004; Tu, 2011). 
However, it faces several challenges such as frequent rediscovery of known compounds, a time-
consuming purification process and frequent loss of activity during bioassay-guided fractionation. MN 
combined with bioactivity data has emerged as a useful tool to overcome these drawbacks and it further 
has been proven to facilitate and accelerate the isolation process for targeted discovery of new bioactive 
natural products (Li et al., 2018; Nothias et al., 2018; Olivon et al., 2017a).  
 
Figure 13. a) Neoguillauminin A isolated from two plants (Bocquillonia nervosa and Neoguillauminia cleopatra) 
based on ‘bioactivity mapping’ approach. b-c). Selective anti CHIKV deoxyphorbol esters isolated from 
Euphorbia dendroides (Euphorbiaceae) guided by bioactivity-based MN. 
Combining bioassay results with MN generated the so-called “bioactivity mapping” (Olivon et al., 
2017a). Bioactivity mapping classifies crude extracts or fractions according to their activity level 
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(reported as IC50/EC50 values) and then assigns different color tags to different bioactivity levels. This 
colorful mapping enables a simple visualization of nodes exclusively derived from bioactive extracts or 
fractions, thus enabling detection of potentially new bioactive scaffolds already at a very early stage of 
the analysis workflow. In a collection of 292 crude extracts from 107 New Caledonian Euphorbiaceae 
species, exploration of nodes frequently occurred in bioactive samples yielded the purification of a 
novel daphnane diterpene orthoester named neoguillauminin A from two plants (Bocquillonia 
nervosa and Neoguillauminia cleopatra). Neoguillauminin A showed anti-Chikungunya virus (CHIKV) 
bioactivity with EC50 value of 17.7μM (Figure 13a). Furthermore, application of statistical methods 
(Pearson correlation coefficient) to MN resulted in the development of a “bioactivity-based molecular 
networking (MN)”, which was first introduced by Nothias et al. (2018). Bioactivity-based MN 
optimized the natural products isolation process by the following steps: 1). Acquiring LC-MS/MS data 
and modifying data using LC-MS feature-based software such as MZmine2, detecting and quantifying 
the ions detected in crude extracts/fractions; 2). Calculating bioactivity scores using Pearson correlation 
method, thus taking into account the intensity of detected ion peaks and bioactivity level of each 
subfraction; 3).  Generating the MN using the GNPS derived feature-based platform, combining 
predicted bioactivity score and annotated dereplication in MN (Figure 14). This bioactivity-based MN 
approach has been applied to a latex extract from the plant Euphorbia dendroides (Euphorbiaceae) for 
reinvestigation of bioactive metabolites and yielded the isolation of two selective CHIKV replication 
inhibitors with half effective concentration (EC50) values of 0.40 μM and 0.60 μM (Nothias et al., 2018) 
(Figure 13b-c). Compared to traditional bioactivity-guided isolation, the bioactivity mapping or 
bioactivity-based MN reduced the “fractionation-test” iterative cycle through targeting predicted 
bioactive molecules, considerably saving time and money (Figure 14). To our knowledge, bioactivity-
based MN has not yet been applied for isolation of bioactive compounds from marine fungal extracts.  
 
Figure 14. Comparison between traditional bioactivity-based workflow and bioactivity mapping/bioactivity-
based molecular networking. (A). “Classical” bioassay-guided isolation (B). Bioactivity mapping/bioactivity-
based molecular networking. Figure was adapted from Nothias et al., 2018. 
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6. Research objective 
MAF are prolific sources of new SMs with excellent bioactivities (Teixeira et al., 2019; Zhang et 
al., 2016). However, epiphytic and endophytic fungi derived from Baltic Sea Fucus vesiculosus were 
rarely studied for their biodiscovery potential as of yet. Until now, the distribution as well as the 
anticancer potential of fungi associated with F. vesiculosus has not yet been investigated. As indicated 
by a previous study (Parrot et al., 2019), the fungal community associated with Baltic Sea F. vesiculosus 
showed great potential to produce new bioactive metabolites. Objective of this study was a biodiscovery 
approach targeting fungi associated to the brown algal species F. vesiculosus. Fungal isolates associated 
to the surface (epiphytes) and inner tissue (endophytes) of F. vesiculosus were studied for their potential 
to yield antincancer lead compunds. This is the first study investigating the fungal diversity associated 
to Fucus vesiculosus.  
In order to activate silent BGCs for production of new SMs, the OSMAC approach was applied to 
26 selected isolates to increase their chemical space. We aimed to test the applicability of molecular 
networking combined bioactivity in the biodiscovery workflow based on marine fungi. We applied a 
combination of bioactivity and MN on two different levels, i) bioactivity mapping of crude extracts for 
strain prioritization and ii) bioactivity-based MN on SPE fractions to enable a targeted isolation of novel 
compounds from the prioritized strains.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GENERAL INTRODUCTION   
22 
 
References 
Abastabar, M., Akbari, A., Akhtari, J., Hedayati, M. T., Shokohi, T., Mehrad-Majd, H., Ghalehnoei, H., 
Ghasemi, S., 2017. In vitro antitumor activity of patulin on cervical and colorectal cancer cell lines. 
Curr. Med. Mycol. 3, 25-29. DOI: 10.18869/acadpub.cmm.3.1.25 
Abdel-Gawad, K. M., Hifney, A. F., Issa, A. A., Gomaa, M., 2014. Spatio-temporal, environmental 
factors, and host identity shape culturable-epibiotic fungi of seaweeds in the Red Sea, Egypt. 
Hydrobiologia 740, 37-49. DOI: 10.1007/s10750-014-1935-0 
Abdel-Lateff, A., Fisch, K. M., Wright, A. D., Konig, G. M., 2003. A new antioxidant isobenzofuranone 
derivative from the algicolous marine fungus Epicoccum sp. Planta Med. 69, 831-834. DOI: 
10.1055/s-2003-43209 
Abdelwahab, M. F., Kurtán, T., Mándi, A., Müller, W. E. G., Fouad, M. A., Kamel, M. S., Liu, Z., 
Ebrahim, W., Daletos, G., Proksch, P., 2018. Induced secondary metabolites from the endophytic 
fungus Aspergillus versicolor through bacterial co-culture and OSMAC approaches. Tetrahedron 
Lett. 59, 2647-2652. DOI: 10.1016/j.tetlet.2018.05.067 
Allard, P.-M., Péresse, T., Bisson, J., Gindro, K., Marcourt, L., Pham, V. C., Roussi, F., Litaudon, M., 
Wolfender, J.-L., 2016. Integration of molecular networking and in-silico MS/MS fragmentation for 
natural products dereplication. Anal. Chem. 88, 3317-3323. DOI: 10.1021/acs.analchem.5b04804 
Amend, A. S., Barshis, D. J., Oliver, T. A., 2012. Coral-associated marine fungi form novel lineages 
and heterogeneous assemblages. ISME J. 6, 1291-1301. DOI: 10.1038/ismej.2011.193 
Ardehed, A., Johansson, D., Sundqvist, L., Schagerstrom, E., Zagrodzka, Z., Kovaltchouk, N. A., 
Bergstrom, L., Kautsky, L., Rafajlovic, M., Pereyra, R. T., Johannesson, K., 2016. Divergence within 
and among seaweed siblings (Fucus vesiculosus and F. radicans) in the Baltic Sea. PLOS ONE 11, 
e0161266-e0161281. DOI: 10.1371/journal.pone.0161266 
Arruebo, M., Vilaboa, N., Sáez-Gutierrez, B., Lambea, J., Tres, A., Valladares, M., González-Fernández, 
Á., 2011. Assessment of the evolution of cancer treatment therapies. Cancers 3, 3279-3330. DOI: 
10.3390/cancers3033279 
Baral, B., Akhgari, A., Metsä-Ketelä, M., 2018. Activation of microbial secondary metabolic pathways: 
Avenues and challenges. Syst. Synth. Biol. 3, 163-178. DOI: 10.1016/j.synbio.2018.09.001 
Bergmann, S., Schümann, J., Scherlach, K., Lange, C., Brakhage, A. A., Hertweck, C., 2007. Genomics-
driven discovery of PKS-NRPS hybrid metabolites from Aspergillus nidulans. Nat. Chem. Biol. 3, 
213-217. DOI: 10.1038/nchembio869 
Blayney, D. W., Huang, L., Mohanlal, R., 2019. A randomized phase 3 clinical trial of the combination 
of plinabulin (plin)+pegfilgrastim (peg) versus (vs) peg alone for tac (docetaxel, doxorubicin, 
cyclophosphamide) induced neutropenia (cin). Blood 134, 3590-3590. DOI: 10.1182/blood-2019-
127310 
Bode, H. B., Bethe, B., Höfs, R., Zeeck, A., 2002. Big effects from small changes: Possible ways to 
explore nature's chemical diversity. ChemBioChem 3, 619-627. DOI: 10.1002/1439-
7633(20020703)3:7<619::aid-cbic619>3.0.co;2-9 
Boyer, N., Morrison, K. C., Kim, J., Hergenrother, P. J., Movassaghi, M., 2013. Synthesis and anticancer 
activity of epipolythiodiketopiperazine alkaloids. Chem. Sci. 4, 1646-1657. DOI: 
10.1039/C3SC50174D 
Brakhage, A. A., Schuemann, J., Bergmann, S., Scherlach, K., Schroeckh, V., Hertweck, C., 2008. 
Activation of fungal silent gene clusters: A new avenue to drug discovery. In: Petersen, F., Amstutz, 
R. (Eds.), Natural Compounds as Drugs: Volume II. Birkhäuser Basel, Basel, pp. 1-12. DOI: 
10.1007/978-3-7643-8595-8_1 
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., Jemal, A., 2018. Global cancer 
statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 
countries. CA: Cancer J. Clin. 68, 394-424. DOI: 10.3322/caac.21492 
Bugni, T. S., Ireland, C. M., 2004. Marine-derived fungi: A chemically and biologically diverse group 
of microorganisms. Nat. Prod. Rep. 21, 143-163. DOI: 10.1039/b301926h 
Calvo, A. M., Wilson, R. A., Bok, J. W., Keller, N. P., 2002. Relationship between secondary metabolism 
and fungal development. Microbiol. Mol. Biol. Rev. 66, 447-459. DOI: 10.1128/mmbr.66.3.447-
459.2002 
Camila Dos Santos Dias, A., Couzinet-Mossion, A., Ruiz, N., Le Bellec, M., Gentil, E., Wielgosz-Collin, 
  GENERAL INTRODUCTION 
23 
 
G., Bertrand, S., 2017. Sugar induced modification in glycolipid production in Acremonium sp. 
revealed by LC-MS lipidomic approach. Curr. Biotechnol. 6, 227-237. DOI: 
10.2174/2211550105666160922130029 
Chai, Y.-J., Cui, C.-B., Li, C.-W., Wu, C.-J., Tian, C.-K., Hua, W., 2012. Activation of the dormant 
secondary metabolite production by introducing gentamicin-resistance in a marine-derived 
Penicillium purpurogenum G59. Mar. Drugs 10, 559-582. DOI: 10.3390/md10030559 
Chen, Q., Jiang, J. R., Zhang, G. Z., Cai, L., Crous, P. W., 2015. Resolving the Phoma enigma. Stud. 
Mycol. 82, 137-217. DOI: 10.1016/j.simyco.2015.10.003 
Chiang, Y.-M., Szewczyk, E., Davidson, A. D., Keller, N., Oakley, B. R., Wang, C. C. C., 2009. A gene 
cluster containing two fungal polyketide synthases encodes the biosynthetic pathway for a 
polyketide, asperfuranone, in Aspergillus nidulans. J. Am. Chem. Soc. 131, 2965-2970. DOI: 
10.1021/ja8088185 
Choi, B.-K., Trinh, P. T. H., Lee, H.-S., Choi, B.-W., Kang, J. S., Ngoc, N. T. D., Van, T. T. T., Shin, H. 
J., 2019. New ophiobolin derivatives from the marine fungus Aspergillus flocculosus and their 
cytotoxicities against cancer cells. Mar. Drugs 17, 346. DOI: 10.3390/md17060346 
Cimino, P. J., Huang, L., Du, L., Wu, Y., Bishop, J., Dalsing-Hernandez, J., Kotlarczyk, K., Gonzales, 
P., Carew, J., Nawrocki, S., Jordan, M. A., Wilson, L., Lloyd, G. K., Wirsching, H. G., 2019. 
Plinabulin, an inhibitor of tubulin polymerization, targets KRAS signaling through disruption of 
endosomal recycling. Biomed. Rep. 10, 218-224. DOI: 10.3892/br.2019.1196 
Clipson, N. J. W., Jennings, D. H., 1992. Dendryphiella salina and Debaryomyces hansenii: Models for 
ecophysical adaptation to salinity by fungi that grow in the sea. Can. J. Bot. 70, 2097-2105. DOI: 
10.1139/b92-260 
Crüsemann, M., O’Neill, E. C., Larson, C. B., Melnik, A. V., Floros, D. J., da Silva, R. R., Jensen, P. R., 
Dorrestein, P. C., Moore, B. S., 2017. Prioritizing natural product diversity in a collection of 146 
bacterial strains based on growth and extraction protocols. J. Nat. Prod. 80, 588-597. DOI: 
10.1021/acs.jnatprod.6b00722 
Cueto, M., Jensen, P. R., Kauffman, C., Fenical, W., Lobkovsky, E., Clardy, J., 2001. Pestalone, a new 
antibiotic produced by a marine fungus in response to bacterial challenge. J. Nat. Prod. 64, 1444-
1446. DOI: 10.1021/np0102713 
Dalsgaard, P. W., Blunt, J. W., Munro, M. H. G., Frisvad, J. C., Christophersen, C., 2005. Communesins 
G and H, new alkaloids from the psychrotolerant fungus Penicillium rivulum. J. Nat. Prod. 68, 258-
261. DOI: 10.1021/np049646l 
de Gruyter, J., Woudenberg, J. H. C., Aveskamp, M. M., Verkley, G. J. M., Groenewald, J. Z., Crous, P. 
W., 2010. Systematic reappraisal of species in Phoma section Paraphoma, Pyrenochaeta and 
Pleurophoma. Mycologia 102, 1066-1081. DOI: 10.3852/09-240 
de Gruyter, J., Woudenberg, J. H. C., Aveskamp, M. M., Verkley, G. J. M., Groenewald, J. Z., Crous, P. 
W., 2013. Redisposition of Phoma-like anamorphs in Pleosporales. Stud. Mycol. 75, 1-36. DOI: 
10.3114/sim0004 
Du, Z.-Y., Zienkiewicz, K., Vande Pol, N., Ostrom, N. E., Benning, C., Bonito, G. M., 2019. Algal-
fungal symbiosis leads to photosynthetic mycelium. eLife 8, e47815-e47836. DOI: 
10.7554/eLife.47815 
Egan, S., Harder, T., Burke, C., Steinberg, P., Kjelleberg, S., Thomas, T., 2013. The seaweed holobiont: 
Understanding seaweed-bacteria interactions. FEMS Microbiol. Rev. 37, 462-476. DOI: 
10.1111/1574-6976.12011 
Elsebai, M. F., Natesan, L., Kehraus, S., Mohamed, I. E., Schnakenburg, G., Sasse, F., Shaaban, S., 
Gütschow, M., König, G. M., 2011. HLE-inhibitory alkaloids with a polyketide skeleton from the 
marine-derived fungus Coniothyrium cereale. J. Nat. Prod. 74, 2282-2285. DOI: 
10.1021/np2004227 
English, A. L., Boufridi, A., Quinn, R. J., Kurtböke, D. I., 2017. Evaluation of fermentation conditions 
triggering increased antibacterial activity from a near-shore marine intertidal environment-
associated Streptomyces species. Syst. Synth. Biol. 2, 28-38. DOI: 10.1016/j.synbio.2016.09.005 
Fenical, W., Jensen, P. R., Cheng, X. C., 2000. Halimide, a cytotoxic marine natural product, and 
derivatives thereof. World Intellectual Property Organization.  
Flewelling, A., J., Johnson, J. A., Gray, C. A., 2013a. Isolation and bioassay screening of fungal 
endophytes from North Atlantic marine macroalgae. Bot. Mar. 56, 287-297. DOI: 10.1515/bot-2012-
GENERAL INTRODUCTION   
24 
 
0224 
Flewelling, A. J., Currie, J., Gray, C. A., Johnson, J. A., 2015. Endophytes from marine macroalgae: 
Promising sources of novel natural products. Curr. Sci. 109, 88-111. Web: www. 
jstor.org/stable/24905694 
Flewelling, A. J., Ellsworth, K. T., Sanford, J., Forward, E., Johnson, J. A., Gray, C. A., 2013b. 
Macroalgal endophytes from the Atlantic coast of Canada: A potential source of antibiotic natural 
products? Microorganisms 1, 175-187. DOI: 10.3390/microorganisms1010175 
Flewelling, A. J., Johnson, J. A., Gray, C. A., 2013c. Antimicrobials from the marine algal endophyte 
Penicillium sp. Nat. Prod. Commun. 8, 373-374. DOI: 10.1177/1934578X1300800324 
Fox Ramos, A. E., Evanno, L., Poupon, E., Champy, P., Beniddir, M. A., 2019. Natural products 
targeting strategies involving molecular networking: Different manners, one goal. Nat. Prod. Rep. 
36, 960-980. DOI: 10.1039/C9NP00006B 
Fukumoto, K., Kohno, S., Kanoh, K., Asari, T., Kawashima, H., Sekiya, H., Ohmizo, K., Harada, T., 
2002. Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds. United 
States Patent.  
Fulton, C. J., Abesamis, R. A., Berkström, C., Depczynski, M., Graham, N. A. J., Holmes, T. H., 
Kulbicki, M., Noble, M. M., Radford, B. T., Tano, S., Tinkler, P., Wernberg, T., Wilson, S. K., 2019. 
Form and function of tropical macroalgal reefs in the Anthropocene. Funct. Ecol. 33, 989-999. DOI: 
10.1111/1365-2435.13282 
Garbary, D. J., MacDonald, K. A., 1995. The ascophyllum/polysiphonia/mycosphaerella symbiosis. IV. 
mutualism in the ascophyllum/mycosphaerella interaction. Bot. Mar. 38, 221-225. DOI: 
10.1515/botm.1995.38.1-6.221 
Gnavi, G., Garzoli, L., Poli, A., Prigione, V., Burgaud, G., Varese, G. C., 2017. The culturable mycobiota 
of Flabellia petiolata: First survey of marine fungi associated to a Mediterranean green alga. PLOS 
ONE 12, e0175941-e0175960. DOI: 10.1371/journal.pone.0175941 
Gomes, N. G. M., Lefranc, F., Kijjoa, A., Kiss, R., 2015. Can some marine-derived fungal metabolites 
become actual anticancer agents? Mar. Drugs 13, 3950-3991. DOI: 10.3390/md13063950 
Greve, H., Schupp, P. J., Eguereva, E., Kehraus, S., Kelter, G., Maier, A., Fiebig, H.-H., König, G. M., 
2008. Apralactone A and a new stereochemical class of curvularins from the marine fungus 
Curvularia sp. Eur. J. Org. Chem. 2008, 5085-5092. DOI: 10.1002/ejoc.200800522 
Gulder, T. A. M., Hong, H., Correa, J., Egereva, E., Wiese, J., Imhoff, J. F., Gross, H., 2012. Isolation, 
structure elucidation and total synthesis of lajollamide A from the marine fungus Asteromyces 
cruciatus. Mar. Drugs 10, 2912-2935. DOI: 10.3390/md10122912 
Gutiérrez, M. H., Pantoja, S., Tejos, E., Quiñones, R. A., 2011. The role of fungi in processing marine 
organic matter in the upwelling ecosystem off Chile. Mar. Biol. 158, 205-219. DOI: 10.1007/s00227-
010-1552-z 
Gutiérrez, S., Marcos, A. T., Casqueiro, J., Kosalková, K., Fernández, F. J., Velasco, J., Martín, J. F., 
1999. Transcription of the pcbAB, pcbC and penDE genes of Penicillium chrysogenum AS-P-78 is 
repressed by glucose and the repression is not reversed by alkaline pHs. Microbiology 145, 317-324. 
DOI: 10.1099/13500872-145-2-317 
Hemphill, C. F. P., Sureechatchaiyan, P., Kassack, M. U., Orfali, R. S., Lin, W., Daletos, G., Proksch, 
P., 2017. OSMAC approach leads to new fusarielin metabolites from Fusarium tricinctum. J. 
Antibiot. 70, 726-732. DOI: 10.1038/ja.2017.21 
Hewage, R. T., Aree, T., Mahidol, C., Ruchirawat, S., Kittakoop, P., 2014. One-strain-many-compounds 
(OSMAC) method for production of polyketides, azaphilones, and an isochromanone using the 
endophytic fungus Dothideomycete sp. Phytochemistry 108, 87-94. DOI: 
10.1016/j.phytochem.2014.09.013 
Huang, C.-Y., Ju, D.-T., Chang, C.-F., Muralidhar Reddy, P., Velmurugan, B. K., 2017. A review on the 
effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer. 
Biomedicine (Taipei) 7, 12-23. DOI: 10.1051/bmdcn/2017070423 
Hubert, J., Nuzillard, J.-M., Renault, J.-H., 2017. Dereplication strategies in natural product research: 
How many tools and methodologies behind the same concept? Phytochem. Rev. 16, 55-95. DOI: 
10.1007/s11101-015-9448-7 
Imhoff, J. F., 2016. Natural products from marine fungi-still an underrepresented resource. Mar. Drugs 
14, 19. DOI: 10.3390/md14010019 
  GENERAL INTRODUCTION 
25 
 
Jadulco, R., Edrada, R. A., Ebel, R., Berg, A., Schaumann, K., Wray, V., Steube, K., Proksch, P., 2004. 
New communesin derivatives from the fungus Penicillium sp. derived from the Mediterranean 
sponge Axinella verrucosa. J. Nat. Prod. 67, 78-81. DOI: 10.1021/np030271y 
Ji, N.-Y., Wang, B.-G., 2016. Mycochemistry of marine algicolous fungi. Fungal Divers. 80, 301-342. 
DOI: 10.1007/s13225-016-0358-9 
Jiménez-Medina, E., Berruguilla, E., Romero, I., Algarra, I., Collado, A., Garrido, F., Garcia-Lora, A., 
2008. The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest 
of cell cycle and induction of apoptosis. BMC Cancer 8, 78. DOI: 10.1186/1471-2407-8-78 
Jones, E. B. G., 2011. Are there more marine fungi to be described? Bot. Mar. 54, 343. DOI: 
10.1515/bot.2011.043 
Jones, E. B. G., Pang, K.-L., Abdel-Wahab, M. A., Scholz, B., Hyde, K. D., Boekhout, T., Ebel, R., 
Rateb, M. E., Henderson, L., Sakayaroj, J., Suetrong, S., Dayarathne, M. C., Kumar, V., Raghukumar, 
S., Sridhar, K. R., Bahkali, A. H. A., Gleason, F. H., Norphanphoun, C., 2019. An online resource 
for marine fungi. Fungal Divers. 96, 347-433. DOI: 10.1007/s13225-019-00426-5 
Jones, E. B. G., Suetrong, S., Sakayaroj, J., Bahkali, A. H., Abdel-Wahab, M. A., Boekhout, T., Pang, 
K.-L., 2015. Classification of marine bscomycota, basidiomycota, blastocladiomycota and 
chytridiomycota. Fungal Divers. 73, 1-72. DOI: 10.1007/s13225-015-0339-4 
Jones, E. G., 2000. Marine fungi: some factors influencing biodiversity. Fungal Divers. 4, 53-73.  
Kang, K. B., Park, E. J., da Silva, R. R., Kim, H. W., Dorrestein, P. C., Sung, S. H., 2018. Targeted 
isolation of neuroprotective dicoumaroyl neolignans and lignans from Sageretia theezans using in 
silico molecular network annotation propagation-based dereplication. J. Nat. Prod. 81, 1819-1828. 
DOI: 10.1021/acs.jnatprod.8b00292 
Kanoh, K., Kohno, S., Asari, T., Harada, T., Katada, J., Muramatsu, M., Kawashima, H., Sekiya, H., 
Uno, I., 1997. (-)-Phenylahistin: A new mammalian cell cycle inhibitor produced by Aspergillus 
ustus. Bioorg. Med. Chem. Lett. 7, 2847-2852. DOI: 10.1016/S0960-894X(97)10104-4 
Kanoh, K., Kohno, S., Katada, J., Takahashi, J., Uno, I., 1999a. (-)-Phenylahistin arrests cells in mitosis 
by inhibiting tubulin polymerization. J. Antibiot. 52, 134-141. DOI: 10.7164/antibiotics.52.134 
Kanoh, K., Kohno, S., Katada, J., Takahashi, J., Uno, I., Hayashi, Y., 1999b. Synthesis and biological 
activities of phenylahistin derivatives. Bioorg. Med. Chem. 7, 1451-1457. DOI: 10.1016/S0968-
0896(99)00059-0 
Kato, N., Nogawa, T., Takita, R., Kinugasa, K., Kanai, M., Uchiyama, M., Osada, H., Takahashi, S., 
2018. Control of the stereochemical course of [4+2] cycloaddition during trans-decalin formation 
by Fsa2-family enzymes. Angew. Chem. Int. Ed. 57, 9754-9758. DOI: 10.1002/anie.201805050 
Keller, N. P., Turner, G., Bennett, J. W., 2005. Fungal secondary metabolism-from biochemistry to 
genomics. Nat. Rev. Microbiol. 3, 937-947. DOI: 10.1038/nrmicro1286 
Kiran, G. S., Hema, T. A., Gandhimathi, R., Selvin, J., Thomas, T. A., Rajeetha Ravji, T., 
Natarajaseenivasan, K., 2009. Optimization and production of a biosurfactant from the sponge-
associated marine fungus Aspergillus ustus MSF3. Colloids Surf. B: Biointerfaces 73, 250-256. DOI: 
10.1016/j.colsurfb.2009.05.025 
Kohlmeyer, J., Kohlmeyer, E., 1979. Marine mycology: the higher fungi. Academic Press, New York. 
DOI: 10.1016/C2013-0-10998-1 
König, G. M., Kehraus, S., Seibert, S. F., Abdel-Lateff, A., Müller, D., 2006. Natural products from 
marine organisms and their associated microbes. ChemBioChem 7, 229-238. DOI: 
10.1002/cbic.200500087 
Kumar, A., Sørensen, J. L., Hansen, F. T., Arvas, M., Syed, M. F., Hassan, L., Benz, J. P., Record, E., 
Henrissat, B., Pöggeler, S., Kempken, F., 2018. Genome sequencing and analyses of two marine 
fungi from the North Sea unraveled a plethora of novel biosynthetic gene clusters. Sci. Rep. 8, 10187. 
DOI: 10.1038/s41598-018-28473-z 
Lang, G., Mitova, M. I., Ellis, G., van der Sar, S., Phipps, R. K., Blunt, J. W., Cummings, N. J., Cole, 
A. L. J., Munro, M. H. G., 2006. Bioactivity profiling using HPLC/microtiter-plate analysis:  
Application to a New Zealand marine alga-derived fungus, Gliocladium sp. J. Nat. Prod. 69, 621-
624. DOI: 10.1021/np0504917 
Leutou, A. S., Yun, K., Kang, J. S., Son, B. W., 2013. Induced production of methyl 
bromodihydroxyphenyl acetates by the marine-derived fungus Aspergillus sp. Chem. Pharm. Bull. 
61, 483-485. DOI: 10.1248/cpb.c12-01048 
GENERAL INTRODUCTION   
26 
 
Li, D., Liu, S., 2019. Chapter 9-Seawater quality detection. In: Li, D., Liu, S. (Eds.), Water Quality 
Monitoring and Management. Academic Press, pp. 233-249. DOI: 10.1016/B978-0-12-811330-
1.00009-0 
Li, F., Janussen, D., Peifer, C., Pérez-Victoria, I., Tasdemir, D., 2018. Targeted isolation of 
tsitsikammamines from the Antarctic deep-sea sponge Latrunculia biformis by molecular 
networking and anticancer activity. Mar. Drugs 16, 268. DOI: 10.3390/md16080268 
Li, Q., Wang, G., 2009. Diversity of fungal isolates from three Hawaiian marine sponges. Microbiol. 
Res. 164, 233-241. DOI: 10.1016/j.micres.2007.07.002 
Lin, Z., Zhu, T., Wei, H., Zhang, G., Wang, H., Gu, Q., 2009. Spicochalasin A and new aspochalasins 
from the marine-derived fungus Spicaria elegans. Eur. J. Org. Chem.. 2009, 3045-3051. DOI: 
10.1002/ejoc.200801085 
Liu, Y., Li, X.-M., Meng, L.-H., Jiang, W.-L., Xu, G.-M., Huang, C.-G., Wang, B.-G., 2015. 
Bisthiodiketopiperazines and acorane sesquiterpenes produced by the marine-derived fungus 
Penicillium adametzioides AS-53 on different culture media. J. Nat. Prod. 78, 1294-1299. DOI: 
10.1021/acs.jnatprod.5b00102 
Maciá-Vicente, J. G., Shi, Y.-N., Cheikh-Ali, Z., Grün, P., Glynou, K., Kia, S. H., Piepenbring, M., 
Bode, H. B., 2018. Metabolomics-based chemotaxonomy of root endophytic fungi for natural 
products discovery. Environ. Microbiol. 20, 1253-1270. DOI: 10.1111/1462-2920.14072 
Madhusudan, C., Manoj, S., Rahul, K., Rishi, C. M., 2011. Seaweeds: A diet with nutritional, medicinal 
and industrial value. Res. J. Med. Plant 5, 153-157. DOI: 10.3923/rjmp.2011.153.157 
Malm, T., Kautsky, L., 2003. Differences in life-history characteristics are consistent with the vertical 
distribution pattern of Fucus serratus and Fucs vesiculosus (Fucales, phaeophyceae) in the central 
Baltic Sea. J. Phycol. 39, 880-887. DOI: 10.1046/j.1529-8817.2003.02115.x 
Margulis, L., 1990. Words as battle cries: Symbiogenesis and the new field of endocytobiology. 
BioScience 40, 673-677. DOI: 10.2307/1311435 
Meng, L.-H., Li, X.-M., Liu, Y., Xu, G.-M., Wang, B.-G., 2017. Antimicrobial alkaloids produced by 
the mangrove endophyte Penicillium brocae MA-231 using the OSMAC approach. RSC Adv. 7, 
55026-55033. DOI: 10.1039/C7RA12081H 
Miao, L., Kwong, T. F. N., Qian, P.-Y., 2006. Effect of culture conditions on mycelial growth, 
antibacterial activity, and metabolite profiles of the marine-derived fungus Arthrinium c. f. 
saccharicola. Appl. Microbiol. Biot. 72, 1063-1073. DOI: 10.1007/s00253-006-0376-8 
Mohimani, H., Pevzner, P. A., 2016. Dereplication, sequencing and identification of peptidic natural 
products: From genome mining to peptidogenomics to spectral networks. Nat. Prod. Rep. 33, 73-86. 
DOI: 10.1039/C5NP00050E 
Montaser, R., Luesch, H., 2011. Marine natural products: A new wave of drugs? Future Med. Chem. 3, 
1475-1489. DOI: 10.4155/fmc.11.118 
Murdoch, J. M., Speirs, C. F., Geddes, A. M., Wallace, E. T., 1964. Clinical trial of cephaloridine 
(ceporin), a new broad-spectrum antibiotic derived from cephalosporin C. Br. Med, J. 2, 1238-1240. 
DOI: 10.1136/bmj.2.5419.1238 
Nguyen, D. D., Wu, C.-H., Moree, W. J., Lamsa, A., Medema, M. H., Zhao, X., Gavilan, R. G., Aparicio, 
M., Atencio, L., Jackson, C., Ballesteros, J., Sanchez, J., Watrous, J. D., Phelan, V. V., van de Wiel, 
C., Kersten, R. D., Mehnaz, S., De Mot, R., Shank, E. A., Charusanti, P., Nagarajan, H., Duggan, B. 
M., Moore, B. S., Bandeira, N., Palsson, B. Ø., Pogliano, K., Gutiérrez, M., Dorrestein, P. C., 2013. 
MS/MS networking guided analysis of molecule and gene cluster families. PNAS 110, E2611-E2620. 
DOI: 10.1073/pnas.1303471110 
Nielsen, K. F., Månsson, M., Rank, C., Frisvad, J. C., Larsen, T. O., 2011. Dereplication of microbial 
natural products by LC-DAD-TOFMS. J. Nat. Prod. 74, 2338-2348. DOI: 10.1021/np200254t 
Noble, R. L., 1990. The discovery of the vinca alkaloids-chemotherapeutic agents against cancer. 
Biochem. Cell. Biol. 68, 1344-1351. DOI: 10.1139/o90-197 
Nogawa, T., Kato, N., Shimizu, T., Okano, A., Futamura, Y., Takahashi, S., Osada, H., 2017. 
Wakodecalines A and B, new decaline metabolites isolated from a fungus Pyrenochaetopsis sp. 
RK10-F058. J. Antibiot. 71, 123-128. DOI: 10.1038/ja.2017.103 
Nothias, L.-F., Nothias-Esposito, M., da Silva, R., Wang, M., Protsyuk, I., Zhang, Z., Sarvepalli, A., 
Leyssen, P., Touboul, D., Costa, J., Paolini, J., Alexandrov, T., Litaudon, M., Dorrestein, P. C., 2018. 
Bioactivity-based molecular networking for the discovery of drug leads in natural product bioassay-
  GENERAL INTRODUCTION 
27 
 
guided fractionation. J. Nat. Prod. 81, 758-767. DOI: 10.1021/acs.jnatprod.7b00737 
Numata, A., Takahashi, C., Ito, Y., Takada, T., Kawai, K., Usami, Y., Matsumura, E., Imachi, M., Ito, T., 
Hasegawa, T., 1993. Communesins, cytotoxic metabolites of a fungus isolated from a marine alga. 
Tetrahedron Lett. 34, 2355-2358. DOI: 10.1016/S0040-4039(00)77612-X 
Núñez-Pons, L., Avila, C., Romano, G., Verde, C., Giordano, D., 2018. UV-Protective compounds in 
marine organisms from the Southern Ocean. Mar. Drugs 16, 336. DOI: 10.3390/md16090336 
O'Malley, M. A., 2017. From endosymbiosis to holobionts: Evaluating a conceptual legacy. J. Theor. 
Biol. 434, 34-41. DOI: 10.1016/j.jtbi.2017.03.008 
Oberlies, N. H., Kroll, D. J., 2004. Camptothecin and taxol: Historic achievements in natural products 
research. J. Nat. Prod. 67, 129-135. DOI: 10.1021/np030498t 
Ogaki, M. B., de Paula, M. T., Ruas, D., Pellizzari, F. M., García-Laviña, C. X., Rosa, L. H., 2019. 
Marine fungi associated with Antarctic macroalgae. In: Castro-Sowinski, S. (Ed.), The ecological 
role of micro-organisms in the Antarctic environment. Springer International Publishing, Cham, pp. 
239-255. DOI: 10.1007/978-3-030-02786-5_11 
Olivon, F., Allard, P.-M., Koval, A., Righi, D., Genta-Jouve, G., Neyts, J., Apel, C., Pannecouque, C., 
Nothias, L.-F., Cachet, X., Marcourt, L., Roussi, F., Katanaev, V. L., Touboul, D., Wolfender, J.-L., 
Litaudon, M., 2017a. Bioactive natural products prioritization using massive multi-informational 
molecular networks. ACS Chem. Biol 12, 2644-2651. DOI: 10.1021/acschembio.7b00413 
Olivon, F., Grelier, G., Roussi, F., Litaudon, M., Touboul, D., 2017b. MZmine2 data-preprocessing to 
enhance molecular networking reliability. Anal. Chem. 89, 7836-7840. DOI: 
10.1021/acs.analchem.7b01563 
Olivon, F., Roussi, F., Litaudon, M., Touboul, D., 2017c. Optimized experimental workflow for tandem 
mass spectrometry molecular networking in metabolomics. Anal. Bioanal. Chem. 409, 5767-5778. 
DOI: 10.1007/s00216-017-0523-3 
Oppong-Danquah, E., Parrot, D., Blümel, M., Labes, A., Tasdemir, D., 2018. Molecular networking-
based metabolome and bioactivity analyses of marine-adapted fungi co-cultivated with 
phytopathogens. Front. Microbiol. 9, 2072. DOI: 10.3389/fmicb.2018.02072 
Orsi, W. D., Richards, T. A., Santoro, A. E., 2015. Cellular maintenance processes that potentially 
underpin the survival of subseafloor fungi over geological timescales. Estuar. Coast. Shelf Sci. 164, 
A1-A9. DOI: 10.1016/j.ecss.2015.04.009 
Osterhage, C., Kaminsky, R., König, G. M., Wright, A. D., 2000. Ascosalipyrrolidinone A, an 
antimicrobial alkaloid, from the obligate marine fungus Ascochyta salicorniae. J. Org. Chem. 65, 
6412-6417. DOI: 10.1021/jo000307g 
Osterhage, C., König, G. M., Jones, P. G., Wright, A. D., 2002. 5-Hydroxyramulosin, a new natural 
product produced by Phoma tropica, a marine-derived fungus isolated from the alga Fucus spiralis. 
Planta Med. 68, 1052-1054. DOI: 10.1055/s-2002-35670 
Overy, D. P., Bayman, P., Kerr, R. G., Bills, G. F., 2014. An assessment of natural product discovery 
from marine (sensu strictu) and marine-derived fungi. Mycology 5, 145-167. DOI: 
10.1080/21501203.2014.931308 
Özkaya, F. C., Ebrahim, W., El-Neketi, M., Tansel Tanrıkul, T., Kalscheuer, R., Müller, W. E. G., Guo, 
Z., Zou, K., Liu, Z., Proksch, P., 2018. Induction of new metabolites from sponge-associated fungus 
Aspergillus carneus by OSMAC approach. Fitoterapia 131, 9-14. DOI: 10.1016/j.fitote.2018.10.008 
Parrot, D., Blümel, M., Utermann, C., Chianese, G., Krause, S., Kovalev, A., Gorb, S. N., Tasdemir, D., 
2019. Mapping the surface microbiome and metabolome of brown seaweed Fucus vesiculosus by 
amplicon sequencing, integrated metabolomics and imaging techniques. Sci. Rep. 9, 1061-1077. 
DOI: 10.1038/s41598-018-37914-8 
Petersen, L.-E., Kellermann, M. Y., Schupp, P. J., 2020. Secondary metabolites of marine microbes: 
From natural products chemistry to chemical ecology. In: Jungblut, S., Liebich, V., Bode-Dalby, M. 
(Eds.), YOUMARES 9 - The Oceans: Our Research, Our Future: Proceedings of the 2018 conference 
for YOUng MArine RESearcher in Oldenburg, Germany. Springer International Publishing, Cham, 
pp. 159-180. DOI: 10.1007/978-3-030-20389-4_8 
Purves, K., Macintyre, L., Brennan, D., Hreggviðsson, G. Ó., Kuttner, E., Ásgeirsdóttir, M. E., Young, 
L. C., Green, D. H., Edrada-Ebel, R., Duncan, K. R., 2016. Using molecular networking for 
microbial secondary metabolite bioprospecting. Metabolites 6, 2. DOI: 10.3390/metabo6010002 
Rateb, M. E., Ebel, R., 2011. Secondary metabolites of fungi from marine habitats. Nat. Prod. Rep. 28, 
GENERAL INTRODUCTION   
28 
 
290-344. DOI: 10.1039/C0NP00061B 
Rédou, V., Navarri, M., Meslet-Cladière, L., Barbier, G., Burgaud, G., 2015. Species richness and 
adaptation of marine fungi from deep-subseafloor sediments. Appl. Environ. Microbiol. 81, 3571-
3583. DOI: 10.1128/aem.04064-14 
Reen, F. J., Romano, S., Dobson, A. D. W., Gara, F., 2015. The sound of silence: Activating silent 
biosynthetic gene clusters in marine microorganisms. Mar. Drugs 13, 4754-4783. DOI: 
10.3390/md13084754 
Reich, M., Labes, A., 2017. How to boost marine fungal research: A first step towards a 
multidisciplinary approach by combining molecular fungal ecology and natural products chemistry. 
Mar. Genomics 36, 57-75. DOI: 10.1016/j.margen.2017.09.007 
Richards, T. A., Jones, M. D. M., Leonard, G., Bass, D., 2012. Marine fungi: Their ecology and 
molecular diversity. Annu. Rev. Mar. Sci. 4, 495-522. DOI: 10.1146/annurev-marine-120710-
100802 
Rokas, A., Mead, M. E., Steenwyk, J. L., Raja, H. A., Oberlies, N. H., 2020. Biosynthetic gene clusters 
and the evolution of fungal chemodiversity. Nat. Prod. Rep. DOI: 10.1039/C9NP00045C 
Rokas, A., Wisecaver, J. H., Lind, A. L., 2018. The birth, evolution and death of metabolic gene clusters 
in fungi. Nat. Rev. Microbiol. 16, 731-744. DOI: 10.1038/s41579-018-0075-3 
Romano, S., Jackson, S. A., Patry, S., Dobson, A. D. W., 2018. Extending the “One-Strain-Many-
Compounds” (OSMAC) pinciple to mrine mcroorganisms. Mar. Drugs 16, 244. 
DOI:10.3390/md16070244 
Ruiz, B., Chávez, A., Forero, A., García-Huante, Y., Romero, A., Sánchez, M., Rocha, D., Sánchez, B., 
Rodríguez-Sanoja, R., Sánchez, S., Langley, E., 2010. Production of microbial secondary 
metabolites: Regulation by the carbon source. Crit. Rev. Microbiol. 36, 146-167. DOI: 
10.3109/10408410903489576 
Rutledge, P. J., Challis, G. L., 2015. Discovery of microbial natural products by activation of silent 
biosynthetic gene clusters. Nat. Rev. Microbiol. 13, 509-523. DOI: 10.1038/nrmicro3496 
Sánchez, S., Chávez, A., Forero, A., García-Huante, Y., Romero, A., Sánchez, M., Rocha, D., Sánchez, 
B., Ávalos, M., Guzmán-Trampe, S., Rodríguez-Sanoja, R., Langley, E., Ruiz, B., 2010. Carbon 
source regulation of antibiotic production. J. Antibiot. 63, 442-459. DOI: 10.1038/ja.2010.78 
Santiago, C., Fitchett, C., Munro, M. H., Jalil, J., Santhanam, J., 2012. Cytotoxic and antifungal 
activities of 5-hydroxyramulosin, a compound produced by an endophytic fungus isolated from 
Cinnamomum mollisimum. Evid-based. compl. alt. 2012, 689310-689315. DOI: 
10.1155/2012/689310 
Silber, J., Kramer, A., Labes, A., Tasdemir, D., 2016. From discovery to production: Biotechnology of 
marine fungi for the production of new antibiotics. Mar. Drugs 14, 137. DOI:10.3390/md14070137 
Singh, S. B., Zink, D. L., Goetz, M. A., Dombrowski, A. W., Polishook, J. D., Hazuda, D. J., 1998. 
Equisetin and a novel opposite stereochemical homolog phomasetin, two fungal metabolites as 
inhibitors of HIV-1 integrase. Tetrahedron Lett. 39, 2243-2246. DOI: 10.1016/S0040-
4039(98)00269-X 
Smetanina, O. F., Yurchenko, A. N., Ivanets, E. V., Kirichuk, N. N., Khudyakova, Y. V., Yurchenko, E. 
A., Afiyatullov, S. S., 2016. Metabolites of the marine fungus Penicillium citrinum associated with 
a brown alga Padina sp. Chem. Nat. Compd. 52, 111-112. DOI: 10.1007/s10600-016-1560-4 
Sun, H.-F., Li, X.-M., Meng, L., Cui, C.-M., Gao, S.-S., Li, C.-S., Huang, C.-G., Wang, B.-G., 2012. 
Asperolides A-C, tetranorlabdane diterpenoids from the marine alga-derived endophytic fungus 
Aspergillus wentii EN-48. J. Nat. Prod. 75, 148-152. DOI: 10.1021/np2006742 
Sutherland, G. K., 1915. New marine fungi on Pelvetia. New Phytol. 14, 33-42. DOI: 10.1111/j.1469-
8137.1915.tb07171.x 
Takahashi, C., Numata, A., Ito, Y., Matsumura, E., Araki, H., Iwaki, H., Kushida, K., 1994a. Leptosins, 
antitumour metabolites of a fungus isolated from a marine alga. Perkin Trans. 1, 1859-1864. DOI: 
10.1039/P19940001859 
Takahashi, C., Numata, A., Matsumura, E., Minoura, K., Eto, H., Shingu, T., Ito, T., Hasegawa, T., 
1994b. Leptosins I and J, cytotoxic substances produced by a Leptosphaeria sp. Physico-chemical 
properties and structures. J. Antibiot. 47, 1242-1249. DOI: 10.7164/antibiotics.47.1242 
Teixeira, T. R., Santos, G. S. d., Armstrong, L., Colepicolo, P., Debonsi, H. M., 2019. Antitumor 
potential of seaweed derived-endophytic fungi. Antibiotics 8, 205. DOI: 10.3390/antibiotics8040205 
  GENERAL INTRODUCTION 
29 
 
Tu, Y., 2011. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat. Med. 17, 
1217-1220. DOI: 10.1038/nm.2471 
Unsöld, I. A., Li, S.-M., 2006. Reverse prenyltransferase in the biosynthesis of fumigaclavine C in 
Aspergillus fumigatus: Gene expression, purification, and characterization of fumigaclavine C 
synthase FGAPT1. ChemBioChem 7, 158-164. DOI: 10.1002/cbic.200500318 
Usami, Y., Aoki, S., Hara, T., Numata, A., 2002. New dioxopiperazine metabolites from a Fusarium 
species separated from a marine alga. J. Antibiot. 55, 655-659. DOI: 10.7164/antibiotics.55.655 
Vala, A. K., 2010. Tolerance and removal of arsenic by a facultative marine fungus Aspergillus candidus. 
Bioresour. Technol. 101, 2565-2567. DOI: 10.1016/j.biortech.2009.11.084 
Valenzuela-Lopez, N., Cano-Lira, J. F., Guarro, J., Sutton, D. A., Wiederhold, N., Crous, P. W., Stchigel, 
A. M., 2018. Coelomycetous dothideomycetes with emphasis on the families Cucurbitariaceae and 
Didymellaceae. Stud. Mycol. 90, 1-69. DOI: 10.1016/j.simyco.2017.11.003 
Vallet, M., Strittmatter, M., Murúa, P., Lacoste, S., Dupont, J., Hubas, C., Genta-Jouve, G., Gachon, C. 
M. M., Kim, G. H., Prado, S., 2018. Chemically-mediated interactions between macroalgae, their 
fungal endophytes, and protistan pathogens. Front. Microbiol. 9, 3161-3161. DOI: 
10.3389/fmicb.2018.03161 
Wang, F.-W., 2012. Bioactive metabolites from Guignardia sp., an endophytic fungus residing in 
Undaria pinnatifida. Chin. J. Nat. Medicines 10, 72-76. DOI: 10.1016/S1875-5364(12)60016-8 
Wang, H., Eze, P. M., Höfert, S.-P., Janiak, C., Hartmann, R., Okoye, F. B. C., Esimone, C. O., Orfali, 
R. S., Dai, H., Liu, Z., Proksch, P., 2018. Substituted L-tryptophan-L-phenyllactic acid conjugates 
produced by an endophytic fungus Aspergillus aculeatus using an OSMAC approach. RSC Adv. 8, 
7863-7872. DOI: 10.1039/C8RA00200B 
Wang, M., Carver, J. J., Phelan, V. V., Sanchez, L. M., Garg, N., Peng, Y., Nguyen, D. D., Watrous, J., 
Kapono, C. A., Luzzatto-Knaan, T., Porto, C., Bouslimani, A., Melnik, A. V., Meehan, M. J., Liu, 
W.-T., Crüsemann, M., Boudreau, P. D., Esquenazi, E., Sandoval-Calderón, M., Kersten, R. D., Pace, 
L. A., Quinn, R. A., Duncan, K. R., Hsu, C.-C., Floros, D. J., Gavilan, R. G., Kleigrewe, K., Northen, 
T., Dutton, R. J., Parrot, D., Carlson, E. E., Aigle, B., Michelsen, C. F., Jelsbak, L., Sohlenkamp, C., 
Pevzner, P., Edlund, A., McLean, J., Piel, J., Murphy, B. T., Gerwick, L., Liaw, C.-C., Yang, Y.-L., 
Humpf, H.-U., Maansson, M., Keyzers, R. A., Sims, A. C., Johnson, A. R., Sidebottom, A. M., Sedio, 
B. E., Klitgaard, A., Larson, C. B., Boya P, C. A., Torres-Mendoza, D., Gonzalez, D. J., Silva, D. B., 
Marques, L. M., Demarque, D. P., Pociute, E., O'Neill, E. C., Briand, E., Helfrich, E. J. N., 
Granatosky, E. A., Glukhov, E., Ryffel, F., Houson, H., Mohimani, H., Kharbush, J. J., Zeng, Y., 
Vorholt, J. A., Kurita, K. L., Charusanti, P., McPhail, K. L., Nielsen, K. F., Vuong, L., Elfeki, M., 
Traxler, M. F., Engene, N., Koyama, N., Vining, O. B., Baric, R., Silva, R. R., Mascuch, S. J., Tomasi, 
S., Jenkins, S., Macherla, V., Hoffman, T., Agarwal, V., Williams, P. G., Dai, J., Neupane, R., Gurr, 
J., Rodríguez, A. M. C., Lamsa, A., Zhang, C., Dorrestein, K., Duggan, B. M., Almaliti, J., Allard, 
P.-M., Phapale, P., Nothias, L.-F., Alexandrov, T., Litaudon, M., Wolfender, J.-L., Kyle, J. E., Metz, 
T. O., Peryea, T., Nguyen, D.-T., VanLeer, D., Shinn, P., Jadhav, A., Müller, R., Waters, K. M., Shi, 
W., Liu, X., Zhang, L., Knight, R., Jensen, P. R., Palsson, B. Ø., Pogliano, K., Linington, R. G., 
Gutiérrez, M., Lopes, N. P., Gerwick, W. H., Moore, B. S., Dorrestein, P. C., Bandeira, N., 2016. 
Sharing and community curation of mass spectrometry data with Global Natural Products Social 
Molecular Networking. Nat. Biotechnol. 34, 828-837. DOI: 10.1038/nbt.3597 
Wang, W.-J., Li, D.-Y., Li, Y.-C., Hua, H.-M., Ma, E.-L., Li, Z.-L., 2014a. Caryophyllene sesquiterpenes 
from the marine-derived fungus Ascotricha sp. ZJ-M-5 by the One-Strain-Many-Compounds 
strategy. J. Nat. Prod. 77, 1367-1371. DOI: 10.1021/np500110z 
Wang, Y., Lu, Z., Sun, K., Zhu, W., 2011a. Effects of high salt stress on secondary metabolite production 
in the marine-derived fungus Spicaria elegans. Mar. Drugs 9, 535-542. DOI: 10.3390/md9040535 
Wang, Y., Wang, L., Zhuang, Y., Kong, F., Zhang, C., Zhu, W., 2014b. Phenolic polyketides from the 
co-cultivation of marine-derived Penicillium sp. WC-29-5 and Streptomyces fradiae 007. Mar. 
Drugs 12, 2079-2088. DOI: 10.3390/md12042079 
Wang, Y., Zheng, J., Liu, P., Wang, W., Zhu, W., 2011b. Three new compounds from Aspergillus terreus 
PT06-2 grown in a high salt medium. Mar. Drugs 9, 1368-1378. DOI: 10.3390/md9081368 
Wikström, S. A., Kautsky, L., 2007. Structure and diversity of invertebrate communities in the presence 
and absence of canopy-forming Fucus vesiculosus in the Baltic Sea. Estuar. Coast. Shelf Sci. 72, 
168-176. DOI: 10.1016/j.ecss.2006.10.009 
GENERAL INTRODUCTION   
30 
 
Wu, J.-S., Yao, G.-S., Shi, X.-H., Rehman, S. U., Xu, Y., Fu, X.-M., Zhang, X.-L., Liu, Y., Wang, C.-Y., 
2020. Epigenetic agents trigger the production of bioactive nucleoside derivatives and bisabolane 
sesquiterpenes from the marine-derived fungus Aspergillus versicolor. Front. Microbiol. 11, 1-9. 
DOI: 10.3389/fmicb.2020.00085 
Xu, S., Wang, J.-J., Wei, Y., Deng, W.-W., Wan, X., Bao, G.-H., Xie, Z., Ling, T.-J., Ning, J., 2019. 
Metabolomics based on UHPLC-orbitrap-MS and Global Natural Product Social Molecular 
Networking reveals effects of time scale and environment of storage on the metabolites and taste 
quality of raw Pu-erh tea. J. Agric. Food Chem. 67, 12084-12093. DOI: 10.1021/acs.jafc.9b05314 
Yamada, T., Iwamoto, C., Yamagaki, N., Yamanouchi, T., Minoura, K., Hagishita, S., Numata, A., 2004. 
Leptosins O-S, cytotoxic metabolites of a strain of Leptosphaeria sp. isolated from a marine alga. 
Heterocycles 63, 641-653. DOI: 10.3987/COM-03-9967 
Yamada, T., Iwamoto, C., Yamagaki, N., Yamanouchi, T., Minoura, K., Yamori, T., Uehara, Y., Andoh, 
T., Umemura, K., Numata, A., 2002. Leptosins M–N1, cytotoxic metabolites from a Leptosphaeria species separated from a marine alga. Structure determination and biological activities. Tetrahedron 
58, 479-487. DOI: 10.1016/S0040-4020(01)01170-X 
Yanagihara, M., Sasaki-Takahashi, N., Sugahara, T., Yamamoto, S., Shinomi, M., Yamashita, I., 
Hayashida, M., Yamanoha, B., Numata, A., Yamori, T., Andoh, T., 2005. Leptosins isolated from 
marine fungus Leptoshaeria species inhibit DNA topoisomerases I and/or II and induce apoptosis 
by inactivation of Akt/protein kinase B. Cancer Sci. 96, 816-824. DOI: 10.1111/j.1349-
7006.2005.00117.x 
Yang, J. Y., Sanchez, L. M., Rath, C. M., Liu, X., Boudreau, P. D., Bruns, N., Glukhov, E., Wodtke, A., 
de Felicio, R., Fenner, A., Wong, W. R., Linington, R. G., Zhang, L., Debonsi, H. M., Gerwick, W. 
H., Dorrestein, P. C., 2013. Molecular networking as a dereplication strategy. J. Nat. Prod. 76, 1686-
1699. DOI: 10.1021/np400413s 
Zain ul Arifeen, M., Ma, Y.-N., Xue, Y.-R., Liu, C.-H., 2019. Deep-sea fungi could be the new arsenal 
for bioactive molecules. Mar. Drugs 18, 9. DOI: 10.3390/md18010009 
Zhang, P., Li, X., Wang, B.-G., 2016. Secondary metabolites from the marine algal-derived endophytic 
fungi: Chemical diversity and biological activity. Planta Med. 82, 832-842. DOI: 10.1055/s-0042-
103496 
Zhu, T. J., Du, L., Hao, P. F., Lin, Z. J., Gu, Q. Q., 2009. Citrinal A, a novel tricyclic derivative of 
citrinin, from an algicolous fungus Penicillium sp. i-1-1. Chin. Chem. Lett. 20, 917-920. DOI: 
10.1016/j.cclet.2009.03.009 
Zhuravleva, O. I., Kirichuk, N. N., Denisenko, V. A., Dmitrenok, P. S., Yurchenko, E. A., Min′ko, E. 
M., Ivanets, E. V., Afiyatullov, S. S., 2016. New diorcinol J produced by co-cultivation of marine 
fungi Aspergillus sulphureus and Isaria felina. Chem. Nat. Compd. 52, 227-230. DOI: 
10.1007/s10600-016-1601-z 
Zuccaro, A., Schoch, C. L., Spatafora, J. W., Kohlmeyer, J., Draeger, S., Mitchell, J. I., 2008. Detection 
and identification of fungi intimately associated with the brown seaweed Fucus serratus. Appl. 
Environ. Microbiol. 74, 931-941. DOI: 10.1128/aem.01158-07 
Zuccaro, A., Schulz, B., Mitchell, J. I., 2004a. Molecular detection of ascomycetes associated with 
Fucus serratus. Mycol. Res. 107, 1451-1466. DOI: 10.1017/S0953756203008657 
Zuccaro, A., Summerbell, R. C., Gams, W., Schroers, H.-J., Mitchell, J. I., 2004b. A new Acremonium 
species associated with Fucus spp., and its affinity with a phylogenetically distinct marine 
Emericellopsis clade. Stud. Mycol. 50, 283-297. DOI: ci.nii.ac.jp/naid/10027837088/ 
Zugazagoitia, J., Guedes, C., Ponce, S., Ferrer, I., Molina-Pinelo, S., Paz-Ares, L., 2016. Current 
challenges in cancer treatment. Clin. Ther. 38, 1551-1566. DOI: 10.1016/j.clinthera.2016.03.026 
 
   
 
 
II. RESULTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
  RESULTS 
33 
 
 
 
Chapter 1. Influence of OSMAC-Based Cultivation in Metabolome and Anticancer Activity of 
Fungi Associated with the Brown Alga Fucus vesiculosus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
RESULTS   
34  
 
  
marine drugs 
Article
Influence of OSMAC-Based Cultivation in
Metabolome and Anticancer Activity of Fungi
Associated with the Brown Alga Fucus vesiculosus
Bicheng Fan 1, Delphine Parrot 1, Martina Blümel 1, Antje Labes 1,† and Deniz Tasdemir 1,2,*
1 GEOMAR Centre for Marine Biotechnology (GEOMAR-Biotech), Research Unit Marine Natural Products
Chemistry, GEOMAR Helmholtz Centre for Ocean Research Kiel, Am Kiel-Kanal 44, 24106 Kiel, Germany;
bfan@geomar.de (B.F.); delphine.parrot@gmail.com (D.P.); mbluemel@geomar.de (M.B.);
antje.labes@hs-flensburg.de (A.L.)
2 Faculty of Mathematics and Natural Sciences, Kiel University, Christian-Albrechts-Platz 4,
24118 Kiel, Germany
* Correspondence: dtasdemir@geomar.de; Tel.: +49-431-600-4430
† Current address: Flensburg University of Applied Sciences, Department Energy and Biotechnology,
Kanzleistraße 91-93, 24943 Flensburg, Germany.
Received: 6 January 2019; Accepted: 16 January 2019; Published: 19 January 2019


Abstract: The fungi associated with marine algae are prolific sources of metabolites with high
chemical diversity and bioactivity. In this study, we investigated culture-dependent fungal
communities associated with the Baltic seaweed Fucus vesiculosus. Altogether, 55 epiphytic and
endophytic fungi were isolated and identified. Twenty-six strains were selected for a small-scale
One-Strain-Many-Compounds (OSMAC)-based fermentation in four media under solid and liquid
culture regimes. In total, 208 fungal EtOAc extracts were tested for anticancer activity and general
cytotoxicity. Ten most active strains (i.e., 80 extracts) were analyzed for their metabolome by molecular
networking (MN), in-silico MS/MS fragmentation analysis (ISDB–UNPD), and manual dereplication.
Thirty-six metabolites belonging to 25 chemical families were putatively annotated. The MN clearly
distinguished the impact of culture conditions in chemical inventory and anticancer activity of the
fungal extracts that was often associated with general toxicity. The bioactivity data were further
mapped into MN to seek metabolites exclusively expressed in the active extracts. This is the first
report of cultivable fungi associated with the Baltic F. vesiculosus that combined an OSMAC and an
integrated MN-based untargeted metabolomics approaches for efficient assessment and visualization
of the impact of the culture conditions on chemical space and anticancer potential of the fungi.
Keywords: Marine fungi; Fucus vesiculosus; OSMAC; molecular network; metabolomics;
dereplication; bioactivity mapping
1. Introduction
Marine fungi are found in all habitats and make a significant contribution to marine environments,
e.g., by decomposition of substrates and animal remains. Marine fungi are regarded as saprotrophs,
parasites, or symbionts (epiphytic an endophytic), as a consequence of the evolution of fungal cell
biology and feeding strategies [1–3]. Recent culture-dependent studies reveal that fungi establish a
symbiotic association with marine macroalgae (seaweeds) [1–3]. The sedentary lifestyle and the lack
of an immune system have led to the evolution of a seaweed holobiont, in which macroalga and its
associated microbiota, including fungi, jointly exercise to enhance the tolerance to abiotic and biotic
stresses [4]. The algicolous fungi have been shown to produce diverse types of secondary metabolites,
presumably contributing to the fitness of its host. Some of these metabolites have demonstrated
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bioactivities, e.g., antioxidant, antimicrobial, and cytotoxic [5–7] that are beneficial to human health.
A prominent example is halimide, a diketopiperazine obtained from an Aspergillus sp. isolated from
the green alga Halimeda copiosa [8]. Plinabulin (NPI-2358) is a synthetic tert-butyl analog of halimide
and the only marine fungal metabolite-based compound that has entered clinical trials (currently in
Phase III) to date [9]. This clearly highlights the potential of seaweed-derived fungi as a valuable
source for discovery of anticancer lead compounds.
Recent bioinformatic approaches in the genomics field points out a significant discrepancy
between the number of secondary metabolite biosynthetic gene clusters (BGCs) and the actual
number of chemically characterized compounds obtained from microorganisms. This stems from
the so-called ‘silent’ or ‘cryptic’ BGCs that are not expressed under standard laboratory conditions
due to a lack of essential natural stimuli for activation of secondary metabolite BGCs [10]. Hence,
fermentation of microorganisms in artificial laboratory conditions represents a major limitation in
microbial drug discovery. Culture-based strategies such as OSMAC (One-Strain-Many-Compounds)
or co-cultivation are vital to evoke the expression of silent BGCs to produce new compounds [11].
The OSMAC approach is highly efficient for induction of chemical diversity by variation of cultivation
parameters [12]. It has been successfully applied to stimulate the production of several new marine
fungal secondary metabolites, exemplified by lajollamide A, a new pentapeptide produced by the
marine green alga-derived fungus Asteromyces cruciatus [13]. This observation, in addition to numerous
other OSMAC-based cultivation studies on microorganisms, suggest that variation of culture conditions
is a promising approach for enhancing the chemical space of alga-derived fungi.
MS/MS based Global Natural Products Social Molecular Networking (GNPS) is a platform,
which enables rapid and automated mass spectral mining of large number of samples. It groups
similar compounds based on similarities of their MS/MS fragmentation patterns and links known
and unknown compounds belonging to the same molecular family in networks [14]. This approach
not only substantially accelerates dereplication capabilities and enhances annotation rates, but also
delivers more in-depth information on chemical inventory of biological organisms [15]. Integration of
MN with in-silico fragmentation pattern database (Universal Natural Product Database (ISDB–UNPD))
further speeds up the tedious dereplication processes [16]. A few recent studies have used molecular
networks (MN) for optimizing the culture conditions and the extraction methods for bacterial natural
products [17]. MN also offers the possibility to map additional information over the network.
The integration of bioactivity data of crude extracts and fractions obtained therefrom with MN is
gaining popularity for prioritization of bioactive extracts and targeted isolation of bioactive metabolites
from botanical sources [18].
The canopy-forming seaweed Fucus vesiculosus L. (bladder wrack) is the most-widespread brown
alga in the shallow coastal regions of the Baltic Sea [19]. It serves as a primary producer providing
food and shelter for marine animals [20]. Previous studies conducted on this seaweed indicate its rich
chemistry and various bioactivities [21]. In a recent study, we investigated seasonal variations in the
metabolome of the Baltic Sea F. vesiculosus and its impact on antioxidant, anticancer and antimicrobial
activity profile of the F. vesiculosus extracts [22]. However, the associated microbiota of this seaweed or
their biotechnological potential has remained poorly investigated. The fungi derived from the North
Atlantic F. vesiculosus were tested for antibacterial and antifungal activity [6,7]. An isobenzofuranone
derivative with antioxidative activity was reported from an Epicoccum sp. isolated from the North Sea
F. vesiculosus [23]. The present study aimed at identification of cultivable fungal communities associated
with the Baltic F. vesiculosus. By using an OSMAC approach, the isolated epi- and endophytic fungi
were grown in, altogether, eight solid and liquid-based culture media. The generated extracts were
tested for their anticancer and cytotoxic properties and the selected ones were dereplicated by an
untargeted LC-MS/MS-based molecular network using automated (GNPS and ISDB-UNPD) [14,16]
and classical manual dereplication methods. The UPLC-MS/MS based MN revealed different culture
conditions to lead to significant differences in chemical inventory and bioactivity of the extracts.
The bioactivity data combined with MN allowed the detection of specific metabolites in the anticancer
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or toxic extracts. This is the first study on fungi associated with the Baltic Sea F. vesiculosus applying an
untargeted metabolomics study integrated with OSMAC and bioactivity mapping.
2. Results
2.1. Isolation of Fungi
In total, 87 fungal strains were obtained (Table S1). Of which, 55 strains were isolated and
identified from F. vesiculosus collected at Kiel Fjord (Baltic Sea, Germany), while 32 fungi originated
from its surrounding environment, i.e.,—sediment (30 isolates) and seawater (2 isolates) controls.
Four solid media (indicated by an “S” in the medium name), i.e., modified Wickerham medium
(WM-S), Potato Dextrose medium (PDM-S), Glucose Yeast Peptone medium (GYP-S), and Glucose
Casein medium (GCM-S) were used for their isolation. The highest number of fungal isolates was
retrieved from WM-S medium (21 isolates), followed by PDM-S (15 isolates), GCM-S (10 isolates), and
GYP-S (9 isolates) (Figure 1A and Figure S1). Overall, 11 epiphytic and 44 endophytic fungi were
obtained from algal thalli after surface sterilization (Figure 1B). Sanger sequencing of the PCR-amplified
ITS1-5.8S rRNA gene-ITS2 region allowed identification of 39 Penicillium sp. that constituted the
largest fraction (71%) of the fungi. In general, a considerable fungal diversity was obtained with
10 strains belonging to seven fungal genera (identified at the genus level). Six isolates were identified
only to a higher taxonomic (i.e., order) level (Figure 2). Penicillium was the predominant genus
in both endophytic and epiphytic fungi. Gibellulopsis sp. was isolated from both endophytic and
epiphytic communities. The endophytic fungi showed a four-fold higher abundance (44 isolates) and
represented by five specific genera, i.e., Acremonium, Trichoderma, Cadophora, Wallemia, and Emericellopsis
(Figure 3A). The media used had a great impact on the diversity of the isolated fungi. For example,
four fungal genera (Acremonium, Fusarium, Trichoderma and Wallemia) were exclusively isolated from
WM-S medium (Figure S2A). Other media also produced unique isolates, e.g., Cadophora sp. was
only retrieved from GYP-S medium (Figure S2B). Both Emericellopsis sp. (WM-S and PDM-S, Figure
S2A,C) and Gibellulopsis sp. were isolated from two different media (WM-S and GCM-S, Figure
S2A,D). Penicillium species were obtained from all media, with PDM-S and GCM-S yielding the highest
numbers (14 and 9 isolates, respectively) (Figure S2C,D).
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Figure 1. The number of identified fungal isolates from Fucus vesiculosus. (A) The number of fungal
strains isolated from single solid medium (S). WM-S = modified Wickerham medium, PDM-S: Potato
Dextrose medium, GCM-S; Glucose Casein mediu , GYP-S; and Glucose Yeast Peptone medium.
(B) The origin of fungi from F. vesiculosus microhabitats.
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Figure 2. Taxonomical diversity of 55 fungal genera isolated from F. vesiculosus (excluding sediment
and seawater). Strains that were not identified to genus level were indicated with ‘Higher taxa’.
The sediment control sample yielded 30 fungal strains, while only two isolates were retrieved
from the seawater (Figure 3A). The genus Penicillium was also dominant among sediment isolates,
accounting for 67% of the isolated strains (20 out of 30), followed by Fusarium sp. (5 isolates).
Three genera, Phoma, Cladosporium, and Stereum were represented by one species each in sediment
samples. Two other sediment-derived strains were only identified at order level (Figure 3A, Table S1).
The seawater control yielded one Penicillium sp. and one Candida sp. Figure 3A depicts the co parative
diversity of fungal isolates from F. vesiculosus and its surrounding habitats.
Several fungal genera, i.e., Acremonium, Gibellulopsis, Trichoderma, Wallemia, Cadophora, and
Emericellopsis were exclusive to F. vesiculosus. The fungal communities isolated from different
origins were compared by a 2D MDS plot to visualize their similarity (Figure 3B). All Fucus-derived
fungal communities (Fucus-epi and Fucus-endo in Figure 3B) clustered more closely, showing a clear
differentiation to those deriving from seawater and sediment controls.
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2.2. OSMAC Cultivation, Extraction and Anticancer Assays
Twenty-three endophytic and three epiphytic fungal strains (Table 1) deriving from F. vesiculosus
thalli were selected for subsequent small-scale fermentation using an OSMAC approach. The strain
selection criteria were: (i) genetic diversity at genus or order level and (ii) morphology differences in
colony (especially Penicillium sp.). Four different culture media, PDM, WM, Sucrose Yeast Medium
(SYM), and Czapek (Cza) were selected based on variations they offer with respect to carbon source
Mar. Drugs 2019, 17, 67 6 of 25
and salt concentration. Additionally, the solid (“S”, agar plates, static) and liquid (“L”, 300 mL flasks,
shaking at 120 rpm) culture regimes were applied in order to enhance the chemical diversity of the
selected strains. The temperature was set to 22 ◦C in all samples. A simple coding system including the
strain number, growth medium, and culture regime was used to describe the extracts (e.g., 1PDM-L).
Table 1. The list of 26 F. vesiculosus-derived fungal isolates selected for OSMAC-based cultivation. Strain
I.D. numbers correspond to those used in strain collection in Table S1. Closest relative identification
showing high sequence similarity according to NCBI GenBank by BLAST and the original isolation
medium are displayed. * Strain could not be identified to genus level, but to a higher taxa (order) level.
Strain I.D. Epiphytic/Endophytic Fungus Closest Taxonomical Relative Sequence Similarity (%) Isolation Solid Medium
1 * Endophytic Pleosporales (order) 100 WM-S
11 Epiphytic Gibellulopsis sp. 100 GCM-S
12 Endophytic Acremonium sp. 99 WM-S
35 Endophytic Cadophora malorum 100 GYP-S
37 * Endophytic Hypocreales (order) 99 GYP-S
38 Endophytic Penicillium biourgeianum 100 WM-S
50 Endophytic Penicillium sp. 99 PDM-S
55 Endophytic Penicillium glabrum 100 PDM-S
56 Endophytic Penicillium sp. 100 WM-S
58 Endophytic Fusarium graminearum 96 WM-S
59 * Endophytic Glomerellales (order) 100 WM-S
61 Endophytic Penicillium brevicompactum 100 PDM-S
62 Endophytic Penicillium brevicompactum 100 PDM-S
67 Endophytic Gibellulopsis nigrescens 100 WM-S
68 Endophytic Penicillium sp. 100 WM-S
78 Endophytic Penicillium sp. 100 PDM-S
81 Endophytic Wallemia muriae 100 WM-S
82 Endophytic Emericellopsis sp. 99 WM-S
84 * Endophytic Hypocreales (order) 100 WM-S
86 Endophytic Emericellopsis terricola 99 PDM-S
87 * Endophytic Pleosporales (order) 99 WM-S
89 Endophytic Trichoderma sp. 100 WM-S
91 Endophytic Penicillium virgatum 100 GCM-S
96 Epiphytic Penicillium brevicompactum 100 GYP-S
104 Epiphytic Penicillium chrysogenum 100 WM-S
122 Endophytic Penicillium brevicompactum 100 GCM-S
The selected strains were cultured, and overall, under eight different conditions, for two weeks and
subsequently extracted with EtOAc to yield 208 crude extracts. These extracts were profiled for their
in vitro activity against six cancer cell lines (liver cancer cell line HepG2, colorectal adenocarcinoma
cell line HT29, malignant melanoma cell line A375, colon cancer cell line HCT116, lung carcinoma cell
line A549, human breast cancer line MDA-MB231) and for toxicity against the noncancerous human
keratinocyte cell line (HaCaT). Twenty-six samples that showed >90% growth inhibition at the initial
test concentration (200 µg/mL) against at least one cancer line were selected and further tested for
determination of their IC50 values. A threshold in anticancer activity (IC50 value ≤ 100 µg/mL against
at least one cancer line) was set as a second filter for further prioritization of the extracts. Hence,
10 endophytic strains complying with this criterium were selected and grown in four liquid and four
solid culture conditions to generate 80 extracts. Of these, only 16 extracts, all deriving from endophytic
strains (Table 2) inhibited at least one cancer cell line with an IC50 value of ≤ 100 µg/mL, whereas
the remaining 64 were inactive (IC50 > 100 µg/mL). Notably, 14 of the 16 fungal extracts that showed
anticancer activity (IC50 values 2–100 µg/mL) also inhibited the growth of HaCaT cells with similar
IC50 values, indicating a general toxicity. Only two crude extracts (1PDM-L and 58Cza-S) were active
against cancer cell lines (IC50 values 39–98 µg/mL) and possessed no toxicity against HaCaT cell lines
at 100 µg/mL concentration (Table 2). All sixteen extracts were selected for further studies.
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Table 2. List of 16 extracts deriving from 10 fungi with IC50 values ≤ 100 µg/mL against at least
one cancer line. Crude extracts were tested against six cancer cell lines (human liver cancer cell line
HepG2, human colorectal adenocarcinoma cell line HT29, human malignant melanoma cell line A375,
human colon cancer cell line HCT116, human lung carcinoma cell line A549 and human breast cancer
line MDA-MB231) and the non-cancerous human keratinocyte cell line HaCaT. Stand.: Standard for
positive control (doxorubicin). Strain I.D. corresponds to strain collection I.D. in Table S1.
Strain I.D. Taxonomic ID Medium & Regime
IC50 Value (µg/mL)
HepG2 HT29 A375 HCT116 A549 MDA-MB231 HaCaT
1 Pleosporales PDM-L 47 39 >100 >100 98 49 >100
35 Cadophora malorum PDM-L 15 50 4 6 16 35 5
37 Hypocreales PDM-L 11 27 5 7 18 7 8
50 Penicillium sp. PDM-L 11 100 8 8 15 7 9
PDM-S 6 16 29 8 10 2 2
Cza-S >100 >100 53 23 23 6 4
56 Penicillium sp. PDM-L 43 36 66 >100 42 35 69
Cza-L 100 100 63 >100 40 32 32
58 Fusariumgraminearum PDM-L 74 69 72 74 85 78 78
PDM-S 69 63 59 69 71 62 44
Cza-S 65 79 52 65 74 74 >100
59 Glomerellales PDM-S >100 >100 42 32 83 14 30
68 Penicillium sp. PDM-L 10 32 8 7 10 5 8
PDM-S 12 18 28 6 9 3 3
78 Penicillium sp. PDM-L 17 21 15 25 19 9 10
87 Pleosporales PDM-L 43 35 56 91 36 30 60
Stand. 14.9 3 0.13 10.6 31.4 15.2 10
The composition of the medium, as well as the culture regime, had a profound impact in bioactivity
and toxicity of the fungi (Table 2). For example, the crude extracts of strains 1 (order Pleosporales),
35 (Cadophora malorum), 37 (order Hypocreales), 78 (Penicillium sp.), and 87 (order Pleosporales),
inhibited the cancer cell lines only when fermented in liquid PDM medium (PDM-L). Similarly, strain
59 (order Glomerellales), cultivated only in PDM-S, displayed activity against four cancer cell lines,
particularly against MDA-MB231 cells (IC50 value 14 µg/mL, Table 2). The remaining strains were
either active in both liquid and solid cultures of one medium (e.g., Penicillium sp.—strain 68 in PDM),
or in multiple media and culture conditions, e.g., strain 56 (Penicillium sp.) and strain 58 (Fusarium
graminearum) (Table 2). In the case of strain 50 (Penicillium sp.), the extracts deriving from PDM-L and
PDM-S media showed higher potency in comparison to that deriving from the Cza-S medium.
2.3. Evaluation of the Chemical Diversity Using Molecular Network Approach
An UPLC-QToF-MS/MS based comparative untargeted metabolomics study (in positive
ionization mode) was carried out on those 10 initially selected strains (Figure S3). To ascertain
the impact of media and culture regime on the chemical profile, as well as to detect potentially
specific metabolites produced in the bioactive samples, 80 EtOAc extracts (10 strains grown in
8 culture conditions) were subjected to MN-based metabolomics analysis. The MS/MS data of
the extracts were analyzed using the publicly available Global Natural Products Social Molecular
Networking (GNPS) platform (https://gnps.ucsd.edu) [14] combined with both in-silico MS/MS
database (ISDB-UNPD) [16] and manual dereplication employing multiple databases (Dictionary
of Natural Products (DNP) [24], Scifinder [25], and Chemspider [26]). The global MN revealed
4782 nodes in total, of which 1700 were clustered in 255 chemical families, whereas the remaining
single nodes were considered as unique chemistries without link to others. Some nodes represent
adducts, thus, not all network nodes correspond to a single molecule. In the MN, 25 different chemical
families were annotated (Figures 4, 6 and 7 and Table S2), including various types of alkaloids,
polyketides, peptides, lipids, amino acid derivatives, dihydroxyanthraquinones, bile acids, polyenes,
and binaphthoquinones. Characteristic information for all annotated peak ions to known metabolites
(retention time, MS, MS/MS fragmentation, molecular formula, biological source and structure) is
displayed in Table S2. The global MN of fungal extracts based on culture regime and growth media
are shown in Figures 4A and 6A, respectively. The global MN-derived Euler and Venn diagrams
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(Figures 4B and 6B) display node (ion) distribution in different culture conditions, as discussed below.
The chemical composition of each individual strain is displayed in a separate MN (Figures S4–S23).Mar. Drugs 2019, 17, x 9 of 26 
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2.3.1. Impact of Culture Regime on Chemical Diversity
The effect of culture regime (liquid versus solid) was ascertained by comparing liquid and solid
culture groups from the MN (Figure 4A). The Euler diagram derived from MN (Figure 4B) pointed
out to clear differences in the chemical profile of the liquid and solid culture extracts. In total 4782
nodes (ions) were identified. The extracts deriving from the solid cultures (in total 3235 nodes) and
the liquid cultures (in total 2699 nodes) had only 1152 nodes in common, indicating <24% similarity
of total 4782 nodes (Figure 4B). Approximately, 32% of the total nodes (i.e., 1547 specific nodes) were
expressed exclusively in the liquid culture extracts, while 2083 nodes (≈43%) in the solid culture
extracts. The comparison of the liquid and solid culture-derived fungal extracts clearly points out a
differential chemistry. The observed metabolic differences suggest activation of different BGCs under
different culture regimes.
Annotation efforts of the chemical inventory of the extracts revealed only a few metabolites
to be common in both liquid and solid cultures, e.g., the aminolipid family (7–11) and aromatic
polyketide deoxyherquenone (25) (Figure 4A, Table S2) in both Cza-L and Cza-S media. Interestingly,
several metabolites were mapped to only one culture regime. For example, the cyclic depsipeptide
enniatin B1 (34) (Figure 4A and Figure S6) was detected only in liquid culture conditions. Importantly,
their production was dependent on the culture regime, but was not much affected by the growth media.
In addition to induction of different chemical families in individual culture regimes, we also observed
production of compounds in both culture regimes. A good example is the aromatic polyketide
family (21, 25, 29) that was detected in multiple extracts of strain 68 (Penicillium sp., Table S2).
Deoxyherquenone (25, m/z [M + H]+ 357.1544) was present in all liquid and solid culture extracts,
whereas its analogues atrovenetinone (29, m/z [M + H]+ 341.1123) and atrovenetin (21, m/z [M + H]+
343.1276) were exclusive to liquid culture regimes. As shown in Figure 5, with 22 nodes observed in
liquid culture-based extracts and 13 nodes in solid extracts of the strain 68, liquid culture conditions
clearly led to a higher chemical diversity for this molecular family, clearly demonstrating the impact of
the culture regime on variable chemical composition of the same strain.
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2.3.2. Impact of Cul ure Media on Chemical Diver i
Next, we investigated the influence of culture media on the extracts of 10 selected strains
(Figure 6A). The global MN-derived Venn diagram (Figure 6B) displays the distribution of altogether
4782 detected nodes. Notably, the Cza medium contained the highest number of nodes (2820),
whereas the lowest number of nodes (1615) was detected in the WM medium. The Venn diagram also
clearly indicated unique expression of significant numbers of nodes in one single culture medium.
For example, 1476 of all nodes (ions) were specifically mapped to the Cza medium, corresponding
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to 31% of in total 4782 nodes. Significantly lower levels of nodes that were found to be exclusive to
other media, i.e., 487 (PDM), 441 (SYM), and 370 (WM) (Figure 6B). These results confirmed that the
chemical composition and other characteristics (e.g., selected carbon resource) of the growth media had
a significant effect on the chemical machinery of the fungi derived from F. vesiculosus. The inspection
of Table 2 indicated that most of the bioactive extracts that inhibited the growth of the cancer cell lines
derived from the liquid PDM medium. Three extracts obtained from the Czapek culture also showed
activities with lower potency.
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The global MN of the crude extracts deriving from different media (Figure 6A) indicated variations
in chemical diversity of the extracts. The annotated natural product clusters included e.g., fumagillin
(26) type meroterpenoid mycotoxins, which were only expressed by strain 35 (Cadophora malorum) in
SYM-L (Figure 6A, Figure S6 and Table S2), while the small binaphthoquinone family represented only
by xanthoepocin (19) and bisdehydroxanthomegnin (20) that was exclusively mapped to PDM-L extract
of strain 59 (order Glomerellales) (Figure 6A, Figure S16 and Table S2). Another striking example
was the aminolipid family (7–11) produced by the same strain 59. This very large molecular cluster
was expressed in both liquid and solid Cza media, with 52 of total 71 analogues with m/z ranging
from 300 to 1300 Da exclusively mapped to the Cza medium (Table S2, Figure S24). The identification
of this rare lipid family was based on the database search in GNPS, with a high spectral similarity
score (>0.7) to our experimental MS/MS fragmentation pattern. The inspection of Figures 4 and 6,
the Supplementary Figures S4–S23 and Table S2 shows that, with the exception of the amide alkaloid
pseurotin A (6) and the polyketide deoxyherquenone (25), all annotated chemical families/compounds
are produced by one single strain often in one or more growth media. In most cases, both culture
regime and culture media had an effect on chemical production, in which 15 of the total 36 known
metabolites were exclusively annotated in one single culture medium under one single culture regime
(Table S2). This was exemplified by the amino acid derivative acetylcarnitine (1, SYM-S) (Figure S5),
the tetrahydrofuranone polyketide griseofulvin (15, WM-L) (Figure S18), and the indole diterpenoid
penitrem B (30, SYM-S) (Figure S19). Despite the use of an integrated and detailed metabolomics
approach, we were able to annotate only a few nodes to known compounds. This may suggest potential
novelty of the remaining compounds.
2.3.3. Bioactivity Mapping
As a last step, we mapped the bioactivity data (IC50 values) of altogether 80 extracts over the MN
and searched for a link between spectral molecular networks and their anticancer activity (or toxicity).
To this end, we classified the fungal extracts into three groups based on their anticancer activity (IC50
values), assigned them a specific color tag, and applied this color mapping to all nodes to establish a
visible MN (Figure 7A). Thus i) 64 extracts that did not kill any cancer cell line in preliminary testing
(IC50 > 100 µg/mL, see Section 2.2) were regarded as ‘inactive’ (tagged in grey), ii) 14 extracts that
exhibited anticancer activity towards at least one cancer cell line and general toxicity to HaCaT cells
with IC50 values < 100 µg/mL were treated as ‘toxic’ (tagged in red) and iii) 2 crude extracts (1PDM-L
and 58Cza-S) that were devoid of toxicity against HaCaT cells (IC50 > 100 µg/mL) and killed at least
one cancer cell line (IC50 < 100 µg/mL) were regarded as ‘bioactive’ (tagged in blue) (Figure 7A).
Then, we explored the networks and compared the chemical composition of all three classes with
different color mapping to all nodes in the MN. The rationale behind it is that if certain clusters/nodes
are uniquely present in an extract, these compounds may possibly be responsible for the observed
bioactivity and this extract(s) can be prioritized for further bioactivity-guided isolation studies.
As shown in the Euler diagram (Figure 7B), altogether 4452 nodes were detected in the inactive
extracts, 2207 nodes in the toxic extracts, while the two bioactive extracts collectively comprised
175 nodes. Respectively, 2499 and 295 nodes were exclusive to the inactive and the toxic extracts.
The bioactive extracts had only eight nodes that were specifically produced in them, but shared 27
nodes with the toxic and 68 with inactive extracts. Seventy-two nodes were common to all extracts.
The combination of massive MN with activity mapping allowed an easy visual inspection of the
networks and their inhibitory activity against cancerous and non-cancerous cell lines. As shown in
Figure 7A, the MN revealed eight fully exclusive (completely blue) ions for bioactive extracts 1PDM-L
and 58Cza-S, five of which belonging to 1PDM-L and three of which belonging to 58Cza-S. Only one
of these nodes identified from 1PDM-L (m/z [M + H]+ 428.2081, C25H34NO5) was embedded in a large
molecular cluster containing 38 nodes (Figure 7A and Figure S25). The remaining seven were single
nodes (single compound-single molecular family, Figure 7A), four of which being exclusive to 1PDM-L
(m/z [M + Na]+ 452.2278 (C25H35NO5Na), m/z [M + H]+ 469.2242 (C27H33O7), m/z [M + H]+ 463.2679
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(C26H39O7), m/z [M + H]+ 939.6554 (C55H91N2O10)) and 3 nodes being exclusive to 58Cza-S (m/z
[M + H]+ 232.1525 (C11H22NO4), m/z [M + H]+ 681.3819 (C31H57N2O14), and m/z [M + H]+ 685.3978
(C32H61O15)). None of these eight nodes found a match to any known compound in databases, hence
represent potentially new compounds that may be responsible or contributing to the bioactivity of
these extracts. On the other hand, the blue nodes were also common to a number of networks that
were toxic. This may suggest that the observed toxicity and anticancer activity is dependent on their
final concentration in the extract and the chemical structure of the individual compounds and/or their
molecular clusters. The fully toxic ions (fully red nodes) were represented by small networks and a
number of single nodes. However, similar to bioactive samples, the toxicity was also embedded in
many inactive (grey) networks. As expected, there were many fully inactive molecular clusters, but a
large number of clusters included toxic and/or bioactive nodes, again pointing to general phenomenon
of toxicity associated with anticancer activity.Mar. Drugs 2019, 17, x 13 of 26 
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3. Discussion
3.1. Fungal Isolation
Only a few studies have investigated endophytic fungi associated with the seaweed genus
Fucus and their metabolites with antioxidant and antibiotic activities [6,7]. In this study, we isolated
fungal assemblages present on the surface and in the inner tissues of the Baltic Sea F. vesiculosus.
Isolation media (mostly favoring the growth of Ascomycetes) used herein were similar to those used
for obtaining endophytic fungi from the North Se F. serratus [1,27]. In accordance with previous
studies, our isola s were also domi ated by Penicillium sp. that are common in macroalgae [28].
The abundance of Pe icillium sp. (39 isolat s) in our study was even higher than that (14 isolates)
observed in the previous study [1]. Reportedly, the abundance of Penicillium sp. in macroalgae is
negatively correlated with water temperature [29]. Low water temperatures (8.3 ◦C) during our
sampling campaign may provide a possible explanation for the higher abundance of Penicillium sp.
Vice versa, the abundance of another very common genus in macroalgae, Aspergillus, is reportedly
positively correlated with increasing temperatures [29], which may underlie the absence of Aspergillus
sp. in our study. Zuccaro et al. [1] isolated only a few (5 isolates) Aspergillus sp. during their study
on F. serratus for a full calendar year, suggesting an overall low abundance of the genus Aspergillus in
Fucus species.
In addition, we identified four genera Acremonium, Gibellulopsis, Trichoderma, and Emericellopsis
(Figure 3A) from the Baltic F. vesiculosus. Since they are absent in the sediment or seawater samples,
they can be regarded as specific to the seaweed. These genera have also been isolated from the
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North Sea F. serratus samples [1]. A Cadophora sp. has previously been reported from the green alga
Enteromorpha sp. [30], but not from any brown algae before. In the present study, we identified an
endophytic Wallemia sp. This fungal genus is generally considered as xerophilic (adapted to dry
conditions or high salinity) [31], and has previously been obtained from air, soil, dried food, and salt.
To our knowledge, this is the first report of this genus being associated with a marine alga. The seawater
control sample yielded a Candida sp., which is commonly found in seawater [32]. Finally, we isolated
three fungal strains, Cladosporium sp., Phoma sp. and Stereum sp., that were exclusive to sediment
surrounding F. vesiculosus (Figure 3A). Cladosporium and Phoma species are very common molds in
sediment samples [33]. Stereum species belong to mycobiota of trees and known for wood-destroying
and carbon recycling properties of arid forest ecosystems [34], but has never been isolated from a
marine sediment before.
Interestingly, two known plant pathogens i.e., Cadophora malorum and Fusarium graminearum were
also isolated from the inner tissues of F. vesiculosus. The presence of potential phytopathogens in
macroalgae has already been described [1,27]. Those endophytes live in a healthy host resuming a
saprophytic growth only during senescence of the hosts [1]. While their ecological role in F. vesiculosus
remains elusive, these fungal genera that produce bioactive compounds, such as the hydroxylated
sclerosporin derivatives reported from Cadophora malorum [30], may be involved in the well-being of
the marine algae.
It is widely accepted that Fucus sp. employs various mechanisms to control their surface biofilm
and microbiota. This includes mechanical means, i.e., cuticle shedding [35], production of reactive
oxygen species (ROS) [36], and the release of secondary metabolites, such as the carotenoid fucoxanthin,
onto the algal surface [37,38]. Such regulatory mechanisms of epiphytic control may underlie the
4-fold lower abundance of epiphytic fungi (11 isolates) compared to endophytic fungi (44 isolates).
The diversity of epiphytic fungi was also poor and only three genera, Gibellulopsis (1 isolate), Phoma
(1 isolate), and Penicillium (9 isolates) represented the cultivable epiphytic fungal community. Notably,
none of the epiphytic fungi showed growth inhibitory activity against cancer cell lines in initial
screenings, and hence, were not prioritized for in-depth metabolomics and IC50 determinations.
3.2. Evaluation of Chemical Diversity Under Different Culture Conditions
OSMAC is regarded as an essential method for activating silent BGCs to enhance the chemical
diversity of microorganisms [39]. Here, we applied for the first time an OSMAC-based cultivation
approach to F. vesiculosus-derived fungal strains, 10 of which inhibited the growth of multiple cancer
cell lines in vitro. The UPLC-HRMS/MS-based untargeted metabolomics study by employing MN on
16 fungal extracts deriving from 10 selected fungal isolates revealed an enhanced chemical diversity,
as shown in their respective MNs (Figures S4–S23). As discussed below, MNs provided opportunities
to identify known compounds/molecular families and putatively new molecular families and to
assess differences due to changes in the culture regime and the growth media. Overall, 36 metabolites
belonging to 25 clusters were putatively identified, spanning from simple amino acids, fatty acid
derivatives (including sphingolipids, aminolipids, aminoglycolipids), various types of alkaloids and
polyketides, terpenoids, meroterpenoids, and steroids.
In this study, liquid and solid culture extracts only shared 24% nodes and more than 30% nodes
were produced only under one single culture regime (Figure 4B). In-depth MN studies revealed
that 16 putatively identified metabolites were exclusive to liquid culture regimes and 11 to solid
regimes (Table S2). A similar MN-based metabolomics study conducted on marine bacterial extracts
confirmed the strong impact of the culture regime on chemical diversity in which only 7% of the
nodes were shared [17]. The differences in chemical production under different culture conditions
may stem from changes in physical parameters, e.g., shaking that increases the availability of oxygen.
As reviewed by Papagianni et al. [40], the production of metabolites in different morphological and
physiological conditions is unique for each fungus. In this study, we applied shaking (120 rpm)
to the liquid cultures, while the solid cultures were grown statically. Previous research on fungal
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antibiotics showed that fungi formed mycelial mat under static conditions and dispersed mycelia under
shaking condition. The chemical production was affected by different mycelial growth conditions [41].
Our results confirmed differential biosynthesis of various types of metabolites in liquid (1547 specific
nodes) and solid (2083 specific nodes) cultures (Figure 4B). Another factor affecting the fungal growth
and metabolome is the availability of oxygen. The lack of oxygen in solid media has been shown
to lead to impairment of the fungal growth and decreased production of fungal metabolites [42].
Conversely, shaking (in liquid conditions) facilitates aeration and the uptake of oxygen, thereby
promoting fungal growth and potential accumulation of bioactive metabolites. While a lower number
of nodes were expressed in the liquid culture extracts (i.e., 1547 specific nodes versus 2083 nodes in
the solid extracts, 32 versus 43%, respectively) the liquid culture regime appeared more favorable for
the expression of bioactive/cytotoxic metabolites than the solid regime. Many fungal mycotoxins,
such as the enniatin type cyclic depsipeptides (31, 34, 36) (produced by strain 35), fumagillins (26),
and the diterpene glycoside virescenoside E (35) (produced by strain 1), were exclusively expressed
in liquid culture extracts. Ten of the total 16 active extracts with activity against cancer cell lines
derive from liquid growth media and only six strains showed bioactivity against cancer cell lines when
grown under solid static condition (Table 2). Expression of specific fungal metabolites under shaking
has previously been observed by Guo and co-workers [43] where the switch of the culture condition
of a Penicillium sp. from static to shaking led to the biosynthesis of five new nitrogen-containing
sorbicillinoids [44]. Analogously, we detected 16 specific metabolites in liquid culture extracts,
exemplified by the antifungal polyketide griseofulvin (Figure S18).
The culture media also played a significant role in the chemical diversity of the F. vesiculosus
associated fungi. The Venn diagram (Figure 6B) showed that Cza medium provided not only chemically
the most diverse extracts with the highest numbers of nodes (2820), but also the highest number of
nodes (1476) exclusively produced in this medium. MN annotated specific metabolites that were
produced in a single medium i.e., Cza (4, 8, 9, 10, 11, 32), PDM (5, 19, 20), SYM (1, 14, 26, 28, 30, 33),
and WM (2, 12, 15) (Table S2). Annotation of metabolites that can be mapped exclusively to a certain
medium suggests activation of silent BGCs due to varying culture parameters. This metabolism shift
may be due to different nutrients used in this study, e.g., carbon, trace elements and salt. For example,
Cza is the only medium containing sucrose (as carbon source) and trace metals (e.g., Mg2+) at the
same time. The influence of carbon source on fungal metabolism is well known. For example only
sucrose has stimulated the production of antibiotic metabolite bikaverin in Fusarium fujikuroi [45].
In the current work, the linear aminolipid family (7–11) produced by strain 59 (Table S2, Figure S24)
was exclusively detected in the sucrose-containing medium Cza. Chatzifragkou and co-workers (2010)
showed that carbon source affects the lipid production in fungi and the highest oleic acid concentration
was obtained when a sucrose-based medium was used [46]. Additional research showed several
enzymes that are involved in the regulation of lipid synthesis, e.g., ATP citrate lyase, were dependent
of Mg2+ for their activities [47,48]. The use of Cza as medium for culturing the strain 59 (order
Glomerellales) resulted in the highest number of metabolites (2820 nodes) and highest percentage
(31%) of compounds unique to this medium, as a response to the presence of specific nutrients, e.g.,
trace elements and sucrose.
PDM was the only medium containing a mixed carbon source, i.e., the polymer starch and the
monomer dextrose. The anti-inflammatory metabolite dihydroxyanthraquinone questinol (5) [49] was
previously isolated from the marine derived fungus Eurotium amstelodami incubated in a starch-based
SWS medium. The strain 50 (Penicillium sp.) exclusively produced this compound in the starch
containing medium PDM (Figure S10), pointing out the importance of the polymeric starch as carbon
resource. The total number of nodes in PDM extracts was 1628, of which 487 were exclusive to this
medium. Only a few nodes mapped to PDM were annotated to known metabolites, this suggests that
fungal strains are able to produce a rich number of putative new natural products when cultured in a
PDM medium. Importantly, most of the extracts with growth inhibitory activity against cancerous
(and non-cancerous) cell lines were grown in solid or liquid PDM (Table 2). Thus, all 10 strains showed
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low IC50 values (<100 µg/mL) against cancer cell lines in PDM (six fungi only in PDM-L, one fungus
only in PDM-S, and three strains—50, 58, and 68 in both PDM-L and PDM-S) (Table 2).
The third medium, SYM, contained sucrose and yeast extract as nutrient provider. These two
components appeared suitable for production of mycotoxins. There were altogether 1990 nodes
detected in SYM extracts, with 441 nodes being exclusive. Previous research on Aspergillus flavus
showed that the absence of yeast extract led to silencing of mycotoxin production in fungi [44]. In the
present study, several known fungal mycotoxins families, such as the small cluster of fumagillin family
(26 produced by strain 35, Figure S6) and a very large cluster of penitrem family (30, produced by
strain 68, Figure S19) were assigned to be exclusive to SYM by analysis of the MN.
The last medium, WM contains high concentrations of salt (NaCl 30 g/L). As shown in Figure 6B,
1615 nodes in total were observed in WM extracts, 370 of these being specific to this medium. One such
compound is griseofulvin (15), a chlorinated tetrahydrofuranone polyketide produced by the strain 68
(Figure S18). Griseofulvin was only annotated from the 68WM-L extract, potentially as a response to
high Cl+ concentration. Glucose is an excellent carbon resource for fungal growth, however, it may
repress the transcription of biosynthetic genes, such as pcbAB, pcbC, and penDE in Penicillium sp. [50]
resulting in a poor metabolite diversity. Finally the presence of salts may impair the growth of some
fungi, leading to a poor chemical composition. This could be another factor contributing to the low
chemical diversity and lack of bioactivity of the crude extracts derived from salt-containing media,
SYM and WM.
It is important to mention that the chemical production of strains was not only affected by the
culture regime but also by the culture media. The most striking example is represented by the indole
diterpenoid penitrem B (30). A previous study showed that penitrems were only produced under
static conditions and enhanced production occurs upon addition of sucrose and yeast extract into
medium [51]. Accordingly, we detected the penitrem B (30), exclusively, in solid SYM culture of strain
68 (Penicillium sp.) (Figure S19). This indicates that both culture regime and culture media strongly
affect fungal chemical diversity of the fungi. Our research that employed detailed metabolomics
by MN and bioactivity testing underlines the complexity of the media effect on fungal metabolism
and bioactivity as a result of it. Overall, the OSMAC approach applied here suggests PDM-L as the
best culture condition for a high chemical diversity coupled with cancer growth inhibitory activity
in F. vesiculosus-derived fungi. While the Cza medium provided the highest chemical diversity and
exclusiveness in metabolites, only a few extracts deriving from this medium showed generally low
anticancer activity associated with toxicity. It is very likely that these extracts/induced compounds
have other biological activities, which warrants further screenings in future.
3.3. Bioactivity
Based on the proven anticancer potential of algal-derived fungi [9], we focused on
the assessment of the anticancer activity and general toxicity of F. vesiculosus derived fungi.
An IC50 value ≤ 100 µg/mL was set to define the bioactivity of the crude extracts. The changes
in the fungal metabolism due to composition of the culture medium and/or the culture regime played
a very important role in the observed bioactivity of the crude extracts. Hence, out of 80 extracts,
only 16 fulfilled the IC50 value criterium (≤100 µg/mL). Some extracts showed significant variations
in their potency against different cancer cells. For example, 50Cza-S was inactive against HepG2 and
HT29 cells, but showed good IC50 values against other cancerous cell lines, in particular towards
MDA-MB231. However, the majority of the extracts suffered from the lack of selectivity, as their
anticancer activity was often comparable to their general toxicity towards non-cancerous HaCaT cells.
As exemplified by doxorubicin, the standard drug used as a positive control herein (Table 2), toxicity
is a well-known general side effect of anticancer drugs. Only two extracts 1PDM-L and 58Cza-S
lacked toxicity at the highest test concentrations (IC50 >100 µg/mL), but their anticancer effect was
also moderate.
Mar. Drugs 2019, 17, 67 17 of 25
Our dereplication study indicated the presence of some known chemical families, including
mycotoxins, in the fungal extracts. Indeed, we annotated 11 individual mycotoxins belonging to
eight chemical families that were previously reported as fungal mycotoxins. These include the
amide alkaloid pseurotin A (6), polyketide griseofulvin (15), polyene fusarin C (16), bis-anhydrides
rubratoxins A (18) and B (17), meroterpenoid fumagillin (26), indole diterpenoid penitrem B (30), cyclic
depsipeptides enniatins B, B1, and A (31, 34, 36), and the diterpene glycoside virescenoside E (35).
Several mycotoxins with demonstrated anticancer and/or cytotoxic activities (the existing literature
mostly measured their anticancer activity without assessing their toxicity) were detected, and their
bioactivity was often dependent on the culture conditions. Rubratoxins are common mycotoxins of
Penicillium sp. [52,53] with specific protein phosphatase A2 inhibitory and anticancer/antimetastasis
activities [54]. Rubratoxins A (18, m/z [M + H]+ 521.1890) and B (17, m/z [M + H]+ 519.1832) were only
annotated in the toxic PDM-L and Cza-L extracts of strain 50 (Penicillium sp.) (Table S2, Figure S10).
This molecular cluster contained four additional unannotated nodes (m/z [M + H]+ 598.1872, 577.1812,
767.2503, and 768.2531), which were only induced in this strain when incubated in PDM-L medium
(Figure S10). These results suggest that culture conditions enhance the expression of fungal BGCs to
induce biosynthesis of certain molecular families with new, potentially bioactive congeners. Enniatin
type mycotoxins (31, 34, 36) with known anticancer properties [55] were also abundant in the toxic
PDM-L extract of strain 35 (Cadophora malorum) (Figure S6). Other mycotoxin families, e.g., fumagillins
(26) and pseurotins (6) with known anticancer/cytotoxic activity were expressed in 35SYM-L and
78WM-S, which lacked anticancer activity. The bioactivity mapping further proved this, as many
toxic/anticancer mycotoxin clusters (fumagillins, pseurotins, penitrems, etc) were detected in grey
colored networks belonging to inactive extracts. This may stem from their low concentrations in the
extract and/or overall chemical composition of these extracts.
MN has found successful applications in drug discovery, in the form of bioactivity mapping
and bioactivity-based MN for prioritization of extracts and targeted isolation of bioactive natural
products [17,56]. In this study, we applied OSMAC approach with varied growth media and culture
regime and mapped its results on MN for assessing both bioactivity and molecular profile of the
extracts. The crude extracts were classified into three different groups based on their IC50 values (≤100
µg/mL) and toxicity to HaCaT. The layout assigned color tags to each group, which allowed i) rapid
and efficient visualization and analysis of molecular clusters, and ii) analysis of whether these specific
cluster of nodes were restricted to certain strain, growth medium, or culture regime. By using this
visible network, we attempted to detect unique metabolites produced in bioactive samples. Toxicity
is the main limitation in anticancer drug discovery. Accordingly, 14 extracts showed significant
toxicity whereas the extracts derived from the strain 1 (order Pleosporales) in PDM-L and strain 58
(Fusarium graminearum) in Cza-S media showed moderate anticancer potential with no toxicity at
100 µg/mL. MN-based bioactivity mapping identified 8 unannotated nodes to be exclusively present
in these two extracts, indicating their potential impact in the observed activity. Then, we attempted
to annotate known metabolites in these bioactive extracts. The only secondary metabolite we could
annotate in the 1PDM-L extract was the diterpene glycoside virescenoside E (35, Figure S4), which is
regarded as a fungal mycotoxin [57]. This compound belonged to a small, four-membered molecular
cluster, however, none of the compounds in this cluster were unique to 1PDM-L, so their significant
contribution to bioactivity is unclear. We were unable to dereplicate any nodes in the other selectively
active extract 58Cza-S. However, we found one significant cluster in this crude extract (Figure S26) that
was distributed in all three groups of extracts (inactive, toxic and bioactive). Dereplication efforts on
three nodes specific to 58Cza-S, i.e., m/z [M + H]+ 401.3221, [M + H]+ 403.3355, [M + H]+ 419.3300, and
their MS spectral fragments did not match any known compounds in the databases used. These three
compounds are closely related and may potentially represent new metabolites.
Besides the mycotoxins described above, a few other dereplicated metabolites reportedly exerting
anticancer activity were mapped to toxic or inactive extracts. For example, ergosterol (28), the major
steroidal constituent of fungal membranes with inhibitory activity against several cancer cell lines [58]
Mar. Drugs 2019, 17, 67 18 of 25
was detected in the inactive 35SYM-L extract (Figure S6). Phomopsidin (33) is a polyketide that
interacts with microtubules [59]. This compound that was embedded in a small molecular family was
annotated and originated from the inactive sample 87SYM-L (Figure S22). We also observed various
chemical families without reported anticancer activity. This was exemplified by the sesterterpenoid
citreohybridonol (13, m/z 501.2903, [M + H]+) identified from strain 68 (Penicillium sp.) grown in
several solid-liquid media, however only the 68PDM-S showed activity associated with strong toxicity
(Table S2, Figure S18).
In conclusion, we have isolated and identified, for the first time, a diverse cultivable fungal
community associated with the Baltic Sea F. vesiculosus. The use of an OSMAC approach combined
with efficient and modern tools such as MN coupled with bioactivity mapping, enabled the
identification of optimal culture conditions and clear visual comparison of the chemical diversity and
bioactivity of the extracts. Based on this important information, strain 1 (order Pleosporales) was
prioritized for large-scale fermentation to be followed by purification and structure elucidation of its
bioactive components.
4. Materials and Methods
4.1. General Experimental Procedures
EtOAc (used for fungal extraction) was purchased from VWR International GmbH, Hannover,
Germany. UPLC grade methanol, acetonitrile and water used for UPLC/MS analysis were purchased
from BiosolveChimie, Dieuze, France. Formic acid (UPLC/MS optigrade) was obtained from LGC
Standards Promochem©, Wesel, Germany. UPLC-QToF-MS/MS analyses were carried out on an
ACQUITY UPLC I-Class System coupled to the Xevo G2-XS QToF Mass Spectrometer (Waters®,
Milford, MA, USA). Czapek broth, yeast extracts and malt extracts were purchased from BD Bioscience,
Sparks, NE, USA. Agar was purchased from Applichem, Darmstadt, Germany. Peptone from
soymeal and glucose were purchased from Merck, Darmstadt, Germany. Potato extract was from
Sigma-Aldrich, Schnelldorf, Germany. Sucrose was purchased from Handelsmarken, Offenburg,
Germany. Casein hydrolysate was purchased from Carl Roth, Karlsruhe, Germany.
4.2. Sampling and Isolation of Fungi
All fungi were isolated and identified from F. vesiculosus (Class: Phaeophyceae, Order: Fucales,
Family: Fucaceae) specimens collected in Falckenstein Beach (54◦23′22.6” N, 10◦11′26.4” E), Kiel Fjord,
Baltic Sea, Germany in December 2015 (pH 7, water temperature 8.3 ◦C). For isolation of fungal strains,
four solid media were used: modified Wickerham medium (WM: NaCl 30 g, glucose 10 g, peptone
from soymeal 5 g, yeast extract 3 g, malt extract 3 g, agar 15 g for 1 L), Glucose Yeast Peptone medium
(GPY: glucose monohydrate 1 g, peptone 0.5 g, yeast extract 0.1 g, sodium chloride 15 g, agar 15 g for
1 L; pH 7.2), Potato Dextrose medium (PDM: Potato extract 4 g, dextrose 20 g, agar 15 g for 1 L; pH 5.6),
and Glucose Casein medium (GCM: casein hydrolysate 2.5 g, glucose 40 g, MgSO4 0.1 g, KH2PO4 1.8 g,
agar 15 g for 1 L pH 6.8) [60,61]. All media were enriched with 100µg/mL streptomycin and 100 µg/mL
of penicillin to suppress bacterial growth. Before plating, the macroalgal specimens were washed
three times with sterilized saline solution (0.9 g/L NaCl). Epibionts were obtained from the surface of
conceptacles, stipe, and holdfast regions by sterile cotton swabs. For isolation of endophytic fungi, the
algal surface was disinfected by 40% ethanol and 1% sodium hypochlorite for 1 min [62]. Algal tissues
from conceptacles, stipe and holdfast regions were cut into approximately 4 mm × 1 mm fragments.
Each fragment was put into a 2 mL innuSPEED lysis tube type S containing 0.4–0.6 mm ceramic beads
(Analytik Jena, Jena, Germany) and 600 µL of sterilized 0.9% saline. Samples were homogenized for
about 2 min at 15 Hertz (15/s) with the RetschMM200 mixer mill (RetschGmbHH, Haan, Germany)
to release the endophytes from tissue to saline. Low speed mixing was pursued in order to prevent
destruction of the endophytic fungal cells. After homogenization, two dilutions of mixture (containing
endophyte fungi and saline), namely 10−1 and 10−2 were prepared. An aliquot (100 µL) of the dilutions
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as well as of the undiluted sample were inoculated on the above-mentioned 4 agar media and spread
evenly using drigalski spatula. Surface sterilized tissues of F. vesiculosus was swabbed again and
incubated on the same 4 solid media to evaluate the effects of surface sterilization. Samples were
incubated for 14 days at 22 ◦C and checked for fungal growth twice per week. Fungal colonies were
transferred to new plates and incubated until pure cultures were obtained. For cryopreservation,
the pure fungal strains were transferred to cryobank tubes (MAST Diagnostica, Reinfeld, Germany)
and stored at −100 ◦C following the manufacturer’s instructions.
4.3. Identification of Fungal Strains
Fungal communities were identified based on the nuclear ribosomal internal transcribed spacer
(ITS) region containing the ITS1 and ITS2 regions, which frame the 5.8S rRNA gene. The ITS region is
generally accepted as a universal phylogenetic marker for fungi [63]. DNA extraction was performed
according to the protocol published previously [64]. PCR amplification was performed using primers
ITS1F and ITS4R, in a total reaction volume of 25 µL, consisting of 1 µL of template DNA, 1 µL of
each primer (concentration: 10 µM), 12.5 µL Dream Taq Master mix (ThermoFisherScientific, Schwerte,
Germany), and 9.5 µL DNA free water (ThermoFisher Scientific, Schwerte, Germany). DNA free water
was used as negative control for PCR. The following protocol was used in a Biometra T1 thermocycler
for amplification: initial denaturation for 85 s at 94 ◦C, followed by 30 cycles of denaturation of DNA at
94 ◦C for 35 s, primer annealing at 55 ◦C for 55 s, and elongation for 3 min at 72 ◦C. A final elongation
step for 10 min at 72 ◦C completed the PCR. The correct length of PCR products was checked by gel
electrophoresis on a 1% agarose gel run for 20 min at a voltage of 120 V in 1× TBE buffer, taking 100 bp
plus DNA ladder (Thermo Scientific™ GeneRuler™, Sunnyvale, CA, USA) length standard. PCR
products were submitted for Sanger sequencing to the Institute of Clinical Molecular Biology (IKMB)
at Kiel University applying the same primers as used for PCR. Obtained sequences were checked
for quality and trimmed using Chromas Pro (Technelysium Pty Ltd., South Brisbane, Australia).
Sequences were then compared to the NCBI Genbank (https://www.ncbi.nlm.nih.gov/genbank/)
using the Nucleotide BLAST function. Sequences were stored at GenBank and the accession numbers
are displayed in Table S1. An MDS plot showing differences between samples (seawater, sediment,
Fucus epiphytic, Fucus endophytic) was generated using the statistical software PAST based on a
presence/absence matrix of identified fungal genera in 87 identified isolates [65].
4.4. OSMAC-Based Cultivation of Fungi
The fungi were incubated in four different media, which were chosen based on variations in
their carbon and nitrogen sources and salt concentration: The modified Wickerham medium (WM),
Czapek medium (Cza: sucrose 30 g, KH2PO4 1 g, MgSO4 0.5 g, KCl 0.5 g, Fe2(SO4)3 0.01 g for 1 L;
pH 7.3), Potato Dextrose medium (PDM), and Sucrose Yeast medium (SYM: sucrose 20 g, yeast extract
10 g, NaCl 10 g for 1L; pH 5.2) [61]. These media were selected in order to provide different nutrient
regimes to activate biosynthetic gene clusters [12]. Each fungal strain was incubated in all four media
by applying two different culture regimes (solid and liquid). The solid culturing contained 15 g/L agar
as solidifying agent and liquid media (100 mL medium in 300 mL Erlenmeyer flasks). Solid cultures
were incubated at 22 ◦C for 14 days in the dark under static conditions. The liquid cultures were
incubated on an orbital shaker (VKS-75 control, Edmund Bühler, Hechingen, Germany) agitating at
120 rpm at 22 ◦C for 14 days in the dark.
4.5. Extraction
For extraction of the liquid cultures, 100 mL of culture broth were mixed with the same volume
of EtOAc by means of an ultra-turrax (Miccra, Mülheim, Germany) at 19,000 rpm. The mycelia
were filtered by folded filter cellulose membrane type 113P (100% cellulose membrane 210 mm,
Carl Roth, Karlsruhe, Germany). The filtrate was collected into a glass separatory funnel and left
for phase separation. The lower (water) phase was discarded. 40 mL of Milli-Q water (Arium®
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Water Purification Systems, Sartorius, Germany) was added to the organic phase to remove salts
and water-soluble compounds. After phase separation, the water phase was discarded, and the
EtOAc phase was transferred into 40 mL glass tubes. The extracts were evaporated to dryness by
a Speed-Vac concentrator (RVC2-33, Martin Christ Gefriertrocknungsanlagen, Osterode am Harz,
Germany). The dissolved crude extracts were re-dissolved in 2.5 mL MeOH and transferred into 4 mL
pre-weighted HPLC vials (amber glass, VWR, International GmbH, Hannover, Germany). For chemical
analysis, 0.1 mg/mL of extract was prepared in an ULC/MS grade MeOH and transferred into
1.5 mL vials (amber glass, VWR, International GmbH, Hannover, Germany). The dissolved extracts
were filtered through 0.20 µm PTFE syringe filter (Carl Roth, Karlsruhe, Germany) before injection.
Solid fungal cultures were sliced into small pieces (approximately 1 cm2) with a flat spatula and
transferred into a 250 mL glass flask and homogenized with 100 mL EtOAc by means of an ultra-turrax
at 19,000 rpm for 30 s. The extraction process for solid cultures followed the same steps as applied
for liquid cultures. The media blanks were prepared by extracting liquid and solid media using the
same protocol.
4.6. Chemical Analysis
4.6.1. UPLC-QToF-MS/MS Analysis
The extracts were prepared at final concentration of 0.1 mg/mL and injected (2 µL) into an Acquity
UPLC HSS T3 column (High Strength Silica C18, 1.8 µm, 2.1 × 100 mm, Waters®) operating at 40 ◦C.
A mobile phase system (A: 0.1% formic acid in 99.9% ULC/MS grade water and B: 0.1% formic acid
in 99.9% acetonitrile) was pumped at a flow rate of 0.6 mL/min using the following linear gradient:
initial, 99% A–1% B; 0–11.5 min, 0% A–100% B; 11.5–12.5 min 0% A–100% B, and finally a column
reconditioning phase until 15 min. The total run time was 15 min. MS and MS/MS spectra, in positive
mode, were recorded during the UPLC run with the following conditions: capillary voltage: 0.8 kV,
sample cone voltage: 40.0 V, source temperature: 150 ◦C, desolvation temperature: 550 ◦C, cone gas
flow: 50 L/h and desolvation gas flow: 1200 L/h. A scan range was performed from 50 to 1600 Da,
MS2 fragmentation was achieved with ramp collision energy (CE): Low CE from 6–60 eV and a high
CE of 9–80 eV. The solvent (MeOH) and non-inoculated blank media were used as controls. MS and
MS2 data were acquired and analyzed with MassLynx® software (Waters®, V4.1, Waters, Milford,
MA, USA).
4.6.2. Molecular Network and Data Analysis
All MS/MS data were converted from files (.raw) to mzXML file format using the ProteoWizard
tool MSConvert (version 3.0.10051, Vanderbilt University, Nashville, TE, USA) [66]. The data were
uploaded to GNPS server (gnps.ucsd.edu) [14] by using FileZilla (https://filezilla-project.org/) [67].
All mzXML data were analyzed using the molecular networking workflow. A molecular network
was created using the online workflow at GNPS. The data was filtered by removing all MS/MS peaks
within +/− 17 Da of the precursor m/z. The data were then clustered with MS-Cluster with a parent
mass tolerance of 0.1 Da and a MS/MS fragment ion tolerance of 0.1 Da to create consensus spectra.
Further, consensus spectra that contained less than 2 spectra were discarded. A network was then
created where the edges were filtered to have a cosine score above 0.65 and more than 6 matched
peaks. Further edges between two nodes were kept in the network if and only if each of the nodes
appeared in each other’s respective top 10 most similar nodes. The spectra in the network were then
searched against GNPS spectral libraries. The library spectra were filtered in the same manner as the
input data. All matches kept between network spectra and library spectra were required to have a
score above 0.65 and at least 6 matched peaks. The clustered data were downloaded and imported
into Cytoscape® (version 3.5.1, Institute for Systems Biology, Seattle, WA, USA) [68] and visualized
using import network and table, individual (selfloop) nodes without neighbors were also displayed
in molecular network. Nodes derived from the blank media and methanol blank as well as solvent
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nodes were subtracted. Self-loop nodes (single node without link to others) were also displayed in
molecular network. Venn diagram and Euler diagram were drawn by Venn and Euler Diagrams app
available as a plugin for Cytoscape®. To improve the dereplication, the in-silico MS/MS database
based on the Universal Natural Products Database (UNDP) was integrated into the MN following the
workflow from Allard et al. [16] The parent mass was selected as dereplication prefilter. Setting was as
following: Top_K_Result was used to return maximal number of results. Parameters were selected
as following: PM tolerance = 0.05, score threshold = 0.2, Top K Result = 3. Only natural products
reported isolated from fungal resources were selected as putative hits. The manual annotation was
done by using the multiple databases, such as Dictionary of Natural Products (DNP) [24], Scifinder
(https://www.cas.org/products/scifinder) [25] and Chemspider [26] based on m/z value, ppm shift.
4.7. Anticancer Activity
The crude extracts were initially tested in vitro against 6 human cancer cell lines; liver cancer
cell line HepG2 (DSMZ, Braunschweig, Germany), colorectal adenocarcinoma cell line HT-29 (DSMZ,
Braunschweig, Germany), malignant melanoma cell line A-375 (CLS, Eppelheim, Germany), colon
cancer cell line HCT-116 (DSMZ, Braunschweig, Germany), lung carcinoma cell line A549 (CLS,
Eppelheim, Germany), human breast cancer line MDA-MB-231 (CLS, Eppelheim, Germany), and the
non-cancerous human keratinocyte line HaCaT (CLS, Eppelheim, Germany) at a concentration of
200 µg/mL. The antitumoral activity of the crude extracts was evaluated by monitoring the metabolic
activity using the CellTiterBlue Cell Viability Assay (Promega, Mannheim, Germany). HepG2, HT-29
and HaCaT cells were cultivated in RPMI medium, A549 and MDA-MB-231 cells in DMEM:Ham’s
F12 medium (1:1) supplemented with 15mM HEPES and A-375 and HCT-116 cells in DMEM medium
supplemented with 4.5 g/L D-Glucose and 110 mg/L sodium pyruvate. All media were supplemented
with L-Glutamine, 10% fetal bovine serum, 100 U/mL penicillin, and 100 mg/mL streptomycin.
The cultures were maintained at 37 ◦C under a humidified atmosphere and 5% CO2. The cell lines
were transferred every 3 or 4 days. For experimental procedure, the cells were seeded in 96 well plates
at a concentration of 10,000 cells per well. A stock solution of 40 mg/mL in DMSO was prepared of
each extract. After 24 h incubation, the medium was removed from the cells and 100 µl fresh medium
containing the test samples was added. Each sample was prepared in duplicate once. Doxorubicin as a
standard therapeutic drug was used as positive control, 0.5% DMSO and growth media were used as
controls. Following compound addition, plates were cultured at 37 ◦C for 24 h. Afterwards, the assay
was performed according to the manufacturer’s instructions and measured using the microplate reader
Tecan Infinite M200 at excitation 560 nm and emission of 590 nm. For the determination of IC50 values,
a dilution series of the extracts was prepared and tested, as described before. The IC50 values were
calculated by Excel as the concentration that shows 50% inhibition of the viability on the basis of a
negative control (no compound) and compared with the positive control (doxorubicin).
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Abstract: Marine algae represent a prolific source of filamentous fungi for bioprospecting.
In continuation of our search for new anticancer leads from fungi derived from the brown alga Fucus
vesiculosus, an endophytic Pyrenochaetopsis sp. FVE-001 was selected for an in-depth chemical analysis.
The crude fungal extract inhibited several cancer cell lines in vitro, and the highest anticancer activity
was tracked to its CHCl3–soluble portion. A bioactivity-based molecular networking approach was
applied to C18-SPE fractions of the CHCl3 subextract to predict the bioactivity scores of metabolites
in the fractions and to aid targeted purification of anticancer metabolites. This approach led to a
rapid isolation of three new decalinoylspirotetramic acid derivatives, pyrenosetins A–C (1–3) and
the known decalin tetramic acid phomasetin (4). The structures of the compounds were elucidated
by extensive NMR, HR-ESIMS, FT-IR spectroscopy, [α]D and Mosher’s ester method. Compounds
1 and 2 showed high anticancer activity against malignant melanoma cell line A-375 (IC50 values
2.8 and 6.3 µM, respectively), in line with the bioactivity predictions. This is the first study focusing
on secondary metabolites of a marine-derived Pyrenochaetopsis sp. and the second investigation
performed on the member of the genus Pyrenochaetopsis.
Keywords: marine fungus; pyrenosetin; phomasetin; Pyrenochaetopsis sp.; Fucus vesiculosus;
bioactivity-based molecular networking; decalin tetramic acid
1. Introduction
Macroalgae (seaweeds) are regarded as holobionts due to their complex epiphytic and endophytic
microbiota [1]. Seaweed-derived fungi are emerging as a promising source of novel bioactive secondary
metabolites for marine bioprospecting. For example, plinabulin, the synthetic tert-butyl analog
of diketopiperazine halimide, which derives from the seaweed-derived fungus Aspergillus sp. [2]
is currently undergoing phase III clinical trials for treatment of non-small cell lung cancer [2,3].
Over the past decades, fungi associated with brown algal genus Fucus have gained attention as
an untapped source of fungal biodiversity [4,5]. A previous study by Flewelling et al. showed
Fucus-associated fungi to produce antimicrobial compounds [6]. Further studies have shown that
Fucus-derived fungi produced secondary metabolites belonging to diverse structural classes and
exhibited further bioactivities. For example, the culture broth of Fucus spiralis-derived fungus Phoma
Mar. Drugs 2020, 18, 47; doi:10.3390/md18010047 www.mdpi.com/journal/marinedrugs
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sp. yielded the polyketide 5-hydroxyramulosin and 7-methoxycoumarin, which showed anticancer,
antifungal and anti-HIV activities [7,8]. Another study by Lateff et al. (2003) reported a new,
antioxidant isobenzofuranone derivative from Epicoccum sp. associated with Fucus vesiculosus [9].
However, a systematic research exploring bioactive metabolites from fungi associated with Fucus sp. is
still missing.
Mass spectrometry-based molecular networking (MN) in conjunction with the publicly available
web-platform Global Natural Products Social Molecular Network (GNPS) serves as an automated
tool for mining large volumes of mass spectra. MN uses an untargeted metabolomics approach that
powerfully processes the tandem mass spectrometry (MS/MS) fragmentation data. It is a vector-based
workflow that calculates cosine scores (between 0 and 1) to determine the degree of similarity between
the MS2 fragments. These fragment ions (nodes) will then be organized into relational networks
depending on their similarity [10]. MN has been employed for rapid and successful dereplication
of known compounds from complex natural extracts [11,12]. Another advantage of MN is the
possibility for incorporation of additional information, such as the bioactivity data, over the network.
The bioactivity mapping or bioactivity-based MN have been effectively applied in natural product
research on both crude extracts and fractions obtained therefrom [13,14]. In the latter, a further
bioinformatic program is employed to predict the bioactivity score of molecules according to their
relative abundance in the fractions. Bioactivity-based MN (B-B MN) approach, hence assists rapid
prioritization and targeted isolation of bioactive compounds, thereby accelerating natural product
biodiscovery efforts.
Fucus vesiculosus is a habitat forming brown alga commonly found in the shallow coastal regions of
Europe. In a recent study, we profiled the surface microbiome and metabolome of the Baltic F. vesiculosus
and identified primary and secondary metabolites, including many fungal metabolites from its surface
and inner tissues by massive MN coupled with DESI-imaging mass spectrometry [15]. We also reported
the isolation and identification of epiphytic and endophytic fungal communities associated with
F. vesiculosus, and applied an OSMAC approach to assess the impact of culture conditions on chemical
space and anticancer potential of these filamentous fungi [12]. A fungal strain belonging to the order
Pleosporales showed anticancer activity with lower toxicity to non-cancerous cells when cultivated in
liquid potato dextrose medium (PDM) [12]. In the continuation of this project, we have now identified
this fungus as a Pyrenochaetopsis sp. (strain FVE-001) by building a phylogenetic tree and comparing
relationship with closely related fungal species. We further focused on isolation and characterization
of its anticancer constituents. For this aim, we applied a B-B MN workflow [14] on the C18-SPE
fractions obtained from the CHCl3 subextract of the fungus for prioritization of the active fractions
and targeted isolation of new bioactive compounds. This approach enabled rapid identification of
three new and one known decalinoyl tetramic acid derivatives, 1–4. Herein we outline the isolation,
structure elucidation and anticancer activities of the compounds 1–4.
2. Results
2.1. Strain Isolation and Identification
The endophytic fungus FVE-001 was isolated from the thallus of Fucus vesiculosus collected at Kiel
Fjord (Baltic Sea, Germany) [12]. The initial Sanger sequencing of the PCR-amplified ITS1-5.8S rRNA
gene-ITS2 region yielded a total length of 297 bp fragment, which only enabled its identification at
order level, i.e., Pleosporales [12]. In order to further confirm the taxonomic identity of the fungus,
the same genomic DNA extract was re-amplified and sequenced for ITS1-5.8S-ITS2 genes to yield a 394
bp length PCR fragment. The sequence result was subjected to NCBI Blast analysis that showed 100%
sequence similarity to Phoma sp. and 99% sequence similarity to closely related strain, Pyrenochaetopsis
microspore. In order to further validate the taxonomy of the fungus FVE-001, a phylogenetic tree was
constructed with 14 related strains from the NCBI database. As shown in Figure 1, the phylogenetic
tree suggested the fungus FVE-001 to be closely related to Phoma sp. However, in the phylogenetic
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tree, FVE-001 did not cluster with the typical Phoma sp., i.e., Phoma neerlandica and Phoma herbarum.
Further investigation revealed that the closely related Phoma strains MUT 5460, MUT 5462 and
MUT 5465 (Figure 1) have now been reclassified as Pyrenochaetopsis leptospora in the UNITE database
(https://unite.ut.ee/sh/SH1525086.08FU#fndtn-panel1) [16]. This confirmed that the fungus FVE-001 to
be a Pyrenochaetopsis sp.
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2.2. Cultivation, Extraction, Bioactivity Test and Molecular Networking
Based on the results of our One-Strain-Many-Compounds (OSMAC) study [12], the fungus
Pyrenochaetopsis sp. FVE-001 was cultivated at 22 ◦C for 14 days under shaking (120 rpm) in 2 L flasks,
each containing 800 mL PDM liquid medium. The EtOAc extract of the culture broth (12 L in total)
was evaporated, and subjected to a modified Kupchan partition to yield n-hexane (KH), CHCl3 (KC)
and aqueous MeOH (KM) subextracts. All three subextracts were tested against five human cancer cell
lines (malignant melanoma A-375; lu g c rcinoma A-549; colorectal adeno arcinoma HT-29; colorectal
carcinoma HCT-116 and breast cancer MB-231), plus against non-cancerous human keratinocyte cell
HaCaT for ass ssing their cyt toxicity. The KC subextract showed the highest activity against all cancer
cell lines (>75% cell growth inhibition at 100 µg/mL) (Table S1), a d was selected for in-depth chemical
investigations. It was subjected to solid phase extraction (SPE) on a C18 Sep-Pak cartridge (10%
gradient elution from 0% to 100% methanol) to yield 11 fractions. Fractions 5–7 exhibited a promising
activity with high rates of growth inhibition (up to 99% at 100 µg/mL, Table S1). The fraction 8 showed
a moderate inhibition rate (43%) against malignant melanoma cell line A-375 while the rest of the
fractions had no activity (Table S1). In order to investigate their chemical profiles, all 11 fractions were
analyzed by tandem UPLC-QToF-MS/MS (positive ion mode) metabolomics using MN. To facilitate the
bioassay-guided isolation of anticancer metabolites, we integrated the bioactivity and the MS/MS (MS2)
data of the fractions using the B-B MN workflow [14]. Briefly, the acquired MS2 data was processed
using MZmine2 toolbox to detect and assess relative quantification of LC-MS/MS spectral features (ions)
across the chromatographic fractions. The processed data was used to calculate a bioactivity score using
the Pearson correlation coefficient (r) between feature intensity, i.e., the molecule’s relative abundance
calculated from the LC-MS peak (area under the curve) across the fraction, and the anticancer activity
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of each fraction. The nodes with higher r (>0.75) and lower p (<0.05) values indicated the presence of
most active metabolites in fractions 5–7. Since this approach only allowed using single bioactivity data
per analysis, activity results against melanoma cancer cell line A-375 was used to calculate bioactivity
scores. Finally, the processed data was analyzed on the GNPS platform and visualized by Cytoscape®.
The B-B MN of the SPE fractions obtained from the KC subextract of Pyrenochaetopsis sp. FVE-001
is displayed in Figure 2. A total of 175 nodes forming seven different chemical clusters were identified
after removal of nodes from chromatography solvents and the medium. The node size in Figure 2
indicates the statistical significance of bioactivity score, i.e., the largest nodes represent molecules
with strong Pearson correlation (r > 0.75) and a significance (p < 0.05). Since the r value has linear
correlation between the molecule’s relative abundance and the level of the bioactivity, the B-B MN
directly visualizes the relative bioactivity of the detected molecules. The relative abundance of the
detected molecules in the each fraction is shown in each node with a pie chart diagram (colors
corresponding to the bioactivity level of each fraction, i.e., red for samples with inhibition rate >90%,
pink for samples with inhibition rate 90–75%, light pink for samples with inhibition rate 75–20% and
grey for inactive samples). In total, 10.3% (18 of total 175 nodes) of molecules showed a statistically
significant bioactivity score (r > 0.75 and p < 0.05). This approach enabled us to narrow down the
potentially active metabolites to 18 nodes (out of 56 nodes) that were detected in the highly active
fractions 5–7.
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of Pyrenoch etopsis sp. FVE-001. (A) Subcluster of diketopiperazine chemical family detected in MN.
(B) Subcluster of decalin family detected in MN. 1–4: Decalinoyltetramic acid derivatives, 5: known
diketopiperazine cyclo-(leu-pro).
Mar. Drugs 2020, 18, 47 5 of 16
A detailed analysis of the MN permitted the annotation of several fungal metabolites to different
molecular families (Figure 2). The biggest cluster with 144 nodes consisted of several subclusters
(e.g., A and B). The node with the precursor ion m/z 211.1442 ([M + H]+, C11H19N2O2) in subcluster A
showed a close MS/MS spectral matching with GNPS spectral library and was annotated as the known
diketopiperazine cyclo-(leu-pro) (5) [17]. Three related nodes in subcluster A at m/z 209.0637, 241.1498
and 237.1113 that clustered with 5 were also identified as structurally related diketopiperazines.
The subcluster B, which contains the most of the potential bioactive metabolites revealed a node
(m/z 414.2645 [M + H]+, C25H36NO4) suggestive of the known fungal metabolite phomasetin (4) [18]
(Figure 3). This was further confirmed by diagnostic MS/MS fragments corresponding to the loss of the
olefinic side chain of the decalin moiety (m/z 346.2017 and 328.1915) and the cleavage of the tetramic acid
moiety (m/z 271.2062 and 243.2113). No additional spectral annotation could be retrieved from GNPS
library for other related nodes in the subcluster B. However, detailed analysis of MS/MS fragmentation
patterns suggested that molecules in subcluster B are closely related to phomasetin (4). The subcluster
B consisted of the highest number of potentially active nodes (15 of total 18 nodes). Based on the
significant bioactivity score of nodes at m/z 412.2484 (1) ([M − H2O + H]+) and 412.2488 (2) ([M − H2O
+ H]+) (r values of 0.79, 0.93 and p values of 2.2 × 10-3 and 1.30 × 10-5, respectively) and their close
similarity to phomasetin (4), we carried out a targeted isolation of these putatively bioactive molecules.
In addition, a related molecule with m/z 428.2434 [M + H]+ (3) with low bioactivity score (r value 0.45)
was also targeted due to the high probability to be an analogue of the most active metabolites.
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2.3. Purification and Structure Elucidation
The comprehensive analysis of the B-B MN revealed fractions 5 and 6 to have the highest relative
abundance of targeted molecules. Based on this, fractions 5 and 6 were combined (106 mg altogether)
and subjected to RP-HPLC separation to afford three new compounds, 1–3 (Figure 3). The known
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metabolite phomasetin (4) (Figure 3), which was previously identified by MS/MS based dereplication
(see above), was isolated from fraction 7. The chemical structure of phomasetin (4) was confirmed by
comparing its HRMS, NMR (Tables 1 and 2) and [α]D data with those reported in the literature [19].
Compound 1 was isolated as a colorless oil. HR-ESIMS spectrum of 1 contained a molecular ion
peak at m/z 430.2592 [M + H]+ consistent with the molecular formula C25H35NO5 requiring 9 degrees
of unsaturation (Figure S7). The FT-IR spectrum implied the presence of hydroxyl and carbonyl groups
(3249–3554, 1683 and 1721 cm−1, respectively) (Figure S8). The 13C-NMR data (Table 2, Figure S2)
comprised 25 carbon signals, including four olefinic carbons at δc 127.3, 128.1, 131.8 and 138.8 along
with three carbonyl groups at δC 168.6, 207.2 and 213.3. The 1H NMR and DEPT-HSQC spectra of 1
(Table 1, Figures S1 and S3) contained signals corresponding to five methyl groups, of which two are
secondary (δH 1.19, d, J = 6.4 Hz, H3-17; δH 0.90, d, J = 6.5 Hz, H3-19), one tertiary (δH 0.98, s, H3-12),
one olefinic (δH 1.73, br s, H3-18) and one being an N-methyl (δH 3.10, s, H3-7′). The DEPT-HSQC
spectrum also confirmed the presence of four diastereotopic methylene protons corresponding to
H2-7 (δH 0.86 and 1.78), H2-9 (δH 1.01 and 1.72), H2-10 (δH 1.04 and 1.42) and the oxymethylene H2-6′
(δH 4.09, dd, J = 12.2, 2.6 Hz and δH 3.92, dd, J = 12.3, 4.8 Hz). Further detected were ten complex
methine protons, six of which appearing at δH 2.57 (H-3, d, J = 11.4 Hz), δH 1.43 (H-8, m), δH 1.82
(H-6, m), δH 1.63 (H-11, m), δH 3.44 (H-13, dd, J = 11.4, 8.6 Hz) and δH 3.57 (H-5′, dd, J = 4.8, 2.6 Hz).
The seventh (oxy) methine proton appeared at δH 4.24 (H-16, m). The remaining three methine protons
were olefinic; two appeared as part of an AB system at δH 5.75 (H-14, dd, J = 15.4, 8.6 Hz) and δH 5.71
(H-15, dd J = 15.4, 4.8 Hz), while the final olefinic methine (H-5) emerged as a broad singlet at δH 5.24
(Figure S1). The 1H-1H COSY spectrum of 1 (Figure S4) led to the establishment of three spin systems.
As shown in Figure 4A, the shortest spin system belonged to a hydroxyethyl group including H-5′ and
H-6′, while the second spin system was represented by a 16-hydroxypentenyl group (H-13 to H3-17).
The largest and third COSY spin network corresponded to a substituted methylcyclohexane moiety,
starting with the secondary methyl H3-19 and ending with the olefinic H-5 (Figure 4A and Figure S4).
Diagnostic HMBC correlations (Figure 4A and Figure S5) observed from H-3 to C-2, C-4, C-11; from
H-5 to C-3, C-7 and C-11; from H-7 to C-5, C-8 and C-9 and from H-11 to C-2, C-6, C-7, C-9 and C-10
permitted the establishment of the bicyclic partial structure, i.e., the unsaturated decalin moiety (rings
A-B, Figure 4A). The olefinic methyl H3-18 was assigned to C-4 based on the substantial HMBC cross
peaks seen from H3-18 to C-4, C-5 and C-3. The secondary methyl H3-19 was already placed at C-8 by
COSY data and HMBC cross-peaks from H3-19 to C-7, C-8 and C-9 further confirmed its assignment.
The tertiary methyl H3-12 had to be attached at C-2 on the basis of multiple HMBC correlations of
H3-12 with C-1, C-2, C-3 and C-11. Additional correlations, i.e., COSY (between H-3 and H-13, H-13
and H-14) and HMBC (between H-3 with C-13, C-14 and C-15), confirmed the attachment of the
16-hydroxypentenyl side chain at C-3 of the decalin ring (Figure 4A, Figures S4 and S5). Further HMBC
correlations from H-5′ to C-2′, C-4′ and from H3-7′ to C-2′and C-5′ established the terminal N-methyl
tetramic acid structure (ring D) (Figure 4A and Figure S5). The long-range (HMBC) couplings detected
between H-13/C-3′ and H-13/C-2′ confirmed the connectivity of tetramic acid ring to decalin moiety
through a spiro carbon, C-3′ (Figure 4A and Figure S5). A key long range coupling between H3-12/C-1
and H3-12/C-2 and H-3/C-12 clearly assigned the carbonyl group (δc 213.3) at C-1. This completed the
final ring system, C (Figure 4A).
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Table 1. 1H NMR data of compounds 1–4 at 600 MHz.
No.
1 a 2 a 3 a 4 b
δH, Mult (J in Hz) δH, Mult (J in Hz) δH, Mult (J in Hz) δH, Mult (J in Hz)
1 - - - -
2 - - - -
3 2.57, d (11.4) 2.73, d (11.4) 2.66, d (11.3) 3.17, br d (9.4)
4 - - - -
5 5.24, br s 5.22, br s 5.28, br.s 5.22, br s
6 1.82, m 1.82, m 1.83, m 1.84, m
7 1.78, m 1.80, m 1.82, m 1.82, m
0.86, m 0.84, m 0.88, m 0.86, m
8 1.43, m 1.44, m 1.44, m 1.51, m
9 1.72, m 1.73, m 1.73, m 1.76, m
1.01, m 0.93, m 0.99, m 1.04, m
10 1.42, m 1.40, m 1.41, m 1.97, m
1.04, m 1.07, qd (12.8,3.4) 1.04, m 1.06, m
11 1.63, m 1.42, m 1.64, td (11.0, 2.7) 1.64 m
12 0.98, s 1.00, s 1.01, s 1.38, br s
13 3.44, dd (11.4, 8.6) 3.26, dd (11.4, 9.4) 3.57, dd (11.4, 9.8) 5.27, dd (13.6, 10.5)
14 5.75, dd (15.4, 8.6) 5.97, dd (15.3, 9.4) 6.85, dd (15.9, 9.8) 5.78, dd (14.6, 10.5)
15 5.71, dd (15.4 4.8) 5.50, dd (15.3, 8.0) 6.18, d (15.9) 5.91, t (12.8)
16 4.24, m 4.18, m - 5.56, dq (14.2, 6.8)
17 1.19, d (6.4) 1.19, d (6.2) 2.22, s 1.67, d (6.8)
18 1.73, br s 1.69, br s 1.68, br s 1.55, t (1.9)
19 0.90, d (6.5) 0.91, d (6.5) 0.90, d (6.2) 0.91, d (6.5)
2′ - - - -
3′ - - - -
4′ - - - -
5′ 3.57, dd (4.8, 2.6) 3.94, dd (2.7, 1.9) 3.61, dd (4.9, 2.7) 3.61, t (2.7)
6′ 4.09, dd (12.2, 2.6) 4.08, m 4.10, m 3.87, m
3.92, dd (12.3, 4.8) 3.86, dd (12.4, 2.7) 3.94, m 3.81, m
7′ 3.10, s 3.07, s 3.11, s 2.97, brs
6′-OH 2.74, m
a Recorded in CDCl3, b Recorded in CD3CN.
The relative configuration of the stereogenic centers within 1 was established mainly by NOESY
data (Figure 4B and Figure S6). The NOESY correlations observed between H-6/H-8, H-6/H3-12,
H3-12/H-3 and H-11/H-13 revealed the trans junction of the decalin ring, the α-orientation of H-3,
H-6, H-8, H3-12 and the β-orientation of H-11, H-13 and H3-19 methyl group (Figure 4B). The large
coupling constant (J14,15 = 15.4 Hz) and the NOESY correlation detected between H-13 and H-15
indicated the E-geometry of the double bond at ∆14(15). The NOE correlations and the distances (Å)
between relevant protons on the Chem3D optimized model of 1 assisted the assignment of the relative
stereochemistry at C-5′ in the tetramic acid portion (Figure 4B, Table S3). The NOE cross-peaks detected
between H-5′/H-15 (distance 2.96 Å) and H-5′/H-17 (distance 3.28 Å) indicated H-5′ to be β-oriented.
The absolute configuration of C-16 was determined by Mosher’s ester method [20]. The compound
1 was converted to 16-(S)-MTPA methyl ester (6) and 16-(R)-MTPA methyl ester (7) using (S)- and
(R)-MTPA chloride (Figures S25 and S26). The differences of 1H NMR chemical shifts around C-16 of 6
and 7 were measured (Table S2, Figure S29). The results of ∆δ (δS–δR) for H-14 (0.08), H-15 (0.07) and
H3-17 (−0.08) suggested the absolute configuration at C-16 to be S. Thus, we propose the trivial name
pyrenosetin A for compound 1.
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Table 2. 13C NMR data of compounds 1–4 at 150 MHz.
Position
1 a 2 a 3 a 4 b
δC δC δC δC
1 213.3 (C) 209.8 (C) 212.1 (C) 197.6 (C)
2 54.8 (C) 54.1 (C) 54.7 (C) 49.9 (C)
3 53.6 (CH) 52.8 (CH) 53.6 (CH) 50.2 (CH)
4 131.8 (C) 132.3 (C) 130.9 (C) 132.4 (C)
5 128.1 (CH) 127.6 (CH) 128.8 (CH) 127.1 (CH)
6 37.6 (CH) 37.6 (CH) 37.6 (CH) 40.1 (CH)
7 41.9 (CH2) 42.0 (CH2) 41.8 (CH2) 43.1 (CH2)
8 33.0 (CH) 32.9 (CH) 32.9 (CH) 34.3 (CH)
9 35.3 (CH2) 35.3 (CH2) 35.2 (CH2) 36.6 (CH2)
10 25.3 (CH2) 25.3 (CH2) 25.2 (CH2) 29.0 (CH2)
11 37.4 (CH) 38.0 (CH) 37.4 (CH) 40.6 (CH)
12 15.0 (CH3) 15.2 (CH3) 15.2 (CH3) 14.2 (CH3)
13 51.5 (CH) 51.0 (CH) 50.6 (CH) 131.6 (CH)
14 127.3 (CH) 130.5 (CH) 144.4 (CH) 133.4 (CH)
15 138.8 (CH) 137.8 (CH) 133.9 (CH) 132.1 (CH)
16 67.9 (CH) 69.0 (CH) 197.6 (C) 129.2 (CH)
17 23.5 (CH3) 22.9 (CH3) 27.6 (CH3) 18.1 (CH3)
18 24.2 (CH3) 23.9 (CH3) 23.7 (CH3) 22.5 (CH3)
19 22.4 (CH3) 22.4 (CH3) 22.4 (CH3) 22.7 (CH3)
2′ 168.6 (C) 168.6 (C) 167.8 (C) 178.1 (C)
3′ 73.1 (C) 73.8 (C) 72.7 (C) 101.6 (C)
4′ 207.2 (C) 205.0 (C) 206.4 (C) 191.5 (C)
5′ 69.8 (CH) 69.4 (CH) 69.8 (CH) 68.8 (CH)
6′ 60.3 (CH2) 58.3 (CH2) 60.3 (CH2) 59.6 (CH2)
7′ 28.3 (CH3) 27.7 (CH3) 28.5 (CH3) 27.4 (CH3)
a Recorded in CDCl3, b Recorded in CD3CN.
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Compound 2 was isolated as an optically active colorless oil. Its molecular formula C25H35NO5
deduced by HR-ESIMS (m/z 452.2401 [M + Na]+) was found to be the same as 1 (Figure S15). A close
inspection of its FT-IR, 1D and 2D NMR spectra (Figures S9–S14 and S16) revealed that 2 had the
same 2D structure as 1. As depicted in Tables 1 and 2, 1D NMR spectra of 2 however contained slight
changes in chemical shifts of H-14 (1 δH 5.75 and 2 δH 5.97) and C-14 (1 δc 127.3 and 2 δC 130.5); H-15
(1 δH 5.71 and 2 δH 5.50) and C-15 (1 δc 138.8 and 2 δC 137.8); and H-16 (1 δH 4.24 and 2 δH 4.18) and
C-16 (1 δc 67.9 and 2 δC 69.0). These differences were indicative of an opposite (R) stereochemistry at
C-16. The absolute configuration of C-16 was investigated by Mosher’s method. The chemical shift
differences [∆δ(δS-δR)] in the 1H-NMR of the MTPA esters (8 and 9) for H-14 (−0.01), H-15 (−0.13) and
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H3-17 (+0.04) suggested a 16-R absolute configuration, which was opposite to 1 (Table S2, Figures S27,
S28 and S30). The absence of any NOESY correlation between H-5′and H-15 or between H-5′and H-17
suggested the α-orientation of H-5′. The distances calculated on the 3D structure of compound 2 (with
both α- and β-epimers of H-5′) (Table S3) supported this assignment. Based on the NOESY spectrum
(Figure S14), the relative configuration of all other chiral centers within 2 was identified to be the same
as in compound 1. We suggest the trivial name pyrenosetin B for compound 2.
HR-ESIMS analysis of compound 3 revealed a molecular ion (m/z 428.2434 [M + H]+) that
corresponded to a molecular formula C25H33NO5 (Figure S23). This requires 10 degrees of unsaturation.
The FT-IR, 1D and 2D NMR data of 3 closely resembled compounds 1 and 2 (Figures S17–S22 and S24).
The two most striking differences were the absence of H-16 oxymethine resonance in the 1H-NMR
spectrum of 2, and the appearance of an additional carbonyl singlet at δC 197.6 (C-16) in its 13C-NMR
spectrum (Tables 1 and 2, Figures S17 and S18). This clearly suggested 3 to be an oxidized analog of 1
and 2. The conversion of the secondary methyl group H3-17 into a highly deshielded singlet at δH 2.22
(Table 1) indicated that the hydroxyl group at C-16 was replaced by a ketone function. The remarkable
shift of H-14 and H-15 protons to downfield up to +0.8 and 1.0 ppm, respectively, further supported
this assumption (Table 1). Clear HMBC correlations from H-14, H-15 and H3-17 to C-16 provided the
final proof for the presence of a carbonyl function at C-16. The planar structure of 3 was confirmed
by detailed analysis of 1H, 13C, DEPT-HSQC, COSY and HMBC data (Figures S17–S22). The relative
configuration of the chiral centers at C-3, C-6, C-8, C-11, C-2, C-13, C-3′ and C-5′ within 3 was deduced
to be the same as in 2 by analyzing its NOESY spectrum (Figure S22) and distances between proton
pairs H-5′/H-15 and H-5′/H-17 (Table S3). We suggest the trivial name pyrenosetin C for compound 3.
2.4. Biological Activity of Compounds 1–4
Compounds 1–4 were tested against the human malignant melanoma cancer cells (A-375).
As shown in Table 3, compounds 1 and 2 showed the highest anticancer activity with IC50 values of 2.8
and 6.3 µM, respectively. Compound 3 and the known metabolite 4 were less potent (IC50 140.3 and
37.3 µM). The general toxicity of the isolated metabolites was assessed against the human keratinocyte
cell line HaCaT. Interestingly the IC50 values of 1, 3 and 4 against HaCaT cells were very similar to their
IC50 values against melanoma cells, indicating them to be non-selectively toxic. However, compound 2
exerted lower toxicity towards HaCaT cells (IC50 35.0 µM) with a relatively better selectivity index
around 5.6 (calculated by dividing IC50 value against HaCaT cells / IC50 value against A-375 cells)
compared to other three fungal metabolites.
Table 3. In vitro activity of compounds 1–4 against human malignant melanoma cell line (A-375) and
non-cancerous keratinocyte cell line (HaCaT). The IC50 values are in µM. Positive control: Doxorubicin.
Compound A-375 Cells HaCaT Cells
1 2.8 (±0.0) 4.2 (±0.0)
2 6.3 (±0.0) 35.0 (±0.0)
3 140.3 (±0.9) 142.9 (±1.4)
4 37.3 (±0.1) 45.0 (±0.2)
Positive control 0.6 (±0.0) 22.1 (±2.9)
3. Discussion
Phylogenetic tree analysis confirmed the fungus FVE-001 to be a Pyrenochaetopsis sp. The genus
Pyrenochaetopsis has previously been reported as a close relative of Pyrenochaeta, which is a member of
the family Cucurbitariaceae. The genus Pyrenochaetopsis shows genetic similarity to the genus Phoma,
but their conidiogenesis is considered to be significantly different [21,22]. The chemical machinery of
the genus Pyrenochaetopsis has not received much attention so far. To our knowledge, only one chemical
study has been performed on terrestrial soil fungus Pyrenochaetopsis sp., reporting the isolation of
phomasetin (4) and two new decalinoyl tetramic acids, wakodecalines A and B [18]. A very recent study
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by Kato et al. (2018) has identified the biosynthetic gene cluster of phomasetin in a Pyrenochaetopsis
sp. RK10-F058 [23]. The wakodecalines A and B showed moderate antimalarial activity against the
Plasmodium falciparum 3D7, but were inactive against cancer cell lines [18]. Phomasetin (4) has been
reported from few fungal genera, e.g., Phoma and Pyrenochaetopsis. It exerts anti-HIV and antitumor
activities against cancer cell lines such as HeLa and HL-60 [18,19]. In this study phomasetin showed
weak antitumor activity, which was associated with general toxicity.
The major drawbacks of the traditional bioassay-guided isolation process include its time
consuming nature and the re-isolation of known compounds. Molecular network-based metabolomics
is emerging as an efficient method in identification of chemical inventory of biological organisms
and dereplication of natural products from crude extracts [11,24]. In our previous work, we used
OSMAC approach to investigate chemical diversity and anticancer activity of fungi associated with
Fucus vesiculosus [12] where we mapped the anticancer activity data of large number of fungal extracts
over the MN and searched for a link between spectral molecular networks and their anticancer
activity [12]. One fungus from this study that was identified herein as Pyrenochaetopsis sp. FVE-001
(order Pleosporales) was selected for work-up, based on its anticancer activity. The combination of both
bioassay-guided fractionation and MN approaches in the form of B-B MN allowed the rapid isolation
of three new compounds 1–3. As expected, pyrenosetins A (1) and B (2) had the highest anticancer
activity, supporting the bioactivity scores obtained by B-B MN at fractionation stage. Pyrenosetin B
(2) that differs from 1 by the stereochemistry of the C-16 hydroxyl group displayed less pronounced
anticancer activity but also lower toxicity. The replacement of the OH group at C-16 with a keto
function in pyrenosetin C (3) was not favorable for bioactivity, leading to a low IC50 value against
A-375 cells. This indicates that the presence of an OH group at C-16 impacts the anticancer and toxic
potential of pyrenosetins A-C.
Compounds 1–3 possess unique decalinoylspirotetramic acid structures characterized by a
trans-decalin ring, a fused spiro system with a carbonyl unit (cyclopentanone) and a terminal tetramic
acid moiety. Bioactive natural products containing trans-decalin ring are common in fungi (e.g.,
genera Fusarium, Penicillium and Alternaria) [25], however, molecules containing a decalin ring with
a terminal tetramic acid structure linked through a spiro ring are rare in Nature. Some known
examples include fusarisetins A and B from a soil-derived Fusarium sp., fusarisetins C-D from a
marine-derived Fusarium sp. [26,27], altercrasins A-E from a sea urchin-derived Alternaria sp. [28].
Wakodecalines A and B obtained from the terrestrial soil fungus Pyrenochaetopsis sp. RK10-F058 possess
a N-methylated serine moiety instead of the terminal tetramic acid ring [18]. Interestingly some
Fusarium sp. [29] contain equisetin, the enantiomeric homolog of phomasetin, which possesses totally
opposite stereochemistry in all chiral centers. Such compounds have been proposed to be mixed
biosynthesis products of PKS and NRPS pathways [23]. Despite the structural similarities, biosynthesis
of decalin derivatives is highly controlled by stereospecific enzymes [19,30]. A recent study by Kato et
al. (2018) reported that the stereospecific enzyme fas2 determines the formation of the trans-decalin ring
in equisetin (and fusarisetin), while phm7 enzyme controls the biosynthesis of the trans-decalin ring in
the enantiomeric homolog phomasetin (4) [23]. In this study, we isolated phomasetin (4) and three
new related metabolites 1–3 from Pyrenochaetopsis sp. FVE-001. This is the first chemical study carried
out on a marine-derived Pyrenochaetopsis sp. and the second investigation performed on a member of
the genus Pyrenochaetopsis. Although the anticancer activity the compounds 1 and 2 is associated with
cytotoxicity, a medicinal chemistry approach in future may improve their potency and selectivity.
4. Material and Methods
4.1. General Procedures
NMR spectra were recorded on a Bruker AV 600 spectrometer (600 and 150 MHz for 1H- and
13C-NMR, respectively, Bruker®, Billerica, MA, USA) or a Bruker Avance III spectrometer (500
and 125 MHz for 1H- and 13C-NMR, respectively). The residual solvent signals were used as
Mar. Drugs 2020, 18, 47 11 of 16
internal references: δH 7.26/δC 77.2 ppm (CDCl3), δH 1.94/δC 118.3 and δC 1.3 (CD3CN). 4-Dimethyl-
4-silapentane-1-sulfonic acid (DSS) was used as internal standard. High-resolution MS2 data were
recorded on a Xevo G2-XS QTof Mass Spectrometer (Waters®, Milford, MA, USA) coupled to a Waters
Acquity I-Class UPLC system). HR-ESIMS was recorded on a Bruker microTOF II-High-performance
TOF-MS system equipped with an electrospray ionization source. Solid phase extraction (SPE) was
performed on the Chromabond C18 SPE cartridges (6 mL/2000 mg, Macherey-Nagel, Duren, Germany).
HPLC separations were performed on a VWR Hitachi Chromaster system (VWR International, Allison
Park, PA, USA) consisting of a 5430 diode array detector (VWR International, Allison Park, PA, USA),
a 5310 column oven, a 5260 autosampler and a 5110 pump combined in parallel with a VWR Evaporative
Light Scattering Detector (ELSD 90). Routine HPLC separations were performed on semipreparative
(Onyx, 100 × 10 mm, Phenomenex, Torrance, CA, USA) C18 monolithic column, analytic (SeQuant®,
250 × 4.6 mm, Merck, Darmstadt, Germany) ZIC-HILIC column and analytic (SynergiTM, 4 µm,
250 × 4.6 mm, Phenomenex) polar-RP 80 Å LC column. The water used was MilliQ-water produced
by in-house Arium® Water Purification Systems (Sartorius, Germany). EtOAc, n-hexane, methanol
and acetonitrile were purchased from VWR International GmbH (Hannover, Germany). Potato extract
and dextrose that were used for culture medium were purchased from Sigma-Aldrich (Schnelldorf,
Germany) and from Merck, respectively. Agar was purchased from Applichem (Darmstadt, Germany).
(S)- and (R)-MTPA chloride were purchased from Merck. The 3D structures of compounds 1–3 were
obtained by using ChemBio3D Ultra 12.0 software (PerkinElmer, Waltham, MA, USA).
4.2. Strain Identification and Cultivation
The fungal strain was isolated from Fucus vesiculosus specimens collected in Falckenstein Beach
(54◦23′22.6′′ N, 10◦11′26.4′′ E), Kiel Fjord, Baltic Sea, Germany in December 2015 [12]. The fungus
was identified using ITS-5.8s rRNA sequencing to species level through building phylogenetic tree
(Figure 1). The evolutionary history was inferred by using the Maximum Likelihood method based
on the General Time Reversible model [31]. The percentage of trees in which the associated taxa
clustered together is shown next to the branches. Initial tree(s) for the heuristic search were obtained
automatically by applying Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances
estimated using the Maximum Composite Likelihood (MCL) approach, and then selecting the topology
with superior log likelihood value. A discrete Gamma distribution was used to model evolutionary
rate differences among sites (5 categories (+G, parameter = 0.8198)). The rate variation model allowed
for some sites to be evolutionarily invariable ([+I], 37.97% sites). The tree is drawn to scale, with
branch lengths measured in the number of substitutions per site. The analysis involved 14 nucleotide
sequences. Evolutionary analyses were conducted in MEGA7 [32]. The fungal sample was deposited
at the GEOMAR-Biotech laboratory (Kiel, Germany). The strain was cultured on potato dextrose
agar (PDA: potato extract 4 g, dextrose 20 g, agar 15g for 1 L, pH 5.6). After 3 days of pre-culturing,
the conidia was inoculated in 500 mL cylindrical flasks containing 100 mL of seed medium (PDM:
potato extract 4 g, dextrose 20 g for 1 L; pH 5.6) incubated at 22 ◦C for 7 days on a rotary shaker at
120 rpm.
4.3. Extraction and Isolation
The 12 L of culture broth was partitioned with the same volume of EtOAc twice. The resulting
organic extract was evaporated in vacuo to afford light yellow oily extract (2.66 g). The crude extract
was subjected to a modified Kupchan partition to yield three subextracts, namely n-hexane (KH,
1.99 g), CHCl3 (KC, 345.4 mg) and aqueous MeOH (KM, 68.7 mg). Briefly, the crude extract was
dissolved in 500 mL aqueous methanol (90% MeOH) and partitioned against n-hexane (KH, 2 × 500 mL).
The MeOH content of the aq. MeOH phase was increased to 30% before partitioning against CHCl3
(KC, 2 × 500 mL). The KC subextract showed relatively high anticancer bioactivity against all five
cancer cell lines (>75% inhibition rate at 100 µg/mL) and was fractionated on a Chromabond C18
SPE cartridge. A 10% stepwise gradient elution with MeOH: H2O mixtures (0% to 100%) afforded 11
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fractions (fraction 0–10). Anticancer activity was tracked to fractions 5–7. The fraction 5 (92.7 mg) and
fraction 6 (13.3 mg) were combined and subjected to semi-preparative RP–HPLC, eluting with MeCN:
H2O (40% isocratic MeCN over 28 min, and gradual increase to 60% by 40 min, flow 3.0 mL/min)
to yield 7 subfractions (fraction 5.1 to 5.7). Subfraction 5.4 contained the pure compound 1 (2.4 mg,
tR 16.5 min). Fraction 5.7 (3.6 mg) was rechromatographed by RP-HPLC (isocratic mixture H2O: MeCN
(45:55, flow 1.0 mL/min) to yield 2 (1.2 mg, tR 8.0 min) and 3 (0.8 mg, tR 9.5 min). The fraction 7 (25.4 mg)
was subjected to a semi-prep. RP–HPLC (65% isocratic MeCN over 30 min, and gradual decrease
to 60% MeCN to 60%MeCN by 35 min, flow 3.0 mL/min) to yield 5 subfractions (fraction 7.1–7.5).
Fraction 7.4 (12.9 mg) was separated on HPLC equipped with an analytical HPLC column (SynergiTM,
250 × 4.6 mm, Phenomenex) using MeCN:H2O (50% isocratic MeCN over 6 min and gradual increase
to 78% MeCN by 12 min (flow 1.0 mL/min)) to yield 4 (1.4 mg, tR 6.5 min) in a pure state.
Pyrenosetin A (1): Colorless oil; [α]22D +30 (c 0.10, MeOH); IR (oil) vmax 3554, 3249, 2952, 2875, 1721, 1683,
1456, 1378, 1271 cm−1; 1H-NMR (CDCl3, 600 MHz) and 13C-NMR (CDCl3, 150 MHz), Tables 1 and 2;
HR-ESIMS found m/z [M + H]+ 430.2592, C25H36NO5, calculated for 430.2588.
Pyrenosetin B (2): Colorless oil; [α]22D +13 (c 0.10, MeOH); IR (oil) vmax 3550, 3185, 2944, 2862, 1726, 1675,
1456, 1378, 1249 cm−1; 1H-NMR (CDCl3, 600 MHz) and 13C-NMR (CDCl3, 150 MHz), Tables 1 and 2;
HR-ESIMS found m/z [M + Na]+ 452.2401 C25H35NO5Na, calculated for 452.2407.
Pyrenosetin C (3): Colorless oil; [α]22D +12 (c 0.10, MeOH); IR (oil) vmax 3559, 3259, 2952, 2858, 1726, 1683,
1451, 1369, 1253 cm−1; 1H-NMR (CDCl3, 600 MHz) and 13C-NMR (CDCl3, 150 MHz), Tables 1 and 2;
HR-ESIMS found m/z [M + H]+ 428.2434, C25H34NO5, calculated for 428.2431.
Phomasetin (4): Colorless oil; [α]22D +116 (c 0.15, CDCl3);
1H-NMR (CD3CN, 600 MHz) and 13C- NMR
(CD3CN, 150 MHz), Tables 1 and 2; HR-ESIMS found m/z [M + H]+ 414.2645, C25H36NO4, calculated
for 414.2639.
4.4. UHPLC-QToF-MS/MS Analysis and Molecular Networking
The SPE fractions derived from the KC subextract were analyzed on an ACQUITY UPLC I-Class
System coupled to the Waters® Xevo G2-XS QToF Mass Spectrometer equipped with an electrospray
ionization (ESI) source operating with a mass range of m/z 50–1600 Da. The 0.1 mg/mL MeOH solution
of each fraction was filtered through a 0.2 µm PTFE syringe filter (Carl Roth, Karlsruhe, Germany) and
then injected (injection volume: 0.2 µL) into the system that equipped with Acquity UPLC HSS T3
column (High Strength Silica C18, 1.8 µm, 100 × 2.1 mm I.D., Waters®) operating at 40 ◦C. Separation
was achieved with a binary LC solvent system controlled by MassLynx® (version 4.1) using mobile
phase A (99%) water/ 0.1 % formic acid (ULC/MS grade) and B 99.9% ACN/ 0.1% formic acid (ULC/MS
grade), pumped at a rate of 0.6 mL/ min with the following gradient: initial, 1% B; 0.0–6.0 min to 30%
B; 6.0–11.5 min to 100% B; 11.5–13.5 min 100% B, and a column reconditioning phase until 15 min.
ESI conditions were set with the capillary voltage at 0.8 kV, sample cone voltage at 40.0 V, source
temperature at 150 ◦C, desolvation temperature at 550 ◦C, cone gas flow in 50 L/h and desolvation gas
flow in 1200 L/h. MS/MS setting was a ramp collision energy (CE): low CE from 6 eV to 60 eV and high
CE from 9 eV to 80 eV. As a control, solvent (methanol) was injected. MassLynx® (Waters®, V4.1) was
used to analyze the achieved MS and MS2 data.
The raw data were converted to mzXML file format using MSConvert (version 3.0.10051, Vanderbilt
University, Nashville, TN, USA). The resulting mzXML data were processed in MZmine2 (version
2.32). Mass lists were created using the mass detection module with a noise level of 1500 counts for
MS1 and 10 counts for MS2. The chromatogram builder module was used to create peak lists with a
scan retention time from 0.01 min to 13.0 min, a minimum retention time of 0.01 min, a minimum peak
height of 10,000 counts and an m/z tolerance of 0.01 Da or 10 ppm. The peak lists were deconvoluted
using the local minimum search algorithm with the following parameters: chromatographic threshold
0.01%, search minimum in RT range 0.20, minimum relative height 0.01%, minimum absolute height
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1000 counts, minimum ratio of peak top/edge 2, peak duration range 0.01–3 min. For MS2 scan pairing,
the m/z range was set to 0.05 Da and retention time range to 0.2 min. Furthermore, the deconvoluted
peak lists were deisotoped with the following parameters: m/z tolerance 0.02 or 10 ppm, retention time
tolerance 0.01 min and maximum charge 2. The deisotoped peak lists were aligned through using
the Join aligner module with an m/z tolerance of 0.01 Da or 10 ppm and a retention time tolerance of
0.2 min. Weight for m/z and retention time were both set to 50. The aligned peak list was filtered to
exclude peaks derived from solvent and peaks with m/z lower than 125 Da. The peak ID’s were lastly
reset and the peak list was exported as mgf file for GNPS analysis. The reset peak list was exported as
CSV table file for bioactivity score analysis.
The adjusted mgf files were uploaded to GNPS for molecular networking analysis. A molecular
network was created with the feature based molecular networking work flow (https://ccms-ucsd.github.
io/GNPSDocumentation/featurebasedmolecularnetworking/) on the GNPS website (http://gnps.ucsd.
edu) [33]. The data was filtered by removing all MS/MS fragment ions within ±17 Da of the precursor
m/z. MS/MS spectra were window filtered by choosing only the top 6 fragment ions in the ±50 Da
window throughout the spectrum. The precursor ion mass tolerance was set to 0.02 Da and a MS/MS
fragment ion tolerance of 0.02 Da. A network was then created where edges were filtered to have
a cosine score above 0.65 and more than 6 matched peaks. Further, edges between two nodes were
kept in the network if and only if each of the nodes appeared in each other’s respective top 10 most
similar nodes. Finally, the maximum size of a molecular family was set to 250, and the lowest scoring
edges were removed from molecular families until the molecular family size was below this threshold.
The spectra in the network were then searched against GNPS spectral libraries. The library spectra
were filtered in the same manner as the input data. All matches kept between network spectra and
library spectra were required to have a score above 0.65 and at least 6 matched peaks. The CSV table
generated from MZmine2 (ver. 2.32) was input to R studio (version 1.1.463) to calculate the bioactivity
score based on the workflow reported by Nothias et al. [14]. The obtained bioactivity score list and
GNPS data were downloaded and imported into Cytoscape® (version 3.5.1, Institute for Systems
Biology, Seattle, WA, USA) to generate the bioactivity-based molecular networking.
4.5. Mosher’s Esterification
4.5.1. Preparation of 16-(S) MTPA Ester 6 and 16-(R)-MTPA Ester 7
To a solution of 1 (1.1 mg, 2.1 µmol) in abs. pyridine (0.3 mL), (S)-MTPA chloride (3.2 mg,
12.6 µmol) was added, and the reaction mixture was stirred at room temperature for 12 h. Subsequently
1.0 mL water was added to the reaction mixture and extracted using CH2Cl2. The organic layer was
evaporated under reduced pressure, and the residue was purified by RP-HPLC eluted with MeCN:H2O
(gradient from 50:50 to 100:0 in 10 min, 100:0 in 10 to 15 min, and from 100:0 to 50:50 in 15 to 21 min,
flow 1.0 mL/min) to afford 16-(S)-MTPA ester 6 (0.7 mg, tR 12.0 min) as a colorless oil. The 16-(R)-MTPA
ester 7 was prepared from 1 using (R)-MTPA chloride in pyridine employing the same procedure.
The 16-(R)-MTPA ester 7 (0.5 mg, tR 11.9 min) was a colorless oil. Both 6 and 7 were dissolved in CDCl3
and analysed by 1H-NMR spectroscopy.
4.5.2. Preparation of 16-(S) MTPA Ester 8 and 16-(R)-MTPA Ester 9
Compound 8 and 9, respectively, were individually prepared from 2 using either with (S)-MTPA
chloride) or (R)-MTPA chloride. The same procedure used for preparation of 6 was employed.
Both 16-(S)-MTPA ester 8 (0.3 mg, tR 11.3 min) and 16-(R)-MTPA ester 9 (0.3 mg, tR 11.2 min) were
colorless oils. They were dissolved in CDCl3 and analysed by 1H-NMR spectroscopy.
4.6. Bioactivity Assays
The crude extracts were initially tested in vitro against 5 human cancer cell lines: colorectal
adenocarcinoma cell line HT-29 (DSMZ, Braunschweig, Germany), malignant melanoma cell line
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A-375 (CLS, Eppelheim, Germany), colon cancer cell line HCT-116 (DSMZ), lung carcinoma cell line
A-549 (CLS, Eppelheim, Germany), human breast cancer line MB-231 (CLS), and the non-cancerous
human keratinocyte line HaCaT (CLS) at a concentration of 100 µg/mL. The antitumoral activity of the
crude extracts was evaluated by monitoring the metabolic activity using the CellTiterBlue Cell Viability
Assay (Promega, Mannheim, Germany). HT-29 and HaCaT cells were cultivated in RPMI medium,
A-549 and MB-231 cells in DMEM: Ham’s F12 medium (1:1) supplemented with 15 mM HEPES and
A-375 and HCT-116 cells in DMEM medium supplemented with 4.5 g/L D-Glucose and 110 mg/L
sodium pyruvate. All media were supplemented with L-Glutamine, 10% fetal bovine serum, 100 U/mL
penicillin, and 100 mg/mL streptomycin. The cultures were maintained at 37 ◦C under a humidified
atmosphere and 5% CO2. The cell lines were transferred every 3 or 4 days. For experimental procedure,
the cells were seeded in 96 well plates at a concentration of 10,000 cells per well. A stock solution of
40 mg/mL in DMSO was prepared of each extract. After 24 h incubation, the medium was removed
from the cells and 100 µL fresh medium containing the test samples was added. Each sample was
prepared in duplicate once. Doxorubicin as a standard therapeutic drug was used as positive control,
0.5% DMSO and growth media were used as controls. Following compound addition, plates were
cultured at 37 ◦C for 24 h. Afterwards, the assay was performed according to the manufacturer’s
instructions and measured using the microplate reader Tecan Infinite M200 at excitation 560 nm and
emission of 590 nm. For determination of IC50 values, a dilution series of the extracts was prepared
and tested, as described before for the crude extract. The IC50 values were calculated by Excel as
the concentration that shows 50% inhibition of the viability on the basis of a negative control (no
compound) and compared with the positive control (doxorubicin).
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Abstract: The fungal genus Pyrenochaetopsis is commonly found in soil, terrestrial, and marine
environments, however, has received little attention as a source of bioactive secondary metabolites
so far. In a recent work, we reported the isolation and characterization of three new anticancer
decalinoyltetramic acid derivatives, pyrenosetins A–C, from the Baltic Fucus vesiculosus-derived
endophytic fungus Pyrenochaetopsis sp. FVE-001. Herein we report a new pentacyclic
decalinoylspirotetramic acid derivative, pyrenosetin D (1), along with two known decalin derivatives
wakodecalines A (2) and B (3) from another endophytic strain Pyrenochaetopsis FVE-087 isolated from
the same seaweed and showed anticancer activity in initial screenings. The chemical structures of the
purified compounds were elucidated by comprehensive analysis of HR-ESIMS, FT-IR, [α]D, 1D and
2D NMR data coupled with DFT calculations of NMR parameters and optical rotation. Compounds
1–3 were evaluated for their anticancer and toxic potentials against the human malignant melanoma
cell line (A-375) and the non-cancerous keratinocyte cell line (HaCaT). Pyrenosetin D (1) showed
toxicity towards both A-375 and HaCaT cells with IC50 values of 77.5 and 39.3 µM, respectively, while
2 and 3 were inactive. This is the third chemical study performed on the fungal genus Pyrenochaetopsis
and the first report of a pentacyclic decalin ring system from the fungal genus Pyrenochaetopsis.
Keywords: Pyrenochaetopsis; pyrenosetin; marine fungus; decalinoyltetramic acid; Fucus vesiculosus;
anticancer
1. Introduction
Seaweeds harbor diverse microbial communities, such as bacteria, fungi, bacteriophage,
and viruses, forming a complex holobiont [1–3]. Endophytic fungi are one of the predominant
microbial communities associated with seaweeds and are gaining growing interest as a source of small
molecule natural products with high chemical diversity and wide-ranging bioactivity profiles [4].
Over the past decades, several structurally unique metabolites from different classes of natural products,
such as polyketides [5], terpenes [6], steroids [7], non-ribosomal peptides [8], and alkaloids [9] were
Mar. Drugs 2020, 18, 281; doi:10.3390/md18060281 www.mdpi.com/journal/marinedrugs
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reported from seaweed-derived (algicolous) fungi, with multiple bioactivities, including anticancer [7],
antibiotic [9], and antioxidant [10].
Fungal metabolites with a ‘decalin ring system’ represent a large group of architecturally complex
structural scaffolds [11]. The decalin ring system is usually substituted with, e.g., a terpene side
chain [12] or γ-lactam [13], pyrone [14], diene [15], pyrrolizidine [16], and tetramic acid rings [17].
Decalin derivatives are also intriguing for their remarkable biological activities, including anticancer [18],
antiviral [19], and antimicrobial [20]. So far, several decalin derivatives with multiple ring systems
(e.g., tricyclic ring system [21]) or rare functional groups (e.g., deoxytetramic acid [17]) have been
isolated from different algicolous fungi. As an example, Ascochyta salicorniae, an endophytic fungus
derived from the green seaweed Ulva sp. yielded ascosalipyrrolidinones A and B, unusual decalin
derivatives with an ether function on the terminal tetramic acid [17]. Ascosalipyrrolidinone A is a
potent antiplasmodial agent that inhibits both the drug-resistant and the drug-sensitive Plasmodium
falciparum strains K1 and NF54 (IC50 736 and 378 ng/mL, respectively). It also shows antimicrobial and
tyrosine kinase inhibiting activities [17].
As part of our on-going project aiming to investigate the cultivable mycobiome of seaweeds,
we have previously isolated 55 epiphytic and endophytic fungi from the Baltic brown alga
Fucus vesiculosus [22]. In-depth chemical investigation of the endophytic fungus Pyrenochaetopsis
sp. FVE-001 by using a bioactivity-based molecular networking approach led to the rapid isolation
and characterization of three new decalinoylspirotetramic acid derivatives pyrenosetins A–C and the
known decalin phomasetin [23]. All four compounds showed notable activity against human malignant
melanoma cancer cells (A-375) [23]. In the continuation of our search for new anticancer metabolites
from Fucus vesiculosis-associated fungi, a second strain of Pyrenochaetopsis sp. FVE-087 attracted our
attention. In preliminary screenings, the crude extract of this strain also exerted potent anticancer
activity [22]. Chemical work-up of this endophyte monitored by anticancer activity against the same
melanoma cell line (A-375) resulted in the purification of a new pentacyclic decalinoyltetramic acid
derivative, pyrenosetin D (1), along with two known decalins wakodecaline A (2) and wakodecaline B
(3). In this study, we report the isolation, detailed structure elucidation, the anticancer activity, and the
toxicity of compounds 1–3.
2. Results
2.1. Strain Identification and Cultivation
The endophytic fungus FVE-087 (GenBank accession number: MH881502) was isolated from the
inner thallus of the brown alga Fucus vesiculosus collected at Kiel Fjord (Baltic Sea, Germany). The initial
taxonomic study of FVE-087 revealed its taxonomical identity at order level, i.e., Pleosporales [22].
The re-amplification of ITS1-5.8S rRNA gene-ITS2 region yielded a longer 408 bp fragment, which
enabled its identification at the genus level. A phylogenetic tree was constructed using the nucleotide
sequences for related strains (obtained from NCBI database) including the previously identified
Pyrenochaetopsis sp. FVE-001 from the same seaweed, indicating that the fungus FVE-087 was a close
relative of the co-existing fungus Pyrenochaetopsis sp. FVE-001. Based on the phylogenetic tree analysis
(Figure S1), the strain FVE-087 was confirmed to be a Pyrenochaetopsis sp. The fungus FVE-087 was
cultivated in the same manner as described in our previous study [23], i.e., in liquid potato dextrose
medium (PDM) at 22 ◦C for 14 days under continuous shaking.
2.2. Extraction, Bioactivity Testing, and Isolation
The culture broth (24 L) was extracted with EtOAc. The crude EtOAc extract of the fungus was
subjected to a modified Kupchan partitioning scheme to yield n-hexane (KH), CHCl3 (KC), and aqueous
MeOH (KM) subextracts. All three subextracts were tested for their activity against five cancer cell lines;
malignant melanoma (A-375), lung carcinoma (A-549), colorectal adenocarcinoma (HT-29), colorectal
carcinoma (HCT-116), and breast cancer cell line (MDA-MB-231). The KC subextract showed the
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highest inhibitory activity against all tested cell lines (>84% cell growth inhibition at 100 µg/mL) and
was selected for a detailed chemical work-up. The KC subextract was fractionated on a C18 SPE
cartridge using a 10% gradient of MeOH in water. This yielded 11 subfractions, and the anticancer
activity was tracked to late fractions 7–9 (Table S6). Reversed-phase HPLC purification of the fractions
7 and 8, monitored by the anticancer activity against malignant melanoma (A-375) cells, afforded
compounds 1–3 (Figure 1).
Figure 1. Chemical structures of compounds 1–4.
2.3. Structure Elucidation
Compound 1 was obtained as a colorless oil. The molecular formula C25H35NO6 that required
nine degrees of unsaturation (DoU) was assigned based on the HR-ESIMS spectrum of 1 (Figure S10).
The FT-IR spectrum (Figure S11) indicated the presence of hydroxyl (vmax 3226–3560 cm-1), carbonyl
(vmax 1679 and 1734 cm-1) and aliphatic ether (vmax 1064 and 1159 cm-1) functions. Comprehensive
analysis of the 1H NMR data in conjunction with the DEPT-HSQC spectrum (CD3CN, Table 1,
Figures S4 and S6) revealed the presence of five methyl groups, including one secondary (H3-19, δH
0.89, d, J = 6.6 Hz), one tertiary ( H3-12, δH 0.88, s), one olefinic (H3-18, δH 1.76, br s), one methylketone
(H3-17, δH 2.09, s), plus an N-methyl (H3-7′, δH 2.86, s) signal. In addition, also observed were five
pairs of diastereotopic methylene protons, namely H2-7 (δH 0.75, q, J = 11.9 Hz and 1.82, m), H2-9 (δH
0.83, dq, J = 2.7, 12.6 Hz and 1.71, m), H2-10 (δH 1.02, m and 1.29, dq, J = 12.9, 3.0 Hz), H2-15 (δH 2.52,
dd, J = 16.2, 9.4 Hz and δH 2.70, dd, J = 16.2, 3.1 Hz), and the oxymethylene protons of H2-6′ (δH 3.79,
dd, J = 11.6, 6.4 Hz and δH 3.86, dd, J = 11.6, 4.1 Hz). The 1H NMR spectrum also comprised signals
belonging to eight methine protons; this included six aliphatic methine protons which were assigned
to H-3 (δH 2.32, d, J = 10.0 Hz), H-6 (δH 1.84, m), H-8 (1.44, m), H-11 (1.48, ddd, J = 11.8, 10.5, 2.7 Hz),
H-13 (δH 2.67, dd, J = 10.1, 3.4 Hz), H-5′ (δH 3.44, dd, J = 7.0, 4.1 Hz), plus one olefinic methine proton
that appeared as a broad singlet at δH 5.25 (H-5) and an oxymethine proton that resonated at δH 4.90
(H-14, dt, J = 9.3, 3.3 Hz) (Table 1). The 13C NMR spectrum of 1 (Table 1, Figure S5) contained 25 signals
accounting for three carbonyls δC 170.2 (C-2′), 206.8 (C-16), and 213.2 (C-1), and two olefinic carbons at
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δC 128.0 (C-5), and 133.2 (C-4), accounting for four DoU. This indicated 1 to be a pentacyclic compound.
Comparison of the NMR data of 1 with those of tetracyclic decalinoylspirotetramic acid derivatives
pyrenosetins A–C [23] indicated close similarities. Thus, 1 was identified as a pyrenosetin-type
decalinoylspirotetramic acid with an additional ring system.
Table 1. 1H NMR (600 MHz) and 13C NMR (150 MHz) data of compound 1 (CD3CN).
No.
1
δH, mult (J in Hz) δC
1 - 213.2
2 - 56.4
3 2.32, d (10.0) 54.8
4 - 133.2
5 5.25, br s 128.0
6 1.84, m 37.7
7 eq 1.82, m 42.9
ax 0.75, q (11.9)
8 1.44, m 33.5
9 eq 1.71, m 36.0
ax 0.83, dq (2.7, 12.6)
10 eq 1.29, dq (12.9, 3.0) 25.8
ax 1.02, m
11 1.48, ddd (11.8, 10.5, 2.7) 37.9
12 0.88, s 14.2
13 2.67, dd (10.1, 3.4) 57.0
14 4.90, dt (9.3, 3.3) 83.7
15 a 2.70, dd (16.2, 3.1) 50.3
b 2.52, dd (16.2, 9.4)
16 - 206.8
17 2.09, s 30.8
18 1.76, br s 23.2
19 0.89, d (6.6) 22.5
2′ - 170.2
3′ - 75.3
4′ - 110.3
5′ 3.44, dd (7.0, 4.1) 68.3
6′ a 3.86, dd (11.6, 4.1) 60.4
b 3.79, dd (11.6, 6.4)
7′ 2.86, s 29.5
In order to identify the position of the fifth ring system and the complete planar structure of 1,
we undertook DQF-COSY and HMBC experiments. The 1H-1H COSY spectrum of 1 comprised three
spin systems (a–c) (Figure 2A and Figure S7). The largest spin system (a) started with the olefinic
proton H-5 that coupled with H-6, then included the methyl substituted cyclohexane moiety that
terminated with the H-11. The latter proton was in turn coupled with H-6, while H3-19 coupled with
H-8, completing the structure of the ring A with a secondary methyl group attached at C-8. Further
detected in the COSY spectrum was a short spin system (b) that corresponded to a hydroxyethyl
group (H-5′ to H-6′). The final proton network (c) covered the protons of H-3, H-13, H-14, and H2-15
(Figure 2A and Figure S7).
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Figure 2. (A) Key COSY (bold) and HMBC (blue) correlations within 1. a–c: Spin systems extracted
from the COSY spectrum. (B) NOESY (red) correlations on the lowest-energy DFT conformer of 1.
In-depth analysis of the 1H-13C HMBC data (Figure 2A and Figure S8) enabled to assemble the
three COSY spin systems with quaternary carbons and heteroatoms, hence completing the full structure
of 1. Firstly, the position of the H3-19 at C-8 (ring A) was further confirmed by the HMBC correlations
between H3-19 with C-7, C-8, and C-9. The ring B of the unsaturated decalin moiety was constructed
on the basis of the HMBC cross-peaks observed from H-3 to C-2, C-4, C-5, and C-11, from H-5 to C-3
and C-11, and from the olefinic methyl group H3-18 to C-3, C-4, and C-5. The tertiary methyl H3-12
was assigned to C-2 based on the key HMBC correlations from H3-12 to C-2, C-3, and C-11. Additional
HMBC correlations between H3-12/C-1, H-3/C-3′, and H-13/C-3′ confirmed the spiro (cyclopentanone)
ring system C (Figure 2A). The ring D comprising of an N-methyl tetramic acid was built with the aid
of the HMBC correlations between H-5′/C-2′, H-5′/C-4′, H-6′/C-4′, H-6′/C-5′, H3-7′/C-2′, H3-7′/C-5′.
The upfield chemical shift of C-4′ (δC 110.3) in comparison to other pyrenosetins, such as pyrenosetin C
(4) suggested the presence in 1 of an acetal or hemiacetal rather than a ketone function. The connection
of the ring D at C-3′ of the ring C was evident due to further HMBC cross-peak seen between H-5′/C-3′.
Pyrenosetins A–C bear a C-16 oxygenated butyl substitution with a double bond ∆14(15) in the
side chain (attached at C-13) [23]. The comparison of the 1H and 13C NMR data of 1 from C-13 to
C-15 (Table 1) with those of pyrenosetin C (4) [23] clearly showed that 1 lacks the double bond at
C-14. Instead, the H-14 was converted to an oxymethine signal (δH 4.90) that showed a diagnostic
HMBC coupling with C-4′ (Figure 2A and Figure S8). This fact, in addition to above mentioned COSY
correlations between H-13/H-14 and H-14/H2-15 confirmed the fifth tetrahydrofuran ring (E). Final
HMBC correlations from H3-17 to C-15 (δC 50.3) and C-16 (δC 206.8) completed the side chain that
ended with a methylketone. Thus, the pentacyclic 2D structure of 1 was established as shown in
Figure 1.
The relative configuration of the stereogenic centers within 1 was deduced based on NOESY
correlations and coupling constant analysis (Figure 2B and Figure S9). The two large axial-axial
couplings experienced by H-11 (ddd, J = 11.8, 10.5, and 2.7 Hz) established the trans junction between
rings A and B. The observed NOESY correlations between H-3/H3-12, H-3/H-14, H-6/H-8, H-6/H3-12,
and H-11/H-13 indicated the α-orientation of H-3, H-6, H-8, H3-12, H-14, and the β-orientation of
H-11, H-13, and the H3-19 methyl group. This left three stereogenic centers (C-3′, C-4′, and C-5′) in the
tetramic acid moiety to be assigned.
Assignment of configuration at C-3‘ and C-4′ was based on the high geometric strain of
trans-5,5-fused ring systems, which are known to be less stable than their cis counterparts by more
than 6 kcal/mol [24]. As the hemiacetal function at C-4′ would readily open in case of steric strain,
the possibility of strained trans junctions between rings C and E and/or between rings E and D was
ruled out, and the requirement of cis junctions between rings C, E, and D defined configurations at
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C-3′ and C-4′ as depicted in structure 1. The configuration at C-5′ was suggested by a very weak NOE
correlation between H-5′ and H-15b (δH 2.52) (Figure 2B).
As the determined configuration at C-3′ was opposite to that found in the other pyrenosetin
analogues (including compound 4), and configuration at C-5′ was only based on a single weak NOE
correlation, the structure of 1 was validated using DFT prediction of NMR parameters. Compound
1, its epimer at C-3′, namely 3′-epi-1 (which has also opposite configuration at C-4′, to keep the
cis junction between rings D and E), and its epimer at C-5′, namely 5′-epi-1 were considered for
calculations (see Supplementary Figure S2 for structures, and Materials and Methods Section for details
on computational methods). After a molecular dynamics-based conformational search, conformers
were optimized at the B3LYP/TZVP/SMD level; then, 1H and 13C isotropic shieldings were calculated,
respectively, at the WP04/aug-cc-pVDZ/PCM and mPW1PW91/6-311+G(2d,p) levels of theory, and
scaled to chemical shifts using the linear regression method [25]. Calculations on 3′-epi-1 were
soon stopped, because optimized conformers showed energies constantly higher than 1 by more
than 10 kcal/mol (as expected, because of the strained trans junction between rings C and E) and
root-mean-square deviations (RMSD) of 13C NMR chemical shifts of rings C, D, and E constantly over
6 ppm. In contrast, chemical shifts calculated for compound 1 were in excellent agreement with the
experimental values (RMSD of 1.66 ppm for 13C and 0.076 for 1H). While this results provided solid
support to the overall structure of 1 and to configurations at C-3′ and C-4′, they did not support the
assignment of the configuration at C-5′, because chemical shifts of 5′-epi-1 also showed a comparable
agreement with the experiment (RMSD of 1.69 ppm for 13C and 0.077 ppm for 1H) (Figure S3). Even
restricting the comparison to atoms of ring D and/or using DP4+ analysis [26], no clear-cut answer
about configuration at C-5′ could be obtained from the predicted chemical shifts. Therefore, coupling
constants were examined.
Analysis of structures 1 and 5′-epi-1 showed that the main difference between the two compounds
was expected in the 1H-13C coupling constants of H-5′. In particular, the coupling constant between
H-5′ and C-2′ was calculated as 4.3 Hz for 1 and 0.6 Hz for 5′-epi-1 (Table S5). When not measured
directly, 1H-13C coupling constants can be estimated from the intensity of the corresponding HMBC
peaks, an intense peak indicating a relatively large JCH [27]. The prominent correlation peak observed
between H-5′ and C-2′ was not consistent with the small 0.6 Hz coupling constant predicted for 5′-epi-1,
and conclusively determined the relative stereochemistry of pyrenosetin D as in structure 1. Finally,
the observed weak NOE correlation between H-5 and H-15b was in good agreement with the distance
between 3.96 and 4.16 Å of these protons measured for the DFT optimized conformers of 1 (Figure 2B).
The absolute configuration of compound 1 was determined on the basis of its predicted optical
rotation (OR). DFT prediction of OR is a valuable, although not as general, alternative to ECD for
determining the absolute configuration of natural products, and can be reliably used for this purpose
provided that (i) the magnitude of the measured OR is not close to zero and (ii) the sign of the calculated
OR is the same for all, or at least for most conformers [28]. The OR of compound 1 was predicted
at the B3LYP/TZVP/PCM(MeOH) level of theory; the calculated [α]D (as the Boltzmann average of
individual conformers) was -104, compared to the experimental value -56. In addition, the OR values
calculated for individual conformers were all negative, and with similar magnitude. These results
strongly supported the absolute configuration of pyrenosetin D as shown in Figure 1.
The known compounds 2 and 3 were identified as wakodecalines A and B (Figure 1), respectively,
based on their HR-ESIMS and MS/MS data, plus by comparison of their 1D/2D NMR and [α]D data
with those reported in the literature [29].
2.4. Bioactivity Tests
Due to the limited availability, compounds 1–3 were tested for their inhibitory activity against
only one cancer cell line, i.e., the human malignant melanoma cell line (A-375). The general toxicity of
the isolated metabolites was assessed against the human keratinocyte cells (HaCaT). Compound 1
exhibited moderate anticancer activity against the A-375 cells (IC50 value 77.5 µM), but it was also
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toxic towards the HaCaT cells (IC50 value of 39.3 µM). The known compounds 2 and 3 did not exert
anticancer or toxic effects, even at the highest test concentration of 200 µM.
3. Discussion
Pyrenochaetopsis is a ubiquitous fungal genus found in both terrestrial and marine
environments [30,31]. However, the members of this genus have remained almost fully unexplored for
their bioactive secondary metabolites. To our knowledge, the very first chemical study was published in
2017 by Nogawa et al. on a Pyrenochaetopsis sp. isolated from a soil sample collected in Japan [29]. This
work reported wakodecalines A, B, two new tricyclic decalin derivatives with a spiro pentanone ring
(C) and N-methylated terminal serine moiety as well as phomasetin, a known decalin compound with
a terminal tetramic acid function [29]. The lack of any other investigation in the literature on chemical
constituents or biological activity has initiated our interest into this unexplored fungal taxon. In a very
recent study, we demonstrated that, when cultured in liquid potato dextrose medium, the algicolous
Pyrenochaetopsis sp. FVE-001 produces pyrenosetins A–C, new tetracyclic decalin derivatives with
good activity against malignant melanoma cells (A-375) [23]. In addition, also isolated and identified
from this fungus was the known compound phomasetin [23].
The ‘decalin’ moiety is a common structural motif in an array of marine fungal natural
products [13,32,33]. It has been proposed that the decalin ring serves as a primary ring system
or a scaffold to form polycyclic metabolites, with bicyclic decalins being the most common [11,13,32–35].
The chemical investigation of the marine sponge-derived fungus Trichoderma harzianum in 1993 led
to the isolation of the first bicyclic decalin derivative trichoharzin isolated from a marine fungus.
Trichoharzin contains rare alkyl and acyl moieties [36]. So far, more than 50 decalin derivatives have
been reported from marine fungi [11,13,32–37]. The marine-derived bicyclic decalin derivatives often
incorporate additional ring systems, e.g., pyrone [37], cyclopentanone [13], and tetramic acid [34] to
lead tricyclic [35,37], tetracyclic [13], and pentacyclic scaffolds [34]. Of all, tetramic acid represents
one of the most common substituents [13,34,38]. Pyrenosetins A–C, which we recently reported from
Pyrenochaetopsis sp. FVE-001, an endophyte of the Baltic brown alga Fucus vesiculosus, represent one of
the most complex tetracyclic decalinoylspirotetramic acids reported to date [23]. Such complex decalin
scaffold is rare in fungi. To our knowledge, only a few fungal genera such as Fusarium sp. [34,39],
Alternaria sp. [13], Diaporthe sp. [40], and Pyrenochaetopsis sp. [23] have been reported to produce such
type of unique molecules. Decalinoyltetramic acid derivatives are also intriguing for remarkable
biological activities they exhibit. For example, altercrasins D and E isolated from sea-urchin-derived
Alternaria sp., have shown potent activity against murine P388 leukemia, human HL-60 leukemia,
and murine L1210 leukemia cell lines [13]. However, most of the decalin derivatives suffer from poor
selectivity, i.e., they also possess toxicity towards non-cancerous cells. This is a common characteristic
of mycotoxins [34,41].
Our previous research on pyrenosetins highlighted the importance of the side chain attached at
C-13 for their bioactivity [23]; both the anticancer activity and the general toxicity were significantly
reduced with the oxidation of the C-16 hydroxyl group to a ketone. Notably, wakodecalines (2 and 3)
that lack the terminal tetramic acid moiety did not show any bioactivity against A-375 cells, even at the
highest test concentrations. This suggests that both side chain and the tetramic acid moiety are crucial
for bioactivity of the decalin derivatives. Additionally, the presence of the additional tetrahydrofuran
ring as found in 1 may be improving the activity against A-375 cells (IC50 77.5 µM) when compared to
the anticancer activity of pyrenosetin C on the same cell line (IC50 140.3 µM) [23]. A previous study
showed that fusarisetin A that possesses a tetrahydrofuran ring exhibits higher activity against the
invasive breast cancer cell line MDA-MB-231 than its precursor equisetin [42].
In conclusion, a new cytotoxic pentacyclic decalinoylspirotetramic acid derivative, pyrenosetin D
(1) and two known and non-toxic tricyclic metabolites, wakodecalines A (2) and B (3), were purified
from the algicolous fungus Pyrenochaetopsis sp. To our knowledge, only fusarisetins that were isolated
from Fusarium sp. possess somehow similar pentacyclic skeleton [34,39]. This is the third study
Mar. Drugs 2020, 18, 281 8 of 12
performed on the chemical constituents of the fungal genus Pyrenochaetopsis and the first report of a
pentacyclic decalin ring system from Pyrenochaetopsis species. Further investigation of the anticancer
activity, selectivity, and mechanism of cytotoxic action of our metabolites might expand our knowledge
of the structure–activity relationship of decalinoyltetramic acid derivatives.
4. Materials and Methods
4.1. General Procedures
FT-IR spectra were recorded on a PerkinElmer Spectrum Two FT-IR spectrometer (PerkinElmer,
Boston, MA, USA). Specific rotation ([α]D) values were measured in MeOH on a Jasco P-2000 polarimeter
(Jasco, Pfungstadt, Germany). NMR data were recorded on a Bruker AV 600 spectrometer (600 and
150 MHz for 1H and 13C NMR, respectively, Bruker®, Billerica, MA, USA). The residual solvent
signals were detected in NMR spectra as internal references: δH 1.94/δC 118.3 and δC 1.3 (CD3CN).
4-Dimethyl-4-silapentane-1-sulfonic acid (DSS) was used as an internal standard. HRESIMS was
recorded on a microTOF II-high-performance TOF-MS system (Bruker®, Billerica, MA, USA) equipped
with an electrospray ionization source. Solid-phase extraction (SPE) was performed on a C18 cartridge
(50µm, 65Å, Phenomenex, 411 Madrid Avenue, Torrance, CA, USA). HPLC separations were performed
on a VWR Hitachi Chromaster system (VWR International, Allison Park, PA, USA) consisting of a
5430 diode array detector (VWR International, Allison Park, PA, USA), a 5310 column oven, a 5260
autosampler, and a 5110 pump. The eluents used for HPLC separations were milli Q water (A) and
MeCN (B). Routine HPLC separations were performed on a semi-preparative C18 monolithic column
(Onyx, 100 × 10 mm, Phenomenex, Torrance, CA, USA) and an analytical synergi polar-RP 80 Å LC
column (250 × 4.6 mm, Phenomenex, Torrance, CA, USA). The organic solvents used for chemical
analysis were of HPLC grade (ITW Reagents, Germany). An in-house Arium® Water Purification
Systems (Sartorius, Germany) was used for the preparation of milli Q water. Solvents used in extraction,
Kupchan partition, and purification (including EtOAc, n-hexane, MeOH and MeCN) were purchased
from VWR International GmbH (Hannover, Germany). Potato extract and dextrose that used for
fungal cultivation were purchased from Sigma-Aldrich (Schnelldorf, Germany) and Merck (Darmstadt,
Germany), respectively. Agar was purchased from Applichem (Darmstadt, Germany).
4.2. Strain Identification and Cultivation
The fungal strain Pyrenochaetopsis sp. FVE-087 (GenBank accession number: MH881502) was
obtained from Fucus vesiculosus specimens that were collected in Falckenstein Beach (54◦23′22.6′′ N,
10◦11′26.4′′ E), Kiel Fjord, Baltic Sea, in December 2015, Germany [22]. The fungus was identified
by morphological observation, analysis of the ITS1-5.8S rRNA gene-ITS2 region and by building a
phylogenetic tree with 14 related strains including the Pyrenochaetopsis sp. FVE-001, using the method
described in our previous work [23]. The initial cultures were maintained on potato dextrose agar
plates (PDA: potato extract 4 g, dextrose 20 g, agar 15g for 1 L, pH 5.6). After 3 days of pre-cultivation,
pieces of mycelia were cut into small segments and aseptically inoculated into an Erlenmeyer flask
(300 mL) that contained 100 mL of potato dextrose broth media (PDM: potato extract 4 g, dextrose 20 g
for 1 L; pH 5.6). After 7 days inoculation, 1 mL liquid seed was added into Erlenmeyer flasks (2 L),
each containing 800 mL PDM. A 24 L culture broth was fermented at 22 ◦C for 14 days on a rotary
shaker at 120 rpm.
4.3. Extraction and Isolation
The culture broth was partitioned against the same volume of EtOAc twice at room temperature.
The EtOAc phase was evaporated to dryness under reduced pressure to afford 17.64 g yellow oily
extract. The extract was subjected to a modified Kupchan partition scheme to yield three subextracts,
n-hexane (KH, 6.93 g), CHCl3 (KC, 4.57 g), and aqueous MeOH (KM, 440.5 mg). All three subextracts
were tested for their bioactivity against five cancer cell lines and non-cancerous cell line HaCaT. The KC
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subextract showed high anticancer bioactivity against all five cancer cell lines (>84% inhibition rate at
100 µg/mL) and was fractionated on a C18-SPE column eluting with 10% stepwise gradient of MeOH
in water (0–100%) to afford 11 fractions (F0–F10). Anticancer bioactivity was tracked to fractions F7–F9
(Table S6). The fraction 7 (F7, 138 mg) was subjected to semi-preparative RP–HPLC equipped with an
Onyx monolithic C18 column. Elution with a gradient MeCN:H2O mixture (25–35% MeCN over 30 min,
flow 3.0 mL/min) yielded eight subfractions (F7-1 to F7-8). The F7-7 (10.8 mg) was further purified
by RP-HPLC on an analytical synergi polar-RP 80 Å column eluting with MeCN:H2O (52% isocratic
MeCN over 19 min, flow 1.0 mL/min) to yield wakodecaline B (3, 2.4 mg, tR 8.8 min) and pyrenosetin D
(1, 1.2 mg, tR 10.3 min). The subfraction 8 (F8, 369.6 mg) was chromatographed by RP-HPLC equipped
with Onyx monolithic C18 column using MeCN:H2O mixtures (40% isocratic MeCN over 28 min
and gradual increase to 60% MeCN by 40 min, flow 3.0 mL/min) to yield 14 subfractions (F8-1 to
14). Wakodecaline A (2) was tracked to F8-3 (7 mg). This fraction was subjected to RP-HPLC on an
analytical synergi polar-RP 80 Å LC column using an isocratic mixture of MeCN:H2O (45:55) (flow
1.0 mL/min) to yield wakodecaline A (2, 2.9 mg, tR 9.5 min).
Pyrenosetin D (1): Colorless oil; [α]20D −56 (c 0.10, MeOH); IR (oil) vmax 3226-3560, 2947, 2921, 1734,
1679, 1460, 1406, 1377, 1159, 1064 cm−1. 1H NMR (CD3CN, 600 MHz) and 13C NMR (CD3CN, 150 MHz)
are shown in Table 1; HR-ESIMS found m/z 446.2520 [M + H]+, C25H36NO6, calculated for 446.2537.
4.4. Computational Details
Conformational search for 1 and 5′-epi-1 was based on a 10-ns molecular dynamics (MD) simulation
at 600 K as previously described [43]. The MD simulation generated 101 and 102 different conformers
for 1 and 5′-epi-1, respectively, within 5 kcal/mol from the lowest energy conformer. Optimizations
of geometries from MD were performed using density functional theory (DFT) with the Gaussian 16
program [44], the B3LYP functional, the 6-31G(d,p) basis set, and the SMD model for the solvent, ACN.
This resulted in 15 and 17 conformers for 1 and 5′-epi-1, respectively, within 3 kcal/mol from the lowest
energy conformer. Finally, these conformers were further optimized at the B3LYP/TZVP/SMD level of
theory, giving a final set of 10 significantly populated (population > 1% at 298 K) conformers for 1 and 11
significantly populated conformers for 5′-epi-1. Vibrational frequency analysis revealed no imaginary
frequencies, confirming that all conformers were in a true energy minimum. The Cartesian coordinates
and relative energies of the conformers are reported in Tables S1 and S2. These conformational
ensembles were used for all the subsequent calculations.
NMR isotropic shieldings of 1 and 5′-epi-1 were calculated using WP04/aug-cc-pVDZ/PCM for
1H and mPW1PW91/6-311+G(2d,p) for 13C, which have been shown to be most accurate levels of
theory, among those tested, for NMR data acquired in CD3CN [45]. Average shieldings were obtained
by Boltzmann statistics based on internal energies of conformers. Finally, shieldings were scaled to
chemical shifts using linear regression [25]. The results are reported in Tables S3 and S4. Coupling
constants were calculated at the B3LYP/6-31G(d,p) level and using the keyword "mixed", which
augments the basis set for the calculation of the Fermi Contact term, and averaged by Boltzmann
statistics. The results are reported in Table S4.
Optical rotations of DFT-optimized conformer of 1 were calculated using TDDFT at the
B3LYP/TZVP/PCM(MeOH) level; the results can be found in Table S1. The Boltzmann mean of
individual optical rotations gave [α]D = −105.
4.5. Biological Assays
The bioactivity tests were performed as described previously [23]. The crude extract, the subextracts
and the SPE fractions of the KC subextract were tested in vitro against five human cancer cell lines:
colorectal adenocarcinoma cell line HT-29 (DSMZ, Braunschweig, Germany), malignant melanoma
cell line A-375 (CLS, Eppelheim, Germany), colon cancer cell line HCT-116 (DSMZ, Braunschweig,
Germany), lung carcinoma cell line A-549 (CLS, Eppelheim, Germany), human breast cancer line
MDA-MB-231 (CLS, Eppelheim, Germany), as well as for the non-cancerous human keratinocyte
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line HaCaT (CLS, Eppelheim, Germany) at a concentration of 100 µg/mL. The bioactivity of the
extracts was evaluated by monitoring the metabolic activity using the CellTiterBlue Cell Viability
Assay (Promega, Mannheim, Germany). HT-29 and HaCaT cells were cultivated in RPMI medium,
A-549 and MDA-MB-231 cells in DMEM:Ham’s F12 medium (1:1) supplemented with 15mM HEPES
and A-375 and HCT-116 cells in DMEM medium supplemented with 4.5 g/L D-Glucose and 110 mg/L
sodium pyruvate. All media were supplemented with L-glutamine, 10% fetal bovine serum, 100 U/mL
penicillin, and 100 mg/mL streptomycin. The cultures were maintained at 37 ◦C under a humidified
atmosphere and 5% CO2. The cell lines were transferred every 3 or 4 days. For the experimental
procedure, the cells were seeded in 96-well plates at a concentration of 10,000 cells per well. A stock
solution of 40 mg/mL in DMSO was prepared for each extract. After 24 h incubation, the medium
was removed from the cells and 100 µL fresh medium containing the test samples was added. Each
sample was prepared in duplicate once. Doxorubicin as a standard therapeutic drug was used as a
positive control, 0.5% DMSO and growth media were used as negative controls. Following compound
addition, plates were cultured at 37 ◦C for 24 h. Afterward, the assay was performed according to
the manufacturer’s instructions and measured using the microplate reader Tecan Infinite M200 at
excitation 560 nm and emission of 590 nm. For determination of IC50 values, a dilution series of the
extracts were prepared and tested, as described before for the crude extract. The IC50 values were
calculated by Excel as the concentration that shows 50% inhibition of the viability based on a negative
control (no compound) and compared with the positive control (doxorubicin).
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/18/6/281/s1;
NMR, HRESIMS, and FT-IR spectra of compound 1. Tables with detailed information of computational results.
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1. Discussion 
Marine fungi are important microbial associates of various marine macroorganisms, including 
sponges, echinoderms, vertebrates, seagrasses and macroalgae (Abdel-Gawad et al., 2014; Höller et al., 
2001; Li and Wang, 2009; Richards et al., 2012; Wainwright et al., 2018). Macroalgae contribute 
approximately one-third of all marine fungal isolates and hence constitute an important study object for 
marine fungal biodiversity and biodiscovery research (Balabanova et al., 2018; Ji and Wang, 2016). 
With regard to Fucus, a key brown seaweed genus in Northern hemisphere coastal ecosystems, previous 
molecular and culture-based studies have contributed to understanding the fungal community associated 
to F. serratus (Zuccaro et al., 2008; Zuccaro et al., 2004). Further, molecular and metabolomic evidence 
(based on CARD-FISH and a comparative surface metabolome study) suggests a metabolically active 
fungal community associated to F. vesiculosus (Parrot et al., 2019). However, the present study (Chapter 
1) represents the first report of cultivable fungi associated with Baltic F. vesiculosus for anticancer 
biodiscovery. After publication of Chapter 1, another study was published examining the fungal 
community associated to Fucus sp. yielding 13 genera from22 fungal isolates (Patyshakuliyeva et al., 
2020).  
In this study, 55 fungal isolates were obtained from Baltic Sea F. vesiculosus belonging to 8 genera 
and 3 higher taxonomic levels (e.g. order level). Six fungal genera including Acremonium, Gibellulopsis, 
Trichoderma, Emericellopsis, Wallemia and Cadophora were exclusively isolated from F. vesiculosus, 
but not from seawater or sediment references. The genera Acremonium, Gibellulopsis, and Trichoderma 
are rather generalists and common in marine environments (Jones et al., 2009). In the genus 
Emericellopsis two distinct ecological clades are known, one containing terrestrial isolates and the other 
consisting of predominantly marine representatives suggesting an adaptation to the marine habitat of 
the latter clade (Grum-Grzhimaylo et al., 2013). All of them have been previously reported associated 
to F. serratus (Zuccaro et al., 2008). The genus Wallemia, a cosmopolitan xerophilic fungus was 
previously isolated from soil, salts and seafloor (Oleinikova et al., 2010; Zalar et al., 2005) but not from 
macroalgae. Unlike the other isolates, which all belong to Ascomycota, Wallemia sp. is a basidiomycete 
(Zalar et al., 2005). Wallemia ichthyophaga serves as a model halophilic fungus, so an adaption to the 
marine environment is highly probable (Janja et al., 2011). The genus Cadophora was previously 
isolated from the green alga Enteromorpha sp. (Almeida et al., 2010) and also from other marine 
substrata (Rämä et al., 2014). The genus Cadophora contains several terrestrial plant pathogens such 
as C. malorum or C. luteo-olivacea, but their role in the marine realm remains unknown (Rämä et al., 
2014). We therefore conclude that all obtained isolates from F. vesiculosus in this study represent 
facultative marine fungi. We did not obtain any obligate marine fungi, which may due to the low number 
of isolates but also to the selection of a brackish environment like the Baltic Sea as a study site. 
Compared to fully marine conditions (35 psu), the Baltic Sea has a reduced salinity (15-18 psu in Kiel 
Bight) potentially promoting the presence of facultative marine fungi over obligately marine 
representatives.  
Although some genera were only isolated from the alga, we do not regard them as specific to F. 
vesiculosus, because all have been reported from other marine environments including other macroalgae. 
A recently published study (Patyshakuliyeva et al., 2020) also isolated Penicillium and Trichoderma sp. 
from a Fucus sp., but also detected fungi of the ascomycete genera Cladosporium, Clonostachys, 
Rhizopus, Epicoccum, Aspergillus, Alternaria, Engyodontium, Exophiala and the basidiomycete genera 
Symmetrospora, Cryptococcus and Leucosporidium, which could not be isolated in this study. Vice 
versa, Patyshakuliyeva et al. (2020) did not observe many genera isolated during our study. Different 
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isolation media, sampling season, salinity of the Fucus sp. habitat and a different algal species explain 
the observed differences, but also show that isolation-based studies reflect only a snapshot of the entire 
fungal community.  A non-culture-based mycobiome study is needed to allow conclusive evidence on 
the entire fungal species inventory associated to Fucus sp. and potential host-specificity of Fucus 
associated fungi. In conclusion, our results (Chapter 1) suggest that Baltic Sea F. vesiculosus represents 
a promising resource for the isolation of facultative marine fungi.   
Out of the 55 Fucus-derived isolates, 26 fungi were selected for a small-scale fermentation based 
on their genetic diversity and morphological differences. In order to stimulate the expression of silent 
BGCs and to enlarge chemical space, an OSMAC approach has been applied to these 26 fungal isolates. 
Cultivation media and culture regimes were varied with the aim to explore potential anticancer natural 
products. The observed in vitro anticancer bioactivity (IC50 values < 100 μg/ml) of 10 (out of 26) strains 
against at least one cancer cell line under at least one culture condition underlines the importance of 
OSMAC for biodiscovery studies. Interestingly, all of these 10 strains were endophytes of F. vesiculosus. 
In contrast, none of the Fucus-epiphytes showed anticancer bioactivity when culture conditions were 
changed. A  recent study on anticancer potential of Indian algal endophytes showed similar patterns 
(Kamat et al., 2020). As reviewed by Ji and Wang, algal endophytes appeared to be more prolific 
producers of new metabolites (almost 50%) than algal epiphytes (ca. 30%, Ji and Wang, 2016). There 
is a scientific consensus, that algal endophytes are a prolific source of bioactive natural products 
(Sarasan et al., 2017; Teixeira et al., 2019). However, a systematic approach to understand the biology 
of alga-endophyte interaction is still lacking. Compared to the algal surface, there must be a tight 
interaction between algal internal tissue and endophytes, which stimulate endophytes to contribute to 
host´s defense by producing secondary metabolites (Maciá-Vicente et al., 2018). This may explain the 
high capacity of endophytes to produce bioactive SMs.  
It is difficult to predict the effects of any OSMAC approach on SM production. For biodiscovery, 
early dereplication and strain prioritization are however crucial. Therefore, molecular networking (MN) 
was integrated with multi-informational data (i.e. culture regimes, culture media and bioactivity results) 
to observe chemical changes of the 10 selected fungal strains (Chapter 1). Previously, MN has been 
applied to 146 marine bacteria for analyzing the effects of culture regime, culture media, sampling site 
and extraction method on chemical production (Crüsemann et al., 2017), proving the suitability of this 
approach for biodiscovery studies. This strategy enables assessment of chemical differences following 
changes in culture regime and growth media at extract stage, generating a global metabolome, which 
can be used as a roadmap for future isolation prioritization. MN confirmed that the 10 selected strains 
produced diverse types of secondary metabolites under different culture conditions, including 
polyketides, alkaloids, cyclic depsipeptides and lipids. Simultaneously, MN clearly demonstrated that 
culture regime change had a significant impact on those 10 strains’ secondary metabolite production. 
Several metabolites were mapped to only one culture regime, e.g. cyclic depsipeptide enniatin B1 was 
restricted to liquid cultures. Vice versa, the indole diterpenoid penitrem B was only produced by 
Penicillium sp. FVE-68 in sucrose yeast medium (SYM) on agar plates but not in liquid culture. 
Moreover, 9 of the 10 strains produced toxic/anticancer metabolites only in liquid culture regime. These 
different performances of chemical production in liquid and solid media suggest that those fungi were 
particularly sensitive to culture regime changes. Reasons for this differential production include 
different levels of aeration of the culture (Nout et al., 1987) as well as different mycelium structures in 
liquid (dispersed mycelia) and solid (mycelial mat) medium (Bigelis et al., 2006). Consequently, a 
change of culture regime is expected to affect the chemical inventory of marine fungi and was observed 
previously (Guo et al., 2013). The present study confirms the important effect of the cultivation regime 
on the metabolome of marine fungi. 
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In parallel, the MN showed the important effect of the medium on the chemical production of those 
10 Fucus-associated fungi. Several metabolites were exclusively detected in extracts of specific media, 
e.g. dihydroxyanthraquinone questinol in potato dextrose medium (PDM), and chlorinated 
tetrahydrofuranone polyketide griseofulvin in modified Wickerham medium (WM). The different media 
reflect different nutrient regimes with respect to carbon and salt. Bioactivity results showed that PDM 
seems to be the best medium for inducing the production of anticancer/toxic metabolites, since all 10 
strains showed strong anticancer/toxic activity against tested cell lines when cultured in PDM. Moreover, 
MN revealed a number of unannotated clusters/nodes specifically induced in PDM-derived crude 
extracts. The major difference between PDM and other media applied in this study is the carbon 
resource. PDM is the only medium featuring a combination of polysaccharides (potato starch) and 
monosaccharides (dextrose) as slowly and fast available organic carbon sources. These results suggest 
that the type of carbon source played a core role in inducing bioactive metabolites production of Fucus-
derived fungi. This is in perfect accordance with other studies reporting a successful induction of novel 
secondary metabolite production, supporting the core role of carbon for marine fungal metabolism (Lin 
et al., 2009; Romano et al., 2018). Notably, none of the 10 selected strains showed any anticancer 
bioactivity after cultivation on NaCl-containing medium (SYM or WM). These results further indicate 
that the selected fungi are facultative marine fungi not requiring salt and suggest that salt may impair 
the production of bioactive metabolites. This thesis further highlights the importance of OSMAC 
approaches for the optimization of cultivation conditions. 
Identification of potentially bioactive natural products at early stages (e.g. crude extracts level) is 
crucially important for natural product discovery. To facilitate the dereplication process and allow an 
early prioritization of fungal strains, for the first time the combination of bioactivity data and MN in 
“bioactivity mapping” was applied to marine fungal crude extracts (Chapter 1). The bioactivity mapping 
was established by embedding bioactivity data into MN, and aimed at highlighting potential bioactive 
molecules in crude extracts (Olivon et al., 2017). Besides annotation of known compounds to avoid the 
time-consuming re-isolation, bioactivity mapping could be used as an indicator for the selection of 
potentially active compounds (Olivon et al., 2017). In this study, bioactivity mapping was performed 
by visualizing the MS-derived clusters in MN followed by color-tagging of each node detected in 
samples showing different bioactivity (Chapter 1). Guided by bioactivity mapping, several mycotoxins 
were annotated in MN, such as the bis-anhydride rubratoxins (Moss et al., 1971) and the cyclic 
depsipeptide enniatins (Jestoi, 2008). These potent molecules are thought to be responsible for the 
observed bioactivity of many crude extracts derived from Fucus-associated fungi against human cancer 
and non-cancer cell lines. Usually, mycotoxins lack selective anticancer bioactivity but show a general 
cytotoxicity (Pitt and Miller, 2017). Since inselectivity restricts their application in drug discovery, 
strains exhibiting general cytotoxicity to all tested cell lines were not prioritized for the following large-
scale fermentation. Instead, we focused on those extracts showing more selective toxicity against cancer 
cell lines. Thus, the Fucus-endophyte Pyrenochaetopsis sp. FVE-001, which showed bioactivity against 
several different cancer cell line types such as HepG2 (human hepatoma cancer cell line), HT29 (human 
colon cancer cell line), A549 (human lung carcinoma cancer cell line) and MDA-MB-231 (human breast 
cancer cell line) at 100 μg/ml in PDM liquid medium was selected for following large-scale 
fermentation (Chapter 2). The comparative bioactivity mapping of FVE-001 (Chapter 1) including all 
OSMAC-derived crude extracts interestingly revealed five nodes exclusively in PDM-L, i.e. m/z 
[M+H]+ 428.2081 belonging to a large unidentified cluster containing 38 nodes as well as four single 
nodes with m/z [M+H]+ 463.2679, m/z [M+H]+  469.2242, m/z [M+H]+ 939.6554 and m/z [M+Na]+ 
452.2278. Those nodes could not be annotated to any known natural product suggesting their chemical 
novelty and potential as new anticancer metabolites. The bioactivity mapping of crude extracts showed 
obvious differences between bioactive samples and non-bioactive samples and annotated potential 
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interesting candidates for isolation at an early stage and thus substantially helped prioritization. 
Another endophytic strain FVE-087 showing similar morphology but higher chemical complexity 
than FVE-001 was also selected for chemical investigation (Chapter 3). Initial genetic identification of 
FVE-001 and FVE-087 only enabled the classification at order level (order: Pleosporales). Re-
amplification and sequencing for ITS1-5.8S-ITS2 genes along with phylogenetic tree construction 
identified both strains as Pyrenochaetopsis sp. To our knowledge, there is only one study focusing on 
secondary metabolite production of Pyrenochaetopsis sp. collected from Japanese soil samples 
(Nogawa et al., 2017). Therefore, this yet underexplored genus is considered to be a valuable candidate 
for the discovery of novel bioactive natural products. Large-scale fermentation and extraction yielded 
2.66g crude extract from Pyrenochaetopsis sp. FVE-001 (Chapter 2) and 17.64g oily extract from 
Pyrenochaetopsis sp. FVE-087 (Chapter 3). After sequential extraction with n-hexane (KH), chloroform 
(KC) and methanol (KM) for both crude extracts, anticancer bioactivity and the toxicity of obtained 
subfractions were evaluated. The anticancer bioactivity was tracked to the KC fractions of both FVE-
001 and FVE-087. Thus, the purification process was focused on 345.4mg and 4.57g KC subextracts 
derived from FVE-001 and FVE-087, respectively. In order to accelerate the compound purification 
process, another metabolomic tool combining bioactivity and MN was applied. Bioactivity-based MN 
was applied to SPE subfractions derived from Pyrenochaetopsis sp. FVE-001 KC fraction. It applies 
the Pearson correlation coefficient to fractions with different bioactivity levels (Nothias et al., 2018). 
Compared to the bioactivity mapping, the bioactivity-based MN integrates the measurement of linear 
correlation between peak area detected in the mass chromatogram and bioactivity data into MN (Nothias 
et al., 2018). It enabled a prediction of the bioactivity score of nodes detected in MN through calculating 
their p and r values and further guide the bioactivity-based targeted isolation. Based on the bioactivity 
score, three new decalinoylspirotetramic acid derivatives, namely pyrenosetins A-C (1-3) and one 
known compound phomasetin (4) were targeted and purified from FVE-001 (Chapter 2, Figure 1). 
Motivated by this study, bioactivity-guided isolation of second strain Pyrenochaetopsis sp. FVE-087 
yielded another new decalinoyltetramic acid derivative, pyrenosetin D (5) along with two known 
decalins wakodecalines A (6,) and B (7) (Chapter 3, Figure 1). 
This study represents the first application of bioactivity-based MN to marine fungi for biodiscovery. 
In the bioactivity-based MN, the decalinoylspirotetramic acid derivatives pyrenosetins A (1) and B (2) 
were annotated as nodes with high bioactivity scores, displaying r values of 0.79, 0.93 and p values of 
2.2 × 10-5 and 1.30 × 10-5, respectively. These high predicted bioactivity scores suggest a high anticancer 
potential of 1 and 2. Confirming the prediction, 1 and 2 showed high toxicity against the malignant 
melanoma cell line A-375 with IC50 values of 2.8 and 6.3 μM, respectively. More interestingly, 2 
exhibited selective bioactivity against A-375 (IC50 value = 6.3 μM) but lower toxicity to HaCaT (IC50 
value = 35.0 μM). Experimental bioassay results verified the predictions; beyond this, bioactivity-based 
MN allowed targeted compound isolation, hence rendering it a powerful tool for substantially 
facilitating the biodiscovery process.  
The pure compound pyrenosetin C (3) exhibited weak anticancer bioactivity against the melanoma 
cell line A-375 (140.3 μM) as well as low toxicity to HaCaT (142.9 μM). From a structural point of 
view, 2 differs from 1 only in the stereochemistry of the C-16 hydroxyl group, while 3 contains a ketone 
group at C-16. The differences in their bioactivity suggested that the presence of a hydroxyl group at 
C-16 had impact on anticancer activity and toxicity of pyrenosetins. Phomasetin (4) was previously 
reported from fungal genera Phoma and Pyrenochaetopsis with anti-HIV activity and cytotoxicity 
(Nogawa et al., 2017; Singh et al., 1998). In this study, phomasetin (4) exhibited activity against A-375 
and HaCaT with almost identical IC50 values of 37.5 and 45.0 μM respectively, suggesting a general 
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toxicity. 
     
Figure 1. Compounds purified from Fucus vesiculosus-derived fungi Pyrenochaetopsis sp. FVE-001 and FVE-
087 during this study. 1-3. New decalinoylspirotetramic acid derivatives pyrenosetin A-C isolated from 
Pyrenochaetopsis sp. FVE-001. 4. Known decalin phomasetin isolated from Pyrenochaetopsis sp. FVE-001. 5. 
New decalinoyltetramic acid derivative pyrenosetin D isolated from Pyrenochaetopsis sp. FVE-087. 6-7. Known 
decalins wakodecalines A-B isolated from Pyrenochaetopsis sp. FVE-087. 
Similar to FVE-001, KC subfraction of strain Pyrenochaetopsis sp. FVE-087 also exhibited high 
anticancer bioactivity. The bioactivity-guided isolation process yielded three compounds from this 
subfraction, including one new decalinoyltetramic acid derivative - namely pyrenosetin D (5) and two 
known decalin derivatives - wakodecalines A (6) and B (7). NMR-based structure elucidation showed 
that compound 5 contained a complex pentacyclic motif with ten stereocenters. This pentacyclic ring 
system comprised a trans-decalin moiety (6/6) and a tricyclic moiety (5/5/5). To our knowledge, only 
Fusarium sp. was previously reported to produce structurally similar decalin derivatives fusarisetin A – 
B (Jang et al., 2011; Zhao et al., 2019). The NOE spectrum assisted determination of the relative 
configuration of 5 between decalin skeleton and the side chain. However, there were still three 
stereogenic centers (C-3’, C-4’ and C-5’) left to be assigned. Since compound 5 could not be purified 
in enough amounts for crystallization, a density functional theory (DFT) calculation of NMR chemical 
shifts was performed to determine the relative configuration at C-3’, C-4’ and C-5’, shown in Figure 1. 
This approach, together with the coupling constant analyses and prediction of optical rotation values 
confirmed the structure of 5 as shown in Figure 1. DFT calculation of NMR parameters is an emerging 
method and has been previously applied to marine-derived metabolites for determination of their 
absolute configurations (Grauso et al., 2020). The present study represents the first example for the 
application of this method to algal-derived fungal metabolites to overcome the difficulty in determining 
the configuration of compounds with multiple stereocenters. Compound 5 exhibited weak activity 
against A-375 with IC50 77.5 μM. Although 5 had the same cyclopentanone fused decalin skeleton and 
ketone group at C-16 as 3, they displayed different bioactivity against A-375 (3, 140.3 μM and 5, 77.5 
μM). This difference suggested the importance of tetrahydrofuran ring in 5 with regard to anticancer 
bioactivity. Moreover, 6 and 7, which lack the terminal tetramic acid moiety did not exhibit any 
bioactivity against A-375 cells up to 200 μM. This suggested that the tetramic acid moiety is important 
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for anticancer bioactivity. 
All isolated compounds obtained during this study contained a decalin ring as the skeleton. The 
‘decalin’ moiety has been found in an array of marine natural products from marine fungi. The marine-
derived decalin derivatives represent a big group of architecturally complex structural scaffolds, which 
contain multiple ring systems ranging from bicyclic to pentacyclic rings (Li et al., 2014a; Wu et al., 
2015; Yamada et al., 2019). They show diverse bioactivities, such as anticancer (Zhuravleva et al., 
2012), phytotoxic (Zhao et al., 2019), and antibiotic (Nguyen et al., 2007). The compounds obtained in 
this study were polyketide type decalin derivatives most probably biosynthesized by an enzymatic 
intramolecular Diels-Alder cycloaddition (Kato et al., 2015; Kato et al., 2018). All pyrenosetins and 
wakodecalines contained a cyclopentanone fused decalin skeleton that is rare in nature. To our 
knowledge, only a few compounds, e.g. altercrasins A-C (Yamada et al., 2019) and fusarisetins A-D 
(Zhao et al., 2019) have been reported as natural products with a similar planar skeleton. This study 
enlarged the space of marine-derived decalins with multiple ring systems. As reported, the 
stereochemistry of trans-decalin formation is enzymatically controlled (e.g. Fsa2 and its analogues) 
encoded by BGCs (e.g. fsa) (Kato et al., 2015). Previous genome analysis of soil-derived 
Pyrenochaetopsis sp. RK10-F058 revealed the importance of the phm gene cluster in the biosynthesis 
of phomasetin (Kato et al., 2018). As reported from Kato et al., phm encoding a PKS-NRPS hybrid 
enzyme determined the stereoselectivity of decalin formation of phomasetin, making its decalin unit 
opposite to that of equisetin (Kato et al., 2018). Since pyrenosetins are structurally related to phomasetin, 
it is reasonable to assume that gene cluster phm and its homologues are involved in the synthesis of 
pyrenosetins, leading to the opposite stereochemistry between pyrenosetins versus fusarisetins and 
altercrasins. Genome sequencing and BGC analysis of Pyrenochaetopsis sp. FVE-001 and FVE-087 
would further help to understand the formation and stereochemistry of those pyrenosetins in the future. 
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2. Outlook 
This study aimed at investigating the biological diversity of Fucus vesiculosus-derived fungal 
isolates, and prospecting new anticancer lead compounds from them. A total of 55 fungal isolates were 
obtained from Baltic Sea Fucus vesiculosus. Application of OSMAC approach to 26 selected Fucus-
derived strains successfully induced the production of anticancer/toxic compounds under at least one 
certain cultural condition in 10 endophytic strains. Following strain prioritization and targeted isolation 
due to the application of new bioinformatic tool (MN) with predictive power, two Fucus-derived 
Pyrenochaetopsis sp. have yielded four new decalin derivatives (1-3, 5) and three known compounds 
(4, 6-7). Compounds 1-5 showed anticancer bioactivity against A-375 with IC50 values ranging from 
2.8 to 140.3 μM. Results from this thesis suggest that Fucus-derived fungi are a good resource for 
bioprospecting and natural product discovery. Future research activities in this direction should include 
the following aspects: 
 Collection of a larger number of Fucus samples 
Chemical diversity is mirrored by the biodiversity of marine fungal isolates (Ji and Wang, 2016; 
Saleem et al., 2007). Thus, it is important to obtain diverse fungal samples for the selection of interesting 
candidates for chemical and bioactivity profiling. Increasing the biological diversity of fungi by using 
different media, culture conditions, or increasing the sampling size is an important aspect. In this study, 
8 genera and 3 higher taxonomic levels of fungi were achieved from three F. vesiculosus specimens 
from a single sampling site, suggesting that F. vesiculosus is a promising candidate for bioprospection. 
However, we did not obtain any strain belonging to the genus Aspergillus, which has been isolated from 
several other Fucus sp. before (Zuccaro et al., 2008). Moreover, an intensified isolation effort including 
multiple sampling sites, other Fucus species or other brown algae may afford potentially obligate marine 
fungi, which we were unable to retrieve although they have been reported from diverse algal hosts (Ji 
and Wang, 2016).  
 Integration of genomics and OSMAC 
In this study, we evaluated the influence of nutrient and culture regimes on the metabolism of 
Fucus-associated fungal isolates. Future studies could include further OSMAC approaches, e.g. 
addition of epigenetic modifiers, different amino acids, host extracts, to name a few, may lead induction 
of even more interesting chemistry. Furthermore, genomics studies could be incorporated into the 
optimization of OSMAC approach through monitoring the expression of BGCs under different cultural 
conditions (Romano et al., 2018). Moreover, genome-scale biological models would be integrated with 
OSMAC-based cultivation to predict the production of secondary metabolites under certain cultural 
conditions (Xu et al., 2018). 
 Broad bioactivity screenings 
Fungal natural products were frequently reported to possess multiple biological activities (Ji and 
Wang, 2016; Saleem et al., 2007), i.e. one compound may represent a lead compound in different target 
diseases. This is exemplified by rapamycin, which has been applied in clinical treatment to prevent 
organ transplant rejection. Moreover, rapamycin exhibited a strong inhibitory effect on the mammalian 
target of rapamycin (mTOR) signaling pathway, which regulates cell growth, cell proliferation, cell 
motility and plays an important role in mammalian metabolism. It has been approved by the FDA for 
lymphangioleiomyomatosis, a rare, progressive lung disease caused by abnormal activation of the 
mTOR signaling pathway in humans (Li et al., 2014b). This may also hold true for compounds isolated 
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from Pyrenochaetopsis sp. FVE-001 and FVE-087. Beyond the observed anticancer activity, they 
should be also evaluated for their antifungal, antibacterial, antifouling activities to probe their 
biotechnological potential. 
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1. Table 1. Natural products reported from algicolous fungi with anticancer potential   
 
Compound name Structure Chemical family Resources  (fungal resource) Bioactivity Reference 
(−)-Sclerodin 
 
Polyketide Green alga Enteromorpha sp. (Coniothyrium cereale) 
Toxicity against cancer cell line: HLE: IC50 = 10.9 μM 
(Nazir et al., 2015) 
(−)-Cereoaldomine 
 
Polyketide Green alga Enteromorpha sp.  (Coniothyrium cereale) 
Toxicity against cancer cell line: HLE:  IC50 = 3.01 μM 
(Elsebai et al., 2011; Nazir et al., 2015) 
(−)-Cereolactam 
 
Polyketide Green alga Enteromorpha sp. (Coniothyrium cereale) 
Toxicity against cancer cell line: HLE: IC50 = 9.28 μM  
(Elsebai et al., 2011; Nazir et al., 2015) 
(+)-(10E,15R)-10,11-Dehydrocurvularin 
 
Macrolide Red alga Acanthophora spicifera  (Curvularia sp.) 
Toxicity to 36 human tumor cell lines: mean IC50 = 1.25 μM 
(Greve et al., 2008) 
(+)-(10E,15R)-13-Hydroxy-10,11-dehydrocurvularin 
 
Macrolide Red alga Acanthophora spicifera  (Curvularia sp.) 
Toxicity to 36 human tumor cell lines: mean IC50 = 30.06 μM 
(Greve et al., 2008) 
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(+)-(11R,15R)-11-Hydroxycurvularin 
 
Macrolide Red alga Acanthophora spicifera  (Curvularia sp.) 
Toxicity to 36 human tumor cell lines: Mean IC50 = 12.99 μM 
(Greve et al., 2008) 
(+)-(11S,15R)-11-Hydroxycurvularin 
 
Macrolide Red alga Acanthophora spicifera  (Curvularia sp.) 
Toxicity to 36 human tumor cell lines: mean IC50 = 6.09 μM 
(Greve et al., 2008) 
(+)-Epiepoxydon 
 
Epoxyquinone Red alga Polysiphonia violacea  (Apiospora montagnei) 
Toxicity against cancer cell line: HM02: GI50 = 0.7 μg/mL HepG2 GI50 = 0.75 μg/mL MCF-7 GI50 = 1.5 μg/mL 
(Klemke et al., 2004)  
Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Toxicity against cancer cell line: P388: ED50 = 0.2 μg/mL 
(Iwamoto et al., 1999) 
(+)-Formylanserinone B 
 
Polyketide Brown alga Padina sp. ( Penicillium citrinum) Toxicity against cancer cell line: EAC: ED50 = 35.7 μM 
(Smetanina et al., 2016) 
- Toxicity against cancer cell line: MDA-MB-435: IC50 = 2.9 μg/mL 
(Gautschi et al., 2004) 
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(3R,4aR,5S,6R)-6-Hydroxy-5-methylramulosin 
 
Polyketide Green alga Codium fragile (Valsa ceratosperma) 65% growth inhibition against HeLa at 50 μg/mL (El-Beih et al., 2007) 
(3S, 11aS)-3- [(1H-Indol-3-yl) Methyl]-7,9- dihydroxy-8-methoxy- 2,3,11,11a-tetrahydro- 6H- pyrazino [1,2-b] isoquinoline-1,4-dione  
Diketopiperazine alkaloid Green alga Enteromorpha tubulosa (Aspergillus flavus c-f-3) 
Toxicity against cancer cell line: HL-60: IC50 = 36.5 μg/mL 
(Lin et al., 2008) 
(R)-Phenylahistin 
 
Diketopiperazine alkaloid Unidentified alga (Aspergillus ustus NSC-F038) 
Toxicity against cancer cell line: P388: IC50 = 3.8 μM 
(Kanoh et al., 1997) 
(S)-Phenylahistin (Halimide) 
 
Diketopiperazine alkaloid Unidentified alga (Aspergillus ustus NSC-F038)  
Toxicity against cancer cell line: P388: IC50 = 3.5 μM 
(Kanoh et al., 1997) 
Toxicity against cancer cell line:  A549: IC50 = 0.3 μM 
(Kanoh et al., 1999) 
Green alga Halimedia copiosa (Aspergillus sp. CNC139) 
Toxicity against cancer cell lines: HCT116:  IC50 = 1.0 μM A2780:  IC50 = 0.8 μM 
(Fenical et al., 2000b) 
Anti-proliferative activity against 38 cancer cell lines with GI50 values ranging from 2.3 ×10-7 M to 4.0 ×10-5 M 
(Fukumoto et al., 2002) 
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11,11’-Dideoxyverticillin A 
 
Epidithiodioxopiperazine Green alga Avrainbillea longicaulis  (Penicillium sp. CNC-350) 
Toxicity against cancer cell line: HCT116: IC50 = 30 ng/mL 
(Son et al., 1999) 
11’-Deoxyverticillin A 
 
Epidithiodioxopiperazine Green alga Avrainbillea longicaulis (Penicillium sp. CNC-350) 
Toxicity against cancer cell line: HCT116: IC50 = 30 ng/mL 
(Son et al., 1999) 
14,15-Dehydro-(Z)-14-ophiobolin G 
 
Sesterpenoid Brown alga Padina sp. (Aspergillus flocculosus) Cytotoxicity against 6 cancer cell lines: HCT-15: GI50 = 1.67 μM NUGC-3: GI50 = 1.53 μM NCI-H23: GI50 = 1.84 μM ACHN: GI50 = 2.01 μM PC-3: GI50 = 1.60 μM MDA-MB-231: GI50 = 1.75 μM 
(Choi et al., 2019) 
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14,15-Dehydro-6-epi-ophiobolin G 
 
Sesterpenoid Brown alga Padina sp.  (Aspergillus flocculosus) Cytotoxicity against 6 cancer cell lines: HCT-15: GI50 = 0.96 μM NUGC-3: GI50 = 0.88 μM NCI-H23: GI50 = 1.40 μM ACHN: GI50 = 1.14 μM PC-3: GI50 = 1.00 μM MDA-MB-231: GI50 = 1.05 μM 
(Choi et al., 2019) 
14,15-Dehydro-6-epi-ophiobolin K 
 
Sesterpenoid Brown alga Padina sp. (Aspergillus flocculosus) Cytotoxicity against 6 cancer cell lines: HCT-15: GI50 = 0.21 μM NUGC-3: GI50 = 0.19 μM NCI-H23: GI50 = 0.24 μM ACHN: GI50 = 0.24 μM PC-3: GI50 = 1.00 μM MDA-MB-231: GI50 = 0.14 μM 
(Choi et al., 2019) 
14,15-Dehydro-ophiobolin K 
 
Sesterpenoid Brown alga Padina sp. (Aspergillus flocculosus) Cytotoxicity against 6 cancer cell lines: HCT-15: GI50 = 0.44 μM NUGC-3: GI50 = 0.50 μM NCI-H23: GI50 = 0.61 μM ACHN: GI50 = 0.53 μM PC-3: GI50 = 0.47 μM MDA-MB-231: GI50 = 0.63 μM 
(Choi et al., 2019) 
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14,15-Dehydro-ophiobolin G 
 
Sesterpenoid Brown alga Padina sp. (Aspergillus flocculosus) Cytotoxicity against 6 cancer cell lines: HCT-15: GI50 = 1.24 μM NUGC-3: GI50 = 1.07 μM NCI-H23: GI50 = 1.50 μM ACHN: GI50 = 1.40 μM PC-3: GI50 = 1.38 μM MDA-MB-231: GI50 = 1.35 μM 
(Choi et al., 2019) 
14-O-Acetylinsulicolide A 
 
Sesquiterpenoid Red alga Coelarthrum sp. (Aspergillus ochraceus Jcma1F17) 
Cytotoxicity against cancer cell lines: ACHN: IC50 = 4.1 μM; OS-RC-2: IC50 = 5.3 μM;  786-O: IC50 = 2.3 μM 
(Tan et al., 2018) 
1-Deoxyrubralactone 
 
Polyketide Unknown alga (Undetermined fungus HJ33moB) 
Inhibitor of Eukaryotic DNA polymerases (pols) β and к : Eukaryotic DNA polymerases (pols) β: IC50 = 11.9 μM Eukaryotic DNA polymerases (pols) к: IC50 = 59.8 μM 
(Naganuma et al., 2008) 
2-(4-Hydroxybenzyl)quinazolin- 4(3H)-one 
 
Quinazolinone Brown alga Sargassum palladium  (Penicillium chrysogenum EN-118) 
Cytotoxicity against cancer cell lines:  Du145: IC50 = 8 μg/mL; A549: IC50 = 20 μg/mL; HeLa: IC50 = 20 μg/mL 
(An et al., 2013) 
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3-(2-(1-Hydroxy-1-methyl-ethyl)-6-Methyl-2,3-dihydrobenzofuran-4-yloxy)-5-methylphenol 
 
Dihydrobenzofuran derivative Unidentified alga (Aspergillus tennesseensis) Cytotoxicity against cancer cell line:  THP-1: IC50 = 7.0 μg/mL 
(Li et al., 2018) 
3-Hydroxy-5-(hydroxymethyl)-4-(4’-hydroxyphenoxy)pyrrolidin-2-one 
 
Pyrrolidine derivative Green alga Codium fragile  (Gibberella zeae) Cytotoxicity against cancer cell lines at  10 μM: A549: 61.8% inhibitory rate BEL-7402: 17.6% inhibitory rate 
(Liu et al., 2011) 
3β,11α-Dihydroxyergosta-8,24(28)-dien-7-one 
 
Steroid Brown alga Sargassum kjellmanianum (Aspergillus ochraceus EN-31) 
Cytotoxicity against cancer cell line:  SMMC-7721: IC50 = 28.0 μg/mL 
(Cui et al., 2010b) 
4-Keto-clonostachydiol 
 
Macrodiolide Brown alga Durvillaea antarctica  (Gliocladium sp.) 
Cytotoxicity against cancer cell line:  P388: IC50 = 0.55 μM 
(Lang et al., 2006) 
5-Hydroxyramulosin 
 
Polyketide Brown alga Fucus spiralis  (Phoma tropica) - (Osterhage et al., 2002) 
- Cytotoxicity against cancer cell line:  P388: IC50 = 2.1 μg/mL 
(Santiago et al., 2012) 
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5-Methoxysterigmatocystin 
 
Polyketide Brown alga Sargassum (Aspergillus BM-05 and BM-05ML) 
Cytotoxicity against cancer cell lines:  K562: IC50 = 13.4 μM HCT116: IC50 = 4.4 μM A2780: IC50 = 51.0 μM 
(Ebada et al., 2014a) 
6-Epi-ophiobolin N 
 
Sesterpenoid Brown alga Padina sp. (Aspergillus flocculosus) Cytotoxicity against 6 cancer cell lines: HCT-15: GI50 = 0.30 μM NUGC-3: GI50 = 0.22 μM NCI-H23: GI50 = 0.22 μM ACHN: GI50 =  0.23 μM PC-3: GI50 = 0.20 μM MDA-MB-231: GI50 = 0.21 μM 
(Choi et al., 2019) 
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6-Epi-ophiobolin C 
 
Sesterpenoid Brown alga Padina sp. (Aspergillus flocculosus) Cytotoxicity against 6 cancer cell lines: HCT-15: GI50 = 0.24 μM NUGC-3: GI50 = 0.22 μM NCI-H23: GI50 = 0.24 μM ACHN: GI50 =  0.43 μM PC-3: GI50 = 0.27 μM MDA-MB-231: GI50 = 0.19 μM 
(Choi et al., 2019) 
6β,9α-Dihydroxy-14-p-nitrobenzoylcinnamolide 
 
Nitrobenzoyl sesquiterpenoid - Cytotoxicity against cancer cell lines: H1975: IC50 = 2.08 μM U937: IC50 = 1.95 μM K562: IC50 = 4.33 μM BGC823: IC50 = 2.32 μM Molt-4: IC50 = 2.39 μM MCF-7: IC50 = 4.25 μM A549: IC50 = 2.41 μM HeLa: IC50 = 6.12 μM HL-60: IC50 = 2.44 μM Hub7: IC50 = 3.28 μM 
(Fang et al., 2014) 
Red alga Coelarthrum sp.  (Aspergillus ochraceus Jcma1F17) 
Cytotoxicity against cancer cell lines: ACHN: IC50 = 11 μM; OS-RC-2: IC50 = 8.2 μM;  786-O: IC50 = 4.3 μM 
(Tan et al., 2018) 
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7-Nor-ergosterolide 
 
Steroid Brown alga Sargassum kjellmanianum  (Aspergillus ochraceus EN-31) 
Cytotoxicity against cancer cell lines: NCI-H460: IC50 = 5.0 μg/mL SMMC-7721: IC50 = 7.0 μg/mL SW1990: IC50 = 28.0 μg/mL 
(Cui et al., 2010b) 
7α-Hydroxycholesterol 
 
Steroid Brown alga Sargassum sp.  (Aspergillus BM-05 and BM-05ML) 
Antiproliferative activity against K562, HCT116, A2780, A2780 CisR with IC50 values from 10.0 to 100.0 μM 
(Ebada et al., 2014b) 
7β-Hydroxycholesterol 
 
Steroid Brown alga Sargassum sp.  Aspergillus BM-05 and BM-05ML) 
Antiproliferative activity against K562, HCT116, A2780, A2780 CisR with IC50 values from 10.0 to 100.0 μM 
(Ebada et al., 2014b) 
7β-Hydroxycholesterol-1β-carboxylic acid 
 
Steroid Brown alga Sargassum sp.  Aspergillus BM-05 and BM-05ML) 
Antiproliferative activity against K562, HCT116, A2780, A2780 CisR with IC50 values from 10.0 to 100.0 μM 
(Ebada et al., 2014b) 
9-Deoxyinsulicolide A 
 
Sesquiterpenoid Red alga Coelarthrum sp.  (Aspergillus ochraceus Jcma1F17) 
Cytotoxicity against cancer cell lines: ACHN: IC50 = 25 μM OS-RC-2: IC50 = 30 μM 786-O: IC50 = 20 μM 
(Tan et al., 2018) 
9α,14-Dihydroxy-6β-p-nitrobenzoylcinnamolid 
 
Sesquiterpenoid Green alga Penicillus captitatus  (Aspergillus versicolor) 
Cytotoxicity against cancer cell lines: HCC-298: LD50 = 0.53 μg/mL HCT116: LD50 = 0.44 μg/mL SNB75: LD50 = 0.44 μg/mL BT549: LD50 = 0.27 μg/mL 
(Belofsky et al., 1998) 
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AI-77-B 
 
Polyketide Unkown alga (Alternaria tenuis Sg17-1) Cytotoxicity against cancer cell lines: A375-S2: IC50 = 0.3 mM  HeLa: IC50 = 0.05 mM 
(Huang et al., 2006) 
AI-77-F 
 
Polyketide Unkown alga (Alternaria tenuis Sg17-1) Cytotoxicity against cancer cell line: HeLa: IC50 = 0.4 mM 
(Huang et al., 2006) 
Anserinone B 
 
Benzoquinone derivatives Brown alga Padina sp. (Penicillium citrinum)  Cytotoxicity against cancer cell line: Ehrlich carcinoma cell:  ED50 = 46.1 μM 
(Smetanina et al., 2016) 
Apralactone A 
 
Macrolide Red alga Acanthophora spicifera  (Curvularia sp.) 
Toxicity to 36 human tumor cell lines: mean IC50 = 9.87 μM 
(Greve et al., 2008) 
Arugosin A 
 
Benzophenone derivative Unknown green alga (Emericella nidulans var. acristata) 
Toxicity against 7 tumor cell lines growth at 10 μg/mL 
(Kralj et al., 2006) 
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Arugosin B 
 
Benzophenone derivative Unknown green alga (Emericella nidulans var. acristata) 
Toxicity against 7 tumor cell lines growth at 10 μg/mL 
(Kralj et al., 2006) 
Asperolide A 
 
Tetranorlabdane diterpenoid  
Brown alga Sargassum (Aspergillus wentii EN-48) Cytotoxicity against cancer cell line: HeLa: IC50 = 97 μM HepG2: IC50 = 63 μM NCI-H460: IC50 = 42 μM SMMC-7721: IC50 = 52 μM SW1990: IC50 = 69 μM 
(Sun et al., 2012) 
Asperolide B 
 
Tetranorlabdane diterpenoid Brown alga Sargassum (Aspergillus wentii EN-48) Toxicity Cytotoxicity against cancer cell line: HeLa: IC50 = 56 μM MCF-7: IC50 = 63 μM MDA-MB-231: IC50 = 35 μM NCI-H460: IC50 = 63 μM SW1990: IC50 = 69 μM 
(Sun et al., 2012) 
Asperpyrone A 
 
Dimeric naphtho-γ-pyrone Brown alga Leathesia nana  (Aspergillus sp. XNM-4) 
Cytotoxicity against PANC-1, A549, MDA-MB-231, Caco-2, and SK-OV-3 at 50 μM 
(Xu et al., 2019) 
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Asperpyrone B 
 
Dimeric naphtho-γ-pyrone Brown alga Leathesia nana  (Aspergillus sp. XNM-4) 
Cytotoxicity against PANC-1, A549, MDA-MB-231, Caco-2, and SK-OV-3 at 50 μM 
(Xu et al., 2019) 
Aurasperone F 
 
Dimeric naphtho-γ-pyrone Brown alga Leathesia nana  (Aspergillus sp. XNM-4) 
Cytotoxicity against PANC-1, A549, MDA-MB-231, Caco-2, and SK-OV-3 at 50 μM 
(Xu et al., 2019) 
Avrainvillamide  
 
Diketopiperazine Green alga Avrainvillea sp.  (Aspergillus sp.  CNC358) 
Cytotoxicity against cancer cell line: HCT116: IC50 = 2.0 μg/mL 
(Fenical et al., 2000a) 
Chaetoglobosin A 
 
Indole alkaloid Green alga Enteromorpha intestinalis  (Penicillium sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.6 μg/mL 
(Numata et al., 1996) 
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Chaetoglobosin F 
 
Indole alkaloid Green alga Enteromorpha intestinalis  (Penicillium sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.9 μg/mL 
(Numata et al., 1996) 
Chaetoglobosin O 
 
Indole alkaloid Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 2.4 μg/mL 
(Iwamoto et al., 2001) 
Chaetopyranin 
 
Benzaldehyde derivative Red alga Polysiphonia urceolata (Chaetomium globosum) 
Cytotoxicity against cancer cell lines: HMEC: IC50 = 15.4 μg/mL SMMC-7721: IC50 = 28.5  μg/mL A549: IC50 = 39.1 μg/mL  
(Wang et al., 2006) 
Chromanone A 
 
Chromone Green alga Ulva sp. (Penicillum sp.) Inhibit CYP1A activity up to 60% of the stimulated-CYP1A in Hepa1c1c7 
(Gamal-Eldeen et al., 2009) 
Chryxanthone A 
 
Benzophenone Red alga Grateloupia turuturu  (Penicillium chrysogenum AD-1540) 
Cytotoxicity against cancer cell lines: A549: IC50 = 41.7 μM BT549: IC50 = 20.4 μM HeLa: IC50 = 23.5 μM HepG2: IC50 = 33.6 μM MCF-7: IC50 = 46.4 μM 
(Zhao et al., 2018) 
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Chryxanthone B 
 
Benzophenone Red alga Grateloupia turuturu  (Penicillium chrysogenum AD-1540) 
Cytotoxicity against cancer cell lines: A549: IC50 = 20.4 μM THP-1: IC50 = 41.1 μM 
(Zhao et al., 2018) 
Cis-bisdethiodi (methylthio) silvatin 
 
Cyclodipeptide Red alga Carpopeltis affinis (Fusarium chlamydosporum OUPS-N124) 
Cytotoxicity against cancer cell line: P388: ED50 = 7.7 μg/mL 
(Usami et al., 2002) 
Citrinadin A 
 
Pentacyclic indolinone Red alga Actinotrichia fragilis  (Penicillium citrinum (N059)) 
Cytotoxicity against cancer cell lines: L1210: ED50 = 6.2 μg/mL 
(Mugishima et al., 2005) 
KB: ED50 = 10 μg/mL (Tsuda et al., 2004) 
Citrinadin B 
 
Pentacyclic indolinone Red alga Actinotrichia fragilis  (Penicillium citrinum) 
Cytotoxicity against cancer cell line: L1210: IC50 = 10 μg/mL 
(Mugishima et al., 2005)  
Citrinal A 
 
Polyketide Green alga Blidingia minima  (Penicillum sp. i-1-1) 
Cytotoxicity against cancer cell lines: A549: IC50 = 80.7 μmol/L HL-60: IC50 = 143.1 μmol/L 
(Zhu et al., 2009) 
Citrinin 
 
Polyketide Green alga Blidingia minima  (Penicillum sp. i-1-1) 
 Cytotoxicity against cancer cell lines: A549: IC50 = 43.5  μmol/L HL-60 = 62.5 μmol/L 
(Zhu et al., 2009) 
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Cladosporin 
 
Polyketide Brown alga Fucus spiralis  (Penicillium sp.) - (Flewelling et al., 2013) 
- -79% antitumor induction in Agrobacterium tumefacien potato disc assay at 25 μg/disc  
(Bryant et al., 1994) 
Cladosporol C 
 
Polyketide Red alga Laurencia okamurai  (Cladosporium cladosporioides EN-399) 
Cytotoxicity against cancer cell line: H446: IC50 = 4 μM 
(Li et al., 2017) 
Cladosporol H 
 
Polyketide Red alga Laurencia okamurai  (Cladosporium cladosporioides EN-399)  
Cytotoxicity against cancer cell lines: A549: IC50 = 5.0 μM   Hub7: IC50 = 1.0 μM LM3: IC50 = 4.1 μM 
(Li et al., 2017) 
Clonostachydiol 
 
Macrodiolide Brown alga Durvillaea antarctica  (Gliocladium sp.) 
Cytotoxicity against cancer cell line: P388: IC50 = 25 μM 
(Lang et al., 2006) 
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Communesin A 
 
Alkaloid Green alga Enteromorpha intestinalis  (Penicillium sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 3.5 μg/mL 
(Numata et al., 1993) 
Communesin B 
 
Alkaloid Green alga Enteromorpha intestinalis  (Penicillium sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.45 μg/mL 
(Numata et al., 1993) 
Conioscleroderolide 
 
Phenalenone derivative Green alga Enteromorpha sp. (Coniothyrium cereale) 
Cytotoxicity against cancer cell line: HLE IC50 = 13.3 μM 
(Nazir et al., 2015) 
Coniosclerodin 
 
Phenalenone derivative Green alga Enteromorpha sp. (Coniothyrium cereale) 
Cytotoxicity against cancer cell line: HLE IC50 = 7.2 μM 
(Nazir et al., 2015) 
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Cristatumin E 
 
Pyrrolidinoindoline diketopiperazin Green alga Enteromorpha prolifera  (Eurotium herbariorum HT-2) 
Cytotoxicity against cancer cell line: K562: IC50 = 8.3 μmol/L 
(Li et al., 2013b) 
Cyclo-(Phe-Pro) 
 
Diketopiperazine  Green alga Undaria pinnatifida  (Guignardia sp.) 
Cytotoxicity against cancer cell line: KB: IC50 = 10 μg/mL 
(Wang, 2012) 
Cyclo-(Tyr-Leu)  
 
Diketopiperazine  Green alga Undaria pinnatifida  (Guignardia sp.) 
Cytotoxicity against cancer cell line: KB: IC50 = 10 μg/mL 
(Wang, 2012) 
Cytoglobosin C 
 
Indole alkaloid Green alga Ulva pertusa  (Chaetomium globosum QEN-14) 
Cytotoxicity against cancer cell line: A549: IC50 = 2.26 μM 
(Cui et al., 2010a) 
Cytoglobosin D 
 
Indole alkaloid Green alga Ulva pertusa  (Chaetomium globosum QEN-14) 
Cytotoxicity against cancer cell line: A549: IC50 = 2.55 μM  
(Cui et al., 2010a) 
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Dihydrocarneamide A 
 
Prenylated indole alkaloid Red alga Grateloupia turuturu  (Paecilomyces variotii EN-291) 
Cytotoxicity against cancer cell line: NCI-H460: IC50 = 69.3 μmol/L 
(Zhang et al., 2015) 
Emericellamide A 
 
Cyclic depsipeptide Green alga Halimeda sp.  (Emericella sp. CNL-878) Cytotoxicity against cancer cell line: HCT116: IC50 = 23 μM 
(Oh et al., 2007) 
Emericellamide B 
 
Cyclic depsipeptide Green alga Halimeda sp.  (Emericella sp. CNL-878) Cytotoxicity against cancer cell line: HCT116: IC50 = 40 μM 
(Oh et al., 2007) 
emindole DA 
 
Indole diterpene Unkonwn green alga (Emericella nidulans var. acristata) 
Toxicity against 36 tumor cell lines:  mean IC50  = 5.5 μg/mL 
(Kralj et al., 2006) 
Emodine 
 
Anthraquinone Green alga Halimeda opuntia  (Aspergillus versicolor) 
Weak anticancer bioactivity against HCT116 at 250 μg/disk  
(Hawas et al., 2012) 
Ergosterol peroxide 
 
Steroid Green alga Undaria pinnatifida  (Guignardia sp.) 
Cytotoxicity against cancer cell line: KB: = IC50 20 μg/mL 
(Wang, 2012) 
Brown alga Sargassum sp.  Aspergillus BM-05 and BM-05ML) 
Antiproliferative activity against K562, HCT116, A2780, A2780 cisR with 
(Ebada et al., 2014b) 
APPENDIX 
 
128 
 
IC50 values from 10 to 100 μM 
Fumigaclavine C 
 
Indole alkaloid Unknown green alga (Aspergillus fumigatus ) Inducing apoptosis in MCF-7 cell at 60 μM (Li et al., 2013a) 
Fusaperazine A 
 
Dioxopiperazine Red alga Carpopeltis affinis  (Fusarium chlamydosporum OUPS-N124) 
Cytotoxicity against cancer cell line: P388: ED50 = 22.8 μg/mL 
(Usami et al., 2002) 
Gliotoxin 
 
Diketopiperazine Unknown brown alga (Aspergillus sp. YL-6)  Toxicity on Hela and human SW1353 cells with inhibition rates 94% and 83% at 10 μM 
(Nguyen et al., 2014) 
Halymecin A 
 
Mannosyl lipid Red alga Halymenia dilatata  (Fusarium sp. FE-71-1) 
Cytotoxicity against cancer cell lineS: HeLa S3 = IC50 6 μg/mL Balb3T3 = IC50 7 μg/mL 
(Chen et al., 1996) 
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Insulicolide A 
 
Nitrobenzoyl sesquiterpenoid Unidentified green alga  (Aspergillus insulicola) - (Rahbæk et al., 1997) 
Red alga Coelarthrum sp. (Aspergillus ochraceus Jcma1F17) 
Cytotoxicity against ACHN IC50 = 1.5 μM OS-RC-2 IC50 = 1.5 μM 786-O IC50 =  0.89 μM  
(Tan et al., 2018) 
Cytotoxicity against cancer cell lines: H1975: IC50 = 4.63 μM U937: IC50 = 3.97 μM K562: IC50 = 4.76 μM BGC823: IC50 = 2.78 μM Molt-4: IC50 = 2.11 μM MCF-7: IC50 = 6.08 μM A549: IC50 = 2.86 μM HeLa: IC50 = 6.35 μM HL-60: IC50 = 2.34 μM Hub7: IC50 = 2.35 μM 
(Fang et al., 2014) 
Insulicolide B 
 
Nitrobenzoyl sesquiterpenoid Red alga Coelarthrum sp.  (Aspergillus ochraceus Jcma1F17) 
Cytotoxicity against cancer cell lines: ACHN: IC50 = 30 μM OS-RC-2: IC50 = 23 μM 786-O IC50 = 24 μM  
(Tan et al., 2018) 
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Insulicolide C 
 
Nitrobenzoyl sesquiterpenoid Red alga Coelarthrum sp.  (Aspergillus ochraceus Jcma1F17) 
Cytotoxicity against cancer cell lines: ACHN: IC50 = 13 μM OS-RC-2: IC50 = 11 μM 786-O IC50 = 14 μM  
(Tan et al., 2018) 
Iso-notoamide B 
 
Prenylated indole alkaloid Red alga Grateloupia turuturu  (Paecilomyces variotii EN-291) 
Cytotoxicity against cancer cell line: NCI-H460: IC50 = 55.9 μmol/L 
(Zhang et al., 2015) 
Isorhodoptilometrin-1-methyl ether 
 
Anthraquinone Green alga Halimeda opuntia  (Aspergillus versicolor) 
Weak anticancer bioactivity against LH1210, H125 and HepG2 at 350, 300, 400 μg/disk 
(Hawas et al., 2012) 
Isosclerone 
 
Polyketide Unknown green alga  (Aspergillus fumigatus) Cytotoxicity against cancer cell line: MCF-7: IC50 = 60 μM 
(Li et al., 2014)  
Iso-α-cyclopiazonic acid 
 
Ergoline alkaloid  Green alga Enteromorpha tubulosa (Aspergillus flavus c-f-3) 
Cytotoxicity against cancer cell lines: HL-60: IC50 = 90 μM MoLT-4: IC50 = 68.6 μM  A-549: IC50 = 42.2 μM  
(Lin et al., 2009) 
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Leptosin A 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: IC50 = 1.85 ng/mL 
(Takahashi et al., 1994a) 
Leptosin B 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: IC50 = 2.40 ng/mL 
(Takahashi et al., 1994a) 
Leptosin C  
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: IC50 = 1.75 ng/mL 
(Takahashi et al., 1994a) 
Leptosin D 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: IC50 = 86 ng/mL 
(Takahashi et al., 1994a) 
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Leptosin E 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: IC50 = 46 ng/mL 
(Takahashi et al., 1994a) 
Leptosin F 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: IC50 = 56 ng/mL 
(Takahashi et al., 1994a) 
Leptosin G 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: IC50 = 4.6 ng/mL 
(Takahashi et al., 1995b) 
Leptosin G1 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 4.3 ng/mL 
(Takahashi et al., 1995b) 
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Leptosin G2 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 4.4 ng/mL 
(Takahashi et al., 1995b) 
Leptosin H 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 3.0 ng/mL 
(Takahashi et al., 1995b) 
Leptosin I 
 
Epipolythiodioxopiperazine Brown alga Sargasssum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 1.13 μg/mL 
(Takahashi et al., 1994b) 
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Leptosin J 
 
Epipolythiodioxopiperazine Brown alga  Sargasssum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 1.25 μg/mL 
(Takahashi et al., 1994b) 
Leptosin K 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 3.8 ng/mL 
(Takahashi et al., 1995a) 
Leptosin K1 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 2.8 ng/mL 
(Takahashi et al., 1995a) 
Leptosin K2 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 2.1 ng/mL 
(Takahashi et al., 1995a) 
APPENDIX   
135 
 
Leptosin M 
 
Epipolythiodioxopiperazine Brown alga  Sargasssum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 1.05 μg/mL 
(Yamada et al., 2002) 
Leptosin M1 
 
Epipolythiodioxopiperazine Brown alga  Sargasssum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 1.40 μg/mL 
(Yamada et al., 2002) 
Leptosin N 
 
Epipolythiodioxopiperazine Brown alga  Sargasssum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.18 μg/mL 
(Yamada et al., 2002) 
Leptosin N1 
 
Epipolythiodioxopiperazine Brown alga  Sargasssum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.19 μg/mL 
(Yamada et al., 2002) 
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Leptosin O 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 1.1 μg/mL Moderate cytotoxicity agains 39 human cancer cell lines with mean log GI50 -4.01M 
(Yamada et al., 2004) 
Leptosin P 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.1 μg/mL 
(Yamada et al., 2004) 
Leptosin Q 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 14.8 μg/mL 
(Yamada et al., 2004) 
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Leptosin R 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 15.2 μg/mL 
(Yamada et al., 2004) 
Leptosin S 
 
Epipolythiodioxopiperazine Brown alga Sargassum tortile  (Leptosphaeria sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 10.1 μg/mL; cytotoxicity agains 39 human cancer cell lines with mean log GI50 -4.01M 
(Yamada et al., 2004) 
N-[(2E)-(4-Hydroxyphenyl)ethenyl]formamide 
 
Alkaloid Brown alga Sargassum palladium  (Penicillium chrysogenum EN-118) 
Cytotoxicity against cancer cell lines: Du145: IC50 = 8 μg/mL A549: IC50 = 20 μg/mL HeLa: IC50 = 20 μg/mL 
(An et al., 2013) 
N-[(2Z)-(4-Hydroxyphenyl)acetyl]formamide 
 
Alkaloid Brown alga Sargassum palladium  (Penicillium chrysogenum EN-118) 
Cytotoxicity against cancer cell lines: Du145: IC50 = 8 μg/mL A549: IC50 = 20 μg/mL HeLa: IC50 = 20 μg/mL 
(An et al., 2013) 
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Neoechinulin A 
 
Indole alkaloid Red alga Lomentaria catenata  (Microsporum sp.) 
Inhibition rate higher than 50% against HeLa cells at 100 μM 
(Wijesekara et al., 2013) 
N-methylsansalvamide 
 
Cyclic depsipeptide Green alga Avrainvillea sp. (Fusarium CNL-619) 
Cytotoxicity against NCI human tumor: GI50 = 8.3 μM 
(Cueto et al., 2000) 
Noduliprevenone 
 
Polyketide Unknown Mediterranean alga (Nodulisporium sp.) 
inhibitor of CYP1A activity in vitro, with an IC50 value of 6.5±1.6 μM 
(Pontius et al., 2008) 
Ophiobolin N 
 
Sesterpenoid Brown alga Padina sp. (Aspergillus flocculosus) Cytotoxicity against 6 cancer cell lines: HCT-15: GI50 = 0.30 μM NUGC-3: GI50 = 0.22 μM NCI-H23: GI50 = 0.22 μM ACHN: GI50 = 0.23 μM PC-3: GI50 = 0.20 μM MDA-MB-231: GI50 = 0.21 μM 
(Choi et al., 2019) 
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Ophiobolin C 
 
Sesterpenoid Brown alga Padina sp. (Aspergillus flocculosus) Cytotoxicity against 6 cancer cell lines: HCT-15: GI50 = 0.21 μM NUGC-3: GI50 = 0.20 μM NCI-H23: GI50 = 0.16 μM ACHN: GI50 = 0.20 μM PC-3: GI50 = 0.36 μM MDA-MB-231: GI50 = 0.22 μM 
(Choi et al., 2019) 
Patulin  
 
Polyketide Brown alga Fucus spiralis  (Penicillium sp.) - (Flewelling et al., 2013) 
Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
 Cytotoxicity against cancer cell line: P388: ED50 = 0.06 μg/mL BSY-1: ED50 = 0.34 μg/mL MCF-7: ED50 = 0.65 μg/mL HCC2998: ED50 = 1.54 μg/mL NCI-H522: ED50 = 0.30 μg/mL DMS114: ED50 = 0.57 μg/mL OVCAR-3: ED50 = 0.37 μg/mL MKN: ED50 = 0.39 μg/mL 
(Iwamoto et al., 1999) 
66% antitumor induction in Agrobacterium tumefacien potato disc assay at 25 μg/disc 
(Bryant et al., 1994) 
SW-48: 55% inhibition rate at 4 μM HeLa: 65% inhibition rate at 4 μM 
(Abastabar et al., 2017) 
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Penicisteroid A 
 
Polyoxygenated steroid Red alga Laurencia sp. (penicillium chrysogenum QEN-24S) 
Cytotoxicity against cancer cell lines: HeLa: IC50 = 15 μg/mL SW1990: IC50 = 31 μg/mL NCI-H460: IC50 = 40 μg/mL 
(Gao et al., 2011b) 
Penicitide A 
 
Polyketide Red alga Laurencia sp.  (Penicillium chrysogenum QEN-24S) 
Cytotoxicity against cancer cell line: HepG2 IC50 = 32 μg/mL 
(Gao et al., 2011a) 
Penochalasin A 
 
Indole alkaloid  Green alga Enteromorpha intestinalis  (Penicillium sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.4 μg/mL 
(Numata et al., 1996) 
Penochalasin B 
 
Indole alkaloid Green alga Enteromorpha intestinalis  (Penicillium sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.3 μg/mL 
(Numata et al., 1996) 
Penochalasin C 
 
Indole alkaloid Green alga Enteromorpha intestinalis  (Penicillium sp.) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.5 μg/mL 
(Numata et al., 1996) 
Penochalasin D 
 
Indole alkaloid Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 3.2 μg/mL 
(Iwamoto et al., 2001) 
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Penochalasin E 
 
Indole alkaloid Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 2.1 μg/mL 
(Iwamoto et al., 2001) 
Penochalasin F 
 
Indole alkaloid Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 1.8 μg/mL 
(Iwamoto et al., 2001) 
Penochalasin G  
 
Indole alkaloid Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 1.9 μg/mL 
(Iwamoto et al., 2001) 
Penochalasin H 
 
Indole alkaloid Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 2.8 μg/mL 
(Iwamoto et al., 2001) 
Penostatin A 
 
Polyketide Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.8 μg/mL 
(Iwamoto et al., 1999; Takahashi et al., 1996) 
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Penostatin B 
 
Polyketide Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 1.2 μg/mL 
(Iwamoto et al., 1999; Takahashi et al., 1996) 
Penostatin C 
 
Polyketide Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 1.0 μg/mL BSY-1: ED50 = 2.0 μg/mL MCF-7: ED50 = 1.6 μg/mL HCC2998: ED50 = 2.0 μg/mL NCI-H522: ED50 = 2.5 μg/mL DMS114: ED50 = 2.4 μg/mL OVCAR-3: ED50 = 1.7 μg/mL MKN: ED50 = 1.0 μg/mL 
(Iwamoto et al., 1999; Takahashi et al., 1996) 
Penostatin D 
 
Polyketide Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 11.0 μg/mL 
(Iwamoto et al., 1999; Takahashi et al., 1996) 
Penostatin E 
 
Polyketide Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.9 μg/mL 
(Iwamoto et al., 1998; Iwamoto et al., 1999) 
Penostatin F 
 
Polyketide Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 1.4 μg/mL 
(Iwamoto et al., 1998) 
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Penostatin G 
 
Polyketide Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.5 μg/mL 
(Iwamoto et al., 1998) 
Penostatin H 
 
Polyketide Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.8 μg/mL 
(Iwamoto et al., 1998) 
Penostatin I 
 
Polyketide Green alga Enteromorpha intestinalis  (Penicillium sp. OUPS-79) 
Cytotoxicity against cancer cell line: P388: ED50 = 1.2 μg/mL 
(Iwamoto et al., 1998) 
Pestalone 
 
Chlorinated benzophenone Brown alga Rosenvingea sp. (Pestalotia sp. CNL-365) 
Toxicity to 60 cancer cell lines: mean GI50 = 6.0 μM 
(Cueto et al., 2001) 
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Phomopsolide A 
 
Tiglic acid Green alga Chlorella vulgaris Beyerinck (Penicillium clavigerum) 
Cytotoxicity against cancer cell lines: HeLa S3: IC50 = 6.3 μM UMUC3: IC50 = 6.5 μM 
(Stierle et al., 2014) 
Phomopsolide C 
 
Tiglic acid Green alga Chlorella vulgaris Beyerinck  (Penicillium clavigerum) 
Cytotoxicity against cancer cell lines: HeLa S3: IC50 = 3.6 μM UMUC3: IC50 = 2.2 μM  
(Stierle et al., 2014) 
Physcion 
 
Anthraquinone Red alga Lomentaria catenata  (Microsporum sp. MFS-YL) 
Toxicity against HeLa with inhibition rate higher than 60% at 100 μM 
(Wijesekara et al., 2014) 
Pinophilin A 
 
Polyketide Green alga Ulva fasciata  (Penicillium pinophilum Hedgcok) 
Cytotoxicity against cancer cell lines: A549: GI50 = 52.5 μM BALL-1: GI50 = 50.2 μM HCT-116: GI50 = 51.3 μM  HeLa: GI50 = 55.6 μM  NUGC-3: GI50 = 54.7 μM 
(Myobatake et al., 2012) 
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Pinophilin B 
 
Polyketide Green alga Ulva fasciata  (Penicillium pinophilum Hedgcok) 
Cytotoxicity against cancer cell lines: A549 : GI50 = 93.1 μM BALL-1: GI50 = 90.4 μM HCT-116: GI50 = 92.5 μM  HeLa: GI50 = 99.0 μM  NUGC-3: GI50 = 96.8 μM 
(Myobatake et al., 2012) 
N-methylpretrichodermamide B 
 
Epidithiodiketopiperazine Brown alga Padina sp. (Penicillium sp. KMM 4672) 
Cytotoxicity against cancer cell line: 22Rv1: IC50 = 0.51 μM PC-3: IC50 = 5.11 μM LNCaP: IC50 = 1.76 μM 
(Yurchenko et al., 2016) 
Pseudodeflectusin 
 
Isochroman derivative Brown alga Sargassum fusiform  (Aspergillus pseudodeflectus) 
Cytotoxicity against cancer cell line: HL-60: LD50 = 39 μM 
(Ogawa et al., 2004) 
Psychrophilin E 
 
Cyclic tripeptide Brown alga Sargassum Aspergillus BM-05 and BM-05ML) 
Cytotoxicity against cancer cell lines: K562: IC50 = 67.8 μM HCT116: IC50 = 28.5 μM A2780: IC50 = 27.3 μM A2780cisR: IC50 = 49.4 μM 
(Ebada et al., 2014a) 
Pyrenocine A 
 
Pyrone Brown alga Sargassum ringgoldianum  (Penicillium waksmanii Zaleski OUPS-N133) 
Cytotoxicity against cancer cell line: P388: ED50 = 0.16 μg/mL 
(Amagata et al., 1998) 
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Pyrenocine B 
 
Pyrone Brown alga Sargassum ringgoldianum  (Penicillium waksmanii Zaleski OUPS-N133) 
Cytotoxicity against cancer cell line: P388: ED50 = 1.4 μg/mL 
(Amagata et al., 1998) 
Pyrenocine E 
 
Pyrone Brown alga Sargassum ringgoldianum  (Penicillium waksmanii Zaleski OUPS-N133) 
Cytotoxicity against cancer cell line: P388: ED50 = 1.3 μg/mL 
(Amagata et al., 1998) 
Sch 54794 
 
Cyclodipeptide Red alga Carpopeltis affinis  (Fusarium chlamydosporum OUPS-N124) 
Cytotoxicity against cancer cell line: P388: ED50 = 21.5 μg/mL 
(Usami et al., 2002) 
Sch 725680 
 
Hydrogenated azaphilone Green alga Ulva fasciata  (Penicillium pinophilum Hedgcok) 
Cytotoxicity against cancer cell lines: A549: GI50 = 65.7 μM BALL-1: GI50 = 62.0 μM HCT-116: GI50 = 64.6 μM HeLa: GI50 = 68.8 μM NUGC-3: GI50 = 66.4 μM 
(Myobatake et al., 2012) 
(-)-Sclerodione 
 
Polyketide Green alga Enteromorpha sp. (Coniothyrium cereale) 
Cytotoxicity against cancer cell line: mouse fibroblast cell: IC50 = 6.4 μM 
(Nazir et al., 2015) 
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Scytalidamide A 
 
Cyclic heptapeptide  Green alga Halimeda sp.  (Sytalidium sp. CNC-310) Cytotoxicity against cancer cell line: HCT116: IC50 = 2.7 μM 
(Tan et al., 2003) 
Scytalidamide B 
 
Cyclic heptapeptide  Green alga Halimeda sp.  (Sytalidium sp. CNC-310) Cytotoxicity against cancer cell line: HCT116: IC50 = 11.0 μM 
(Tan et al., 2003) 
Sg17-1-4 
 
Polyketide Unkown alga (Alternaria tenuis) Cytotoxicity against cancer cell line: A375-S2: IC50 = 0.1 mM  HeLa: IC50 = 0.02 mM 
(Huang et al., 2006) 
Sporiolide A 
 
Macrolide Brown alga Actinotrichia fragilis  (Cladosporium sp.) 
Cytotoxicity against cancer cell line: L1210: IC50 = 0.13 μg/mL 
(Shigemori et al., 2004) 
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Sporiolide B 
 
Macrolide Brown alga Actinotrichia fragilis  (Cladosporium sp.) 
Cytotoxicity against cancer cell line: L1210: IC50 = 0.81 μg/mL 
(Shigemori et al., 2004) 
Sterigmatocystin 
 
Polyketide  Brown alga Sargassum  (Aspergillus (BM-05 and BM-05ML)) 
Cytotoxicity against cancer cell lines: K562: IC50 = 57.0 μM HCT116: IC50 = 10.3 μM A2780: IC50 = 30.6 μM A2780cisR: IC50 = 95.5 μM  
(Ebada et al., 2014a) 
Talaroflavone 
 
Polyketide Unknown alga (Undetermined fungus HJ33moB) 
Inhibitor of Eukaryotic DNA polymerases (pols) β and к : Eukaryotic DNA polymerases (pols) β: IC50 = 16.3 μM Eukaryotic DNA polymerases (pols) к: IC50 = 86.5 μM  
(Naganuma et al., 2008) 
Trichodermamide B 
 
Dipeptide Green alga Halimeda  (Trichoderma virens CNK266) 
Cytotoxicity against cancer cell line: HCT116: IC50 = 0.32 μg/mL 
(Garo et al., 2003) 
(-)-Trypethelone 
 
Polyketide Green alga Enteromorpha sp.  (Coniothyrium cereale) 
Cytotoxicity against cancer cell line: mouse fibroblast cell: IC50 = 7.5 μM 
(Nazir et al., 2015) 
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Variculanol 
 
Sesterterpenoid Green alga Halimeda opuntia (Aspergillus versicolor) 
Weak anticancer bioactivity against Hep G2 at 300 μg/disk 
(Hawas et al., 2012) 
Varioloid A 
 
Indole alkaloid  Red alga Grateloupia turuturu  (Paecilomyces variotii EN-291) 
Cytotoxicity against cancer cell lines: A549: IC50 = 3.5 μg/mL HCT116: IC50 = 6.4 μg/mL HepG2: IC50 = 2.5 μg/mL 
(Zhang et al., 2016) 
Varioloid B 
 
Indole alkaloid Red alga Grateloupia turuturu  (Paecilomyces variotii EN-291) 
Cytotoxicity against cancer cell lines: A549: IC50 = 4.6 μg/mL HCT116: IC50 = 8.8 μg/mL HepG2: IC50 = 6.2 μg/mL 
(Zhang et al., 2016) 
Wentilactone A 
 
Tetranorlabdane diterpenoid  
Brown alga Sargassum  (Aspergillus wentii EN-48) Cytotoxicity against cancer cell lines: HeLa: IC50 = 52 μM HepG2: IC50 = 35 μM  MCF-7: IC50 = 69 μM  NCI-H460: IC50 = 28 μM SMMC-7721: IC50 = 28 μM SW 1990: IC50 = 42 μM    
(Sun et al., 2012) 
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Wentilactone B 
 
Tetranorlabdane diterpenoid  
Brown alga Sargassum (Aspergillus wentii EN-48) Cytotoxicity against cancer cell lines: HeLa: IC50 = 42 μM HepG2: IC50 = 38 μM  MCF-7: IC50 = 56 μM  NCI-H460: IC50 = 24 μM SMMC-7721: IC50 = 17 μM SW 1990: IC50 = 24 μM 
(Sun et al., 2012) 
α-Cyclopiazonic acid  
 
Ergoline alkaloid   Green alga Enteromorpha tubulosa  (Aspergillus flavus c-f-3) 
Cytotoxicity against cancer cell lines: HL-60: IC50 = 2.4 μM MoLT-4: IC50 = 12.3 μM A549: IC50 =  21.5 μM 
(Lin et al., 2009) 
Pallidopenilline G 
 
Polyketide Brown alga Sargassum pallidum (Penicillium thomii KMM 4675) 
Cytotoxicity against cancer cell line: 22Rv1: IC50  = 9.8 μM  
(Sobolevskaya et al., 2016) 
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2. Strain list and MN data for Chapter 1 
 
Table S1. Identification of 87 fungal strains isolated from Fucus vesiculosus and its surrounding environment (sediment and seawater). Identification was done according to 
Sanger sequencing comparison of the ITS1-5.8S rRNA gene-ITS2 fragment to NCBI GenBank nucleotide database using BLASTn (incl. respective assigned Genbank accession 
numbers). The 3 first BLAST hits incl. respective accession numbers are given.  WM: Modified Wickerham medium, PDM: Potato Dextrose medium, GCM: Glucose Casein 
medium, GYP: Glucose Yeast Peptone medium. SE: sediment. SA: seawater. FVE: F. vesiculosus endophytic fungi. FVS: F. vesiculosus surface epiphytic fungi. *Strain could not be 
identified to genus level but only to higher taxa (order) level.  
Series no. I.D. 
  
Source Isolation 
Medium  
Sequence length  Closest relative in  
NCBI GenBank  
 
NCBI accession 
number 
Order Sequence 
similarity 
% 
Accession 
number 
1* 1 
 
FVE WM 297 Pyrenochaetopsis sp. HKU62 LC158605.1 Pleosporales  100 MH881440 
Pyrenochaetopsis sp. CBS:119739 LT623227.1 
Uncultured Leptosphaeria sp.2KK-
2015 
KP747710.1 
2 2 
 
SE PDM 172 Fusarium lateritium 3821 MG066631.1 Hypocreales  100 MH881441 
Fusarium tricinctum IBL277f MF162319.1 
Fusarium avenaceum SFC101774 MF186082.1 
3 6 
 
SE GCM 261 Fusarium culmorum F165 KU891563.1 Hypocreales  100 MH881442 
Fusarium graminearum PGTU10 
18S 
MF497389.1 
Fusarium culmorum Ba4  MH361213.1 
4 8 
 
SE PDM 270 Penicillium sanguifluum IG103 MG973279.1 Eurotiales  100 MH881443 
Penicillium sp. S1a1 KY784181.1 
Penicillium sanguifluum 17_3N1 KY859378.1 
5* 10 
 
SE GYP 426 Pyrenochaetopsis microspora 
MUT4941 
LT623227.1 Pleosporales  100 MH881444 
Roussoellaceae sp. MUT4859 KR014355.1 
Phoma sp. MUT 5462 KU314985.1  
6 11 FVS GCM 385 Gibellulopsis sp. MYf203 KX079890.1 Hypocreales  100 MH881445 
Gibellulopsis sp. P2 KY465972.1 
Gibellulopsis nigrescens LG1401 KX359602.1 
7 12 
 
FVE WM 400 Acremonium furcatum MUT1194 KR709189.1 Hypocreales  99 MH881446 
 Acremonium antarcticum AY913 LT549083.1 
Acremonium antarcticum CBS JX158422.1 
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987.87 
8 13 
 
FVE WM 301 Trichoderma gamsii SCAU130 MF061792.1 Hypocreales  100 MH881447 
 Trichoderma koningii ACCC32855 MF780862.1 
Trichoderma koningii ACCC32853 MF780861.1 
9 14 SE WM 306 Penicillium sp. L2-3C MG813426.1 Eurotiales  100 MH881448 
 Penicillium sp. UCD161305F MG686509.1 
Penicillium thomii MUT<ITA>:2257 MG813165.1 
10 15 
 
SE WM 227 Penicillium sp. L2-3C MG813426.1 Eurotiales  100 MH881449 
Penicillium sp. UCD161305F MG686509.1 
Penicillium thomii MUT<ITA>:2257 MG813165.1 
11 16 
 
SE PDM 358 Penicillium glabrum KAS5827 KY469043.1 Eurotiales  100 MH881450 
 Penicillium glabrum SFC101259 MF185992.1 
Penicillium spinulosum Su-XII-4 MF475933.1 
12 20 
 
SE PDM 287 Penicillium sp. L2-3C MG813426.1 Eurotiales  100 MH881451 
 Penicillium sp. UCD161305F MG686509.1 
Penicillium thomii MUT<ITA>:2257 MG813165.1 
13 24 SE GCM 376 Penicillium murcianum PM1 MF668969.1 Eurotiales  100 MH881452 
Penicillium nucicola KAS 2101 KT887846.1 
Penicillium sp. SFC102007 MF186110.1 
14 25 SE GYP 482 Cladosporium sloanii DTO:130-D5 MF473253.1 Eurotiales  98 MH881453 
Cladosporium psychrotolerans 
DTO:307-H2 
MF473224.1 
Cladosporium psychrotolerans 
DTO:305-G3 
MF473223.1 
15 26 SE GCM 232 Penicillium sp. EMA-2011d JF429677.1 Eurotiales  99 MH881454 
Penicillium thomii MUT<ITA>:2257 MG813165.1 
Penicillium glabrum SFC101259 MF185992.1 
16 27 
 
SE GYP 352 Penicillium coralligerum YK247 LC214562.1 Eurotiales  99 MH881455 
Penicillium atrovenetum bqw5 MF599167.1 
Penicillium sp. 8 KY401130.1 
17 29 SE GYP 430 Penicillium glabrum KAS5827 KY469043.1 Eurotiales  100 MH881456 
Penicillium glabrum SFC10125 MF185992.1 
Penicillium glabrum SYPF 6991 MH279474.1 
18 30 
 
SE GYP 375 Penicillium glabrum KAS5827 KY469043.1 Eurotiales  100 MH881457 
Penicillium glabrum SFC10125 MF185992.1 
Penicillium glabrum SYPF 6991 MH279474.1 
APPENDIX   
159 
 
19 31 SE GYP 338 Penicillium brevicompactum 
GIBI220  
KX965655.1 Eurotiales  100 MH881458 
Penicillium sp. M_FA_V8 MH137760.1 
Penicillium brevicompactum MH047201.1 
20 32 FVE PDM 366 Penicillium brevicompactum 
MERVA5 
MF503895.1 Eurotiales  100 MH881459 
Penicillium brevicompactum MH047201.1 
Penicillium brevicompactum 
KAS5854 
KY469047.1 
21 33 FVE PDM 318 Penicillium atrovenetum bqw5 MF599167.1 Eurotiales  100 MH881460 
Penicillium atrovenetum CBS 243.56  KP016835.1 
Penicillium sp. MT152 MH109377.1 
22 34 FVE GYP 468 Penicillium atrovenetum bqw5  MF599167.1 Eurotiales  100 MH881461 
Penicillium coralligerum YK-247 LC214562.1 
Penicillium antarcticum SFC101809 MF186085.1 
23 35 FVE GYP 323 Cadophora malorum M7 MG813381.1 Incertae sedis 100 MH881462 
Cadophora malorum VKM F-4744 MF494613.1 
Cadophora malorum VKM F-4747 MF494620.1 
24* 37 FVE GYP 304  Emericellopsis sp. SNT1-23 KY379579.1 Hypocreales  99 MH881463 
Acremonium zonatum CSR1-21 KY379556.1 
Sarocladium kiliense 11-84 KX815337.1 
25 38 FVE WM 328 Penicillium biourgeianum UWR031 KX426968.1 Eurotiales  100 MH881464 
Penicillium bialowiezensec 
SFC101475 
MF186021.1 
Penicillium bialowiezensec KAS5860 KY469051.1 
26 39 FVE WM 224 Penicillium brevicompactum 
UWR031 
KX426968.1 Eurotiales  100 MH881465 
Penicillium bialowiezense KAS5860 KY469051.1 
Penicillium brevicompactum 82 KY401133.1 
27 40 FVE WM 347 Penicillium sp. 86 KY401137.1 Eurotiales  100 MH881466 
Penicillium atrovenetum BQW5 MF599167.1 
Penicillium sp. 8 KY401130.1 
28 42 FVE GYP 517 Penicillium brevicompactum F27-02  KX664363.1 Eurotiales  100 MH881467 
Penicillium brevicompactum 
KAS5854 
KY469047.1 
Penicillium brevicompactum KY469041.1 
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KAS5812 
29 43 SE WM 228 Penicillium sp. L2-3C MG813426.1 Eurotiales  100 MH881468 
Penicillium sp. UCD161305F MG686509.1 
Penicillium thomii MUT<ITA>:2257 MG813165.1 
30 44 SE PDM 206 Fusarium chlamydosporum 
CFFSUR-22A 
KY860655.1  Hypocreales 100 MH881469 
Fusarium oxysporum f. sp. 
momordicae GuangX26 
MF445489.1 
Fusarium chlamydosporum Ng30 MH141316.1 
31 46 SE PDM 355 Penicillium glabrum KAS5827 KY469043.1 Eurotiales  100 MH881470 
Penicillium glabrum SFC101259 MF185992.1 
Penicillium glabrum SFC101229 MF185985.1 
32 47 SE PDM 372 Penicillium glabrum KAS5767 KY469033.1 Eurotiales  100 MH881471 
Penicillium glabrum SFC101259 MF185992.1 
Penicillium glabrum PO6 KY463488.1 
33 48 SE PDM 365 Penicillium jensenii P6342 MH063657.1 Eurotiales  100 MH881472 
Penicillium sp.1217_476 MG917754.1 
Penicillium canescens 3S.106 KY458474.1 
34 49 SE GYP 307 Penicillium jensenii P6342  MH063657.1 Eurotiales  100 MH881473 
Penicillium sp.1217_476 MG917754.1 
Penicillium canescens 3S.106 KY458474.1 
35 50 FVE PDM 507 Penicillium sp. 86 KY401137.1 Eurotiales  100 MH881474 
Penicillium sanguifluum IG103 MG973279.1 
Penicillium sp. 8 KY401131.1 
36 52 SE WM 322 Penicillium sp. L2-3C MG813426.1 Eurotiales  100 MH881475 
Penicillium sp. UCD161305F MG686509.1 
Penicillium thomii MUT<ITA>:2257 MG813165.1 
37* 53 FVS GYP 314 Phoma sp. MUT5465 KU314987.1 Pleosporales  99 MH881476 
Roussoellaceae sp. MUT 4859 KR014355.1 
Phoma sp. MUT 5462 KU314985.1 
38 54 FVS GCM 337 Penicillium brevicompactum F27-02 KX664363.1 Eurotiales  100 MH881477 
Penicillium sp. UCD160901G3 MG686505.1 
Penicillium brevicompactum 
KAS5854 
KY469047.1 
39 55 FVE PDM 300 Penicillium glabrum ND70 MG659664.1 Eurotiales  100 MH881478 
Penicillium thomii MUT<ITA>:2257 MG813165.1 
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Penicillium glabrum SFC101229 MF185985.1 
40 56 FVE WM 523 Penicillium coralligerum YK-247 LC214562.1 Eurotiales  100 MH881479 
Penicillium sp. 86 KY401137.1 
Penicillium sp. 76 KY401126.1 
41 57 FVE GYP 331 Penicillium atrovenetum FO.1 KT587349.1 Eurotiales  100 MH881480 
Penicillium antarcticum SFC101809 MF186085.1 
Penicillium coralligerum YK-247 LC214562.1 
42 58 FVE WM 258 Fusarium graminearum WF1 KY985465.1 Hypocreales  96 MH881481 
Fusarium graminearum PGTU11 MF497390.1 
Fusarium graminearum PGTU10 MF497389.1 
43* 59 FVE WM 231 Gibellulopsis nigrescens LG1402 KY459202.1 Glomerellales 100 MH881482 
Plectosphaerella sp. sedF4 KX359602.1 
Uncultured Verticillium JB40C25 
(MOTU06) 
HG935585.1 
44 60 FVE WM 310 Penicillium coralligerum YK-247  LC214562.1 Eurotiales  100 MH881483 
Penicillium atrovenetum bqw5 MF599167.1 
Penicillium sp. 86 KY401137.1 
45 61 FVE PDM 514 Penicillium brevicompactum 
TCDFvLDB1814 
MH71548.1 Eurotiales  100 MH881484 
Penicillium brevicompactum 
Asa3SNA1 
KY558614.1 
Penicillium brevicompactum 
KAS5854 
KY469047.1 
46 62 FVE PDM 324 Penicillium brevicompactum F27-02  KX664363.1 Eurotiales  100 MH881485 
Penicillium brevicompactum 
KAS5854 
KY469047.1 
Penicillium brevicompactum 
KAS5812 
KY469041.1 
47 63 FVE PDM 334 Penicillium brevicompactum F27-02  KX664363.1 Eurotiales  100 MH881486 
Penicillium brevicompactum 
KAS5854 
KY469047.1 
Penicillium brevicompactum 
KAS5812 
KY469041.1 
48 64 FVE PDM 341 Penicillium brevicompactum MERV5 MF503895.1 Eurotiales  100 MH881487 
Penicillium brevicompactum 
SFC102216 
MF186137.1 
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Penicillium brevicompactum 2-Z-30 MH310820.1 
49 65 SA PDM 247 Candida sp. KJS-2016 LC155354.1  Saccharomyceta
les  
99 MH881488 
Candida pseudolambica yHRM77 KM384061.1 
Candida pseudolambica yHRM67 KM384060.1 
50 66 SE PDM 182 Fusarium lateritium 3821 MG066631.1 Hypocreales  100 MH881489 
Fusarium tricinctum SFC101814 MF186086.1 
Fusarium avenaceum SFC101774 MF186082.1 
51 67 FVE WM 250 Gibellulopsis nigrescens STAF302 KU214559.1 Glomerellales  100 MH881490 
Gibellulopsis nigrescens LG1401 
GL11A  
KX359602.1 
Gibellulopsis nigrescens STAF302 KU314961.1 
52 68 FVE WM 316 Penicillium atrovenetum bqw5 MF599167.1 Eurotiales  100 MH881491 
Penicillium coralligerum YK-247 LC214562.1 
Penicillium antarcticum SFC101809 MF186085.1 
53 69 FVE PDM 329 Penicillium brevicompactum MERV5 MF503895.1 Eurotiales  100 MH881492 
Penicillium brevicompactum 
SFC102216 
MF186137.1 
Penicillium brevicompactum 2-Z-30 MH310820.1 
54 72 FVE WM 204 Penicillium coralligerum YK-247 LC214562.1 Eurotiales  100 MH881493 
Penicillium atrovenetum bqw5 MF599167.1 
Penicillium antarcticum SFC101809 MF186085.1 
55 73 FVE GYP 321 Penicillium brevicompactum MERV5 MF503895.1 Eurotiales  98 MH881494 
Penicillium brevicompactum 
SFC102216 
MF186137.1 
Penicillium brevicompactum 2-Z-30 MH310820.1 
56 77 SE PDM 249 Penicillium sp. L2-3C MG813426.1 Eurotiales  100 MH881495 
Penicillium sp. UCD161305F MG686509.1 
Penicillium thomii MUT:2257 MG813165.1 
57 78 FVE PDM 509 Penicillium glabrum DTO313-D4 MF803957.1 Eurotiales  100 MH881496 
Penicillium glabrum DTO313-C1 MF803952.1 
Penicillium camemberti ISSFR-016 KT832784.1 
58 81 FVE WM 227 Wallemia muriae KK18.3 KY322648.1 Wallemiales  100 MH881497 
Wallemia muriae KAS 6011 KX911859.1 
Wallemia muriae KAS 5869 KX911850.1 
59 82 FVE WM 328 Emericellopsis terricola CCF3815 J430737.1 Hypocreales  99 MH881498 
Emericellopsis minima KT290876.1 
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OUCMBII111121 
Uncultured Emericellopsis 
10J50C67 (MOTU75) 
HG936806.1 
60* 84 FVE WM 323 Stilbella fimetaria voucher AF3-097G KX446764.1 Hypocreales  100 MH881499 
Emericellopsis salmosynnemata 
CBS382.62 
AY632666.1 
Stilbella fimetaria D99026 AY952467.1 
61 85 SE PDM 260 Stereum hirsutum P2A KX838369.2 Russulales  100 MH881500 
Stereum hirsutum gap67 KX578081.1 
Stereum hirsutum Wi-XI-1.1 MF476012.1 
62 86 FVE PDM 323 Emericellopsis terricola CCF3815 FJ430737.1 Hypocreales 99 MH881501 
Emericellopsis terricola U57676.1 
Emericellopsis minima A11 KY775297.1 
63* 87 FVE WM 279 Phoma sp. MUT 5465 KU314987.1 Pleosporales  99 MH881502 
Pleosporales sp. AT60 KX953409.1 
Pyrenochaetopsis microspora CBS 
119739 
LT623227.1 
64 89 FVE WM 395 Trichoderma paraviridescens MG646337.1 Hypocreales  100 MH881503 
Trichoderma viride IMF51186 LC317804.1 
Trichoderma koningiopsis 
ACCC32904 
MF871558.1 
65 91 FVE GCM 473 Penicillium spathulatum AS3.15328 KC427190.1 Eurotiales  100 MH881504 
Penicillium spathulatum CBS 
116977 
JX313162.1 
Penicillium sp. DF-2 KT121500.1 
66 92 FVS PDM 330 Penicillium coralligerum YK-247 LC214562.1 Eurotiales  100 MH881505 
Penicillium sp. MT152 MH109377.1 
Penicillium sp. MT57 MH109376.1 
67 95 FVE PDM 350 Penicillium coralligerum YK-247 LC214562.1 Eurotiales  100 MH881506 
Penicillium sp. MT152 MH109377.1 
Penicillium sp. MT57 MH109376.1 
68 96 FVS GYP 502 Penicillium brevicompactum 
BEOFB1102m 
MH630035.1 Eurotiales  100 MH881507 
Penicillium brevicompactum 
TCDFvLDB1814 
MH714548.1 
Penicillium brevicompactum 1 MH047201.1 
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69 97 SE GYP 428 Fusarium culmorum S68 MH681156.1 Eurotiales  100 MH88150 
8 Fusarium culmorum F150 MH681154.1 
Fusarium asiaticum G84 MH681153.1 
70 99 FVS GCM 315 Penicillium brevicompactum 
KAS5854 
KY469047.1 Eurotiales  100 MH881509 
Penicillium brevicompactum 
KAS5812 
KY469041.1 
Penicillium brevicompactum 
KAS5776 
KY469037.1 
71 101 FVE GCM 326 Penicillium brevicompactum KG_6i MG686505.1 Eurotiales  100 MH8815010 
Penicillium brevicompactum 
Asa3SNA1 
KY558614.1 
Penicillium brevicompactum 
Cch1SNA3 
KY558611.1 
72 102 FVE W 349 Penicillium sp. 86 MF599167.1 Eurotiales  100 MH881511 
Penicillium atrovenetum BQW5 KY401137.1 
Penicillium sp. 8 MF599167.1 
73 104 FVS WM-S 318 Penicillium chrysogenum 
DCMAF01BCI 
KY401130.1 Eurotiales  100 MH881512 
Penicillium brevicompactum 
SFC102216 
MF186137.1 
Penicillium brevicompactum 2-Z-30 MH310820.1 
74 105 FVS GCM 377 Penicillium sp. 86 KY401137.1 Eurotiales  100 MH881513 
Penicillium atrovenetum BQW5 MF599167.1 
Penicillium sp. 8 KY401130.1 
75 107 FVE PDM 415 Penicillium sp. 86 KY401137.1 Eurotiales  100 MH881514 
Penicillium atrovenetum BQW5 MF599167.1 
Penicillium sp. 8 KY401130.1 
76 108 FVS WM 305 Penicillium sp. 86 KY401137.1 Eurotiales  100 MH881515 
Penicillium atrovenetum BQW5 MF599167.1 
Penicillium sp. 8 KY401130.1 
77 109 FVS GCM 291 Penicillium sp. 86 KY401137.1 Eurotiales  100 MH881516 
Penicillium atrovenetum BQW5 MF599167.1 
Penicillium sp. 8 KY401130.1 
78 111 FVE GYP 312 Penicillium sp. 86 KY401137.1 Eurotiales  100 MH881517 
Penicillium atrovenetum BQW5 MF599167.1 
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Penicillium sp. 8 KY401130.1 
79 112 FVE GCM 367 Penicillium glabrum R2EK05 KR091814.1 Eurotiales  100 MH881518 
Penicillium glabrum SFC101259 MF185992.1 
Penicillium glabrum SFC101229 MF185985.1 
80* 113 SE GCM 296 Nectria inventa MUT1135  KR709185.1 Hypocreales  100 MH881519 
Acrostalagmus luteoalbus P6424 MH063783.1 
Acrostalagmus luteoalbus H35 KX375795.1 
81 114 FVS PDM 300 Penicillium brevicompactum 
KAS5871 
KY469055.1 Eurotiales  100 MH881520 
Penicillium brevicompactum 
SFC102216 
MF186137.1 
Penicillium brevicompactum 2-Z-30 MH310820.1 
82 115 SA PDM 124 Penicillium coralligerum YK247 LC214562.1 Eurotiales  100 MH881521 
Penicillium atrovenetum bqw5 MF599167.1 
Penicillium sp. 8 KY401130.1 
83 117 SE PDM 434 Phoma sp. MUT 5465 KU314987.1 Pleosporales  100 MH881522 
Phoma sp. MUT 5462 KU314985.1 
Phoma sp. MUT 5460 KU314983.1 
84 121 FVE GCM 287 Penicillium canescens 3S.106 KY458474.1/  Eurotiales  100 MH881523 
 Penicillium murcianum KK19.1 KY322566.1 
 Penicillium jensenii P6342 MH063657.1 
85 122 FVE GCM 376 Penicillium brevicompactum 
KAS5871 
KY469055.1 Eurotiales  100 MH881524 
 Penicillium brevicompactum 
SFC102216 
MF186137.1 
 Penicillium brevicompactum 2-Z-30 MH310820.1 
86 123 SE GCM 102 Penicillium denovo13735 KR266650.1 Eurotiales  100 MH881525 
Penicillium sp. SF1  KX011018.1 
Neosartorya sp. BAB-4715 KU571518.1 
87 124 SE GCM 309 Penicillium coralligerum YK247 LC214562.1 Eurotiales  100 MH881526 
 Penicillium atrovenetum bqw5 MF599167.1 
 Penicillium sp. 8 KY401130.1 
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Table S2. Putatively identified compounds from 40 liquid culture extracts and 40 solid culture extracts. Dereplication of the compounds was based on GNPS, UNPD-ISDB, and 
manual dereplication by using several databases such as DNP, Scifinder and Chemspider.  
Comp. 
No. 
tR 
(min) 
 
Culture 
regime 
(medium) 
Precursor 
m/z 
 
Putative ID 
(chemical family) 
Chemical structure Molecular 
formula 
(change in 
Δ ppm) 
MS/MS 
fragmenta
tion 
Strain number 
1 0.70 Solid 
(SYM) 
204.1113 
[M+H]+ 
Acetylcarnitine 
(amino acid derivative) O
O
N+
O-
 
C9H17NO4 
(-59.3)* 
145.1231; 
85.9665 
1 
2 1.66 Liquid 
(WM) 
189.1130 
[M+H]+ 
Aspinonene 
(pentaketide) 
OH
OH OH
O
 
C9H16O4 
(0) 
- 68 
3 2.24 Solid 
(PDM, SYM, 
Cza, WM) 
239.1592 
[M+H]+ Lysergine (indole alkaloid) 
N
NH
H
 
C16H18N2 
(-7.5) 
197.1551; 
141.9877 
37 
4 3.04 Solid 
(Cza) 
245.1508 
[M+H]+ 
Cyclo(L-Phe-D-Pro) 
(diketopiperazine) 
N
N
O
O
H
H
 
C14H16N2O2 
(1.9) 
217.1613; 
154.1008; 
120.1105 
35 
5 4.15 Liquid 
(PDM) 
301.0852 
[M+H]+ 
Questinol 
(dihydroxyanthraquino
ne) OH
OH
O
O OH
OH
 
C16H12O6 
(-0.5) 
286.0602; 
257.0612 
50 
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6 4.18 Solid 
(WM) 
454.1482 
[M+Na]+ 
 
Pseurotin A 
(amide alkaloid) 
 
O
OOH
OH
O NH
OH
O
O
 
C22H25NO8 
(-0.9) 
422.1124; 
370.0889; 
261.0882; 
216.0832 
78 
 Liquid 
(SYM) 
35 
7 5.19 Liquid 
(Cza) 
Solid 
(Cza) 
536.4123 
[M+H]+ 
2-(21-amino-3, 20-
dihydroxydocosan-2-yl) 
oxy-6-(hydroxymethyl) 
oxane-3, 4, 5-triol 
(aminoglycolipid) 
NH2
O
O
OH
OH
OH
OH
OH
OH
 
C28H57NO8 
(-1.9) 
518.4053; 
500.3958; 
482.3873; 
374.3875; 
338.3654; 
320.3527 
59 
8 5.19 Liquid 
(Cza) 
Solid 
(Cza) 
356.3711 
[M+H]+ 
21-aminodocos-21-ene-
2,3-diol 
(aminolipid) 
NH2
OH
OH
 
C22H45NO2 
(0.5) 
338.3616; 
320.3527 
59 
9 5.20 Liquid 
(Cza) 
Solid 
(Cza) 
374.3796 
[M+H]+ 
21-aminodocosane-
2,3,20-triol 
(aminolipid) 
NH2
OH
OH
OH
 
C22H47NO3 
(42.2) * 
356.3704; 
338.3615; 
320.3528 
59 
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10 5.21 Liquid 
(Cza) 
Solid 
(Cza) 
500.3968 
[M+H]+ 
(E)-2-((21-aminodocosa-
3,21-dien-2-yl)oxy)-6-
(hydroxymethyl)tetrahy
dro-2H-pyran-3, 4, 5-
triol 
(aminolipid) 
NH2
O
O
OH
OH
OH
OH
 
C28H53NO6 
(3.2) 
482.3876; 
374.3875; 
356.3695; 
338.3606; 
320.3527 
59 
11 5.23 Liquid 
(Cza) 
Solid 
(Cza) 
518.4051 
[M+H]+ 
2-(21-amino-3-
hydroxydocos-21-en-2-
yl) oxy)-6-
(hydroxymethyl) 
tetrahydro-2H-pyran-3, 
4, 5-triol 
(aminoglycolipid) 
NH2
O
O
OH
OH
OH
OH
OH
 
C28H55NO7 
(-1.7) 
500.3958; 
482.3873; 
356.3700 
338.3612; 
320.3526 
59 
12 5.47 Solid 
(WM) 
466.3
170 
[M+H]+ 
Glycocholic acid 
(bile acid) 
OH
NH OH
O
OH
OH
O
 
C26H44NO6 
(0.2) 
412.2906; 
337.2691; 
319.2593; 
227.1693 
59 
488.2
957 
[M+Na]+ 
470.2871; 
412.2914 
13 6.32 Liquid 
(Cza, SYM) 
Solid 
(SYM, WM, 
PDM) 
501.2903 
[M+H]+ 
Citreohybridonol 
(sesterterpenoid) O O
O
OH
O
O O
O
 
C28H36O8 
(-0.3) 
486.2682; 
409.2138; 
381.2216; 
363.2131; 
335.2205; 
217.1520; 
179.1021 
68 
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14 6.45 Solid 
(SYM) 
318.3213 
[M+H]+ 
Phytosphingosine 
(sphingolipid) OH
NH2OH
OH
 
C18H39NO3 
(6.5) 
300.3127; 
282.3036; 
270.3043; 
264.2945; 
240.2946; 
56 
15 6.52 Liquid 
(WM) 
353.0795 
[M+H]+ 
Griseofulvin 
(tetrahydrofuranone 
polyketide) 
O
O
O
Cl
O
OO
 
C17H17ClO6 
(0.8) 
285.0648; 
215.0305; 
165.0792 
68 
16 6.70 Liquid 
(Cza) 
Solid 
(WM) 
454.1801 
[M+Na]+ 
Fusarin C 
(polyene) 
O
OH
O
O
NH
OO
OH
 
C23H29NO7 
(-10.4) 
413.2605; 
335.1281; 
290.1098 
58 
17 6.78 Liquid 
(Cza, PDM) 
519.1832 
[M+H]+ 
Rubratoxin B 
(bis-anhydride) 
O
O
OO
OH
O
O
OOHO OH
 
C26H30O11 
(-4.0) 
501.1757; 
451.1306; 
271.1122 
50 
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18 6.99 Liquid 
(Cza, PDM) 
521.1890 
[M+H]+ 
Rubratoxin A 
(bis-anhydride) 
O
O
OO
OH
O
OH
OOHO OH
 
C26H32O11 
(-5.0) 
503.1911; 
435.1422; 
283.1126; 
271.1121 
50 
19 7.14 Liquid 
(PDM) 
589.0890 
[M+H-
H2O]+ 
Xanthoepocin 
(binaphthoquinone) 
O OO OH
O O
O
OH O
O
OH
O
OH O
 
C30H22O14 
(-10.6) 
571.0801; 
483.0744; 
470.0672; 
441.0686; 
413.0764; 
313.0562 
59 
20 7.16 Liquid 
(PDM) 
571.0803 
[M+H]+ 
Bisdehydroxanthomegn
in 
(binaphthoquinone)  
O
O
O
O
OO
O
OOH
O O
OH
 
C30H18O12 
(-12.6) 
511.0682; 
483.0735; 
469.0599; 
286.0680; 
257.0700 
59 
21 7.46 Liquid 
(SYM, PDM, 
Cza) 
343.1276 
[M+H]+ 
Atrovenetin 
(aromatic polyketide) 
O
OH
O
OH
O
OH
 
C19H18O6 
(24.30) 
287.0714; 
255.0495 
68 
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22 7.55 Solid 
(SYM, Cza) 
337.2900 
[M+H-
H2O]+ 
Prostaglandin H1 
(fatty acid derivative) 
O
O
O
OH
H
H
H
H
OH
 
C20H34O5 
(8.6) 
263.2607; 
123.1482; 
109.1327 
78 
23 7.58 Solid 
(WM, Cza) 
513.2470 
[M+H]+ 
Arisugacin D 
(dihydroxanthone 
derivative) 
O
O
O O
O
OH
OH
O
 
C29H36O8 
(-3.9) 
495.2372; 
395.1965; 
209.1114 
50 
24 7.67 Solid 
(SYM, Cza) 
446.2421 
[M+Na]+ 
Brevicompanine E 
(diketopiperazine  
alkaloid) 
N
N
NO
O
O
HH
H
 
C25H33N3O3 
(-0.4) 
386.2237; 
328.1892; 
130.0972; 
358.1982 
68 
25 8.05 Solid 
(WM, SYM, 
PDM, Cza) 
357.1544 
[M+H]+ 
Deoxyherquenone 
(aromatic polyketide) 
C20H20O6 
(5.4) 
342.1268; 
327.1049; 
301.0910 
50 
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Liquid 
(SYM, PDM, 
Cza, WM) 
OH
OOH
O
O
OH
 
68 
26 8.12 Liquid 
(SYM) 
481.2016 
[M+Na]+ 
Fumagillin 
(meroterpenoid) 
OO
OO
O
OH
O
 
C26H34O7 
(-3.8) 
329.2926 35 
27 8.88 Solid 
(SYM) 
448.2588 
[M+H]+ 
Marcfortine C 
(indole alkaloid) 
O O
O
NH
NH
N
 
C27H33N3O3 
(-2.7) 
406.2837; 
330.2077; 
182.1254 
68 
28 9.16 Liquid 
(SYM) 
379.3
329 
[M+H-
H2O] + 
Ergosterol 
(steroid) 
H
H
OH
H
 
C28H44O 
(-9.3) 
309.2665; 
295.2521; 
253.2106; 
213.1840; 
199.1696; 
159.1414 
35 
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29 9.35 Liquid 
(WM, Cza, 
PDM) 
341.1123 
[M+H]+ 
Atrovenetinone 
(aromatic polyketide) 
O
O
O
OHOH
O
 
C19H16O6 
(27.9) 
313.7212; 
287.0724 
68 
30 9.78 Solid 
(SYM) 
584.3291 
[M+H]+ 
Penitrem B 
(indole diterpenoid) 
 C37H46NO5 
(-14.2) 
566.3217; 
514.2602; 
497.2591; 
480.2563; 
478.2471 
304.1931; 
260.1345 
68 
31 10.16 Liquid 
(PDM, Cza) 
640.3732 
[M+H]+ 
Enniatin B 
(cyclic depsipeptide) O
O
O O
N
O
O
O
N
O
O N
 
C33H57N3O9 
(-53.4) * 
527.3075; 
427.2713; 
314.2042; 
214.1643; 
195.1562; 
186.1716 
35 
Liquid 
(PDM, Cza) 
662.3557 
[M+Na]+ 
549.2864; 
336.1829 
32 10.30 Solid 
(Cza) 
481.2922 
[M+Na]+ 
Candelalide C 
(diterpenoid pyrone) 
O O
O
O
OH
 
C28H42O5 
(-1.7) 
355.2387; 
283.2012; 
240.2581; 
133.1116 
50 
NH
O
O OH
O OH
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33 10.61 Liquid 
(SYM) 
331.2302 
[M+H]+ 
Phomopsidin 
(trimethylated 
nonaketide) OHOH
O
 
C21H30O3 
(6.5) 
293.0333; 
273.8689; 
250.8805’ 
192.8811; 
165.0659 
87 
34 10.66 Liquid 
(WM, PDM) 
654.3968 
[M+H]+ 
Enniatin B1 
(cyclic depsipeptide) 
O
O
O
OO
O
O
O
N
N
ON
 
C34H59N3O9 
(-55.3) * 
541.3203; 
441.2848; 
328.2178; 
314.2042; 
210.1696; 
196.1553 
35 
Liquid 
(WM, PDM, 
Cza, SYM) 
676.3968 
[M+Na]+ 
563.2997 
35 10.95 Liquid 
(PDM, Cza, 
WM) 
463.2682 
[M+H]+ 
Virescenoside E 
(diterpene glycoside) OHOH
O
O
O
OH
OH
 
C26H38O7 
(-5.2) 
355.2312 1 
36 11.67 Liquid 
(PDM, WM) 
704.3914 
[M+Na]+ 
Enniatin A 
(cyclic depsipeptide) 
O
O
O
O
O O
N
O
O
O
N
N
 
C36H63N3O9 
(48.5) * 
577.3101 35 
*Peak ions of low intensity (molecular formula prediction with high Δ ppm.
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 Figure S1. Comparison of 55 F. vesiculosus – derived fungi in diversity and distribution according to solid (S) 
isolation media. WM-S = modified Wickerham medium, PDM-S = Potato Dextrose medium, GCM-S = Glucose 
Casein medium, GYP-S = Glucose Yeast Peptone medium. Height of the column represents the total number of 
isolates derived from each media – WM-S: 21 isolates; PDM-S: 15 isolates, GCM-S: 10 isolates. GYP-S: 9 isolates.   
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Figure S2. Pie chart showing the diversity of 55 Fucus vesiculosus – derived fungal community obtained by different 
isolation media. Strains that could not be identified to genus level are indicated as ‘Higher taxa’. (A). Fungal isolates 
obtained from the WM-S medium that were identified as 10 Penicillium sp., 1 Emericellopsis sp., 1 Gibellulopsis sp., 1 
Fusarium sp., 2 Trichoderma sp., 1 Acremonium sp., 1 Wallemia sp. and 4 ‘Higher taxa’. (B). Fungal isolates obtained 
from the GYP-S medium that were identified as 6 Penicillium sp., 2 ‘Higher taxa’, and 1 Cadophora sp. (C). Fungal 
isolates obtained from the PDM-S medium that were identified as 14 Penicillium sp. and 1 Emericelosis sp. (D). 
Fungal isolates obtained from the GCM-S medium that were identified as 9 Penicillium sp. and 1 Gibellulopsis sp. 
 
 
A B 
C D 
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Figure S3. Workflow for the OSMAC study based on the 55 fungal isolates derived from F. vesiculosus. 26 isolates 
were selected for small-scale fermentation. The OSMAC approach was designed using 4 different media and 2 
culture regimes. In total 208 culture extracts were tested for anticancer activity and the bioactive samples were 
further tested for IC50 determination. 10 strains showed IC50 values below 100 μg/mL against at least one cancer cell 
line. In the end, all 80 culture extracts derived from 10 strains were analysed by an integrated metabolomics 
approach.  
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 Figure S4. Molecular network for strain 1 (order Pleosporales) liquid culture extracts in PDM-L (blue), Cza-L (red), 
SYM-L (green), WM-L (grey). Annotated peak ions of putatively known compounds are highlighted by a grey 
loop. 
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 Figure S5. Annotated molecular network for strain 1 (order Pleosporales) solid culture extracts in PDM-S (blue), 
Cza-S (red), SYM-S (green), WM-S (grey). Annotated peak ions of putatively known compounds are highlighted 
by a grey loop. 
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 Figure S6. Annotated molecular network for strain 35 (Cadophora malorum) liquid culture extracts in PDM-L (blue), 
Cza-L (red), SYM-L (green), WM-L (grey). Annotated peak ions of putatively known compounds are highlighted 
by a grey loop. 
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 Figure S7. Annotated molecular network for strain 35 (Cadophora malorum) solid culture extracts in PDM-S (blue), 
Cza-S (red), SYM-S (green), WM-S (grey). Annotated peak ions of putatively known compounds are highlighted 
by a grey loop. 
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Figure S8. Annotated molecular network for strain 37 (order Hypocreales) liquid culture extracts in PDM-L (blue), 
Cza-L (red), SYM-L (green), WM-L (grey).   
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Figure S9. Annotated molecular network for strain 37 (order Hypocreales) solid culture extracts in PDM-S (blue), 
Cza-S (red), SYM-S (green), WM-S (grey). Annotated peak ions of putatively known compounds are highlighted 
by a grey loop. 
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Figure S10. Annotated molecular network for strain 50 (Penicillium sp.) liquid culture extracts in PDM-L (blue), 
Cza-L (red), SYM-L (green), WM-L (grey). Annotated peak ions of putatively known compounds are highlighted 
by a grey loop. 
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 Figure S11. Annotated molecular network for strain 50 (Penicillium sp.) solid culture extracts in PDM-S (blue), Cza-
S (red), SYM-S (green), WM-S (grey). Annotated peak ions of putatively known compounds are highlighted by a 
grey loop. 
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Figure S12. Annotated molecular network for strain 56 (Penicillium sp.) liquid culture extracts in PDM-L (blue), 
Cza-L (red), SYM-L (green), WM-L (grey).  
  
 
 
 
 
 
 
 
 
 
 
 
  APPENDIX 
187 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S13. Annotated molecular network for strain 56 (Penicillium sp.) solid culture extracts in PDM-S (blue), Cza-
S (red), SYM-S (green), WM-S (grey). Annotated peak ions of putatively known compounds are highlighted by a 
grey loop.  
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Figure S14. Annotated molecular network for strain 58 (Fusarium graminearum) liquid culture extracts in PDM-L 
(blue), Cza-L (red), SYM-L (green), WM-L (grey). Annotated peak ions of putatively known compounds are 
highlighted by a grey loop. 
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Figure S15. Annotated molecular network for strain 58 (Fusarium graminearum) solid culture extracts in PDM-S 
(blue), Cza-S (red), SYM-S (green), WM-S (grey). Annotated peak ions of putatively known compounds are 
highlighted by a grey loop. 
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Figure S16. Annotated molecular network for strain 59 (order Glomerellales) liquid culture extracts in PDM-L 
(blue), Cza-L (red), SYM-L (green), WM-L (grey). Annotated peak ions of putatively known compounds are 
highlighted by a grey loop.  
  APPENDIX 
191 
 
 Figure S17. Annotated molecular network for strain 59 (order Glomerellales) solid culture extracts in PDM-S (blue), 
Cza-S (red), SYM-S (green), WM-S (grey). Annotated peak ions of putatively known compounds are highlighted 
by a grey loop. 
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 Figure S18. Annotated molecular network for strain 68 (Penicillium sp.) liquid culture extracts in PDM-L (blue), 
Cza-L (red), SYM-L (green), WM-L (grey). Annotated peak ions of putatively known compounds are highlighted 
by a grey loop.  
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 Figure S19. Annotated molecular network for strain 68 (Penicillium sp.) solid culture extracts in PDM-S (blue), Cza-
S (red), SYM-S (green), WM-S (grey). Annotated peak ions of putatively known compounds are highlighted by a 
grey loop.  
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Figure S20. Annotated molecular network for strain 78 (Penicillium sp.) liquid culture extracts in PDM-L (blue), 
Cza-L (red), SYM-L (green), WM-L (grey).  
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 Figure S21. Annotated molecular network for strain 78 (Penicillium sp.) solid culture extracts in PDM-S (blue), Cza-
S (red), SYM-S (green), WM-S (grey). Annotated peak ions of putatively known compounds are highlighted by a 
grey loop. 
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Figure S22. Annotated molecular network for strain 87 (order Pleosporales) liquid culture extracts in PDM-L (blue), 
Cza-L (red), SYM-L (green), WM-L (grey). Annotated peak ions of putatively known compounds are highlighted 
by a grey loop. 
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 Figure S23. Annotated molecular network for strain 87 (order Pleosporales) solid culture extracts in PDM-S (blue), 
Cza-S (red), SYM-S (green), WM-S (grey).  
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 Figure S24. Molecular network of the aminolipid family detected in strain 59 (order Glomerellales) extracts. Red 
nodes: Ions detected in Cza extracts. Blue nodes: Ions detected in PDM extracts. Green nodes: Ions detected in 
SYM extracts. Grey nodes: Ions detected in WM extracts. 
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 Figure S25. Molecular network of an unannotated cluster containing specific node (m/z [M+H]+ 428.2081) 
generated from the global MN (Figure 7A). Black square: node exclusive to the bioactive 1PDM-L extract. Red 
nodes: Ions detected in toxic samples. Grey nodes: Ions detected in inactive samples. Blue nodes: Ions detected in 
bioactive samples. 
 
 
 
 
 Figure S26. Molecular network of an unannotated cluster containing 3 specific nodes (m/z [M+H]+ 401.3221, [M+H]+ 
403.3355, [M+H]+ 419.3300) generated from the global MN (Figure 7A). Red nodes: Ions detected in toxic samples. 
Grey nodes: Ions detected in inactive samples. Blue nodes: Ions detected in bioactive samples. 
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3. Bioactivity data and NMR spectral data of Chapter 2 
Table S1.  In vitro anticancer activity (%) of Kupchan subextracts (KH, KC, KM) and SPE fractions against cancer cell lines (A-375, A-549, HT-29, HCT-116, MB-231) and non-cancerous HaCaT cell line. 
 Cell growth inhibition (%) 
 A-375 (100 μg/ml) A-549 (100 μg/ml) HT-29 (100 μg/ml) HCT-116 (100 μg/ml) MB-231 (100 μg/ml) HaCaT (100 μg/ml) 
KH 31 0 29 0 0 31 KC 98 99 99 76 99 66 KM 0 0 0 0 0 0 KC Fr.0 0 0 0 0 0 0 KC Fr.1 0 0 0 0 0 0 KC Fr.2 0 0 0 0 0 0 KC Fr.3 0 0 0 0 0 0 KC Fr.4 0 0 0 0 0 0 KC Fr.5 85 54 99 0 63 44 KC Fr.6 99 99 99 99 99 99 KC Fr.7 99 99 99 99 99 99 KC Fr.8 43 0 0 0 0 0 KC Fr.9 0 0 0 0 0 0 KC Fr.10 0 0 0 0 0 0 
              Table S2. The Δδ(δS-δR) data for the S- and R-MTPA esters 6–9 in 1H NMR (CDCl3, 500 MHz). 
 6 (S) 7 (R) ΔδS-R 8 (S) 9 (R) ΔδS-R 
C δH, mult (J in Hz) δH, mult (J in Hz)  δH, mult (J in Hz) δH, mult (J in Hz) 
13 3.39, m 3.35, dd (11.5, 9.5) 0.04 3.27, dd (11.3, 9.7) 3.28, dd (11.4, 9.4) -0.01 14 5.92, dd (15.5, 9.5) 5.84, dd (15.4, 9.8) 0.08 6.09, dd (14.8, 9.7) 6.10, dd (15.3, 9.7) -0.01 15 5.65, dd (15.5, 6.4) 5.58, dd (15.4, 6.4) 0.07 5.39, dd (14.9, 7.8) 5.52, dd (15.3, 7.6) -0.13 16 5.46, m 5.45, m 0.01 5.34, m 5.38, m -0.04 17 1.22, d (6.5) 1.30, d (6.5) -0.08 1.31, d (6.3) 1.27, d (6.5) 0.04   
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Table S3. The distance (Å) between protons H-5’, H-15 and H3-17 in the tetramic acid portion of the compounds 1-3. The red marking indicates the assigned 
relative stereochemistry based on measured the distances allowing observable NOE correlations (up to 4 Å) between relevant protons. 
Compd 2D Structure 3D model H-5’ orientation Distance 
H-5’/H-15 
NOE  
H-5’/H-15 
Distance 
H-5’/H3-17 
NOE 
H-5’/H3-17 
1 (5’-) 
  
β 2.96 Å YES 3.28 Å YES 
1 (5’-) 
  
α 4.83 Å  5.07 Å  
2 (5’-) 
  
β 2.88 Å  3.33 Å  
2 (5’-) 
  
α 5.14 Å NO 6.84 Å NO 
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3 (5’-) 
 
 
β 3.80 Å  5.11 Å  
3 (5’-) 
  
α 5.41 Å NO 6.77 Å NO 
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Figure S1. 1H NMR spectrum of compound 1 (600 MHz, CDCl3).  
 
  
Figure S2. 13C NMR spectrum of compound 1 (150 MHz, CDCl3). 
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Figure S3. DEPT-HSQC spectrum of compound 1 (600 MHz, CDCl3). 
 
Figure S4. COSY spectrum of compound 1 (600 MHz, CDCl3). 
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Figure S5. HMBC spectrum of compound 1 (600 MHz, CDCl3). 
 Figure S6. NOESY spectrum of compound 1 (600 MHz, CDCl3). 
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Figure S7. HR-ESIMS spectrum of compound 1. 
 
  
Figure S8. FT-IR spectrum of compound 1. 
 
 
Figure S9. 1H NMR spectrum of compound 2 (600 MHz, CDCl3). 
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Figure S10.  13C NMR spectrum of compound 2 (150 MHz, CDCl3). 
 Figure S11.  DEPT-HSQC spectrum of compound 2 (600 MHz, CDC
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Figure S12.  COSY spectrum of compound 2 (600 MHz, CDCl3). 
 Figure S13.  HMBC spectrum of compound 2 (600 MHz, CDCl3). 
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Figure S14.  NOESY spectrum of compound 2 (600 MHz, CDCl3). 
 Figure S15. HR-ESIMS spectrum of compound 2. 
 
 
Figure S16. FT-IR spectrum of compound 2. 
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Figure S17.  1H NMR spectrum of compound 3 (600 MHz, CDCl3). 
 
Figure S18.  13C NMR spectrum of compound 3 (150 MHz, CDCl3). 
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Figure S19.  DEPT-HSQC spectrum of compound 3 (600 MHz, CDCl3). 
 
Figure S20.  COSY spectrum of compound 3 (600 MHz, CDCl3). 
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Figure S21.  HMBC spectrum of compound 3 (600 MHz, CDCl3). 
 Figure S22.  NOESY spectrum of compound 3 (600 MHz, CDCl3). 
  
 
 
  APPENDIX 
213 
 
Figure S23. HR-ESIMS spectrum of compound 3. 
 
 
 
Figure S24. FT-IR spectrum of compound 3. 
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Figure S25.  1H NMR spectrum of 16-(S)-MTPA ester 6 (500 MHz, CDCl3). 
 
Figure S26.  1H NMR spectrum of 16-(R)-MTPA ester 7 (500 MHz, CDCl3). 
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Figure S27. 1H NMR spectrum of 16-(S)-MTPA ester 8 (500 MHz, CDCl3).  
 Figure S28. 1H NMR spectrum of 16-(R)-MTPA ester 9 (500 MHz, CDCl3). 
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Figure S29. Δδ(δS-δR) values (ppm) obtained from 16-MTPA esters (6 and 7) of compound 1. 
 
 
 
 
 
 
Figure S30. Δδ(δS-δR) values (ppm) obtained from 16-MTPA esters (8 and 9) of compound 2. 
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4. NMR spectra and DFT calculation tables of Chapter 3 
Figure S1. Molecular phylogenetic analysis of Pyrenochaetopsis sp. FVE-087 by maximum 
likelihood method 
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Figure S2. Structures of compounds 1, 3'-epi-1, and 5'-epi-1.  
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Figure S4. 1H NMR spectrum of compound 1 (600 MHz, CD3CN) 
 Figure S5. 13C NMR spectrum of compound 1 (150 MHz, CD3CN) 
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Figure S6. DEPT-HSQC spectrum of compound 1 (600 MHz, CD3CN). 
 Figure S7. COSY spectrum of compound 1 (600 MHz, CD3CN) 
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Figure S8. HMBC spectrum of compound 1 (600 MHz, CD3CN) 
 Figure S9. NOESY spectrum of compound 1 (600 MHz, CD3CN) 
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Figure S10. HR-ESIMS spectrum of compound 1. 
  
 
 
Figure S11. FT-IR spectrum of compound 1 
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Table S1. Cartesian coordinates, energies, population at 298 K, and calculated optical rotations 
of significantly populated conformers of compound 1. Conformers were optimized at the 
B3LYP/TZVP/SMD(ACN) level; optical rotation were calculated at the 
B3LYP/TZVP/SMD(MeOH) level. 
Conformer 1 Conformer 2 Conformer 3 Relative energy (kcal/mol) 0.00 Relative energy (kcal/mol) 0.65 Relative energy (kcal/mol) 0.74 Population (%) 38.7 Population (%) 13.0 Population (%) 11.1 Calcd. [α]D -98.0 Calcd. [α]D -152.0 Calcd. [α]D -60.4 C 0.37784 -1.20880 -0.98624 C 0.37737 -1.34617 -0.78471 C 0.35542 -1.14535 -1.01927 C 1.33882 -0.08551 -1.33146 C 1.37491 -0.30065 -1.27162 C 1.33359 -0.02559 -1.32422 C 0.45876 1.18190 -1.15193 C 0.56788 1.02286 -1.17951 C 0.48067 1.24912 -1.07753 C 1.24501 2.45527 -0.93746 C 1.41977 2.26895 -1.09615 C 1.29449 2.49540 -0.81247 C 2.53958 2.42724 -0.61405 C 2.72472 2.20334 -0.82419 C 2.59215 2.42770 -0.50819 C 3.35147 1.18120 -0.41803 C 3.48534 0.93837 -0.55724 C 3.38191 1.15875 -0.38199 C 4.32704 1.29607 0.76509 C 4.51929 1.10627 0.56884 C 4.37750 1.20042 0.78932 C 5.21728 0.05475 0.90231 C 5.35369 -0.16229 0.78398 C 5.24396 -0.06322 0.85540 C 4.35852 -1.21443 0.97161 C 4.43776 -1.37302 1.00300 C 4.36028 -1.31658 0.88309 C 3.35848 -1.31982 -0.18571 C 3.38476 -1.52863 -0.10000 C 3.34058 -1.35035 -0.26141 C 2.47423 -0.06913 -0.25011 C 2.55732 -0.24590 -0.24396 C 2.48191 -0.08034 -0.25754 C 1.86943 -0.24438 -2.75773 C 1.83571 -0.61807 -2.69606 C 1.84483 -0.12901 -2.76270 C -0.55980 0.83623 -0.01905 C -0.43369 0.83119 0.00427 C -0.53360 0.87107 0.04871 C -1.98247 1.41987 -0.18158 C -1.81931 1.49899 -0.16331 C -1.94702 1.48727 -0.06764 C -2.45554 2.27802 0.97645 C -2.21757 2.42274 0.97299 C -2.39456 2.27987 1.15445 C -3.77482 2.99401 0.74569 C -3.50296 3.19879 0.74446 C -3.81767 2.80414 1.09308 C -4.51511 3.42281 1.98304 C -4.22431 3.65889 1.98177 C -4.23732 3.57082 -0.13357 C 0.51531 3.75152 -1.15882 C 0.74028 3.57998 -1.38200 C 0.58697 3.81391 -0.96099 C 6.15879 0.16582 2.10008 C 6.35140 0.00623 1.92836 C 6.20706 -0.02508 2.04055 C -0.84124 -1.41805 1.24444 C -0.89885 -1.31350 1.40301 C -0.85371 -1.43353 1.20845 C -0.75917 -0.68759 -0.10454 C -0.73838 -0.67206 0.02261 C -0.76521 -0.64284 -0.10595 C -2.18283 -0.87773 -0.67354 C -2.16172 -0.79884 -0.57539 C -2.19456 -0.78054 -0.67527 C -2.80892 -2.07556 0.08954 C -2.85945 -1.92895 0.21799 C -2.84053 -1.99858 0.03727 C -2.88131 -3.41574 -0.65426 C -2.94460 -3.26561 -0.52439 C -2.94570 -3.30142 -0.76670 C -2.37211 -2.93405 2.43375 C -2.54761 -2.68736 2.61863 C -2.40826 -2.97090 2.33776 H -0.12109 1.30449 -2.07339 H -0.03405 1.09814 -2.09214 H -0.10452 1.42561 -1.98690 H 3.07329 3.36918 -0.50804 H 3.30456 3.12376 -0.81325 H 3.14495 3.35345 -0.36446 H 3.97157 1.04415 -1.31573 H 4.05524 0.69293 -1.46507 H 3.98576 1.05097 -1.29458 H 4.95028 2.18666 0.63544 H 5.17841 1.94799 0.33302 H 5.01669 2.08356 0.69002 H 3.75698 1.44097 1.69102 H 3.99978 1.36335 1.50027 H 3.82481 1.31404 1.73000 H 5.83037 -0.00954 -0.00608 H 5.92244 -0.34017 -0.13806 H 5.84074 -0.09894 -0.06535 H 5.00535 -2.09702 0.98169 H 5.04061 -2.28398 1.06915 H 4.98849 -2.21169 0.84363 H 2.75047 -2.21773 -0.05821 H 2.74056 -2.37921 0.12962 H 2.71567 -2.24031 -0.16344 H 3.90434 -1.43933 -1.12652 H 3.88378 -1.75770 -1.04665 H 3.86959 -1.43970 -1.21506 H 1.97802 0.02137 0.72247 H 2.11040 -0.04308 0.73627 H 1.99982 -0.02327 0.72473 H -0.13990 1.10696 0.94886 H 0.03535 1.13788 0.93867 H -0.09989 1.08856 1.02385 H -2.06179 1.98174 -1.11336 H -1.87302 2.03912 -1.10999 H -2.01649 2.10286 -0.96658 H -2.51088 1.68464 1.89221 H -2.27928 1.86723 1.91159 H -2.29231 1.67150 2.05402 H -1.71996 3.06696 1.17065 H -1.43670 3.17899 1.11597 H -1.73835 3.15047 1.25686 H -3.83546 -1.80564 0.35429 H -3.87411 -1.60745 0.47296 H -3.85966 -1.72039 0.32126 H 3.80935 -1.21881 1.92105 H 3.93099 -1.26313 1.96969 H 3.82600 -1.35190 1.84033 H -3.53414 -4.08251 -0.08734 H -1.96150 -3.56818 -0.88199 H -3.60765 -3.97995 -0.22496 H -3.36820 -3.24042 -1.62118 H -3.32557 -4.04035 0.14355 H -3.43720 -3.07330 -1.72033 H -3.06706 -0.99854 -2.39789 H -2.88286 -1.56220 -2.20896 H -3.09080 -0.83832 -2.39739 H -0.95802 -3.48604 -1.11486 H -4.70422 -3.08324 -1.39746 H -1.02698 -3.38904 -1.24375 H 2.43069 -1.17081 -2.87490 H 0.97986 -0.64703 -3.37356 H 1.00842 -0.10117 -3.46401 H 1.04130 -0.26202 -3.46914 H 2.52603 0.14149 -3.06432 H 2.50812 0.70257 -3.00120 H 2.52197 0.58669 -3.02585 H 2.33441 -1.58561 -2.74710 H 2.38910 -1.05817 -2.92803 H -3.83573 3.90313 2.69138 H -3.52488 4.11319 2.68792 H -5.18898 4.06871 0.04471 H -4.91523 2.53372 2.48053 H -4.65775 2.78704 2.48192 H -4.35030 2.88327 -0.97655 H -5.33387 4.09463 1.73058 H -5.01626 4.36228 1.72972 H -3.47692 4.30207 -0.41604 H -0.31954 3.87513 -0.46380 H -0.05128 3.79501 -0.65889 H -0.23523 3.91801 -0.24803 H 1.18373 4.60464 -1.03296 H 1.45250 4.40608 -1.35284 H 1.27290 4.64762 -0.80350 H 0.09087 3.79356 -2.16719 H 0.26689 3.56909 -2.36911 H 0.14977 3.91289 -1.95989 H 6.81545 -0.70566 2.16988 H 7.02337 0.84994 1.74895 H 6.84595 -0.91221 2.06047 H 5.59588 0.23366 3.03606 H 6.96685 -0.88900 2.05237 H 5.66090 0.01255 2.98809 H 6.79153 1.05456 2.02724 H 5.83438 0.18793 2.87559 H 6.85743 0.85275 1.99630 H -3.41590 -2.73956 2.68660 H -1.84470 -2.51324 3.42958 H -1.77118 -2.75145 3.19127 H -2.25282 -3.99943 2.22405 H -3.52620 -2.28894 2.89689 H -3.44803 -2.77013 2.60175 H -1.74127 -2.66826 3.27866 H -2.64013 -3.76216 2.45426 H -2.30664 -4.02813 2.08241 N -1.98783 -2.12896 1.29210 N -2.05679 -2.01472 1.43059 N -2.01361 -2.12362 1.23048 O 0.47161 -2.35688 -1.36631 O 0.43925 -2.53561 -0.98741 O 0.42465 -2.27738 -1.44897 O -2.87210 0.27548 -0.26463 O -2.77919 0.41487 -0.20496 O -2.85904 0.36860 -0.20966 O -4.19404 3.23058 -0.37004 O -3.90959 3.45683 -0.37123 O -4.58024 2.63000 2.02411 O 0.00013 -1.34143 2.12953 O -0.10148 -1.20589 2.32405 O -0.00527 -1.41430 2.08956 
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O -2.15440 -1.00219 -2.07051 O -2.14733 -0.97330 -1.96157 O -2.17621 -0.84004 -2.07525 O -1.65110 -4.09637 -0.80252 O -3.78253 -3.14652 -1.68401 O -1.73110 -3.99924 -0.95714             Conformer 4 Conformer 5 Conformer 6 Relative energy (kcal/mol) 0.76 Relative energy (kcal/mol) 0.92 Relative energy (kcal/mol) 0.98 Population (%) 10.8 Population (%) 8.2 Population (%) 7.5 Calcd. [α]D -111.8 Calcd. [α]D -134.2 Calcd. [α]D -102.5 C 0.37220 -1.29118 -0.80190 C 0.37633 -1.34379 -0.79126 C 0.38064 -1.20497 -0.99324 C 1.33991 -0.21319 -1.25885 C 1.37416 -0.29718 -1.27527 C 1.34843 -0.08390 -1.33319 C 0.48420 1.08014 -1.16423 C 0.56767 1.02622 -1.17922 C 0.47186 1.18668 -1.15649 C 1.29087 2.35354 -1.05048 C 1.42012 2.27176 -1.09312 C 1.25791 2.45719 -0.92672 C 2.59371 2.32923 -0.76237 C 2.72497 2.20493 -0.82089 C 2.55137 2.42491 -0.59955 C 3.39466 1.08826 -0.50145 C 3.48498 0.93906 -0.55660 C 3.36094 1.17619 -0.41056 C 4.40955 1.27879 0.63831 C 4.51791 1.10351 0.57093 C 4.33542 1.28413 0.77417 C 5.28407 0.03706 0.84947 C 5.35192 -0.16581 0.78324 C 5.22144 0.03963 0.90926 C 4.40689 -1.20519 1.04853 C 4.43567 -1.37717 0.99750 C 4.35831 -1.22673 0.97454 C 3.37229 -1.38640 -0.06797 C 3.38357 -1.52918 -0.10686 C 3.36027 -1.32610 -0.18499 C 2.50487 -0.13033 -0.21097 C 2.55646 -0.24587 -0.24729 C 2.48015 -0.07246 -0.24847 C 1.83215 -0.49741 -2.68043 C 1.83496 -0.61065 -2.70054 C 1.88338 -0.24270 -2.75793 C -0.53206 0.83492 -0.00365 C -0.43333 0.83170 0.00460 C -0.55815 0.84018 -0.03459 C -1.93709 1.45110 -0.19166 C -1.81883 1.50014 -0.16106 C -1.97626 1.42854 -0.20252 C -2.39233 2.34883 0.94340 C -2.21588 2.42390 0.97570 C -2.46537 2.24758 0.97715 C -3.70166 3.07816 0.69693 C -3.49994 3.20215 0.74656 C -3.77677 2.97894 0.74901 C -4.44859 3.52257 1.92469 C -4.22431 3.65848 1.98344 C -4.53642 3.36813 1.98751 C 0.57016 3.64397 -1.32889 C 0.74144 3.58367 -1.37676 C 0.52664 3.75534 -1.13056 C 6.26489 0.22773 2.00489 C 6.34818 -0.00084 1.92940 C 6.16182 0.14475 2.10848 C -0.90867 -1.35683 1.35898 C -0.89337 -1.31702 1.39904 C -0.85011 -1.39406 1.23357 C -0.77744 -0.67894 -0.00522 C -0.73821 -0.67167 0.01993 C -0.76168 -0.68032 -0.12467 C -2.20779 -0.85370 -0.61255 C -2.16347 -0.79746 -0.57348 C -2.19354 -0.88632 -0.70641 C -2.86520 -2.02289 0.17413 C -2.86159 -1.92538 0.22421 C -2.81703 -2.06006 0.08716 C -3.05784 -3.32799 -0.60523 C -2.96150 -3.25846 -0.51073 C -2.88395 -3.42301 -0.61527 C -2.45441 -2.87013 2.52651 C -2.53205 -2.70018 2.61694 C -2.40109 -2.86178 2.45358 H -0.10216 1.14595 -2.08749 H -0.03476 1.10415 -2.09133 H -0.09767 1.31862 -2.08459 H 3.14109 3.26879 -0.73234 H 3.30524 3.12505 -0.80785 H 3.08458 3.36553 -0.48035 H 3.98252 0.87260 -1.40525 H 4.05567 0.69600 -1.46459 H 3.98140 1.04195 -1.30839 H 5.04179 2.14492 0.41809 H 5.17744 1.94578 0.33819 H 4.96162 2.17315 0.64802 H 3.87139 1.50811 1.56635 H 3.99754 1.35802 1.50259 H 3.76453 1.42814 1.69973 H 5.86690 -0.11287 -0.06870 H 5.92180 -0.34092 -0.13863 H 5.83542 -0.02454 0.00146 H 5.03862 -2.09635 1.11369 H 5.03842 -2.28838 1.06129 H 5.00206 -2.11158 0.98390 H 2.75455 -2.25990 0.14843 H 2.73907 -2.38039 0.11962 H 2.74888 -2.22222 -0.06087 H 3.88940 -1.59116 -1.01032 H 3.88325 -1.75533 -1.05388 H 3.90785 -1.44536 -1.12482 H 2.03693 0.04805 0.76395 H 2.10939 -0.04594 0.73343 H 1.98106 0.01687 0.72273 H -0.09518 1.14829 0.94403 H 0.03613 1.13628 0.93948 H -0.14376 1.10774 0.93644 H -1.99734 1.99335 -1.13628 H -1.87324 2.04058 -1.10755 H -2.03972 2.02739 -1.11281 H -2.45040 1.78391 1.87669 H -2.27892 1.86784 1.91385 H -2.53838 1.62338 1.87084 H -1.64325 3.13225 1.10706 H -1.43396 3.17891 1.11930 H -1.72864 3.02559 1.20889 H -3.85919 -1.70114 0.49795 H -3.87331 -1.60026 0.48218 H -3.84536 -1.77967 0.33217 H 3.88599 -1.12040 2.01016 H 3.92804 -1.27035 1.96407 H 3.80738 -1.23117 1.92296 H -3.24122 -4.14388 0.09872 H -1.98316 -3.56440 -0.88787 H -3.52438 -4.07696 -0.01999 H -3.94508 -3.22852 -1.23054 H -3.33477 -4.02740 0.16956 H -3.37468 -3.27884 -1.58290 H -2.06139 -1.92684 -2.21866 H -2.89700 -1.55459 -2.20296 H -2.05193 -0.35024 -2.57399 H -1.13036 -3.56895 -1.05014 H -3.90497 -3.85524 -2.13640 H -0.96622 -3.49256 -1.09899 H 2.48950 0.29834 -3.03154 H 2.52593 0.14946 -3.06644 H 1.05786 -0.25777 -3.47267 H 2.37688 -1.43945 -2.73456 H 2.33296 -1.57841 -2.75438 H 2.53873 0.58706 -3.02328 H 0.98631 -0.55870 -3.36824 H 0.97918 -0.63689 -3.37828 H 2.44252 -1.17045 -2.87434 H -5.26075 4.19792 1.66061 H -4.65897 2.78515 2.47991 H -4.94783 2.46442 2.44804 H -3.77078 4.00438 2.63367 H -5.01556 4.36275 1.73165 H -5.34836 4.05164 1.74459 H -4.85801 2.64051 2.42711 H -3.52646 4.11056 2.69261 H -3.86710 3.82137 2.72286 H 1.25430 4.49273 -1.28434 H -0.05038 3.79776 -0.65367 H -0.30926 3.86652 -0.43436 H 0.10630 3.62799 -2.32038 H 1.45406 4.40937 -1.34570 H 1.19356 4.60743 -0.99082 H -0.23420 3.82497 -0.61064 H 0.26852 3.57488 -2.36412 H 0.10342 3.81222 -2.13874 H 6.90944 1.09541 1.83986 H 6.96338 -0.89650 2.05152 H 5.59793 0.21228 3.04390 H 6.90919 -0.64735 2.12593 H 5.82995 0.17807 2.87650 H 6.79763 1.03154 2.03853 H 5.73344 0.38241 2.94891 H 7.02048 0.84333 1.75341 H 6.81545 -0.72909 2.17706 H -2.63623 -3.91945 2.29265 H -1.86004 -2.47507 3.44155 H -3.45459 -2.68338 2.67488 H -1.68255 -2.80573 3.28903 H -3.53759 -2.35316 2.86464 H -2.25313 -3.93026 2.28032 H -3.37913 -2.43094 2.91074 H -2.56011 -3.78114 2.46836 H -1.79723 -2.55641 3.30487 N -2.00520 -2.14977 1.34966 N -2.05207 -2.01650 1.43070 N -2.00850 -2.08193 1.29734 O 0.48061 -2.47961 -1.02570 O 0.43789 -2.53252 -0.99784 O 0.46947 -2.35182 -1.37882 O -2.85618 0.33009 -0.25689 O -2.77924 0.41673 -0.20180 O -2.87086 0.29328 -0.35009 O -4.10678 3.31339 -0.42420 O -3.90286 3.46488 -0.36937 O -4.17385 3.25838 -0.36490 O -0.13103 -1.21252 2.29168 O -0.09167 -1.21365 2.31674 O -0.00581 -1.31619 2.11586 O -2.26024 -0.99411 -2.00757 O -2.15383 -0.97380 -1.95920 O -2.29130 -1.14870 -2.07984 O -1.99073 -3.66369 -1.49627 O -3.88953 -3.05829 -1.59046 O -1.64556 -4.09589 -0.74690             Conformer 7 Conformer 8 Conformer 9 Relative energy (kcal/mol) 1.33 Relative energy (kcal/mol) 1.46 Relative energy (kcal/mol) 1.71 
  APPENDIX 
225 
 
Population (%) 4.1 Population (%) 3.3 Population (%) 2.2 Calcd. [α]D -76.9 Calcd. [α]D -96.3 Calcd. [α]D -59.0 C 0.34991 -1.22227 -0.87249 C 0.36284 -1.28187 -0.84506 C 0.36200 -1.15414 -1.00456 C 1.32822 -0.13394 -1.27793 C 1.36952 -0.22429 -1.28392 C 1.35317 -0.04510 -1.31565 C 0.49317 1.16400 -1.09939 C 0.58086 1.10254 -1.11377 C 0.51058 1.24033 -1.08720 C 1.32193 2.41638 -0.92508 C 1.45091 2.33103 -0.97296 C 1.32837 2.48155 -0.81260 C 2.62603 2.35551 -0.64834 C 2.75661 2.23362 -0.71443 C 2.62497 2.40668 -0.50603 C 3.40860 1.08967 -0.46158 C 3.50180 0.94646 -0.51996 C 3.40719 1.13306 -0.37872 C 4.43156 1.19827 0.68157 C 4.54526 1.03913 0.60591 C 4.40487 1.17538 0.79081 C 5.28812 -0.06677 0.81431 C 5.36445 -0.24991 0.74370 C 5.26043 -0.09487 0.86723 C 4.39336 -1.30570 0.94471 C 4.43421 -1.45896 0.90378 C 4.36538 -1.33962 0.90850 C 3.34951 -1.40515 -0.17359 C 3.37059 -1.54035 -0.19708 C 3.34581 -1.37569 -0.23594 C 2.50116 -0.12984 -0.23622 C 2.55981 -0.24083 -0.26439 C 2.49785 -0.09850 -0.24543 C 1.80487 -0.34202 -2.71749 C 1.81575 -0.46936 -2.72707 C 1.86851 -0.16846 -2.75145 C -0.50946 0.86759 0.06139 C -0.41108 0.85987 0.06881 C -0.52211 0.87915 0.02664 C -1.91073 1.50678 -0.06800 C -1.79067 1.55068 -0.04386 C -1.92338 1.51393 -0.10097 C -2.33570 2.34252 1.13278 C -2.16531 2.40233 1.16331 C -2.39893 2.22838 1.15911 C -3.75116 2.88689 1.07012 C -3.56338 2.99101 1.12585 C -3.81751 2.76410 1.09451 C -4.17806 3.60898 -0.18070 C -3.99101 3.72313 -0.11900 C -4.19300 3.63117 -0.07849 C 0.62108 3.73118 -1.13001 C 0.78849 3.66405 -1.18815 C 0.62198 3.80264 -0.94363 C 6.27697 0.04095 1.97358 C 6.37340 -0.15761 1.88691 C 6.22601 -0.05351 2.05023 C -0.88025 -1.39283 1.31019 C -0.88918 -1.35085 1.35643 C -0.89938 -1.38929 1.20447 C -0.77426 -0.64137 -0.01725 C -0.73582 -0.63852 0.01035 C -0.77156 -0.62879 -0.12456 C -2.21766 -0.77108 -0.60285 C -2.16541 -0.71922 -0.57997 C -2.19885 -0.76980 -0.73598 C -2.87422 -1.96889 0.14026 C -2.87349 -1.87491 0.16764 C -2.87305 -1.94599 0.01261 C -3.10760 -3.22886 -0.69929 C -2.99465 -3.17055 -0.62891 C -2.97380 -3.28277 -0.73486 C -2.41159 -2.95945 2.42633 C -2.53593 -2.77332 2.51625 C -2.51940 -2.83567 2.35825 H -0.10425 1.29031 -2.00928 H -0.02828 1.23408 -2.01528 H -0.05803 1.42263 -2.00744 H 3.18882 3.28327 -0.57234 H 3.34911 3.14440 -0.66089 H 3.18053 3.32931 -0.35345 H 3.98902 0.91697 -1.37929 H 4.06279 0.74264 -1.44349 H 4.00821 1.01632 -1.29195 H 5.07600 2.06615 0.50875 H 5.21368 1.88416 0.41176 H 5.05129 2.05223 0.68309 H 3.90151 1.38076 1.62448 H 4.03569 1.25067 1.55408 H 3.85442 1.30186 1.73117 H 5.86432 -0.17075 -0.11434 H 5.92336 -0.38391 -0.19168 H 5.85512 -0.14484 -0.05421 H 5.01196 -2.20833 0.95278 H 5.02529 -2.37990 0.91483 H 4.98512 -2.24095 0.87847 H 2.71979 -2.28052 -0.00430 H 2.71653 -2.39337 -0.00808 H 2.71279 -2.25889 -0.12956 H 3.85739 -1.56187 -1.13009 H 3.85891 -1.72440 -1.15901 H 3.87465 -1.47923 -1.18822 H 2.04213 -0.00194 0.75069 H 2.12318 -0.08593 0.72909 H 2.01370 -0.02853 0.73503 H -0.05609 1.12585 1.01778 H 0.07029 1.11168 1.01311 H -0.09334 1.09494 1.00420 H -1.97337 2.09884 -0.98307 H -1.83902 2.14839 -0.95654 H -1.95776 2.19439 -0.95406 H -2.23256 1.76242 2.05084 H -2.06461 1.82055 2.08060 H -2.32307 1.56204 2.01939 H -1.66470 3.20560 1.19916 H -1.46518 3.24320 1.21564 H -1.73821 3.08503 1.33063 H -3.85443 -1.64979 0.50586 H -3.87901 -1.54922 0.44787 H -3.89497 -1.63955 0.25261 H 3.87915 -1.27062 1.91298 H 3.93651 -1.39563 1.87928 H 3.83080 -1.35974 1.86603 H -3.29170 -4.07549 -0.03283 H -2.02072 -3.47557 -1.01797 H -3.64143 -3.93513 -0.16849 H -4.00574 -3.08224 -1.29924 H -3.38308 -3.96308 0.01472 H -3.44805 -3.09221 -1.70261 H -2.12157 -1.76595 -2.26199 H -2.91107 -1.39830 -2.23740 H -2.00303 -0.18787 -2.58432 H -1.19422 -3.47611 -1.19879 H -3.94536 -3.67719 -2.28117 H -1.05314 -3.39782 -1.19867 H 2.33529 -1.28697 -2.83040 H 2.30445 -1.43740 -2.83398 H 1.03495 -0.14193 -3.45644 H 0.95278 -0.35164 -3.40027 H 0.95445 -0.45388 -3.39809 H 2.53896 0.65526 -2.99709 H 2.47128 0.46312 -3.02762 H 2.51068 0.30243 -3.05940 H 2.40564 -1.10374 -2.90471 H -4.31704 2.88821 -0.99144 H -3.21091 4.40964 -0.45522 H -3.41952 4.37622 -0.27683 H -3.41012 4.31384 -0.50653 H -4.91537 4.26759 0.06661 H -5.14688 4.12126 0.10926 H -5.11789 4.13082 -0.00829 H -4.15789 3.00617 -0.92770 H -4.28369 3.01452 -0.97721 H -0.17780 3.88530 -0.39955 H 0.00292 3.85237 -0.45120 H 1.31024 4.63344 -0.78132 H 1.31868 4.56546 -1.04225 H 1.51201 4.47791 -1.11997 H 0.17795 3.91377 -1.93818 H 0.15415 3.77626 -2.11923 H 0.31149 3.71007 -2.17255 H -0.19502 3.89900 -0.22290 H 6.93477 0.90637 1.85577 H 7.05565 0.68549 1.74802 H 6.88422 0.81790 1.99585 H 6.90750 -0.84985 2.04030 H 6.97727 -1.06651 1.95654 H 6.85688 -0.94613 2.07799 H 5.75212 0.14905 2.92770 H 5.86642 -0.02101 2.84704 H 5.68203 -0.00125 2.99832 H -3.36026 -2.58115 2.81575 H -2.55954 -3.84673 2.31905 H -1.92225 -2.57311 3.22836 H -2.53839 -4.00701 2.15031 H -1.86572 -2.58282 3.35100 H -3.57080 -2.63162 2.56631 H -1.65109 -2.88709 3.19956 H -3.54287 -2.44122 2.77757 H -2.39987 -3.90265 2.15621 N -1.98783 -2.16944 1.28526 N -2.05754 -2.03446 1.36267 N -2.08356 -2.03408 1.23243 O 0.43244 -2.39593 -1.17116 O 0.40575 -2.45875 -1.11371 O 0.42660 -2.29217 -1.41920 O -2.84447 0.40350 -0.17810 O -2.76413 0.48513 -0.14577 O -2.84567 0.42447 -0.36307 O -4.50172 2.76341 2.01893 O -4.30001 2.89372 2.08873 O -4.61178 2.51776 1.98162 O -0.07500 -1.31239 2.22687 O -0.07842 -1.30531 2.27070 O -0.06135 -1.37474 2.09576 O -2.29994 -0.84149 -2.00105 O -2.16825 -0.82600 -1.97178 O -2.28232 -0.98935 -2.11672 O -2.06549 -3.53692 -1.62906 O -3.91627 -2.90553 -1.70047 O -1.75552 -3.98990 -0.87465             Conformer 10   Relative energy (kcal/mol) 2.05     Population (%) 1.2     Calcd. [α]D -140.5     C 0.38068 -1.34104 -0.80083         C 1.37588 -0.28871 -1.27685         C 0.56395 1.03100 -1.18390         
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C 1.41015 2.28011 -1.08607         C 2.71397 2.21764 -0.80838         C 3.47835 0.95400 -0.54624         C 4.50676 1.11947 0.58529         C 5.34438 -0.14739 0.79778         C 4.43148 -1.36214 1.00680         C 3.38408 -1.51592 -0.10176         C 2.55327 -0.23511 -0.24299         C 1.84450 -0.59799 -2.70059         C -0.44310 0.82974 -0.00706         C -1.82520 1.49747 -0.17543         C -2.24553 2.39134 0.97507         C -3.53455 3.16170 0.74606         C -4.25403 3.62373 1.98322         C 0.72546 3.59054 -1.36192         C 6.33629 0.01878 1.94752         C -0.89815 -1.30730 1.39884         C -0.74083 -0.67707 0.01141         C -2.16569 -0.80464 -0.57634         C -2.85428 -1.94084 0.21323         C -2.86829 -3.30386 -0.48972         C -2.55569 -2.64682 2.63695         H -0.03171 1.10983 -2.10036         H 3.28966 3.14044 -0.78708         H 4.05280 0.71586 -1.45309         H 5.16404 1.96456 0.35652         H 3.98226 1.37014 1.51566         H 5.91783 -0.31882 -0.12256         H 5.03693 -2.27148 1.07118         H 2.74178 -2.36973 0.12119         H 3.88808 -1.73887 -1.04720         H 2.10132 -0.03872 0.73616         H 0.02138 1.13365 0.93036         H -1.87607 2.05541 -1.11088         H -2.31332 1.81709 1.90191         H -1.47133 3.14952 1.14151         H -3.88482 -1.65146 0.43541         H 3.91994 -1.25864 1.97165         H -1.85744 -3.56672 -0.81367         H -3.20186 -4.05923 0.22237         H -2.83653 -0.41480 -2.35133         H -3.43412 -2.75082 -2.25281         H 2.53187 0.16729 -3.06233         H 2.34904 -1.56231 -2.75352         H 0.99164 -0.62894 -3.38177         H -3.55417 4.07882 2.68832         H -4.68745 2.75249 2.48446         H -5.04624 4.32658 1.73061         H -0.06756 3.79600 -0.63738         H 1.43418 4.41925 -1.32457         H 0.25325 3.58646 -2.34965         H 6.95410 -0.87504 2.06993         H 5.81437 0.19412 2.89326         H 7.00630 0.86555 1.77531         H -2.51597 -3.73270 2.53036         H -1.93213 -2.35354 3.47822         H -3.58823 -2.35069 2.83130         N -2.07184 -1.97695 1.44454         O 0.44701 -2.52764 -1.01545         O -2.78733 0.40455 -0.25755         O -3.94482 3.41158 -0.37007         O -0.08968 -1.20399 2.31113         O -2.16626 -1.01045 -1.98308         O -3.78795 -3.34180 -1.57421                     Table S2. Cartesian coordinates, energies, and population at 298 K of significantly populated 
conformers of compound 5'-epi-1. Conformers were optimized at the B3LYP/TZVP/SMD(ACN) 
level. 
Conformer 1 Conformer 2 Conformer 3 Relative energy (kcal/mol) 0.00 Relative energy (kcal/mol) 0.05 Relative energy (kcal/mol) 0.32 Population (%) 22.7 Population (%) 22.0 Population (%) 13.1 C -0.57638 -1.28034 1.10568 C -0.57215 -1.20718 1.13624 C -0.56244 -1.10536 1.25696 C -1.54097 -0.12372 1.34556 C -1.54821 -0.05054 1.32877 C -1.54621 0.04987 1.36668 C -0.65721 1.12854 1.09419 C -0.68628 1.20025 1.00447 C -0.67292 1.27833 0.98842 
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C -1.43090 2.38102 0.75084 C -1.47824 2.41699 0.58184 C -1.45753 2.47382 0.49787 C -2.71846 2.33053 0.40342 C -2.77033 2.33067 0.25950 C -2.74208 2.37014 0.15099 C -3.53159 1.07468 0.29540 C -3.57068 1.06246 0.24594 C -3.54213 1.10135 0.18235 C -4.48502 1.09868 -0.91118 C -4.54886 1.00609 -0.93969 C -4.49178 0.97930 -1.02112 C -5.37641 -0.14774 -0.97001 C -5.42314 -0.25318 -0.91122 C -5.36565 -0.27863 -0.94331 C -4.52026 -1.41948 -0.92411 C -4.54650 -1.50787 -0.81545 C -4.49142 -1.52569 -0.76053 C -3.54429 -1.43624 0.25808 C -3.54892 -1.44702 0.34661 C -3.51938 -1.40074 0.41803 C -2.65547 -0.18708 0.24454 C -2.67800 -0.18857 0.25006 C -2.64992 -0.14627 0.27242 C -2.10257 -0.17825 2.76813 C -2.08945 -0.03924 2.76078 C -2.11443 0.14215 2.78429 C 0.40101 0.69782 0.02779 C 0.38326 0.72861 -0.03196 C 0.40022 0.75082 -0.01803 C 1.80684 1.32449 0.17331 C 1.77842 1.38115 0.08765 C 1.81042 1.36680 0.10596 C 2.32058 2.02183 -1.07118 C 2.32417 1.92616 -1.23604 C 2.37901 1.87956 -1.22155 C 3.61355 2.79724 -0.88957 C 3.74167 2.44193 -1.08556 C 3.80671 2.36395 -1.06809 C 4.34710 3.15388 -2.15353 C 3.91632 3.90208 -0.78576 C 4.01502 3.82353 -0.79104 C -0.69680 3.68859 0.86906 C -0.75465 3.73590 0.58167 C -0.73227 3.79074 0.45725 C -6.29369 -0.12770 -2.19143 C -6.36653 -0.31248 -2.11122 C -6.28265 -0.40449 -2.15850 C 0.82057 -1.68712 -0.95854 C 0.84782 -1.69549 -0.89116 C 0.73218 -1.70156 -0.83447 C 0.62115 -0.79887 0.27383 C 0.62722 -0.74986 0.29200 C 0.60183 -0.72627 0.33842 C 1.98632 -0.89175 0.98008 C 1.98288 -0.78571 1.02502 C 1.98914 -0.80979 1.03237 C 2.62397 -2.20902 0.48507 C 2.69150 -2.07511 0.55019 C 2.64526 -2.10940 0.50691 C 4.14963 -2.20656 0.36214 C 4.21317 -1.97486 0.35926 C 4.15529 -2.02481 0.23061 C 2.31487 -3.50492 -1.68359 C 2.38812 -3.50528 -1.52865 C 2.19936 -3.54601 -1.53757 H -0.10773 1.32678 2.02098 H -0.14501 1.46451 1.91985 H -0.13797 1.58497 1.89441 H -3.24399 3.26172 0.20303 H -3.30701 3.24074 0.00037 H -3.27375 3.26621 -0.16168 H -4.16859 1.01145 1.18948 H -4.18798 1.04382 1.15565 H -4.18103 1.12938 1.07685 H -5.10766 1.99786 -0.86328 H -5.18281 1.89854 -0.92843 H -5.12684 1.86952 -1.07300 H -3.89698 1.17052 -1.83452 H -3.98073 1.03410 -1.87774 H -3.90219 0.95725 -1.94594 H -6.00785 -0.14118 -0.07193 H -6.03520 -0.20675 -0.00099 H -5.99732 -0.18362 -0.05044 H -5.16934 -2.29942 -0.87954 H -5.18050 -2.39372 -0.71114 H -5.12795 -2.40502 -0.62222 H -2.93732 -2.34236 0.21580 H -2.92987 -2.34565 0.34231 H -2.89759 -2.29674 0.47300 H -4.11048 -1.47956 1.19357 H -4.09771 -1.44703 1.29339 H -4.08784 -1.35380 1.35188 H -2.14064 -0.17196 -0.72320 H -2.17767 -0.21928 -0.72518 H -2.12708 -0.23006 -0.68714 H 0.00574 0.86388 -0.97375 H -0.00782 0.83976 -1.04259 H 0.02849 0.85171 -1.03674 H 1.83953 2.00974 1.02054 H 1.77314 2.17333 0.83871 H 1.81934 2.16994 0.84555 H 2.42883 1.31126 -1.89486 H 2.31812 1.12830 -1.98051 H 2.35910 1.07113 -1.95439 H 1.57662 2.75436 -1.40476 H 1.66522 2.72931 -1.56897 H 1.74167 2.69296 -1.57121 H 2.36840 -2.99185 1.20732 H 2.52053 -2.84922 1.30617 H 2.51543 -2.89078 1.26536 H -3.95222 -1.49768 -1.85927 H -3.99535 -1.62741 -1.75632 H -3.91983 -1.69539 -1.68116 H 4.56408 -1.94504 1.34478 H 4.64127 -1.55518 1.27834 H 4.63310 -1.60114 1.12102 H 4.48990 -3.21747 0.13481 H 4.60967 -2.98699 0.26254 H 4.53552 -3.04182 0.11878 H 2.74024 -0.81258 2.76862 H 2.69281 -0.69453 2.83144 H 1.57539 -1.55653 2.79331 H 4.26461 -0.49320 -0.51859 H 4.42150 -0.33169 -0.71330 H 4.40899 -0.37626 -0.83184 H -2.65535 -1.10090 2.94286 H -2.76444 0.80259 2.91812 H -2.66944 -0.75642 3.05186 H -1.29162 -0.13086 3.49775 H -2.62944 -0.95748 2.98985 H -1.30614 0.26398 3.50841 H -2.77118 0.66176 2.95853 H -1.26912 0.05362 3.47531 H -2.78204 0.99842 2.88377 H 4.78094 2.24377 -2.57955 H 3.27465 4.19750 0.04852 H 5.05779 4.03194 -0.55877 H 5.14120 3.87031 -1.94972 H 3.59035 4.48367 -1.65378 H 3.37166 4.14893 0.03068 H 3.65748 3.55553 -2.89979 H 4.95618 4.13229 -0.56101 H 3.71276 4.39759 -1.67260 H -1.35569 4.53006 0.64932 H -0.30835 3.94063 1.56007 H -0.32534 4.04550 1.44118 H -0.29465 3.82174 1.87867 H 0.06243 3.75134 -0.14555 H 0.11433 3.76635 -0.23496 H 0.15465 3.74275 0.18500 H -1.43280 4.55477 0.33670 H -1.39755 4.59631 0.14278 H -6.92536 0.76479 -2.19973 H -7.01223 0.56894 -2.15330 H -6.92764 0.47233 -2.26215 H -6.95125 -1.00117 -2.20749 H -7.01044 -1.19502 -2.06570 H -6.92701 -1.28429 -2.07907 H -5.71205 -0.13248 -3.11840 H -5.80492 -0.35885 -3.04929 H -5.70089 -0.50067 -3.08037 H 2.36816 -4.45790 -1.15177 H 2.49971 -4.41944 -0.94076 H 1.39154 -3.69623 -2.24958 H 1.56806 -3.57769 -2.47051 H 1.62521 -3.66082 -2.28763 H 3.12251 -3.34020 -2.08092 H 3.28707 -3.29505 -2.13204 H 3.33746 -3.27894 -2.01582 H 2.33071 -4.45582 -0.94705 N 1.92300 -2.44601 -0.77523 N 1.97067 -2.41203 -0.67403 N 1.85078 -2.43778 -0.67088 O -0.71023 -2.41586 1.49357 O -0.70175 -2.32840 1.56397 O -0.63132 -2.16538 1.83686 O 2.70371 0.21430 0.46908 O 2.67565 0.34132 0.54471 O 2.68100 0.31613 0.58776 O 4.01892 3.12915 0.20672 O 4.69406 1.68978 -1.19643 O 4.74199 1.58729 -1.15949 O 0.07534 -1.71141 -1.92869 O 0.09731 -1.79464 -1.85329 O -0.07095 -1.79799 -1.75362 O 1.85503 -0.81134 2.37267 O 1.81606 -0.71736 2.41829 O 1.97642 -0.74706 2.44358 O 4.66350 -1.36471 -0.65783 O 4.64377 -1.27383 -0.78985 O 4.52284 -1.33466 -0.94676             Conformer 4 Conformer 5 Conformer 6 Relative energy (kcal/mol) 0.36 Relative energy (kcal/mol) 0.58 Relative energy (kcal/mol) 0.59 Population (%) 12.4 Population (%) 8.5 Population (%) 8.4 C -0.57953 -1.23719 1.07885 C -0.58549 -1.28230 1.08274 C -0.56595 -1.15379 1.25033 C -1.55622 -0.08567 1.30800 C -1.55312 -0.12902 1.33582 C -1.53098 0.01320 1.38559 C -0.69838 1.17567 1.01220 C -0.67439 1.12940 1.09490 C -0.63038 1.23564 1.05151 C -1.49018 2.39775 0.60428 C -1.44764 2.37907 0.73972 C -1.39429 2.46452 0.61291 C -2.78519 2.31799 0.29259 C -2.73598 2.32671 0.39591 C -2.67654 2.39451 0.24887 C -3.58795 1.05172 0.26869 C -3.54938 1.07042 0.29617 C -3.49506 1.13761 0.21648 C -4.58150 1.02021 -0.90517 C -4.51016 1.09482 -0.90476 C -4.42828 1.07451 -1.00428 C -5.45437 -0.24008 -0.89417 C -5.39759 -0.15430 -0.96401 C -5.32369 -0.17064 -0.98290 C -4.57501 -1.49506 -0.83921 C -4.53647 -1.42281 -0.92831 C -4.47409 -1.43877 -0.82966 
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C -3.56425 -1.45996 0.31239 C -3.55573 -1.44099 0.24965 C -3.51606 -1.37074 0.36517 C -2.69526 -0.19869 0.23625 C -2.67063 -0.18905 0.23788 C -2.62468 -0.12686 0.27300 C -2.08469 -0.11313 2.74505 C -2.10959 -0.19792 2.76003 C -2.11288 0.07365 2.79882 C 0.38158 0.72821 -0.02458 C 0.39706 0.70679 0.03857 C 0.43297 0.72007 0.02640 C 1.77032 1.38242 0.11560 C 1.79768 1.33621 0.19483 C 1.86053 1.29320 0.17890 C 2.37230 1.83062 -1.22209 C 2.34490 1.96565 -1.07180 C 2.40784 1.97935 -1.05730 C 3.75892 2.41458 -1.04446 C 3.64084 2.73861 -0.89927 C 3.71642 2.72389 -0.85587 C 3.87036 3.90586 -0.92799 C 4.41777 3.00674 -2.15880 C 4.48542 3.04831 -2.10718 C -0.76181 3.71404 0.60140 C -0.70864 3.68597 0.83296 C -0.65694 3.77465 0.65797 C -6.41335 -0.27266 -2.08281 C -6.32130 -0.13241 -2.18055 C -6.22305 -0.23939 -2.21579 C 0.88319 -1.65951 -0.93261 C 0.83820 -1.64998 -0.97258 C 0.67457 -1.70805 -0.88936 C 0.63127 -0.75115 0.27295 C 0.62025 -0.78788 0.27534 C 0.59169 -0.77584 0.32473 C 1.97680 -0.80752 1.05336 C 1.98287 -0.90136 1.01202 C 1.99140 -0.93024 0.97538 C 2.71279 -2.05394 0.51927 C 2.63104 -2.19131 0.47383 C 2.54810 -2.27250 0.44728 C 4.23443 -1.90774 0.35705 C 4.15785 -2.16110 0.37501 C 4.06207 -2.31069 0.22490 C 2.46749 -3.41585 -1.60749 C 2.36389 -3.42606 -1.73186 C 2.05392 -3.59142 -1.66900 H -0.16867 1.43226 1.93838 H -0.14010 1.33766 2.03033 H -0.08820 1.49584 1.96744 H -3.32047 3.23207 0.04506 H -3.25964 3.25665 0.18533 H -3.19461 3.31187 -0.02216 H -4.19268 1.01612 1.18623 H -4.17993 1.00568 1.19460 H -4.14755 1.14261 1.10168 H -5.21560 1.91175 -0.86601 H -5.13536 1.99179 -0.85009 H -5.04816 1.97637 -1.03393 H -4.02535 1.06961 -1.84952 H -3.92747 1.17206 -1.83106 H -3.82538 1.07492 -1.92074 H -6.05445 -0.21560 0.02487 H -6.02425 -0.15405 -0.06258 H -5.96806 -0.09505 -0.09728 H -5.20619 -2.38441 -0.74846 H -5.18178 -2.30557 -0.88488 H -5.12811 -2.31040 -0.72965 H -2.94442 -2.35730 0.28059 H -2.94618 -2.34494 0.20181 H -2.90981 -2.27871 0.39690 H -4.10272 -1.48268 1.26478 H -4.11832 -1.48955 1.18703 H -4.09579 -1.34637 1.29293 H -2.20342 -0.20612 -0.74392 H -2.15858 -0.16830 -0.73137 H -2.09187 -0.18701 -0.68253 H -0.00439 0.85903 -1.03471 H 0.00827 0.87848 -0.96439 H 0.06749 0.86671 -0.98916 H 1.73701 2.23251 0.79895 H 1.81027 2.06991 1.00121 H 1.91657 1.96934 1.03261 H 2.43185 0.97435 -1.89601 H 2.46257 1.21522 -1.85783 H 2.51050 1.26603 -1.87935 H 1.70508 2.57654 -1.65597 H 1.61421 2.68834 -1.45359 H 1.68781 2.72970 -1.40210 H 2.55167 -2.86191 1.24072 H 2.37858 -2.99970 1.16828 H 2.32647 -3.04913 1.18914 H -4.03489 -1.59110 -1.78914 H -3.97226 -1.49440 -1.86632 H -3.89270 -1.58814 -1.74765 H 4.63069 -1.48529 1.28702 H 4.54712 -1.92617 1.37261 H 4.54070 -2.04573 1.17517 H 4.65907 -2.90828 0.25605 H 4.51830 -3.15685 0.11468 H 4.36259 -3.33141 -0.01385 H 1.68912 -0.06899 2.82938 H 1.77257 -0.10926 2.77928 H 1.59566 -1.60710 2.76652 H 4.51278 -0.22883 -0.66132 H 4.28712 -0.40604 -0.41726 H 4.19052 -0.60162 -0.66159 H -2.62703 -1.03493 2.95289 H -2.77692 0.64060 2.96141 H -2.68843 -0.82145 3.03288 H -1.25720 -0.04529 3.45457 H -2.66178 -1.12210 2.92783 H -1.31029 0.15696 3.53466 H -2.75349 0.72748 2.93274 H -1.29558 -0.15833 3.48704 H -2.76458 0.93954 2.91775 H 4.88644 4.20305 -0.67509 H 4.85789 2.06757 -2.50855 H 5.29207 3.74774 -1.89390 H 3.16898 4.28035 -0.17772 H 5.21058 3.73038 -1.97680 H 3.82197 3.45777 -2.87270 H 3.58037 4.35862 -1.88134 H 3.75629 3.36144 -2.95280 H 4.90608 2.12314 -2.51355 H -1.44254 4.53693 0.37829 H -0.29139 3.83110 1.83470 H -0.27001 3.97045 1.66332 H -0.29287 3.90926 1.57104 H 0.13258 3.72942 0.13494 H 0.20541 3.78180 -0.01444 H 0.03826 3.73295 -0.14467 H -1.36881 4.52607 0.61210 H -1.30853 4.60263 0.37459 H -5.86391 -0.29703 -3.02890 H -6.95635 0.75770 -2.18192 H -5.62815 -0.31367 -3.13127 H -7.06015 0.60885 -2.09632 H -6.97563 -1.00830 -2.19680 H -6.85184 0.65126 -2.29911 H -7.05596 -1.15668 -2.04914 H -5.74445 -0.13126 -3.11051 H -6.88295 -1.11035 -2.17692 H 3.42171 -3.15869 -2.06900 H 3.34048 -3.19546 -2.15999 H 1.25053 -3.65935 -2.39835 H 2.58383 -4.34672 -1.04717 H 2.41870 -4.39296 -1.22588 H 2.99634 -3.41786 -2.19051 H 1.72087 -3.55865 -2.38487 H 1.62920 -3.48336 -2.53125 H 2.12072 -4.53406 -1.12079 N 2.01806 -2.35774 -0.72558 N 1.94997 -2.39622 -0.80030 N 1.75763 -2.50392 -0.75758 O -0.71578 -2.37293 1.46475 O -0.72218 -2.42333 1.45357 O -0.63855 -2.21923 1.82046 O 2.63843 0.39028 0.71510 O 2.68825 0.24864 0.58740 O 2.71986 0.15079 0.46521 O 4.74010 1.69258 -0.98952 O 4.01500 3.13532 0.18652 O 4.10605 3.05774 0.24540 O 0.14592 -1.74381 -1.90673 O 0.10028 -1.66130 -1.94872 O -0.12812 -1.72497 -1.81266 O 1.90509 -0.93459 2.45163 O 1.95857 -0.98615 2.41158 O 2.03576 -0.83510 2.38045 O 4.66021 -1.18338 -0.77866 O 4.67293 -1.27360 -0.60634 O 4.52597 -1.49235 -0.83793             Conformer 7 Conformer 8 Conformer 9 Relative energy (kcal/mol) 1.04 Relative energy (kcal/mol) 1.06 Relative energy (kcal/mol) 1.12 Population (%) 3.9 Population (%) 3.8 Population (%) 3.4 C 0.53511 -1.31115 -1.01725 C 0.50115 -1.32546 -0.97172 C 0.50291 -1.32818 -0.96691 C 1.49303 -0.16839 -1.33745 C 1.47704 -0.20983 -1.33187 C 1.47711 -0.21184 -1.32970 C 0.62477 1.09597 -1.09413 C 0.63532 1.07771 -1.11286 C 0.63399 1.07509 -1.11237 C 1.41654 2.35561 -0.82661 C 1.45492 2.32759 -0.88688 C 1.45204 2.32631 -0.88826 C 2.71679 2.31048 -0.52912 C 2.75669 2.26444 -0.59923 C 2.75412 2.26527 -0.60161 C 3.52880 1.05488 -0.40969 C 3.54465 0.99645 -0.45224 C 3.54390 0.99853 -0.45369 C 4.52975 1.11539 0.75624 C 4.55525 1.06720 0.70481 C 4.55565 1.07236 0.70217 C 5.41765 -0.13312 0.82266 C 5.41869 -0.19674 0.79791 C 5.42077 -0.19034 0.79640 C 4.55485 -1.40073 0.85591 C 4.53126 -1.44563 0.86981 C 4.53492 -1.44017 0.87127 C 3.53213 -1.45333 -0.28497 C 3.49934 -1.50721 -0.26223 C 3.50199 -1.50488 -0.25965 C 2.64985 -0.19947 -0.28041 C 2.64203 -0.23627 -0.28387 C 2.64301 -0.23509 -0.28260 C 1.99677 -0.27515 -2.77848 C 1.96585 -0.36326 -2.77366 C 1.96508 -0.36725 -2.77158 C -0.39066 0.70897 0.02923 C -0.37412 0.73813 0.03052 C -0.37499 0.73600 0.03155 C -1.80188 1.33204 -0.08739 C -1.77984 1.37562 -0.08245 C -1.78129 1.37220 -0.08180 C -2.26669 2.08208 1.14593 C -2.21193 2.18348 1.12619 C -2.21396 2.17888 1.12743 
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C -3.57127 2.84115 0.98337 C -3.50580 2.95876 0.95048 C -3.50840 2.95325 0.95335 C -4.27346 3.22006 2.25881 C -4.21568 3.34863 2.21829 C -4.21361 3.34798 2.22237 C 0.68357 3.66234 -0.95971 C 0.74708 3.64486 -1.04903 C 0.74221 3.64248 -1.05084 C 6.38381 -0.07565 2.00454 C 6.39418 -0.12814 1.97150 C 6.39747 -0.11860 1.96879 C -0.76309 -1.63954 1.11920 C -0.79658 -1.55893 1.19033 C -0.80076 -1.55984 1.19258 C -0.62343 -0.79520 -0.15157 C -0.63633 -0.76479 -0.11206 C -0.63643 -0.76696 -0.11034 C -2.02128 -0.91066 -0.78946 C -2.04526 -0.86560 -0.73296 C -2.04381 -0.86858 -0.73499 C -2.65187 -2.19045 -0.19941 C -2.65998 -2.14710 -0.13428 C -2.65541 -2.15187 -0.13781 C -4.15728 -2.06953 0.05701 C -4.17843 -2.09149 0.00332 C -4.16941 -2.10749 -0.00958 C -2.20971 -3.44307 1.97217 C -2.29859 -3.27473 2.12328 C -2.30598 -3.27414 2.12401 H 0.03844 1.26453 -2.00435 H 0.04208 1.23396 -2.02071 H 0.04046 1.22937 -2.02038 H 3.25331 3.24541 -0.38234 H 3.31307 3.19198 -0.48256 H 3.30930 3.19372 -0.48638 H 4.12906 0.95700 -1.32578 H 4.13596 0.86235 -1.36959 H 4.13439 0.86383 -1.37147 H 5.15370 2.00889 0.65212 H 5.19613 1.94494 0.57307 H 5.19528 1.95070 0.56833 H 3.97961 1.22243 1.69930 H 4.01432 1.20979 1.64851 H 4.01556 1.21579 1.64621 H 6.01202 -0.16136 -0.09994 H 6.00578 -0.26072 -0.12755 H 6.00692 -0.25513 -0.12959 H 5.19777 -2.28544 0.81647 H 5.15627 -2.34372 0.84904 H 5.16099 -2.33754 0.85138 H 2.92326 -2.35374 -0.18637 H 2.87346 -2.39236 -0.13590 H 2.87738 -2.39062 -0.13136 H 4.06007 -1.53300 -1.24024 H 4.01828 -1.62204 -1.21887 H 4.02017 -1.62055 -1.21660 H 2.17350 -0.14775 0.70554 H 2.17490 -0.14942 0.70406 H 2.17659 -0.14718 0.70561 H 0.04364 0.91348 1.00722 H 0.07527 0.95798 0.99836 H 0.07452 0.95686 0.99911 H -1.86373 1.98404 -0.95952 H -1.85002 1.99205 -0.97995 H -1.85116 1.98964 -0.97869 H -2.33801 1.40608 2.00177 H -2.28036 1.54375 2.00932 H -2.28169 1.53855 2.01024 H -1.51579 2.83332 1.41682 H -1.44579 2.93361 1.35412 H -1.44828 2.92931 1.35596 H -2.47706 -3.01254 -0.90027 H -2.40769 -2.98310 -0.79635 H -2.39794 -2.98567 -0.79969 H 4.02445 -1.44285 1.81519 H 4.00710 -1.45234 1.83343 H 4.01172 -1.44592 1.83542 H -4.57520 -3.05281 0.27303 H -4.55621 -3.00917 0.45847 H -4.54035 -3.03345 0.43877 H -4.34452 -1.41989 0.91399 H -4.47692 -1.24741 0.62266 H -4.47969 -1.26443 0.61035 H -2.84565 -1.11596 -2.53074 H -2.94171 -1.00234 -2.42454 H -2.93550 -1.04364 -2.42361 H -4.76282 -0.61865 -1.09288 H -4.85694 -2.75293 -1.71821 H -5.59678 -1.73742 -1.31219 H 1.15721 -0.25074 -3.47622 H 1.12074 -0.34107 -3.46477 H 2.49011 -1.31139 -2.91458 H 2.65918 0.55508 -3.02537 H 2.64153 0.44752 -3.04785 H 1.11951 -0.34690 -3.46217 H 2.54014 -1.20537 -2.94239 H 2.49030 -1.30754 -2.91791 H 2.63998 0.44355 -3.04761 H -3.56678 3.64030 2.97840 H -5.01207 4.06192 2.01218 H -5.00966 4.06176 2.01665 H -4.69051 2.31640 2.71433 H -3.51091 3.76676 2.94117 H -3.50609 3.76719 2.94189 H -5.07694 3.92793 2.06182 H -4.64239 2.45007 2.67493 H -4.64026 2.45141 2.68299 H -0.13676 3.74577 -0.24140 H -0.06256 3.76541 -0.32394 H 1.43166 4.47868 -0.92432 H 1.35519 4.50715 -0.79920 H 1.43739 4.48004 -0.92049 H 0.28519 3.72120 -2.04261 H 0.23825 3.76201 -1.95493 H 0.29174 3.72526 -2.04146 H -0.06641 3.76278 -0.32454 H 7.01912 0.81295 1.95603 H 7.03002 -1.01685 2.01058 H 7.03443 -1.00646 2.00864 H 7.03771 -0.95178 2.02474 H 5.85807 -0.06094 2.92316 H 5.86235 -0.05044 2.92094 H 5.84013 -0.04472 2.95377 H 7.04734 0.74543 1.89527 H 7.04949 0.75563 1.89036 H -2.33479 -4.39657 1.45397 H -3.24110 -3.02015 2.61099 H -2.39265 -4.26160 1.66423 H -1.39579 -3.52894 2.68813 H -2.39662 -4.25922 1.65934 H -1.52697 -3.30044 2.88218 H -3.13069 -3.21181 2.51069 H -1.51217 -3.31050 2.87340 H -3.25510 -3.02314 2.60064 N -1.87636 -2.40096 1.01944 N -1.93725 -2.28472 1.12679 N -1.94127 -2.28615 1.12686 O 0.64922 -2.46007 -1.37024 O 0.58918 -2.48536 -1.29783 O 0.59359 -2.48895 -1.28912 O -2.70914 0.21724 -0.29672 O -2.70514 0.26676 -0.22292 O -2.70544 0.26301 -0.22423 O -4.01004 3.14639 -0.10796 O -3.92830 3.27023 -0.14542 O -3.93543 3.26026 -0.14208 O 0.02936 -1.63765 2.05092 O -0.00303 -1.54138 2.12079 O -0.01030 -1.54110 2.12550 O -1.96120 -0.91311 -2.19031 O -2.02527 -0.86734 -2.13475 O -2.02426 -0.87219 -2.13592 O -4.82857 -1.58321 -1.10744 O -4.76506 -1.89216 -1.28930 O -4.66131 -1.97152 -1.34933             Conformer 10 Conformer 11  Relative energy (kcal/mol) 1.62 Relative energy (kcal/mol) 1.68   Population (%) 1.5 Population (%) 1.3   C -0.49020 -1.26136 1.00801 C -0.49127 -1.25839 1.01136     C -1.47724 -0.14140 1.32118 C -1.47671 -0.13624 1.32180     C -0.65503 1.14435 1.02912 C -0.65297 1.14775 1.02611     C -1.49288 2.37088 0.74874 C -1.48956 2.37435 0.74218     C -2.79752 2.27760 0.48387 C -2.79425 2.28173 0.47729     C -3.57105 0.99448 0.41278 C -3.56924 0.99929 0.40985     C -4.60093 0.99673 -0.72939 C -4.59894 0.99920 -0.73252     C -5.44867 -0.28081 -0.74696 C -5.44808 -0.27747 -0.74637     C -4.54533 -1.51977 -0.77593 C -4.54614 -1.51753 -0.77128     C -3.49514 -1.51526 0.34090 C -3.49618 -1.51069 0.34573     C -2.65486 -0.23365 0.29044 C -2.65445 -0.23020 0.29137     C -1.94826 -0.22844 2.77463 C -1.94767 -0.21867 2.77552     C 0.34760 0.75945 -0.10541 C 0.34943 0.75852 -0.10719     C 1.74276 1.42555 -0.04744 C 1.74612 1.42179 -0.05057     C 2.15915 2.12770 -1.33401 C 2.16357 2.12265 -1.33760     C 3.56921 2.68884 -1.32934 C 3.57469 2.68094 -1.33179     C 3.97827 3.56413 -0.17377 C 3.98206 3.56067 -0.17891     C -0.79865 3.70264 0.83062 C -0.79400 3.70560 0.82072     C -6.44524 -0.28044 -1.90479 C -6.44434 -0.27967 -1.90446     C 0.82504 -1.59039 -1.13420 C 0.82258 -1.59346 -1.13109     C 0.63955 -0.72762 0.12050 C 0.63895 -0.72827 0.12248     
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C 2.04498 -0.76556 0.75608 C 2.04479 -0.76780 0.75767     C 2.68925 -2.06578 0.23393 C 2.68175 -2.07228 0.23781     C 4.20770 -1.98752 0.10617 C 4.19554 -2.00940 0.11445     C 2.37133 -3.32036 -1.96288 C 2.36562 -3.32711 -1.95876     H -0.05578 1.35395 1.92220 H -0.05368 1.35931 1.91873     H -3.36686 3.19122 0.32706 H -3.36254 3.19554 0.31778     H -4.14606 0.89846 1.34513 H -4.14453 0.90674 1.34239     H -5.25096 1.87188 -0.62911 H -5.24803 1.87536 -0.63505     H -4.07732 1.10030 -1.68779 H -4.07502 1.09926 -1.69113     H -6.01867 -0.30841 0.19090 H -6.01836 -0.30156 0.19142     H -5.15719 -2.42417 -0.70332 H -5.15902 -2.42102 -0.69594     H -2.85905 -2.39696 0.24546 H -2.86110 -2.39342 0.25325     H -3.99778 -1.59248 1.30990 H -3.99911 -1.58426 1.31487     H -2.20215 -0.18780 -0.70697 H -2.20165 -0.18794 -0.70617     H -0.11504 0.91706 -1.07900 H -0.11263 0.91456 -1.08132     H 1.79674 2.11748 0.79533 H 1.80166 2.11418 0.79183     H 2.06423 1.44741 -2.18138 H 2.06806 1.44179 -2.18444     H 1.47901 2.97080 -1.49622 H 1.48488 2.96671 -1.50060     H 2.44692 -2.86821 0.93986 H 2.43488 -2.87035 0.94615     H -4.03652 -1.56424 -1.74672 H -4.03719 -1.56565 -1.74183     H 4.60800 -2.92324 -0.28835 H 4.58441 -2.95460 -0.27424     H 4.49570 -1.17696 -0.56106 H 4.49587 -1.20076 -0.55433     H 2.93081 -0.80194 2.45769 H 2.93122 -0.83913 2.45673     H 4.89610 -2.53128 1.86514 H 5.61207 -1.55332 1.40181     H -1.09603 -0.16479 3.45425 H -2.62718 0.59981 3.01503     H -2.62867 0.58861 3.01638 H -2.46240 -1.15831 2.97444     H -2.46200 -1.16919 2.97085 H -1.09531 -0.15409 3.45489     H 4.12104 2.94862 0.71894 H 3.20423 4.29266 0.04857     H 3.19944 4.29319 0.05972 H 4.91860 4.06669 -0.40742     H 4.91283 4.07340 -0.40313 H 4.12017 2.94900 0.71719     H -1.50106 4.52236 0.67192 H 0.00143 3.79377 0.07551     H -0.32681 3.83948 1.80904 H -1.49533 4.52560 0.65873     H -0.00419 3.79399 0.08472 H -0.32317 3.84489 1.79929     H -7.10877 0.58739 -1.85816 H -7.10696 0.58901 -1.86079     H -7.06950 -1.17804 -1.89063 H -7.06956 -1.17657 -1.88761     H -5.92655 -0.25149 -2.86796 H -5.92536 -0.25438 -2.86758     H 3.31315 -3.07125 -2.45471 H 2.47011 -4.28540 -1.44427     H 2.48483 -4.27708 -1.44730 H 1.59067 -3.41144 -2.71681     H 1.59313 -3.41144 -2.71686 H 3.31160 -3.08303 -2.44516     N 1.98009 -2.28713 -1.02283 N 1.97638 -2.29244 -1.01961     O -0.56317 -2.40583 1.38743 O -0.56595 -2.40186 1.39333     O 2.68761 0.35148 0.18711 O 2.68898 0.34625 0.18392     O 4.33045 2.45518 -2.24859 O 4.33845 2.44132 -2.24744     O 0.03779 -1.64144 -2.06847 O 0.03511 -1.64435 -2.06509     O 2.01591 -0.68717 2.15436 O 2.02069 -0.68826 2.15529     O 4.77659 -1.69856 1.39027 O 4.67596 -1.78367 1.44633                  
Table S3. Isotropic shieldings of significantly populated conformers of compound 1, average 
isotropic shieldings over conformers, linearly scaled calculated chemical shifts, experimental 
chemical shifts, and errors. 
Atom Isotropic shieldings Chemical shifts 1 2 3 4 5 6 7 8 9 10 Average Calcd. Exp. Errors C-1 -37.0 -32.5 -36.8 -39.2 -33.0 -36.7 -38.8 -32.7 -36.5 -31.3 -36.1 215.1 213.2 1.9 C-2 125.4 126.7 125.4 125.8 126.8 125.7 125.8 126.8 126.0 126.8 125.8 58.9 56.4 2.5 C-3 128.8 129.0 128.6 128.9 129.0 126.5 128.8 128.9 126.4 128.2 128.6 56.2 54.8 1.4 C-4 46.0 45.3 47.0 45.5 45.2 46.8 46.3 46.0 47.7 46.2 46.0 135.9 133.2 2.7 C-5 51.9 52.4 51.0 52.4 52.5 51.4 51.5 51.5 50.4 51.6 51.9 130.2 128.0 2.2 C-6 146.3 146.4 146.3 146.6 146.4 146.5 146.5 146.2 146.5 146.5 146.4 39.1 37.7 1.4 C-7 143.5 143.4 143.6 143.5 143.4 143.7 143.5 143.4 143.7 143.5 143.5 41.8 42.9 -1.1 C-8 151.2 151.2 151.1 151.3 151.2 151.3 151.2 151.0 151.1 151.2 151.2 34.4 33.5 0.9 C-9 150.7 150.6 150.7 150.7 150.6 150.8 150.7 150.5 150.8 150.7 150.7 34.9 36.0 -1.1 C-10 160.2 160.3 160.2 160.4 160.3 160.3 160.5 160.4 160.3 160.4 160.3 25.7 25.8 -0.1 C-11 148.3 147.4 148.4 147.4 147.4 148.4 147.7 147.6 148.3 147.6 148.0 37.5 37.9 -0.4 C-12 172.7 172.8 172.7 172.8 172.7 172.2 172.9 172.8 172.1 172.4 172.7 13.7 14.2 -0.5 C-13 127.1 128.0 126.2 128.6 127.9 127.8 127.6 127.0 127.0 128.3 127.4 57.3 57.0 0.3 C-14 100.7 102.0 97.4 100.1 102.1 101.2 97.1 99.2 97.8 99.3 100.3 83.5 83.7 -0.2 C-15 137.2 137.1 133.2 137.0 137.1 136.8 133.0 133.1 132.7 137.4 136.3 48.8 50.3 -1.5 C-16 -24.2 -24.1 -24.1 -23.6 -24.0 -23.9 -24.5 -24.7 -23.7 -24.3 -24.1 203.5 206.8 -3.3 C-17 155.8 155.6 159.4 155.7 155.6 155.8 159.3 159.3 159.5 155.7 156.5 29.3 30.8 -1.5 C-18 161.6 161.7 161.5 161.7 161.7 161.7 161.6 161.5 161.6 161.8 161.6 24.4 23.2 1.2 C-19 164.4 164.4 164.5 164.5 164.4 164.5 164.5 164.5 164.5 164.4 164.4 21.7 22.5 -0.8 
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C-2' 14.2 11.8 14.8 12.8 11.7 14.1 13.6 12.4 14.8 13.5 13.5 167.2 170.2 -3.0 C-3' 107.0 106.2 107.1 104.1 106.0 105.9 104.3 106.2 106.2 106.3 106.3 77.8 75.3 2.5 C-4' 72.7 72.6 72.5 71.1 72.6 72.3 71.0 72.3 71.7 71.7 72.3 110.5 110.3 0.2 C-5' 114.7 118.1 115.1 115.9 119.7 114.5 116.1 120.1 114.7 116.6 116.0 68.4 68.3 0.1 C-6' 126.6 123.1 126.6 126.4 123.5 127.5 126.4 123.3 127.4 124.2 125.8 58.9 60.4 -1.5 C-7' 158.6 158.6 158.6 159.1 158.5 158.7 159.1 158.5 158.7 158.5 158.7 27.2 29.5 -2.3 H-3 29.69 29.68 29.63 29.67 29.68 29.87 29.62 29.62 29.82 29.63 29.69 2.25 2.32 -0.07 H-5 26.49 26.50 26.43 26.50 26.50 26.47 26.44 26.45 26.42 26.50 26.48 5.34 5.25 0.09 H-6 30.10 30.09 30.09 30.08 30.09 30.11 30.08 30.11 30.09 30.10 30.10 1.85 1.84 0.01 H-7eq 30.22 30.23 30.19 30.24 30.23 30.22 30.19 30.19 30.19 30.23 30.22 1.74 1.82 -0.08 H-7ax 31.18 31.20 31.17 31.19 31.20 31.17 31.19 31.21 31.17 31.20 31.18 0.80 0.75 0.05 H-8 30.57 30.58 30.55 30.57 30.58 30.57 30.56 30.56 30.55 30.58 30.57 1.40 1.44 -0.04 H-9eq 30.39 30.41 30.36 30.39 30.41 30.39 30.38 30.39 30.35 30.41 30.39 1.57 1.71 -0.14 H-9ax 31.08 31.15 31.09 31.13 31.15 31.08 31.13 31.15 31.09 31.14 31.11 0.88 0.83 0.05 H-10eq 30.78 30.70 30.79 30.73 30.71 30.77 30.75 30.74 30.77 30.71 30.75 1.22 1.29 -0.07 H-10ax 30.98 31.02 30.98 31.00 31.03 30.98 31.02 31.04 30.97 31.02 31.00 0.99 1.02 -0.03 H-11 30.20 30.49 30.25 30.42 30.48 30.18 30.38 30.48 30.27 30.47 30.31 1.65 1.48 0.17 H-13 29.31 29.40 29.30 29.31 29.40 29.30 29.29 29.39 29.28 29.34 29.33 2.59 2.67 -0.08 H-14 26.89 26.91 26.94 26.82 26.91 26.88 26.87 26.97 26.91 26.75 26.89 4.94 4.90 0.04 H-15a 29.06 29.17 29.65 29.10 29.16 29.07 29.65 29.73 29.68 29.10 29.21 2.70 2.70 0.00 H-15b 29.41 29.50 29.12 29.44 29.50 29.43 29.13 29.17 29.17 29.44 29.38 2.55 2.52 0.03 H-5' 28.60 28.64 28.57 28.49 28.52 28.56 28.49 28.49 28.53 28.61 28.57 3.32 3.44 -0.12 H-6'a 28.19 28.00 28.19 27.79 27.79 28.23 27.78 27.78 28.24 27.82 28.06 3.81 3.86 -0.05 H-6'b 28.06 27.85 28.08 28.28 27.84 27.88 28.27 27.84 27.88 28.31 28.03 3.84 3.79 0.05 H3-12 b 31.02 31.03 31.01 31.02 31.03 31.02 31.02 31.03 31.01 31.01 31.02 0.96 0.88 0.08 H3-17 b 29.75 29.76 29.65 29.75 29.76 29.75 29.61 29.63 29.65 29.75 29.73 2.20 2.09 0.11 H3-18 b 30.25 30.26 30.10 30.24 30.26 30.25 30.10 30.11 30.10 30.26 30.22 1.73 1.76 -0.03 H3-19 b 31.05 31.06 31.04 31.06 31.06 31.05 31.05 31.06 31.04 31.06 31.05 0.93 0.89 0.04 H3-7' b 29.03 29.06 29.04 29.06 29.05 29.02 29.06 29.06 29.03 29.05 29.04 2.87 2.86 0.01 
a Isotropic shieldings for 13C were calculated at the mPW1PW91/6-311+G(2d,p) level; isotropic shielding for 1H were 
calculated at the WP04/aug-cc-pVDZ/PCM(ACN) level. 
b Isotropic shieldings of methyl protons are the arithmetic mean of the shieldings of the three protons of each methyl group.
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Table S4. Isotropic shieldings of significantly populated conformers of compound 5'-epi-1, 
average isotropic shieldings over conformers, linearly scaled calculated chemical shifts, 
experimental chemical shifts, and errors. 
Atom Isotropic shieldings
a Chemical shifts 
1 2 3 4 5 6 7 8 9 10 11 Average Calcd. Exp. Errors C-1 -30.9 -30.6 -36.7 -30.4 -30.6 -36.9 -30.8 -31.4 -31.1 -31.2 -30.9 -32.0 211.7 213.2 -1.5 C-2 127.0 127.6 126.3 128.5 127.6 125.5 127.0 126.7 126.8 126.8 126.8 127.1 57.9 56.4 1.5 C-3 129.1 129.0 128.8 127.3 126.7 128.7 129.1 129.2 129.2 129.1 129.1 128.6 56.5 54.8 1.7 C-4 46.2 47.1 47.1 47.9 47.0 46.6 45.7 45.2 45.3 46.3 46.3 46.7 135.5 133.2 2.3 C-5 51.8 50.7 51.0 50.0 51.1 51.7 52.0 52.4 52.3 51.6 51.5 51.2 131.2 128.0 3.2 C-6 146.2 146.4 146.6 146.7 146.6 146.5 146.4 146.3 146.3 146.2 146.2 146.4 39.2 37.7 1.5 C-7 143.5 143.6 143.8 143.6 143.6 143.8 143.3 143.2 143.2 143.4 143.4 143.6 42.0 42.9 -0.9 C-8 151.2 151.1 151.1 151.1 151.3 151.1 151.2 151.2 151.1 151.0 151.0 151.2 34.7 33.5 1.2 C-9 150.4 150.5 150.8 150.5 150.5 150.8 150.4 150.4 150.4 150.3 150.3 150.5 35.3 36.0 -0.7 C-10 160.4 160.4 159.9 160.5 160.5 159.8 160.5 160.5 160.4 160.3 160.3 160.3 25.8 25.8 0.0 C-11 147.3 147.5 148.8 147.2 147.3 148.7 147.4 147.5 147.5 147.5 147.5 147.7 38.0 37.9 0.1 C-12 172.8 172.7 173.0 172.0 172.2 173.1 172.9 173.0 173.0 172.9 172.9 172.7 13.8 14.2 -0.4 C-13 129.0 127.2 127.4 128.2 129.9 129.4 128.6 128.2 128.2 127.4 127.4 128.3 56.7 57.0 -0.3 C-14 100.3 98.2 97.2 99.0 100.5 98.7 101.1 101.7 101.9 98.6 98.7 99.3 84.8 83.7 1.1 C-15 137.1 137.0 136.6 137.3 136.8 136.9 137.0 137.3 137.1 133.2 133.2 136.9 48.4 50.3 -1.9 C-16 -24.3 -28.0 -28.3 -28.6 -24.2 -23.5 -24.7 -23.9 -24.3 -24.8 -25.2 -26.1 205.9 206.8 -0.9 C-17 156.1 156.6 156.7 156.4 156.0 156.1 156.0 155.9 155.9 159.3 159.3 156.4 29.6 30.8 -1.2 C-18 161.7 161.8 161.9 161.7 161.8 161.8 161.6 161.6 161.7 161.5 161.5 161.7 24.4 23.2 1.2 C-19 164.3 164.4 164.5 164.5 164.4 164.4 164.4 164.4 164.4 164.5 164.4 164.4 21.9 22.5 -0.6 C-2' 12.9 13.4 13.9 13.5 13.0 13.4 12.7 11.7 11.6 12.5 12.3 13.1 168.0 170.2 -2.2 C-3' 106.7 106.6 104.9 106.1 105.8 104.7 106.6 106.6 106.8 106.8 107.0 106.1 78.2 75.3 2.9 C-4' 71.4 71.9 71.7 70.1 70.0 71.4 72.9 73.5 73.6 73.0 73.1 71.5 111.6 110.3 1.3 C-5' 119.0 116.7 114.5 118.3 120.9 117.1 119.8 119.3 121.7 119.4 121.6 118.0 66.7 68.3 -1.6 C-6' 127.5 128.0 127.9 127.9 126.9 127.1 121.7 123.3 123.4 123.3 123.3 127.0 58.0 60.4 -2.4 C-7' 160.3 159.9 159.7 159.6 160.1 160.2 159.9 160.0 160.0 159.9 159.9 160.0 26.1 29.5 -3.4 H-3 29.60 29.65 29.73 29.85 29.82 29.72 29.65 29.65 29.65 29.58 29.59 29.69 2.24 2.32 -0.08 H-5 26.47 26.45 26.46 26.42 26.44 26.47 26.48 26.50 26.50 26.46 26.46 26.46 5.35 5.25 0.10 H-6 30.09 30.10 30.13 30.10 30.09 30.14 30.12 30.13 30.12 30.13 30.13 30.11 1.84 1.84 0.00 H-7eq 30.22 30.21 30.20 30.21 30.21 30.20 30.21 30.21 30.21 30.20 30.21 30.21 1.74 1.82 -0.08 H-7ax 31.18 31.17 31.13 31.19 31.19 31.13 31.21 31.22 31.22 31.21 31.21 31.17 0.81 0.75 0.06 H-8 30.57 30.56 30.56 30.56 30.57 30.57 30.57 30.57 30.57 30.55 30.55 30.57 1.40 1.44 -0.04 H-9eq 30.37 30.34 30.36 30.33 30.37 30.38 30.38 30.38 30.38 30.34 30.33 30.36 1.60 1.71 -0.11 H-9ax 31.12 31.14 31.11 31.14 31.13 31.10 31.14 31.14 31.14 31.13 31.13 31.13 0.86 0.83 0.03 H-10eq 30.69 30.69 30.84 30.65 30.68 30.87 30.74 30.74 30.73 30.76 30.76 30.73 1.25 1.29 -0.04 H-10ax 31.00 30.98 30.97 30.98 30.99 30.98 31.03 31.03 31.03 31.01 31.01 30.99 0.99 1.02 -0.03 H-11 30.54 30.64 30.37 30.66 30.57 30.28 30.48 30.47 30.48 30.54 30.54 30.53 1.44 1.48 -0.04 H-13 29.35 29.30 29.30 29.30 29.35 29.33 29.39 29.40 29.40 29.35 29.35 29.33 2.59 2.67 -0.08 H-14 26.81 27.30 27.28 27.28 26.76 26.77 26.85 26.86 26.86 26.90 26.91 27.03 4.80 4.90 -0.10 H-15a 29.30 28.92 28.92 29.05 29.35 29.28 29.34 29.40 29.39 29.13 29.12 29.15 2.77 2.70 0.07 H-15b 29.02 29.87 29.84 29.88 29.04 29.01 29.03 29.08 29.08 29.67 29.67 29.44 2.49 2.52 -0.03 H-5' 28.37 28.41 28.65 28.47 28.44 28.61 28.10 28.20 28.14 28.19 28.12 28.42 3.46 3.44 0.02 H-6'a 27.92 27.95 27.87 27.85 27.82 27.85 28.06 27.84 27.83 27.85 27.83 27.90 3.97 3.86 0.11 H-6'b 28.20 28.22 28.24 28.23 28.21 28.24 28.27 28.23 28.01 28.26 28.05 28.21 3.66 3.79 -0.13 H3-12 b 31.06 31.05 31.05 31.06 31.05 31.07 31.06 31.06 31.06 31.04 31.04 31.06 0.93 0.88 0.05 H3-17 b 29.76 29.59 29.57 29.57 29.77 29.74 29.74 29.74 29.75 29.62 29.62 29.67 2.26 2.09 0.17 H3-18 b 30.26 30.12 30.12 30.11 30.25 30.27 30.24 30.24 30.24 30.08 30.08 30.19 1.77 1.76 0.01 H3-19 b 31.04 31.04 31.05 31.04 31.04 31.04 31.05 31.05 31.05 31.05 31.05 31.04 0.94 0.89 0.05 H3-7' b 28.96 28.94 28.95 28.93 28.96 28.99 29.14 29.15 29.14 29.14 29.13 28.98 2.93 2.86 0.07 
a Isotropic shieldings for 13C were calculated at the mPW1PW91/6-311+G(2d,p) level; isotropic shielding for 1H were 
calculated at the WP04/aug-cc-pVDZ/PCM(ACN) level. 
b Isotropic shieldings of methyl protons are the arithmetic mean of the shieldings of the three protons of each methyl group.   
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Table S5. Selected coupling constants of compounds 1 and 5'-epi-1 calculated at the B3LYP/6-
31G(d,p) level and relative intensities of the corresponding HMBC peaks. 
Compound 1 
Conformer Population H-5'/C-2' H-5'/C-3' H-5'/C-4' H-5'/C-6' H-5'/C-7' 1 38.7% 4.8 1.7 -5.3 4.0 0.9 2 13.0% 3.7 1.6 -4.7 -2.3 1.5 3 11.1% 4.8 1.7 -5.4 4.0 0.9 4 10.8% 2.7 1.2 -5.6 4.4 1.8 5 8.2% 3.8 1.7 -4.8 -3.1 1.5 6 7.5% 5.5 1.5 -5.9 3.2 0.8 7 4.1% 2.6 1.2 -5.7 4.4 1.8 8 3.3% 3.8 1.7 -4.9 -3.2 1.5 9 2.2% 5.6 1.5 -5.9 3.2 0.8 10 1.2% 4.6 2.2 -5.1 -2.9 1.4 Average coupling (Hz) 4.3 1.6 -5.3 2.2 1.2 
       Compound 5'-epi-1 
Conformer Population H-5'/C-2' H-5'/C-3' H-5'/C-4' H-5'/C-6' H-5'/C-7' 1 22.7% 0.4 -0.2 -2.7 3.8 0.0 2 21.0% 0.8 -0.3 -2.6 3.9 0.2 3 13.1% 0.9 -0.4 -2.2 2.9 0.2 4 12.4% 0.8 -0.4 -2.8 2.8 0.2 5 8.5% 0.4 -0.3 -2.7 3.0 0.1 6 8.4% 0.5 -0.3 -2.2 3.0 0.1 7 3.9% 0.7 -0.2 -2.4 -0.5 0.4 8 3.8% 0.2 -0.1 -2.2 -2.5 0.2 9 3.4% 0.2 -0.1 -2.3 -3.0 0.2 10 1.5% 0.2 -0.1 -2.1 -2.6 0.2 11 1.3% 0.2 -0.1 -2.1 -3.1 0.2 Average  coupling (Hz) 0.6 -0.3 -2.5 2.6 0.2 
       HMBC experiment (optimized for JCH = 8 Hz) 
 Relative peak intensity H-5'/C-2' H-5'/C-3' H-5'/C-4' H-5'/C-6' H-5'/C-7' 0.822 0.149 1.000 0.177 0.072         
Table S6. Bioactivity of Kupchan subextracts (KM, KC, KH) and C18 SPE fractions (F0-F10) 
obtained from Pyrenochaetopsis FVE-087 against cancer cell lines (A-375, A-549, HT-29, HCT-
116, MB-231) and HaCaT cells. The activity is expressed as % inhibition at 100 μg/mL test 
concentration. Reference compound: Doxorubicin. 
Sample A-375 A-549 HT-29 HCT-116 MB-231 HaCaT 
KM 0 0 0 0 0 0 KC 99 99 84 99 99 98 KH 69 35 99 34 0 64 
F0 0 0 0 0 0 0 F1 0 0 0 0 0 0 F2 0 0 0 0 0 0 F3 0 0 0 0 0 0 F4 0 0 0 0 23 0 F5 0 0 0 0 43 20 F6 43 0 0 0 33 45 F7 98 99 99 99 99 98 F8 95 49 74 67 68 78 F9 98 99 99 99 99 98 F10 27 0 0 28 66 25 Reference 88 73 63 90 84 91 
 
